Cutera, Inc. 232109108 US2321091082 07/15/2024 Election of Directors: Kevin Cameron DIRECTOR ELECTIONS ISSUER 10136.000000 36812.000000 FOR 10136.000000 FOR S000004450 Cutera, Inc. 232109108 US2321091082 07/15/2024 Election of Directors: Taylor Harris DIRECTOR ELECTIONS ISSUER 10136.000000 36812.000000 FOR 10136.000000 FOR S000004450 Cutera, Inc. 232109108 US2321091082 07/15/2024 Election of Directors: Keith Sullivan DIRECTOR ELECTIONS ISSUER 10136.000000 36812.000000 FOR 10136.000000 FOR S000004450 Cutera, Inc. 232109108 US2321091082 07/15/2024 Election of Directors: Nicholas Lewin DIRECTOR ELECTIONS ISSUER 10136.000000 36812.000000 FOR 10136.000000 FOR S000004450 Cutera, Inc. 232109108 US2321091082 07/15/2024 Election of Directors: Jeryl Hilleman DIRECTOR ELECTIONS ISSUER 10136.000000 36812.000000 FOR 10136.000000 FOR S000004450 Cutera, Inc. 232109108 US2321091082 07/15/2024 Ratification of BDO USA, P.C. as the Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 10136.000000 36812.000000 FOR 10136.000000 FOR S000004450 Cutera, Inc. 232109108 US2321091082 07/15/2024 Non-binding advisory vote on the compensation of Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 10136.000000 36812.000000 FOR 10136.000000 FOR S000004450 Cutera, Inc. 232109108 US2321091082 07/15/2024 Approval of the amendment and restatement of our 2019 Equity Incentive Plan to increase the total shares available for issuance under the 2019 Equity Incentive Plan by 2,395,275. COMPENSATION ISSUER 10136.000000 36812.000000 FOR 10136.000000 FOR S000004450 Cutera, Inc. 232109108 US2321091082 07/15/2024 Approval of the amendment of outstanding stock options to reduce the exercise price per share to the closing price on the date of the annual meeting. COMPENSATION ISSUER 10136.000000 36812.000000 AGAINST 10136.000000 AGAINST S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 To elect nine (9) directors to the Board of Directors to serve until our 2025 Annual Meeting. You may vote "FOR" up to nine (9) nominees in total. If you vote "FOR" at least one but no more than nine (9) nominees, your shares will only be voted "FOR" those nominees you have so marked. If you vote "FOR" more than nine (9) nominees, all of your votes on Proposal 1 will be invalid and none of your votes on Proposal 1 will be counted. ENHABIT NOMINEES: Jeffrey W. Bolton DIRECTOR ELECTIONS ISSUER 143814.000000 0 FOR 143814.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 To elect nine (9) directors to the Board of Directors to serve until our 2025 Annual Meeting. You may vote "FOR" up to nine (9) nominees in total. If you vote "FOR" at least one but no more than nine (9) nominees, your shares will only be voted "FOR" those nominees you have so marked. If you vote "FOR" more than nine (9) nominees, all of your votes on Proposal 1 will be invalid and none of your votes on Proposal 1 will be counted. ENHABIT NOMINEES: Tina L. Brown-Stevenson DIRECTOR ELECTIONS ISSUER 143814.000000 0 FOR 143814.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 To elect nine (9) directors to the Board of Directors to serve until our 2025 Annual Meeting. You may vote "FOR" up to nine (9) nominees in total. If you vote "FOR" at least one but no more than nine (9) nominees, your shares will only be voted "FOR" those nominees you have so marked. If you vote "FOR" more than nine (9) nominees, all of your votes on Proposal 1 will be invalid and none of your votes on Proposal 1 will be counted. ENHABIT NOMINEES: Charles M. Elson DIRECTOR ELECTIONS ISSUER 143814.000000 0 FOR 143814.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 To elect nine (9) directors to the Board of Directors to serve until our 2025 Annual Meeting. You may vote "FOR" up to nine (9) nominees in total. If you vote "FOR" at least one but no more than nine (9) nominees, your shares will only be voted "FOR" those nominees you have so marked. If you vote "FOR" more than nine (9) nominees, all of your votes on Proposal 1 will be invalid and none of your votes on Proposal 1 will be counted. ENHABIT NOMINEES: Erin P. Hoeflinger DIRECTOR ELECTIONS ISSUER 143814.000000 0 FOR 143814.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 To elect nine (9) directors to the Board of Directors to serve until our 2025 Annual Meeting. You may vote "FOR" up to nine (9) nominees in total. If you vote "FOR" at least one but no more than nine (9) nominees, your shares will only be voted "FOR" those nominees you have so marked. If you vote "FOR" more than nine (9) nominees, all of your votes on Proposal 1 will be invalid and none of your votes on Proposal 1 will be counted. ENHABIT NOMINEES: Barbara A. Jacobsmeyer DIRECTOR ELECTIONS ISSUER 143814.000000 0 FOR 143814.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 To elect nine (9) directors to the Board of Directors to serve until our 2025 Annual Meeting. You may vote "FOR" up to nine (9) nominees in total. If you vote "FOR" at least one but no more than nine (9) nominees, your shares will only be voted "FOR" those nominees you have so marked. If you vote "FOR" more than nine (9) nominees, all of your votes on Proposal 1 will be invalid and none of your votes on Proposal 1 will be counted. ENHABIT NOMINEES: Susan A. La Monica DIRECTOR ELECTIONS ISSUER 143814.000000 0 FOR 143814.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 To elect nine (9) directors to the Board of Directors to serve until our 2025 Annual Meeting. You may vote "FOR" up to nine (9) nominees in total. If you vote "FOR" at least one but no more than nine (9) nominees, your shares will only be voted "FOR" those nominees you have so marked. If you vote "FOR" more than nine (9) nominees, all of your votes on Proposal 1 will be invalid and none of your votes on Proposal 1 will be counted. ENHABIT NOMINEES: Stuart M. McGuigan DIRECTOR ELECTIONS ISSUER 143814.000000 0 FOR 143814.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 To elect nine (9) directors to the Board of Directors to serve until our 2025 Annual Meeting. You may vote "FOR" up to nine (9) nominees in total. If you vote "FOR" at least one but no more than nine (9) nominees, your shares will only be voted "FOR" those nominees you have so marked. If you vote "FOR" more than nine (9) nominees, all of your votes on Proposal 1 will be invalid and none of your votes on Proposal 1 will be counted. ENHABIT NOMINEES: Gregory S. Rush DIRECTOR ELECTIONS ISSUER 143814.000000 0 FOR 143814.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 To elect nine (9) directors to the Board of Directors to serve until our 2025 Annual Meeting. You may vote "FOR" up to nine (9) nominees in total. If you vote "FOR" at least one but no more than nine (9) nominees, your shares will only be voted "FOR" those nominees you have so marked. If you vote "FOR" more than nine (9) nominees, all of your votes on Proposal 1 will be invalid and none of your votes on Proposal 1 will be counted. ENHABIT NOMINEES: Barry P. Schochet DIRECTOR ELECTIONS ISSUER 143814.000000 0 FOR 143814.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 AREX NOMINEES OPPOSED BY ENHABIT: Megan Ambers DIRECTOR ELECTIONS SECURITY HOLDER 143814.000000 0 WITHHOLD 143814.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 AREX NOMINEES OPPOSED BY ENHABIT: James T. Corcoran DIRECTOR ELECTIONS SECURITY HOLDER 143814.000000 0 WITHHOLD 143814.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 AREX NOMINEES OPPOSED BY ENHABIT: Maxine Hochhauser DIRECTOR ELECTIONS SECURITY HOLDER 143814.000000 0 WITHHOLD 143814.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 AREX NOMINEES OPPOSED BY ENHABIT: Mark W. Ohlendorf DIRECTOR ELECTIONS SECURITY HOLDER 143814.000000 0 WITHHOLD 143814.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 AREX NOMINEES OPPOSED BY ENHABIT: Anna-Gene O'Neal DIRECTOR ELECTIONS SECURITY HOLDER 143814.000000 0 WITHHOLD 143814.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 AREX NOMINEES OPPOSED BY ENHABIT: Dr. Gregory S. Sheff DIRECTOR ELECTIONS SECURITY HOLDER 143814.000000 0 WITHHOLD 143814.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 AREX NOMINEES OPPOSED BY ENHABIT: Juan Vallarino DIRECTOR ELECTIONS SECURITY HOLDER 143814.000000 0 WITHHOLD 143814.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 To ratify the appointment by Enhabit's Audit & Finance Committee of PricewaterhouseCoopers LLP as Enhabit's independent registered public accounting firm. AUDIT-RELATED ISSUER 143814.000000 0 FOR 143814.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 To approve, on an advisory basis, the compensation of the named executive officers as disclosed in this proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 143814.000000 0 FOR 143814.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 To elect nine (9) directors to the Board of Directors to serve until the Company's 2025 annual meeting of stockholders: AREX NOMINEES: Megan Ambers DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 To elect nine (9) directors to the Board of Directors to serve until the Company's 2025 annual meeting of stockholders: AREX NOMINEES: James T. Corcoran DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 To elect nine (9) directors to the Board of Directors to serve until the Company's 2025 annual meeting of stockholders: AREX NOMINEES: Maxine Hochhauser DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 To elect nine (9) directors to the Board of Directors to serve until the Company's 2025 annual meeting of stockholders: AREX NOMINEES: Mark W. Ohlendorf DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 To elect nine (9) directors to the Board of Directors to serve until the Company's 2025 annual meeting of stockholders: AREX NOMINEES: Anna-Gene O'Neal DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 To elect nine (9) directors to the Board of Directors to serve until the Company's 2025 annual meeting of stockholders: AREX NOMINEES: Dr. Gregory S. Sheff DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 To elect nine (9) directors to the Board of Directors to serve until the Company's 2025 annual meeting of stockholders: AREX NOMINEES: Juan Vallarino DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 COMPANY NOMINEES UNOPPOSED BY AREX: Barbara A. Jacobsmeyer DIRECTOR ELECTIONS ISSUER 0.000000 0 S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 COMPANY NOMINEES UNOPPOSED BY AREX: Barry P. Schochet DIRECTOR ELECTIONS ISSUER 0.000000 0 S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 COMPANY NOMINEES OPPOSED BY AREX: Jeffrey W. Bolton DIRECTOR ELECTIONS ISSUER 0.000000 0 S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 COMPANY NOMINEES OPPOSED BY AREX: Tina L. Brown-Stevenson DIRECTOR ELECTIONS ISSUER 0.000000 0 S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 COMPANY NOMINEES OPPOSED BY AREX: Charles M. Elson DIRECTOR ELECTIONS ISSUER 0.000000 0 S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 COMPANY NOMINEES OPPOSED BY AREX: Erin P. Hoeflinger DIRECTOR ELECTIONS ISSUER 0.000000 0 S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 COMPANY NOMINEES OPPOSED BY AREX: Susan A. La Monica DIRECTOR ELECTIONS ISSUER 0.000000 0 S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 COMPANY NOMINEES OPPOSED BY AREX: Stuart M. McGuigan DIRECTOR ELECTIONS ISSUER 0.000000 0 S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 COMPANY NOMINEES OPPOSED BY AREX: Gregory S. Rush DIRECTOR ELECTIONS ISSUER 0.000000 0 S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 The Company's proposal to ratify the appointment by the Company's Audit & Finance Committee of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm. AUDIT-RELATED ISSUER 0.000000 0 S000004450 Enhabit, Inc. 29332G102 US29332G1022 07/25/2024 The Company's proposal to approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 0.000000 0 S000004450 Haemonetics Corporation 405024100 US4050241003 07/25/2024 Election of Directors: Robert E. Abernathy DIRECTOR ELECTIONS ISSUER 171951.000000 0 FOR 171951.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 07/25/2024 Election of Directors: Diane M. Bryant DIRECTOR ELECTIONS ISSUER 171951.000000 0 FOR 171951.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 07/25/2024 Election of Directors: Michael J. Coyle DIRECTOR ELECTIONS ISSUER 171951.000000 0 FOR 171951.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 07/25/2024 Election of Directors: Charles J. Dockendorff DIRECTOR ELECTIONS ISSUER 171951.000000 0 FOR 171951.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 07/25/2024 Election of Directors: Lloyd E. Johnson DIRECTOR ELECTIONS ISSUER 171951.000000 0 FOR 171951.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 07/25/2024 Election of Directors: Mark W. Kroll DIRECTOR ELECTIONS ISSUER 171951.000000 0 FOR 171951.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 07/25/2024 Election of Directors: Claire Pomeroy DIRECTOR ELECTIONS ISSUER 171951.000000 0 FOR 171951.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 07/25/2024 Election of Directors: Christopher A. Simon DIRECTOR ELECTIONS ISSUER 171951.000000 0 FOR 171951.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 07/25/2024 Election of Directors: Ellen M. Zane DIRECTOR ELECTIONS ISSUER 171951.000000 0 FOR 171951.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 07/25/2024 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 171951.000000 0 FOR 171951.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 07/25/2024 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending March 29, 2025. AUDIT-RELATED ISSUER 171951.000000 0 FOR 171951.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 07/25/2024 To elect four nominees for director named below to hold office until the 2027 Annual General Meeting of Shareholders: Laura J. Hamill DIRECTOR ELECTIONS ISSUER 202084.000000 0 FOR 202084.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 07/25/2024 To elect four nominees for director named below to hold office until the 2027 Annual General Meeting of Shareholders: Patrick Kennedy DIRECTOR ELECTIONS ISSUER 202084.000000 0 FOR 202084.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 07/25/2024 To elect four nominees for director named below to hold office until the 2027 Annual General Meeting of Shareholders: Kenneth W. O'Keefe DIRECTOR ELECTIONS ISSUER 202084.000000 0 FOR 202084.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 07/25/2024 To elect four nominees for director named below to hold office until the 2027 Annual General Meeting of Shareholders: Mark D. Smith, M.D. DIRECTOR ELECTIONS ISSUER 202084.000000 0 FOR 202084.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 07/25/2024 To ratify, on a non-binding advisory basis, the appointment of KPMG as the independent auditors of Jazz Pharmaceuticals plc for the fiscal year ending December 31, 2024 and to authorize, in a binding vote, the Board of Directors, acting through the audit committee, to determine KPMG's remuneration. AUDIT-RELATED ISSUER 202084.000000 0 FOR 202084.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 07/25/2024 To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 202084.000000 0 FOR 202084.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 07/25/2024 To indicate, on a non-binding advisory basis, the preferred frequency of the advisory vote on the compensation of Jazz Pharmaceuticals plc's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 202084.000000 0 ONE YEAR 202084.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 07/25/2024 To grant the Board of Directors authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders pursuant to the statutory pre-emption right that would otherwise apply. CAPITAL STRUCTURE ISSUER 202084.000000 0 FOR 202084.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 07/25/2024 To approve any motion to adjourn the Annual General Meeting, or any adjournments thereof, to another time and place to solicit additional proxies if there are insufficient votes at the time of the Annual General Meeting to approve Proposal 5. CORPORATE GOVERNANCE ISSUER 202084.000000 0 FOR 202084.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Richard H. Carmona, M.D. DIRECTOR ELECTIONS ISSUER 443400.000000 0 FOR 443400.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Dominic J. Caruso DIRECTOR ELECTIONS ISSUER 443400.000000 0 FOR 443400.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: W. Roy Dunbar DIRECTOR ELECTIONS ISSUER 443400.000000 0 FOR 443400.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Deborah Dunsire, M.D. DIRECTOR ELECTIONS ISSUER 443400.000000 0 FOR 443400.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: James H. Hinton DIRECTOR ELECTIONS ISSUER 443400.000000 0 FOR 443400.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Donald R. Knauss DIRECTOR ELECTIONS ISSUER 443400.000000 0 FOR 443400.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Bradley E. Lerman DIRECTOR ELECTIONS ISSUER 443400.000000 0 FOR 443400.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Maria N. Martinez DIRECTOR ELECTIONS ISSUER 443400.000000 0 FOR 443400.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Kevin M. Ozan DIRECTOR ELECTIONS ISSUER 443400.000000 0 FOR 443400.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Brian S. Tyler DIRECTOR ELECTIONS ISSUER 443400.000000 0 FOR 443400.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Kathleen Wilson-Thompson DIRECTOR ELECTIONS ISSUER 443400.000000 0 FOR 443400.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2025 AUDIT-RELATED ISSUER 443400.000000 0 FOR 443400.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Advisory vote on Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 443400.000000 0 FOR 443400.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Approve Amendment to Certificate of Incorporation to Provide for Officer Exculpation CORPORATE GOVERNANCE ISSUER 443400.000000 0 FOR 443400.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Shareholder Proposal on Independent Board Chairman CORPORATE GOVERNANCE SECURITY HOLDER 443400.000000 0 AGAINST 443400.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Shareholder Proposal on Report on Risks of State Policies Restricting Reproductive Health Care OTHER SOCIAL ISSUES SECURITY HOLDER 443400.000000 0 AGAINST 443400.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 08/01/2024 Election of Directors: Roderick de Greef DIRECTOR ELECTIONS ISSUER 122529.000000 0 FOR 122529.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 08/01/2024 Election of Directors: Joydeep Goswami DIRECTOR ELECTIONS ISSUER 122529.000000 0 FOR 122529.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 08/01/2024 Election of Directors: Amy DuRoss DIRECTOR ELECTIONS ISSUER 122529.000000 0 FOR 122529.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 08/01/2024 Election of Directors: Rachel Ellingson DIRECTOR ELECTIONS ISSUER 122529.000000 0 FOR 122529.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 08/01/2024 Election of Directors: Timothy L. Moore DIRECTOR ELECTIONS ISSUER 122529.000000 0 FOR 122529.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 08/01/2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 122529.000000 0 FOR 122529.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 08/01/2024 To ratify the appointment by the Board of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 122529.000000 0 FOR 122529.000000 FOR S000004450 CorVel Corporation 221006109 US2210061097 08/01/2024 To elect six directors, each to serve until the 2025 annual meeting of stockholders or until his or her successor has been duly elected and qualified: V. Gordon Clemons DIRECTOR ELECTIONS ISSUER 31646.000000 0 FOR 31646.000000 FOR S000004450 CorVel Corporation 221006109 US2210061097 08/01/2024 To elect six directors, each to serve until the 2025 annual meeting of stockholders or until his or her successor has been duly elected and qualified: Joanna M. Burkey DIRECTOR ELECTIONS ISSUER 31646.000000 0 FOR 31646.000000 FOR S000004450 CorVel Corporation 221006109 US2210061097 08/01/2024 To elect six directors, each to serve until the 2025 annual meeting of stockholders or until his or her successor has been duly elected and qualified: Steven J. Hamerslag DIRECTOR ELECTIONS ISSUER 31646.000000 0 FOR 31646.000000 FOR S000004450 CorVel Corporation 221006109 US2210061097 08/01/2024 To elect six directors, each to serve until the 2025 annual meeting of stockholders or until his or her successor has been duly elected and qualified: Alan R. Hoops DIRECTOR ELECTIONS ISSUER 31646.000000 0 FOR 31646.000000 FOR S000004450 CorVel Corporation 221006109 US2210061097 08/01/2024 To elect six directors, each to serve until the 2025 annual meeting of stockholders or until his or her successor has been duly elected and qualified: R. Judd Jessup DIRECTOR ELECTIONS ISSUER 31646.000000 0 WITHHOLD 31646.000000 AGAINST S000004450 CorVel Corporation 221006109 US2210061097 08/01/2024 To elect six directors, each to serve until the 2025 annual meeting of stockholders or until his or her successor has been duly elected and qualified: Jeffrey J. Michael DIRECTOR ELECTIONS ISSUER 31646.000000 0 FOR 31646.000000 FOR S000004450 CorVel Corporation 221006109 US2210061097 08/01/2024 To ratify the appointment of Haskell & White LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2025. AUDIT-RELATED ISSUER 31646.000000 0 FOR 31646.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 08/01/2024 Re-election of Directors: Dr. Esther M. Alegria DIRECTOR ELECTIONS ISSUER 333620.000000 0 FOR 333620.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 08/01/2024 Re-election of Directors: Richard C. Breeden DIRECTOR ELECTIONS ISSUER 333620.000000 0 FOR 333620.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 08/01/2024 Re-election of Directors: Daniel A. Carestio DIRECTOR ELECTIONS ISSUER 333620.000000 0 FOR 333620.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 08/01/2024 Re-election of Directors: Cynthia L. Feldmann DIRECTOR ELECTIONS ISSUER 333620.000000 0 FOR 333620.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 08/01/2024 Re-election of Directors: Christopher S. Holland DIRECTOR ELECTIONS ISSUER 333620.000000 0 FOR 333620.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 08/01/2024 Re-election of Directors: Dr. Jacqueline B. Kosecoff DIRECTOR ELECTIONS ISSUER 333620.000000 0 FOR 333620.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 08/01/2024 Re-election of Directors: Paul E. Martin DIRECTOR ELECTIONS ISSUER 333620.000000 0 FOR 333620.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 08/01/2024 Re-election of Directors: Dr. Nirav R. Shah DIRECTOR ELECTIONS ISSUER 333620.000000 0 FOR 333620.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 08/01/2024 Re-election of Directors: Dr. Mohsen M. Sohi DIRECTOR ELECTIONS ISSUER 333620.000000 0 FOR 333620.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 08/01/2024 Re-election of Directors: Dr. Richard M. Steeves DIRECTOR ELECTIONS ISSUER 333620.000000 0 FOR 333620.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 08/01/2024 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending March 31, 2025. AUDIT-RELATED ISSUER 333620.000000 0 FOR 333620.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 08/01/2024 To appoint Ernst & Young Chartered Accountants as the Company's statutory auditor under Irish law to hold office until the conclusion of the Company's next annual general meeting. AUDIT-RELATED ISSUER 333620.000000 0 FOR 333620.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 08/01/2024 To authorize the Board of Directors of the Company or the Audit Committee of the Board of Directors to determine the remuneration of Ernst & Young Chartered Accountants as the Company's statutory auditor under Irish law. AUDIT-RELATED ISSUER 333620.000000 0 FOR 333620.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 08/01/2024 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed pursuant to the disclosure rules of the U.S. Securities and Exchange Commission, including the compensation discussion and analysis and the tabular and narrative disclosure contained in the Company's proxy statement dated June 12, 2024. SECTION 14A SAY-ON-PAY VOTES ISSUER 333620.000000 0 FOR 333620.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 08/01/2024 To approve a proposal renewing the Board of Director's authority to issue shares under Irish law. CAPITAL STRUCTURE ISSUER 333620.000000 0 FOR 333620.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 08/01/2024 To approve a proposal renewing the Board of Director's authority to opt-out of statutory pre-emption rights under Irish law. CAPITAL STRUCTURE ISSUER 333620.000000 0 FOR 333620.000000 FOR S000004450 Accolade, Inc. 00437E102 US00437E1029 08/06/2024 Election of Directors: Jeffrey Jordan DIRECTOR ELECTIONS ISSUER 236567.000000 0 FOR 236567.000000 FOR S000004450 Accolade, Inc. 00437E102 US00437E1029 08/06/2024 Election of Directors: Cindy Kent DIRECTOR ELECTIONS ISSUER 236567.000000 0 FOR 236567.000000 FOR S000004450 Accolade, Inc. 00437E102 US00437E1029 08/06/2024 Election of Directors: Michael Hilton DIRECTOR ELECTIONS ISSUER 236567.000000 0 FOR 236567.000000 FOR S000004450 Accolade, Inc. 00437E102 US00437E1029 08/06/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement in accordance with SEC rules. SECTION 14A SAY-ON-PAY VOTES ISSUER 236567.000000 0 FOR 236567.000000 FOR S000004450 Accolade, Inc. 00437E102 US00437E1029 08/06/2024 To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending February 28, 2025. AUDIT-RELATED ISSUER 236567.000000 0 FOR 236567.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/06/2024 To elect seven directors to serve until the 2025 Annual Meeting of Stockholders: Ronald M. Lombardi DIRECTOR ELECTIONS ISSUER 167606.000000 0 FOR 167606.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/06/2024 To elect seven directors to serve until the 2025 Annual Meeting of Stockholders: John E. Byom DIRECTOR ELECTIONS ISSUER 167606.000000 0 FOR 167606.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/06/2024 To elect seven directors to serve until the 2025 Annual Meeting of Stockholders: Celeste A. Clark DIRECTOR ELECTIONS ISSUER 167606.000000 0 FOR 167606.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/06/2024 To elect seven directors to serve until the 2025 Annual Meeting of Stockholders: James C. D'Arecca DIRECTOR ELECTIONS ISSUER 167606.000000 0 FOR 167606.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/06/2024 To elect seven directors to serve until the 2025 Annual Meeting of Stockholders: Sheila A. Hopkins DIRECTOR ELECTIONS ISSUER 167606.000000 0 FOR 167606.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/06/2024 To elect seven directors to serve until the 2025 Annual Meeting of Stockholders: John F. Kelly DIRECTOR ELECTIONS ISSUER 167606.000000 0 FOR 167606.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/06/2024 To elect seven directors to serve until the 2025 Annual Meeting of Stockholders: Dawn M. Zier DIRECTOR ELECTIONS ISSUER 167606.000000 0 FOR 167606.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/06/2024 To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Prestige Consumer Healthcare Inc. for the fiscal year ending March 31, 2025. AUDIT-RELATED ISSUER 167606.000000 0 FOR 167606.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/06/2024 Say on Pay - An advisory vote on the resolution to approve the compensation of Prestige Consumer Healthcare Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 167606.000000 0 FOR 167606.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/06/2024 To approve the Amendments to our Amended and Restated Certificate of Incorporation. CORPORATE GOVERNANCE ISSUER 167606.000000 0 FOR 167606.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/06/2024 The election of the nominees for director: Paul B. Bolno, M.D., MBA DIRECTOR ELECTIONS ISSUER 267605.000000 0 FOR 267605.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/06/2024 The election of the nominees for director: Mark H. N. Corrigan, M.D. DIRECTOR ELECTIONS ISSUER 267605.000000 0 FOR 267605.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/06/2024 The election of the nominees for director: Christian Henry DIRECTOR ELECTIONS ISSUER 267605.000000 0 AGAINST 267605.000000 AGAINST S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/06/2024 The election of the nominees for director: Peter Kolchinsky, Ph.D. DIRECTOR ELECTIONS ISSUER 267605.000000 0 FOR 267605.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/06/2024 The election of the nominees for director: Adrian Rawcliffe DIRECTOR ELECTIONS ISSUER 267605.000000 0 FOR 267605.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/06/2024 The election of the nominees for director: Ken Takanashi DIRECTOR ELECTIONS ISSUER 267605.000000 0 FOR 267605.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/06/2024 The election of the nominees for director: Aik Na Tan DIRECTOR ELECTIONS ISSUER 267605.000000 0 FOR 267605.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/06/2024 The election of the nominees for director: Gregory L. Verdine, Ph.D. DIRECTOR ELECTIONS ISSUER 267605.000000 0 FOR 267605.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/06/2024 The election of the nominees for director: Heidi L. Wagner, J.D. DIRECTOR ELECTIONS ISSUER 267605.000000 0 FOR 267605.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/06/2024 To approve the re-appointment of KPMG LLP to serve as our independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2024, and to authorize the Audit Committee of the Board of Directors to fix KPMG LLP's remuneration for services provided through the date of our 2025 Annual General Meeting of Shareholders AUDIT-RELATED ISSUER 267605.000000 0 FOR 267605.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/06/2024 To approve our payment of cash and equity-based compensation to non-employee directors for service on the Board of Directors and its committees, in the manner and on the basis set forth under "Proposal 3: Non-Employee Directors' Compensation" in the proxy statement COMPENSATION ISSUER 267605.000000 0 FOR 267605.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/06/2024 To approve a proposed amendment to our 2021 Equity Incentive Plan, as amended, in the manner and on the basis as set forth under "Proposal 4: Approval of an Amendment to the 2021 Equity Incentive Plan, as amended" in the proxy statement COMPENSATION ISSUER 267605.000000 0 FOR 267605.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/06/2024 To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd. CAPITAL STRUCTURE ISSUER 267605.000000 0 FOR 267605.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/06/2024 To approve, by a non-binding advisory vote, the compensation of our named executive officers as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 267605.000000 0 FOR 267605.000000 FOR S000004450 Immunovant, Inc. 45258J102 US45258J1025 08/12/2024 To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Peter Salzmann, M.D., M.B.A. DIRECTOR ELECTIONS ISSUER 170907.000000 0 WITHHOLD 170907.000000 AGAINST S000004450 Immunovant, Inc. 45258J102 US45258J1025 08/12/2024 To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified: George Migausky DIRECTOR ELECTIONS ISSUER 170907.000000 0 FOR 170907.000000 FOR S000004450 Immunovant, Inc. 45258J102 US45258J1025 08/12/2024 To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Douglas Hughes DIRECTOR ELECTIONS ISSUER 170907.000000 0 FOR 170907.000000 FOR S000004450 Immunovant, Inc. 45258J102 US45258J1025 08/12/2024 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2025. AUDIT-RELATED ISSUER 170907.000000 0 FOR 170907.000000 FOR S000004450 Immunovant, Inc. 45258J102 US45258J1025 08/12/2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 170907.000000 0 FOR 170907.000000 FOR S000004450 Surmodics, Inc. 868873100 US8688731004 08/13/2024 Approve the Merger Agreement, dated as of May 28, 2024, by and among Surmodics, Inc., BCE Parent, LLC, and BCE Merger Sub, Inc., pursuant to which Surmodics, Inc. would be acquired by way of a merger and become a wholly owned subsidiary of BCE Parent, LLC; EXTRAORDINARY TRANSACTIONS ISSUER 47550.000000 0 FOR 47550.000000 FOR S000004450 Surmodics, Inc. 868873100 US8688731004 08/13/2024 Approve, in a non-binding advisory vote, certain compensation that may be paid or become payable to our named executive officers in connection with the merger; and SECTION 14A SAY-ON-PAY VOTES ISSUER 47550.000000 0 FOR 47550.000000 FOR S000004450 Surmodics, Inc. 868873100 US8688731004 08/13/2024 Approve one or more adjournments of the special meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to approve the merger agreement at the time of the special meeting. CORPORATE GOVERNANCE ISSUER 47550.000000 0 FOR 47550.000000 FOR S000004450 Atrion Corporation 049904105 US0499041053 08/19/2024 To adopt the Agreement and Plan of Merger, dated May 28, 2024 (such agreement, as it may be amended, modified or supplemented from time to time, the "Merger Agreement"), by and among Nordson Corporation, an Ohio corporation ("Nordson"), Alpha Medical Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Nordson ("Merger Sub"), and Atrion. Upon the terms and subject to the conditions of the Merger Agreement, Nordson will acquire Atrion via a merger of Merger Sub with and into Atrion, with the separate corporate existence of Merger Sub thereupon ceasing and Atrion continuing as the surviving corporation and a wholly owned subsidiary of Nordson. EXTRAORDINARY TRANSACTIONS ISSUER 4773.000000 0 FOR 4773.000000 FOR S000004450 Atrion Corporation 049904105 US0499041053 08/19/2024 To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Atrion's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 4773.000000 0 FOR 4773.000000 FOR S000004450 Atrion Corporation 049904105 US0499041053 08/19/2024 To adjourn the special meeting of the Atrion stockholders (the "Special Meeting") to a later date or dates, if necessary or appropriate, including to solicit additional proxies to approve the proposal to adopt the Merger Agreement if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting. CORPORATE GOVERNANCE ISSUER 4773.000000 0 FOR 4773.000000 FOR S000004450 23andMe Holding Co. 90138Q306 US90138Q3065 08/26/2024 Elect two Class III Director Nominees: Peter Taylor DIRECTOR ELECTIONS ISSUER 928766.000000 0 FOR 928766.000000 FOR S000004450 23andMe Holding Co. 90138Q306 US90138Q3065 08/26/2024 Elect two Class III Director Nominees: Anne Wojcicki DIRECTOR ELECTIONS ISSUER 928766.000000 0 FOR 928766.000000 FOR S000004450 23andMe Holding Co. 90138Q306 US90138Q3065 08/26/2024 An advisory vote to approve the Fiscal 2024 compensation of the Company's named executive officers ("Say-on-Pay" Vote). SECTION 14A SAY-ON-PAY VOTES ISSUER 928766.000000 0 FOR 928766.000000 FOR S000004450 23andMe Holding Co. 90138Q306 US90138Q3065 08/26/2024 Approve an amendment to the Company's Certificate of Incorporation to combine outstanding shares of the Company's Class A common stock and Class B common stock, respectively, into a lesser number of outstanding shares, or a "reverse stock split," by a ratio of not less than one-for-five and not more than one-for-thirty, with the exact ratio to be set within this range by the Company's Board of Directors in its sole discretion ("Reverse Stock Split" Vote). CAPITAL STRUCTURE ISSUER 928766.000000 0 FOR 928766.000000 FOR S000004450 23andMe Holding Co. 90138Q306 US90138Q3065 08/26/2024 Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2025. AUDIT-RELATED ISSUER 928766.000000 0 FOR 928766.000000 FOR S000004450 Doximity, Inc. 26622P107 US26622P1075 08/29/2024 To elect Class III Directors to serve until the annual meeting of stockholders to be held in 2027 or until his or her successor has been duly elected and qualified: Regina Benjamin, M.D. DIRECTOR ELECTIONS ISSUER 369927.000000 0 FOR 369927.000000 FOR S000004450 Doximity, Inc. 26622P107 US26622P1075 08/29/2024 To elect Class III Directors to serve until the annual meeting of stockholders to be held in 2027 or until his or her successor has been duly elected and qualified: Phoebe Yang DIRECTOR ELECTIONS ISSUER 369927.000000 0 FOR 369927.000000 FOR S000004450 Doximity, Inc. 26622P107 US26622P1075 08/29/2024 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending March 31, 2025. AUDIT-RELATED ISSUER 369927.000000 0 FOR 369927.000000 FOR S000004450 Doximity, Inc. 26622P107 US26622P1075 08/29/2024 To approve, on a non-binding advisory basis, the compensation paid to the Company's named executive officers for the fiscal year 2024. SECTION 14A SAY-ON-PAY VOTES ISSUER 369927.000000 0 FOR 369927.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/30/2024 Election of directors: J. Alltoft DIRECTOR ELECTIONS ISSUER 18180.000000 0 FOR 18180.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/30/2024 Election of directors: S. Ladiwala DIRECTOR ELECTIONS ISSUER 18180.000000 0 FOR 18180.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/30/2024 Election of directors: S. Hall DIRECTOR ELECTIONS ISSUER 18180.000000 0 FOR 18180.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/30/2024 Election of directors: T. Tripeny DIRECTOR ELECTIONS ISSUER 18180.000000 0 FOR 18180.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/30/2024 Election of directors: G. Owens DIRECTOR ELECTIONS ISSUER 18180.000000 0 FOR 18180.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/30/2024 Election of directors: J. Sullivan DIRECTOR ELECTIONS ISSUER 18180.000000 0 FOR 18180.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/30/2024 Election of directors: M. Capone DIRECTOR ELECTIONS ISSUER 18180.000000 0 FOR 18180.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/30/2024 To ratify the appointment of RSM US LLP as the Company's independent registered public accounting firm for the year ending March 31, 2025. AUDIT-RELATED ISSUER 18180.000000 0 FOR 18180.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/30/2024 To approve, on an advisory basis, the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 18180.000000 0 FOR 18180.000000 FOR S000004450 Nuvation Bio Inc. 67080N101 US67080N1019 09/03/2024 Election of Director: Min Cui, Ph.D. DIRECTOR ELECTIONS ISSUER 451611.000000 0 FOR 451611.000000 FOR S000004450 Nuvation Bio Inc. 67080N101 US67080N1019 09/03/2024 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm. AUDIT-RELATED ISSUER 451611.000000 0 FOR 451611.000000 FOR S000004450 Nuvation Bio Inc. 67080N101 US67080N1019 09/03/2024 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 451611.000000 0 FOR 451611.000000 FOR S000004450 Nuvation Bio Inc. 67080N101 US67080N1019 09/03/2024 To approve conversion of the Company's Series A Non-Voting Convertible Preferred Stock to the Company's Class A Common Stock. CAPITAL STRUCTURE ISSUER 451611.000000 0 FOR 451611.000000 FOR S000004450 Nuvation Bio Inc. 67080N101 US67080N1019 09/03/2024 To approve adjournment of the annual meeting, if necessary or appropriate, to solicit additional proxies. CORPORATE GOVERNANCE ISSUER 451611.000000 0 FOR 451611.000000 FOR S000004450 Replimune Group, Inc. 76029N106 US76029N1063 09/04/2024 Election of Directors: Sushil Patel DIRECTOR ELECTIONS ISSUER 144836.000000 0 FOR 144836.000000 FOR S000004450 Replimune Group, Inc. 76029N106 US76029N1063 09/04/2024 Election of Directors: Dieter Weinand DIRECTOR ELECTIONS ISSUER 144836.000000 0 FOR 144836.000000 FOR S000004450 Replimune Group, Inc. 76029N106 US76029N1063 09/04/2024 Election of Directors: Madhavan Balachandran DIRECTOR ELECTIONS ISSUER 144836.000000 0 FOR 144836.000000 FOR S000004450 Replimune Group, Inc. 76029N106 US76029N1063 09/04/2024 To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Replimune Group, Inc. for the fiscal year ending March 31, 2025. AUDIT-RELATED ISSUER 144836.000000 0 FOR 144836.000000 FOR S000004450 Replimune Group, Inc. 76029N106 US76029N1063 09/04/2024 To approve, on a non-binding advisory basis, the compensation of Replimune Group, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 144836.000000 0 FOR 144836.000000 FOR S000004450 Replimune Group, Inc. 76029N106 US76029N1063 09/04/2024 To approve, on a non-binding advisory basis, the preferred frequency of future advisory votes on the compensation of Replimune Group, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 144836.000000 0 ONE YEAR 144836.000000 FOR S000004450 Silk Road Medical, Inc. 82710M100 US82710M1009 09/05/2024 To adopt the Agreement and Plan of Merger, dated June 17, 2024 (as it may be amended, modified, supplemented or waived from time to time), by and among Silk Road, Boston Scientific Corporation and Seminole Merger Sub, Inc. (the "merger agreement" ). EXTRAORDINARY TRANSACTIONS ISSUER 124369.000000 0 FOR 124369.000000 FOR S000004450 Silk Road Medical, Inc. 82710M100 US82710M1009 09/05/2024 To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Silk Road to its named executive officers in connection with the merger contemplated by the merger agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 124369.000000 0 FOR 124369.000000 FOR S000004450 Silk Road Medical, Inc. 82710M100 US82710M1009 09/05/2024 To adjourn the Special Meating, from time to time, to a later date or dates, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes to adopt the merger agreement at the time of the Special Meeting. CORPORATE GOVERNANCE ISSUER 124369.000000 0 FOR 124369.000000 FOR S000004450 MultiPlan Corporation 62548M209 US62548M2098 09/09/2024 Approval of the Amendment of the Second Amended and Restated Certificate of Incorporation to Effect a Reverse Stock Split. CAPITAL STRUCTURE ISSUER 772654.000000 0 FOR 772654.000000 FOR S000004450 MultiPlan Corporation 62548M209 US62548M2098 09/09/2024 Approval of Adjournment of the Meeting to Solicit Additional Proxies in Favor of the Reverse Stock Split Proposal. CORPORATE GOVERNANCE ISSUER 772654.000000 0 FOR 772654.000000 FOR S000004450 Roivant Sciences Ltd. G76279101 BMG762791017 09/10/2024 To elect the Board of Directors' three nominees for Class III Director to serve for a three-year term: Ilan Oren DIRECTOR ELECTIONS ISSUER 1218967.000000 0 FOR 1218967.000000 FOR S000004450 Roivant Sciences Ltd. G76279101 BMG762791017 09/10/2024 To elect the Board of Directors' three nominees for Class III Director to serve for a three-year term: James C. Momtazee DIRECTOR ELECTIONS ISSUER 1218967.000000 0 FOR 1218967.000000 FOR S000004450 Roivant Sciences Ltd. G76279101 BMG762791017 09/10/2024 To elect the Board of Directors' three nominees for Class III Director to serve for a three-year term: Mayukh Sukhatme DIRECTOR ELECTIONS ISSUER 1218967.000000 0 FOR 1218967.000000 FOR S000004450 Roivant Sciences Ltd. G76279101 BMG762791017 09/10/2024 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Roivant's independent registered public accounting firm for Roivant's fiscal year ending March 31, 2025, to appoint Ernst & Young LLP as auditor for statutory purposes under the Bermuda Companies Act 1981, as amended, for Roivant's fiscal year ending March 31, 2025, and to authorize the Board of Directors, through the Audit Committee, to set the remuneration for Ernst & Young LLP as Roivant's auditor for Roivant's fiscal year ending March 31, 2025. AUDIT-RELATED ISSUER 1218967.000000 0 FOR 1218967.000000 FOR S000004450 Roivant Sciences Ltd. G76279101 BMG762791017 09/10/2024 To cast a non-binding, advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1218967.000000 0 FOR 1218967.000000 FOR S000004450 Roivant Sciences Ltd. G76279101 BMG762791017 09/10/2024 To cast a non-binding, advisory vote on the frequency of future non-binding, advisory votes to approve the compensation of our named executive officers every: SECTION 14A SAY-ON-PAY VOTES ISSUER 1218967.000000 0 ONE YEAR 1218967.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/16/2024 To elect nine directors to have terms expiring in 2025, and until their successors shall be elected and duly qualified: John D. Buck DIRECTOR ELECTIONS ISSUER 269964.000000 0 FOR 269964.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/16/2024 To elect nine directors to have terms expiring in 2025, and until their successors shall be elected and duly qualified: Meenu Agarwal DIRECTOR ELECTIONS ISSUER 269964.000000 0 FOR 269964.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/16/2024 To elect nine directors to have terms expiring in 2025, and until their successors shall be elected and duly qualified: Alex N. Blanco DIRECTOR ELECTIONS ISSUER 269964.000000 0 FOR 269964.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/16/2024 To elect nine directors to have terms expiring in 2025, and until their successors shall be elected and duly qualified: Jody H. Feragen DIRECTOR ELECTIONS ISSUER 269964.000000 0 FOR 269964.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/16/2024 To elect nine directors to have terms expiring in 2025, and until their successors shall be elected and duly qualified: Robert C. Frenzel DIRECTOR ELECTIONS ISSUER 269964.000000 0 FOR 269964.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/16/2024 To elect nine directors to have terms expiring in 2025, and until their successors shall be elected and duly qualified: Philip G.J. McKoy DIRECTOR ELECTIONS ISSUER 269964.000000 0 FOR 269964.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/16/2024 To elect nine directors to have terms expiring in 2025, and until their successors shall be elected and duly qualified: Neil A. Schrimsher DIRECTOR ELECTIONS ISSUER 269964.000000 0 FOR 269964.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/16/2024 To elect nine directors to have terms expiring in 2025, and until their successors shall be elected and duly qualified: Pamela J. Tomczik DIRECTOR ELECTIONS ISSUER 269964.000000 0 FOR 269964.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/16/2024 To elect nine directors to have terms expiring in 2025, and until their successors shall be elected and duly qualified: Donald J. Zurbay DIRECTOR ELECTIONS ISSUER 269964.000000 0 FOR 269964.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/16/2024 Advisory approval of executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 269964.000000 0 FOR 269964.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 09/16/2024 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending April 26, 2025. AUDIT-RELATED ISSUER 269964.000000 0 FOR 269964.000000 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 09/18/2024 Election of the Class I directors, each to serve for a three year term until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Stuart A. Arbuckle DIRECTOR ELECTIONS ISSUER 151232.000000 0 FOR 151232.000000 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 09/18/2024 Election of the Class I directors, each to serve for a three year term until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Christophe R. Jean DIRECTOR ELECTIONS ISSUER 151232.000000 0 FOR 151232.000000 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 09/18/2024 Election of the Class I directors, each to serve for a three year term until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Lynn A. Tetrault DIRECTOR ELECTIONS ISSUER 151232.000000 0 FOR 151232.000000 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 09/18/2024 Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 151232.000000 0 FOR 151232.000000 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 09/18/2024 Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 151232.000000 0 FOR 151232.000000 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 09/18/2024 Reapproval of the Rhythm Pharmaceuticals, Inc. 2017 Equity Incentive Plan. COMPENSATION ISSUER 151232.000000 0 FOR 151232.000000 FOR S000004450 Masimo Corporation 574795100 US5747951003 09/19/2024 To elect two Class II Directors, as named in this Proxy Statement Company Recommended Nominees: Christopher Chavez DIRECTOR ELECTIONS ISSUER 150648.000000 0 WITHHOLD 150648.000000 AGAINST S000004450 Masimo Corporation 574795100 US5747951003 09/19/2024 To elect two Class II Directors, as named in this Proxy Statement Company Recommended Nominees: Joe Kiani DIRECTOR ELECTIONS ISSUER 150648.000000 0 FOR 150648.000000 FOR S000004450 Masimo Corporation 574795100 US5747951003 09/19/2024 To elect two Class II Directors, as named in this Proxy Statement Politan Group Nominees OPPOSED by the Company: William Jellison DIRECTOR ELECTIONS SECURITY HOLDER 150648.000000 0 FOR 150648.000000 AGAINST S000004450 Masimo Corporation 574795100 US5747951003 09/19/2024 To elect two Class II Directors, as named in this Proxy Statement Politan Group Nominees OPPOSED by the Company: Darlene J.S. Solomon DIRECTOR ELECTIONS SECURITY HOLDER 150648.000000 0 WITHHOLD 150648.000000 FOR S000004450 Masimo Corporation 574795100 US5747951003 09/19/2024 To ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 28, 2024. AUDIT-RELATED ISSUER 150648.000000 0 FOR 150648.000000 FOR S000004450 Masimo Corporation 574795100 US5747951003 09/19/2024 To provide an advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 150648.000000 0 FOR 150648.000000 FOR S000004450 Masimo Corporation 574795100 US5747951003 09/19/2024 Politan Group Proposal to repeal any provision of, or amendment to, the Company's bylaws adopted by the Board without stockholder approval subsequent to April 20, 2023 and up to and including the date of the 2024 Annual Meeting. CORPORATE GOVERNANCE SECURITY HOLDER 150648.000000 0 FOR 150648.000000 AGAINST S000004450 Masimo Corporation 574795100 US5747951003 09/19/2024 Election of two nominees to serve as directors until the Company's 2025 annual meeting of stockholders and until their successors have been duly elected and qualified: POLITAN NOMINEES: William Jellison DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 S000004450 Masimo Corporation 574795100 US5747951003 09/19/2024 Election of two nominees to serve as directors until the Company's 2025 annual meeting of stockholders and until their successors have been duly elected and qualified: POLITAN NOMINEES: Darlene Solomon DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 S000004450 Masimo Corporation 574795100 US5747951003 09/19/2024 Election of two nominees to serve as directors until the Company's 2025 annual meeting of stockholders and until their successors have been duly elected and qualified: COMPANY NOMINEES OPPOSED BY POLITAN: Christopher G. Chavez DIRECTOR ELECTIONS ISSUER 0.000000 0 S000004450 Masimo Corporation 574795100 US5747951003 09/19/2024 Election of two nominees to serve as directors until the Company's 2025 annual meeting of stockholders and until their successors have been duly elected and qualified: COMPANY NOMINEES OPPOSED BY POLITAN: Joe Kiani DIRECTOR ELECTIONS ISSUER 0.000000 0 S000004450 Masimo Corporation 574795100 US5747951003 09/19/2024 To ratify the selection of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 28, 2024. AUDIT-RELATED ISSUER 0.000000 0 S000004450 Masimo Corporation 574795100 US5747951003 09/19/2024 An advisory vote to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 0.000000 0 S000004450 Masimo Corporation 574795100 US5747951003 09/19/2024 The Politan Parties' proposal to repeal any provision of, or amendment to, the Bylaws, adopted by the Board without Stockholder approval subsequent to April 20, 2023 and up to and including the date of the 2024 Annual Meeting. CORPORATE GOVERNANCE ISSUER 0.000000 0 S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/26/2024 Vote to elect the eight nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2025 Annual Meeting of Stockholders: Mitchel Sayare, Ph.D. DIRECTOR ELECTIONS ISSUER 237672.000000 0 FOR 237672.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/26/2024 Vote to elect the eight nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2025 Annual Meeting of Stockholders: Vipin K. Garg, Ph.D. DIRECTOR ELECTIONS ISSUER 237672.000000 0 FOR 237672.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/26/2024 Vote to elect the eight nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2025 Annual Meeting of Stockholders: John M. Gill DIRECTOR ELECTIONS ISSUER 237672.000000 0 FOR 237672.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/26/2024 Vote to elect the eight nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2025 Annual Meeting of Stockholders: Philip L. Hodges DIRECTOR ELECTIONS ISSUER 237672.000000 0 FOR 237672.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/26/2024 Vote to elect the eight nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2025 Annual Meeting of Stockholders: Diane Jorkasky, M.D. DIRECTOR ELECTIONS ISSUER 237672.000000 0 FOR 237672.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/26/2024 Vote to elect the eight nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2025 Annual Meeting of Stockholders: Wayne Pisano DIRECTOR ELECTIONS ISSUER 237672.000000 0 FOR 237672.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/26/2024 Vote to elect the eight nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2025 Annual Meeting of Stockholders: Klaus O. Schafer, M.D., MPH DIRECTOR ELECTIONS ISSUER 237672.000000 0 FOR 237672.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/26/2024 Vote to elect the eight nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2025 Annual Meeting of Stockholders: Catherine Sohn, Pharm D DIRECTOR ELECTIONS ISSUER 237672.000000 0 FOR 237672.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/26/2024 Vote to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED ISSUER 237672.000000 0 FOR 237672.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/26/2024 Hold an advisory vote on the compensation of the Company's named executive officers as disclosed in the attached Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 237672.000000 0 FOR 237672.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/26/2024 Approve the authorization to adjourn the Annual Meeting, if necessary or appropriate, to solicit additional proxies in favor of the foregoing proposals if there are not sufficient votes to approve the proposals. CORPORATE GOVERNANCE ISSUER 237672.000000 0 FOR 237672.000000 FOR S000004450 Seres Therapeutics, Inc. 81750R201 US81750R2013 09/26/2024 To approve the proposed sale (the "Transaction") of Seres' VOWST microbiome therapeutic business to Societe des Produits Nestle S.A. ("SPN") pursuant to the terms of the Asset Purchase Agreement, dated as of August 5, 2024, by and between Seres and SPN (the "Transaction Proposal"). EXTRAORDINARY TRANSACTIONS ISSUER 107902.000000 298000.000000 FOR 107902.000000 FOR S000004450 Seres Therapeutics, Inc. 81750R201 US81750R2013 09/26/2024 To approve, on a non-binding, advisory basis, certain compensation that will or may become payable to our named executive officers in connection with the Transaction. SECTION 14A SAY-ON-PAY VOTES ISSUER 107902.000000 298000.000000 FOR 107902.000000 FOR S000004450 Seres Therapeutics, Inc. 81750R201 US81750R2013 09/26/2024 To approve the adjournment of the special meeting to a later date or dates, if necessary, to solicit additional proxies if there are insufficient votes to adopt the Transaction Proposal at the time of the special meeting. CORPORATE GOVERNANCE ISSUER 107902.000000 298000.000000 FOR 107902.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 10/16/2024 Election of Directors: Esther M. Alegria, PhD DIRECTOR ELECTIONS ISSUER 212309.000000 0 FOR 212309.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 10/16/2024 Election of Directors: Joseph Carleone, PhD DIRECTOR ELECTIONS ISSUER 212309.000000 0 FOR 212309.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 10/16/2024 Election of Directors: Nicholas S. Green DIRECTOR ELECTIONS ISSUER 212309.000000 0 FOR 212309.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 10/16/2024 Election of Directors: Richard B. Hancock DIRECTOR ELECTIONS ISSUER 212309.000000 0 FOR 212309.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 10/16/2024 Election of Directors: Catherine J. Mackey, PhD DIRECTOR ELECTIONS ISSUER 212309.000000 0 FOR 212309.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 10/16/2024 Election of Directors: Gregory P. Sargen DIRECTOR ELECTIONS ISSUER 212309.000000 0 FOR 212309.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 10/16/2024 Election of Directors: Jeanne A. Thoma DIRECTOR ELECTIONS ISSUER 212309.000000 0 FOR 212309.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 10/16/2024 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending April 30, 2025. AUDIT-RELATED ISSUER 212309.000000 0 FOR 212309.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 10/16/2024 To approve, by an advisory vote, a non-binding resolution approving the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 212309.000000 0 FOR 212309.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 10/16/2024 To approve an amendment to the Company's 2018 Omnibus Incentive Plan to increase the number of shares reserved thereunder. COMPENSATION ISSUER 212309.000000 0 FOR 212309.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 10/16/2024 To approve an amendment to the Company's 2010 Employee Stock Purchase Plan to remove the expiration date. COMPENSATION ISSUER 212309.000000 0 FOR 212309.000000 FOR S000004450 Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Craig Arnold DIRECTOR ELECTIONS ISSUER 4438786.000000 0 FOR 4438786.000000 FOR S000004450 Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Scott C. Donnelly DIRECTOR ELECTIONS ISSUER 4438786.000000 0 FOR 4438786.000000 FOR S000004450 Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Lidia L. Fonseca DIRECTOR ELECTIONS ISSUER 4438786.000000 0 FOR 4438786.000000 FOR S000004450 Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Andrea J. Goldsmith, Ph.D. DIRECTOR ELECTIONS ISSUER 4438786.000000 0 FOR 4438786.000000 FOR S000004450 Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Randall J. Hogan, III DIRECTOR ELECTIONS ISSUER 4438786.000000 0 FOR 4438786.000000 FOR S000004450 Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Gregory P. Lewis DIRECTOR ELECTIONS ISSUER 4438786.000000 0 FOR 4438786.000000 FOR S000004450 Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Kevin E. Lofton DIRECTOR ELECTIONS ISSUER 4438786.000000 0 FOR 4438786.000000 FOR S000004450 Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Geoffrey S. Martha DIRECTOR ELECTIONS ISSUER 4438786.000000 0 FOR 4438786.000000 FOR S000004450 Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Elizabeth G. Nabel, M.D. DIRECTOR ELECTIONS ISSUER 4438786.000000 0 FOR 4438786.000000 FOR S000004450 Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Kendall J. Powell DIRECTOR ELECTIONS ISSUER 4438786.000000 0 FOR 4438786.000000 FOR S000004450 Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2025 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration; AUDIT-RELATED ISSUER 4438786.000000 0 FOR 4438786.000000 FOR S000004450 Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Approving, on an advisory basis, the Company's executive compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 4438786.000000 0 FOR 4438786.000000 FOR S000004450 Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Renewing the Board of Directors' authority to issue shares under Irish law; CAPITAL STRUCTURE ISSUER 4438786.000000 0 FOR 4438786.000000 FOR S000004450 Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Renewing the Board of Directors' authority to opt out of pre-emption rights under Irish law; and CAPITAL STRUCTURE ISSUER 4438786.000000 0 FOR 4438786.000000 FOR S000004450 Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares. CAPITAL STRUCTURE ISSUER 4438786.000000 0 FOR 4438786.000000 FOR S000004450 Sharecare, Inc. 81948W104 US81948W1045 10/17/2024 To adopt the Agreement and Plan of Merger (as it may be amended, supplemented or modified from time to time, the "Merger Agreement"), dated June 21, 2024, by and among Sharecare, Inc. ("Sharecare"), Impact Acquiror Inc. and Impact Merger Sub Inc., a wholly owned subsidiary of Impact Acquiror Inc., pursuant to which Impact Merger Sub Inc. will merge with and into Sharecare (the "Merger"). EXTRAORDINARY TRANSACTIONS ISSUER 958731.000000 0 FOR 958731.000000 FOR S000004450 Sharecare, Inc. 81948W104 US81948W1045 10/17/2024 To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Sharecare to its named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 958731.000000 0 FOR 958731.000000 FOR S000004450 Sharecare, Inc. 81948W104 US81948W1045 10/17/2024 To adjourn the special meeting of the stockholders of Sharecare (the "Special Meeting"), from time to time, to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting. CORPORATE GOVERNANCE ISSUER 958731.000000 0 FOR 958731.000000 FOR S000004450 PetIQ, Inc. 71639T106 US71639T1060 10/22/2024 To adopt the Agreement and Plan of Merger (as it may be amended from time to time), dated August 7, 2024, among Gula Buyer Inc., Gula Merger Sub, Inc. and PetIQ, Inc. (the "merger agreement"). EXTRAORDINARY TRANSACTIONS ISSUER 93356.000000 0 FOR 93356.000000 FOR S000004450 PetIQ, Inc. 71639T106 US71639T1060 10/22/2024 To approve, on a non-binding, advisory basis, the compensation that will or may become payable by PetIQ, Inc. to its named executive officers in connection with the merger agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 93356.000000 0 AGAINST 93356.000000 AGAINST S000004450 PetIQ, Inc. 71639T106 US71639T1060 10/22/2024 To approve any proposal to adjourn the special meeting to a late date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the merger agreement at the time of the special meeting. CORPORATE GOVERNANCE ISSUER 93356.000000 0 FOR 93356.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/24/2024 To set the number of Directors at nine. CORPORATE GOVERNANCE ISSUER 525137.000000 0 FOR 525137.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/24/2024 Election of Directors: Robert V. Baumgartner DIRECTOR ELECTIONS ISSUER 525137.000000 0 FOR 525137.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/24/2024 Election of Directors: Julie L. Bushman DIRECTOR ELECTIONS ISSUER 525137.000000 0 FOR 525137.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/24/2024 Election of Directors: Judith Klimovsky DIRECTOR ELECTIONS ISSUER 525137.000000 0 FOR 525137.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/24/2024 Election of Directors: John L. Higgins DIRECTOR ELECTIONS ISSUER 525137.000000 0 FOR 525137.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/24/2024 Election of Directors: Kim Kelderman DIRECTOR ELECTIONS ISSUER 525137.000000 0 FOR 525137.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/24/2024 Election of Directors: Alpna Seth DIRECTOR ELECTIONS ISSUER 525137.000000 0 FOR 525137.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/24/2024 Election of Directors: Rupert Vessey DIRECTOR ELECTIONS ISSUER 525137.000000 0 FOR 525137.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/24/2024 Election of Directors: Joseph D. Keegan DIRECTOR ELECTIONS ISSUER 525137.000000 0 FOR 525137.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/24/2024 Election of Directors: Roeland Nusse DIRECTOR ELECTIONS ISSUER 525137.000000 0 FOR 525137.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/24/2024 Approve, on an advisory basis, the compensation of our executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 525137.000000 0 FOR 525137.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/24/2024 Ratify the appointment of KPMG, LLP as the Company's independent registered public accounting firm for the 2025 fiscal year. AUDIT-RELATED ISSUER 525137.000000 0 FOR 525137.000000 FOR S000004450 Neogen Corporation 640491106 US6404911066 10/24/2024 Election of Directors: James C. Borel DIRECTOR ELECTIONS ISSUER 687236.000000 0 FOR 687236.000000 FOR S000004450 Neogen Corporation 640491106 US6404911066 10/24/2024 Election of Directors: Jeffrey D. Capello DIRECTOR ELECTIONS ISSUER 687236.000000 0 FOR 687236.000000 FOR S000004450 Neogen Corporation 640491106 US6404911066 10/24/2024 Election of Directors: Ronald D. Green, Ph.D. DIRECTOR ELECTIONS ISSUER 687236.000000 0 FOR 687236.000000 FOR S000004450 Neogen Corporation 640491106 US6404911066 10/24/2024 To Approve, On An Advisory Basis, The Compensation of Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 687236.000000 0 FOR 687236.000000 FOR S000004450 Neogen Corporation 640491106 US6404911066 10/24/2024 Ratification of Appointment of BDO USA P.C. as the Company's Independent Registered Public Accounting Firm. AUDIT-RELATED ISSUER 687236.000000 0 FOR 687236.000000 FOR S000004450 Phibro Animal Health Corporation 71742Q106 US71742Q1067 11/05/2024 Election of Class II Directors: Mary Lou Malanoski DIRECTOR ELECTIONS ISSUER 67907.000000 0 FOR 67907.000000 FOR S000004450 Phibro Animal Health Corporation 71742Q106 US71742Q1067 11/05/2024 Election of Class II Directors: Carol A. Wrenn DIRECTOR ELECTIONS ISSUER 67907.000000 0 FOR 67907.000000 FOR S000004450 Phibro Animal Health Corporation 71742Q106 US71742Q1067 11/05/2024 Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for our fiscal year ending June 30, 2025. AUDIT-RELATED ISSUER 67907.000000 0 FOR 67907.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/06/2024 Election of Directors: Robert W. Azelby DIRECTOR ELECTIONS ISSUER 814799.000000 0 FOR 814799.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/06/2024 Election of Directors: Michelle M. Brennan DIRECTOR ELECTIONS ISSUER 814799.000000 0 FOR 814799.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/06/2024 Election of Directors: Sheri H. Edison DIRECTOR ELECTIONS ISSUER 814799.000000 0 FOR 814799.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/06/2024 Election of Directors: David C. Evans DIRECTOR ELECTIONS ISSUER 814799.000000 0 FOR 814799.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/06/2024 Election of Directors: Patricia A. Hemingway Hall DIRECTOR ELECTIONS ISSUER 814799.000000 0 FOR 814799.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/06/2024 Election of Directors: Jason M. Hollar DIRECTOR ELECTIONS ISSUER 814799.000000 0 FOR 814799.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/06/2024 Election of Directors: Akhil Johri DIRECTOR ELECTIONS ISSUER 814799.000000 0 FOR 814799.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/06/2024 Election of Directors: Gregory B. Kenny DIRECTOR ELECTIONS ISSUER 814799.000000 0 FOR 814799.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/06/2024 Election of Directors: Nancy Killefer DIRECTOR ELECTIONS ISSUER 814799.000000 0 FOR 814799.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/06/2024 Election of Directors: Christine A. Mundkur DIRECTOR ELECTIONS ISSUER 814799.000000 0 FOR 814799.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/06/2024 To approve, on a non-binding advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 814799.000000 0 FOR 814799.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/06/2024 To ratify the appointment of Ernst & Young LLP as our independent auditor for the fiscal year ending June 30, 2025 AUDIT-RELATED ISSUER 814799.000000 0 FOR 814799.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/06/2024 Shareholder proposal to prohibit re-nomination of any director who fails to receive a majority vote, if properly presented CORPORATE GOVERNANCE SECURITY HOLDER 814799.000000 0 AGAINST 814799.000000 FOR S000004450 AngioDynamics, Inc. 03475V101 US03475V1017 11/12/2024 Proposal to elect three Class III directors, for a term of three years: Lorinda A. Burgess DIRECTOR ELECTIONS ISSUER 133513.000000 0 FOR 133513.000000 FOR S000004450 AngioDynamics, Inc. 03475V101 US03475V1017 11/12/2024 Proposal to elect three Class III directors, for a term of three years: Wesley E. Johnson, Jr. DIRECTOR ELECTIONS ISSUER 133513.000000 0 FOR 133513.000000 FOR S000004450 AngioDynamics, Inc. 03475V101 US03475V1017 11/12/2024 Proposal to elect three Class III directors, for a term of three years: Karen A. Licitra DIRECTOR ELECTIONS ISSUER 133513.000000 0 FOR 133513.000000 FOR S000004450 AngioDynamics, Inc. 03475V101 US03475V1017 11/12/2024 To ratify the appointment of Deloitte & Touche LLP as AngioDynamics, Inc. independent registered public accounting firm for the fiscal year ending May 31, 2025. AUDIT-RELATED ISSUER 133513.000000 0 FOR 133513.000000 FOR S000004450 AngioDynamics, Inc. 03475V101 US03475V1017 11/12/2024 Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 133513.000000 0 FOR 133513.000000 FOR S000004450 AngioDynamics, Inc. 03475V101 US03475V1017 11/12/2024 Approval of an amendment to increase the number of shares available for issuance under the AngioDynamics, Inc. 2020 Equity Incentive Plan. COMPENSATION ISSUER 133513.000000 0 FOR 133513.000000 FOR S000004450 Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 11/12/2024 To approve the issuance of shares of Class A Common Stock of Recursion Pharmaceuticals, Inc. ("Recursion") in connection with Recursion's acquisition of the entire issued and to be issued share capital of Exscientia plc pursuant to a scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006, for purposes of complying with the applicable provisions of the Nasdaq Listing Rules (the "Recursion Share Issuance Proposal"). EXTRAORDINARY TRANSACTIONS ISSUER 173964.000000 435000.000000 FOR 173964.000000 FOR S000004450 Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 11/12/2024 To approve any motion to adjourn the special meeting of stockholders of Recursion (the "Recursion Special Meeting") to another time or place, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes at the time of the Recursion Special Meeting to approve the Recursion Share Issuance Proposal. CORPORATE GOVERNANCE ISSUER 173964.000000 435000.000000 FOR 173964.000000 FOR S000004450 R1 RCM Inc. 77634L105 US77634L1052 11/14/2024 To approve and adopt the Agreement and Plan of Merger, dated as of July 31, 2024, by and among R1 RCM Inc. (the "Company"), Raven Acquisition Holdings, LLC, a Delaware limited liability company ("Parent"), and Project Raven Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub will be merged with and into the Company with the Company continuing as the surviving corporation as a wholly owned subsidiary of Parent and approve the transactions contemplated thereby (the "Merger"). EXTRAORDINARY TRANSACTIONS ISSUER 558536.000000 0 FOR 558536.000000 FOR S000004450 R1 RCM Inc. 77634L105 US77634L1052 11/14/2024 To approve, on an advisory and non-binding basis, certain compensation arrangements for the Company's named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 558536.000000 0 FOR 558536.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Carol Burt DIRECTOR ELECTIONS ISSUER 490858.000000 0 FOR 490858.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Christopher DelOrefice DIRECTOR ELECTIONS ISSUER 490858.000000 0 FOR 490858.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Jan De Witte DIRECTOR ELECTIONS ISSUER 490858.000000 0 FOR 490858.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Karen Drexler DIRECTOR ELECTIONS ISSUER 490858.000000 0 FOR 490858.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Michael Farrell DIRECTOR ELECTIONS ISSUER 490858.000000 0 FOR 490858.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Peter Farrell DIRECTOR ELECTIONS ISSUER 490858.000000 0 FOR 490858.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Harjit Gill DIRECTOR ELECTIONS ISSUER 490858.000000 0 FOR 490858.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: John Hernandez DIRECTOR ELECTIONS ISSUER 490858.000000 0 FOR 490858.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Richard Sulpizio DIRECTOR ELECTIONS ISSUER 490858.000000 0 FOR 490858.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Desney Tan DIRECTOR ELECTIONS ISSUER 490858.000000 0 FOR 490858.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Ronald Taylor DIRECTOR ELECTIONS ISSUER 490858.000000 0 FOR 490858.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/20/2024 Ratify our selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2025. AUDIT-RELATED ISSUER 490858.000000 0 FOR 490858.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/20/2024 Approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in the proxy statement ("say-on-pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 490858.000000 0 FOR 490858.000000 FOR S000004450 Bionano Genomics, Inc. 09075F404 US09075F4046 11/27/2024 To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of up to an aggregate of 35,026,272 shares of common stock upon the exercise of certain milestone-linked series warrants issued in connection with a private placement CAPITAL STRUCTURE ISSUER 209070.000000 0 FOR 209070.000000 FOR S000004450 Premier, Inc. 74051N102 US74051N1028 12/06/2024 Election of Directors: Richard J. Statuto DIRECTOR ELECTIONS ISSUER 348639.000000 0 FOR 348639.000000 FOR S000004450 Premier, Inc. 74051N102 US74051N1028 12/06/2024 Election of Directors: Ellen C. Wolf DIRECTOR ELECTIONS ISSUER 348639.000000 0 FOR 348639.000000 FOR S000004450 Premier, Inc. 74051N102 US74051N1028 12/06/2024 Ratification of the appointment of Ernst & Young LLP to serve as our independent registered public accounting firm for our fiscal year ending June 30, 2025. AUDIT-RELATED ISSUER 348639.000000 0 FOR 348639.000000 FOR S000004450 Premier, Inc. 74051N102 US74051N1028 12/06/2024 Approval, on an advisory basis, of the compensation of our Named Executive Officers as disclosed in the proxy statement for the Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 348639.000000 0 FOR 348639.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/06/2024 Election of the following 12 directors, each to hold office until the 2025 annual meeting of shareholders: DIRECTOR ELECTIONS ISSUER 3947551.000000 0 FOR 3947551.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/06/2024 Election of the following 12 directors, each to hold office until the 2025 annual meeting of shareholders: JoEllen Lyons Dillon DIRECTOR ELECTIONS ISSUER 3947551.000000 0 FOR 3947551.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/06/2024 Election of the following 12 directors, each to hold office until the 2025 annual meeting of shareholders: Elisha Finney DIRECTOR ELECTIONS ISSUER 3947551.000000 0 FOR 3947551.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/06/2024 Election of the following 12 directors, each to hold office until the 2025 annual meeting of shareholders: Leo Groothuis DIRECTOR ELECTIONS ISSUER 3947551.000000 0 FOR 3947551.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/06/2024 Election of the following 12 directors, each to hold office until the 2025 annual meeting of shareholders: Melina Higgins DIRECTOR ELECTIONS ISSUER 3947551.000000 0 FOR 3947551.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/06/2024 Election of the following 12 directors, each to hold office until the 2025 annual meeting of shareholders: James M. Kilts DIRECTOR ELECTIONS ISSUER 3947551.000000 0 FOR 3947551.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/06/2024 Election of the following 12 directors, each to hold office until the 2025 annual meeting of shareholders: Harry Korman DIRECTOR ELECTIONS ISSUER 3947551.000000 0 FOR 3947551.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/06/2024 Election of the following 12 directors, each to hold office until the 2025 annual meeting of shareholders: Rajiv Malik DIRECTOR ELECTIONS ISSUER 3947551.000000 0 FOR 3947551.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/06/2024 Election of the following 12 directors, each to hold office until the 2025 annual meeting of shareholders: Richard Mark DIRECTOR ELECTIONS ISSUER 3947551.000000 0 FOR 3947551.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/06/2024 Election of the following 12 directors, each to hold office until the 2025 annual meeting of shareholders: Mark Parrish DIRECTOR ELECTIONS ISSUER 3947551.000000 0 FOR 3947551.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/06/2024 Election of the following 12 directors, each to hold office until the 2025 annual meeting of shareholders: Scott A. Smith DIRECTOR ELECTIONS ISSUER 3947551.000000 0 FOR 3947551.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/06/2024 Election of the following 12 directors, each to hold office until the 2025 annual meeting of shareholders: Rogerio Vivaldi Coelho DIRECTOR ELECTIONS ISSUER 3947551.000000 0 FOR 3947551.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/06/2024 Approval of, on a non-binding advisory basis, the 2023 compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 3947551.000000 0 FOR 3947551.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/06/2024 Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 3947551.000000 0 FOR 3947551.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/06/2024 Approval of an amendment to the Viatris Inc. 2020 Stock Incentive Plan. COMPENSATION ISSUER 3947551.000000 0 FOR 3947551.000000 FOR S000004450 Zymeworks Inc. 98985Y108 US98985Y1082 12/10/2024 Election of Directors: Kenneth Galbraith DIRECTOR ELECTIONS ISSUER 152422.000000 0 FOR 152422.000000 FOR S000004450 Zymeworks Inc. 98985Y108 US98985Y1082 12/10/2024 Election of Directors: Susan Mahony DIRECTOR ELECTIONS ISSUER 152422.000000 0 FOR 152422.000000 FOR S000004450 Zymeworks Inc. 98985Y108 US98985Y1082 12/10/2024 Election of Directors: Kelvin Neu DIRECTOR ELECTIONS ISSUER 152422.000000 0 FOR 152422.000000 FOR S000004450 Zymeworks Inc. 98985Y108 US98985Y1082 12/10/2024 Election of Directors: Scott Platshon DIRECTOR ELECTIONS ISSUER 152422.000000 0 FOR 152422.000000 FOR S000004450 Zymeworks Inc. 98985Y108 US98985Y1082 12/10/2024 Advisory Vote on the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 152422.000000 0 FOR 152422.000000 FOR S000004450 Zymeworks Inc. 98985Y108 US98985Y1082 12/10/2024 Appointment of Auditors Ratification of the appointment of KPMG LLP, chartered professional accountants, as auditors for the year ending December 31, 2024 AUDIT-RELATED ISSUER 152422.000000 0 FOR 152422.000000 FOR S000004450 Tilray Brands, Inc. 88688T100 US88688T1007 12/19/2024 Election of Directors: Thomas Looney DIRECTOR ELECTIONS ISSUER 29349.000000 2726242.000000 FOR 29349.000000 FOR S000004450 Tilray Brands, Inc. 88688T100 US88688T1007 12/19/2024 Election of Directors: David Hopkinson DIRECTOR ELECTIONS ISSUER 29349.000000 2726242.000000 FOR 29349.000000 FOR S000004450 Tilray Brands, Inc. 88688T100 US88688T1007 12/19/2024 The ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending May 31, 2025; AUDIT-RELATED ISSUER 29349.000000 2726242.000000 FOR 29349.000000 FOR S000004450 Tilray Brands, Inc. 88688T100 US88688T1007 12/19/2024 Approval to increase the number of shares of common stock the Company is authorized to issue from 1,208,000,000 shares of capital stock to 1,426,000,000 shares of capital stock (the "Authorized Shares Proposal"); CAPITAL STRUCTURE ISSUER 29349.000000 2726242.000000 FOR 29349.000000 FOR S000004450 Tilray Brands, Inc. 88688T100 US88688T1007 12/19/2024 Approval of the governance changes to the Company's Fourth Amended and Restated Certificate of Incorporation (the "Charter") to (i) declassify the Board and provide that all directors will be elected at each annual meeting of stockholders and (ii) eliminate the provision of the Charter that allows stockholders to remove directors only for cause (collectively, the "Governance Proposal"); and CORPORATE GOVERNANCE ISSUER 29349.000000 2726242.000000 FOR 29349.000000 FOR S000004450 Amedisys, Inc. 023436108 US0234361089 12/30/2024 Election of Directors: Richard M. Ashworth DIRECTOR ELECTIONS ISSUER 107208.000000 0 FOR 107208.000000 FOR S000004450 Amedisys, Inc. 023436108 US0234361089 12/30/2024 Election of Directors: Vickie L. Capps DIRECTOR ELECTIONS ISSUER 107208.000000 0 FOR 107208.000000 FOR S000004450 Amedisys, Inc. 023436108 US0234361089 12/30/2024 Election of Directors: Molly J. Coye, MD DIRECTOR ELECTIONS ISSUER 107208.000000 0 FOR 107208.000000 FOR S000004450 Amedisys, Inc. 023436108 US0234361089 12/30/2024 Election of Directors: Julie D. Klapstein DIRECTOR ELECTIONS ISSUER 107208.000000 0 FOR 107208.000000 FOR S000004450 Amedisys, Inc. 023436108 US0234361089 12/30/2024 Election of Directors: Teresa L. Kline DIRECTOR ELECTIONS ISSUER 107208.000000 0 FOR 107208.000000 FOR S000004450 Amedisys, Inc. 023436108 US0234361089 12/30/2024 Election of Directors: Paul B. Kusserow DIRECTOR ELECTIONS ISSUER 107208.000000 0 FOR 107208.000000 FOR S000004450 Amedisys, Inc. 023436108 US0234361089 12/30/2024 Election of Directors: Bruce D. Perkins DIRECTOR ELECTIONS ISSUER 107208.000000 0 FOR 107208.000000 FOR S000004450 Amedisys, Inc. 023436108 US0234361089 12/30/2024 Election of Directors: Jeffrey A. Rideout, MD DIRECTOR ELECTIONS ISSUER 107208.000000 0 FOR 107208.000000 FOR S000004450 Amedisys, Inc. 023436108 US0234361089 12/30/2024 Election of Directors: Ivanetta Davis Samuels DIRECTOR ELECTIONS ISSUER 107208.000000 0 FOR 107208.000000 FOR S000004450 Amedisys, Inc. 023436108 US0234361089 12/30/2024 To ratify the appointment of KPMG LLP as the Company's Independent registered public accountants for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 107208.000000 0 FOR 107208.000000 FOR S000004450 Amedisys, Inc. 023436108 US0234361089 12/30/2024 To approve, on an advisory (non-binding) basis, the compensation paid to the Company's Named Executive Officers, as set forth in the Company's 2024 Proxy Statement ("Say on Pay" Vote). SECTION 14A SAY-ON-PAY VOTES ISSUER 107208.000000 0 FOR 107208.000000 FOR S000004450 Senseonics Holdings, Inc. 81727U105 US81727U1051 01/10/2025 Approval of an amendment to our Amended and Restated Certificate of Incorporation to effect, at the discretion of the Board of Directors, a reverse stock split of our common stock (with a proportionate reduction in the authorized number of shares of common stock) at a ratio in the range of 1-for-25 to 1-for-50. CAPITAL STRUCTURE ISSUER 972499.000000 703900.000000 FOR 972499.000000 FOR S000004450 Bionano Genomics, Inc. 09075F404 US09075F4046 01/15/2025 To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of up to an aggregate of 19,762,226 shares of common stock upon the exercise of certain Series C warrants and Series D warrants. CAPITAL STRUCTURE ISSUER 2997.000000 307700.000000 FOR 2997.000000 FOR S000004450 Bionano Genomics, Inc. 09075F404 US09075F4046 01/15/2025 To approve a series of alternate amendments to the Company's Amended and Restated Certificate of Incorporation, as amended, to effect, at the option of our Board of Directors, a reverse split of our common stock at a ratio between 1-for-25 and 1-for-75, inclusive, as determined by our Board of Directors in its sole discretion and with such reverse stock split to be effected at such time and date, if at all, as determined by our board of directors in its sole discretion. CAPITAL STRUCTURE ISSUER 2997.000000 307700.000000 FOR 2997.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: William M. Brown DIRECTOR ELECTIONS ISSUER 948278.000000 0 FOR 948278.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: Catherine M. Burzik DIRECTOR ELECTIONS ISSUER 948278.000000 0 FOR 948278.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: Carrie Byington DIRECTOR ELECTIONS ISSUER 948278.000000 0 FOR 948278.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: R. Andrew Eckert DIRECTOR ELECTIONS ISSUER 948278.000000 0 FOR 948278.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: Claire M. Fraser DIRECTOR ELECTIONS ISSUER 948278.000000 0 FOR 948278.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: Jeffrey W. Henderson DIRECTOR ELECTIONS ISSUER 948278.000000 0 FOR 948278.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: Christopher Jones DIRECTOR ELECTIONS ISSUER 948278.000000 0 FOR 948278.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: Thomas E. Polen DIRECTOR ELECTIONS ISSUER 948278.000000 0 FOR 948278.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: Timothy M. Ring DIRECTOR ELECTIONS ISSUER 948278.000000 0 FOR 948278.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: Bertram L. Scott DIRECTOR ELECTIONS ISSUER 948278.000000 0 FOR 948278.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: Joanne Waldstreicher DIRECTOR ELECTIONS ISSUER 948278.000000 0 FOR 948278.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Ratification of the selection of the independent registered public accounting firm. AUDIT-RELATED ISSUER 948278.000000 0 FOR 948278.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 948278.000000 0 FOR 948278.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 01/30/2025 To approve the adoption of the Agreement and Plan of Merger, dated November 6, 2024 (the "Merger Agreement"), by and among Avid Bioservices, Inc., a Delaware corporation ("Avid"), Space Finco, Inc., a Delaware corporation ("Parent"), and Space Mergerco, Inc., a Delaware corporation and a direct wholly owned Subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub will merge with and into Avid, and as a result of which the separate corporate existence of Merger Sub will cease, and Avid will continue as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger"), and approve the Merger (the "Merger Agreement Proposal"). EXTRAORDINARY TRANSACTIONS ISSUER 208997.000000 0 FOR 208997.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 01/30/2025 To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Avid's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 208997.000000 0 FOR 208997.000000 FOR S000004450 Avid Bioservices, Inc. 05368M106 US05368M1062 01/30/2025 To approve the adjournment of the special meeting of Avid stockholders (the "Special Meeting") to a later date or dates, if necessary or appropriate, including to solicit additional proxies to approve the Merger Agreement Proposal if there are insufficient votes to approve the Merger Agreement Proposal at the time of the Special Meeting. CORPORATE GOVERNANCE ISSUER 208997.000000 0 FOR 208997.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2025 Election of Directors: Frank E. Casal DIRECTOR ELECTIONS ISSUER 144278.000000 0 FOR 144278.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2025 Election of Directors: William L. Cornog DIRECTOR ELECTIONS ISSUER 144278.000000 0 FOR 144278.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2025 Election of Directors: Robyn C. Davis DIRECTOR ELECTIONS ISSUER 144278.000000 0 FOR 144278.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2025 Election of Directors: Dipal Doshi DIRECTOR ELECTIONS ISSUER 144278.000000 0 FOR 144278.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2025 Election of Directors: Quentin Koffey DIRECTOR ELECTIONS ISSUER 144278.000000 0 FOR 144278.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2025 Election of Directors: Martin Madaus DIRECTOR ELECTIONS ISSUER 144278.000000 0 FOR 144278.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2025 Election of Directors: Alan J. Malus DIRECTOR ELECTIONS ISSUER 144278.000000 0 FOR 144278.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2025 Election of Directors: John P. Marotta DIRECTOR ELECTIONS ISSUER 144278.000000 0 FOR 144278.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2025 Election of Directors: Erica J. McLaughlin DIRECTOR ELECTIONS ISSUER 144278.000000 0 FOR 144278.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2025 Election of Directors: Tina S. Nova DIRECTOR ELECTIONS ISSUER 144278.000000 0 FOR 144278.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2025 To approve by a non-binding advisory vote the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 144278.000000 0 FOR 144278.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/30/2025 To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered accounting firm for the 2025 fiscal year. AUDIT-RELATED ISSUER 144278.000000 0 FOR 144278.000000 FOR S000004450 Twist Bioscience Corporation 90184D100 US90184D1000 02/05/2025 Election of Class I Directors: Nelson Chan DIRECTOR ELECTIONS ISSUER 191332.000000 0 FOR 191332.000000 FOR S000004450 Twist Bioscience Corporation 90184D100 US90184D1000 02/05/2025 Election of Class I Directors: Robert Ragusa DIRECTOR ELECTIONS ISSUER 191332.000000 0 FOR 191332.000000 FOR S000004450 Twist Bioscience Corporation 90184D100 US90184D1000 02/05/2025 Election of Class I Directors: Melissa Starovasnik DIRECTOR ELECTIONS ISSUER 191332.000000 0 FOR 191332.000000 FOR S000004450 Twist Bioscience Corporation 90184D100 US90184D1000 02/05/2025 To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under "Executive Compensation." SECTION 14A SAY-ON-PAY VOTES ISSUER 191332.000000 0 FOR 191332.000000 FOR S000004450 Twist Bioscience Corporation 90184D100 US90184D1000 02/05/2025 To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending September 30, 2025. AUDIT-RELATED ISSUER 191332.000000 0 FOR 191332.000000 FOR S000004450 Twist Bioscience Corporation 90184D100 US90184D1000 02/05/2025 To approve an amendment and restatement of the Company's 2018 Equity Incentive Plan (the "EIP") to increase the number of shares of common stock reserved for issuance of awards under the EIP, eliminate the "evergreen" provision and make other amendments. COMPENSATION ISSUER 191332.000000 0 FOR 191332.000000 FOR S000004450 Twist Bioscience Corporation 90184D100 US90184D1000 02/05/2025 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation (the "Charter") to increase the number of shares of common stock of the Company authorized thereunder by an additional 100,000,000 shares. CAPITAL STRUCTURE ISSUER 191332.000000 0 FOR 191332.000000 FOR S000004450 Twist Bioscience Corporation 90184D100 US90184D1000 02/05/2025 To approve an amendment to the Charter to provide for officer exculpation. CORPORATE GOVERNANCE ISSUER 191332.000000 0 FOR 191332.000000 FOR S000004450 Surmodics, Inc. 868873100 US8688731004 02/06/2025 Election of Director: Gary R. Maharaj DIRECTOR ELECTIONS ISSUER 46907.000000 0 FOR 46907.000000 FOR S000004450 Surmodics, Inc. 868873100 US8688731004 02/06/2025 Set the number of directors at five (5); CORPORATE GOVERNANCE ISSUER 46907.000000 0 FOR 46907.000000 FOR S000004450 Surmodics, Inc. 868873100 US8688731004 02/06/2025 Ratify the appointment of Deloitte & Touche LLP as Surmodics' independent registered public accounting firm for fiscal year 2025; and AUDIT-RELATED ISSUER 46907.000000 0 FOR 46907.000000 FOR S000004450 Surmodics, Inc. 868873100 US8688731004 02/06/2025 Approve, in a non-binding advisory vote, the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 46907.000000 0 FOR 46907.000000 FOR S000004450 Embecta Corp. 29082K105 US29082K1051 02/12/2025 Election of Directors: Mr. Robert J. Hombach DIRECTOR ELECTIONS ISSUER 180629.000000 0 FOR 180629.000000 FOR S000004450 Embecta Corp. 29082K105 US29082K1051 02/12/2025 Election of Directors: Mr. Devdatt Kurdikar DIRECTOR ELECTIONS ISSUER 180629.000000 0 FOR 180629.000000 FOR S000004450 Embecta Corp. 29082K105 US29082K1051 02/12/2025 Election of Directors: LTG (Ret.) David F. Melcher DIRECTOR ELECTIONS ISSUER 180629.000000 0 FOR 180629.000000 FOR S000004450 Embecta Corp. 29082K105 US29082K1051 02/12/2025 Ratification of the selection of the independent registered public accounting firm AUDIT-RELATED ISSUER 180629.000000 0 FOR 180629.000000 FOR S000004450 Embecta Corp. 29082K105 US29082K1051 02/12/2025 Advisory vote to approve named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 180629.000000 0 FOR 180629.000000 FOR S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/13/2025 Election of Directors: Dr. Daniel Weiner DIRECTOR ELECTIONS ISSUER 52508.000000 0 FOR 52508.000000 FOR S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/13/2025 Election of Directors: Dr. Walter S. Woltosz DIRECTOR ELECTIONS ISSUER 52508.000000 0 FOR 52508.000000 FOR S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/13/2025 Election of Directors: Dr. John K. Paglia DIRECTOR ELECTIONS ISSUER 52508.000000 0 FOR 52508.000000 FOR S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/13/2025 Election of Directors: Dr. Lisa LaVange DIRECTOR ELECTIONS ISSUER 52508.000000 0 FOR 52508.000000 FOR S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/13/2025 Election of Directors: Sharlene Evans DIRECTOR ELECTIONS ISSUER 52508.000000 0 FOR 52508.000000 FOR S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/13/2025 Ratification of the selection of Rose, Snyder & Jacobs LLP as the independent registered public accounting firm for the Company for the fiscal year ending. August 31, 2025. AUDIT-RELATED ISSUER 52508.000000 0 FOR 52508.000000 FOR S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/13/2025 Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 52508.000000 0 FOR 52508.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/13/2025 To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Kathleen L. Bardwell DIRECTOR ELECTIONS ISSUER 133578.000000 0 FOR 133578.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/13/2025 To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Jocelyn D. Chertoff, M.D. DIRECTOR ELECTIONS ISSUER 133578.000000 0 FOR 133578.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/13/2025 To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Timothy E. Guertin DIRECTOR ELECTIONS ISSUER 133578.000000 0 FOR 133578.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/13/2025 To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Jay K. Kunkel DIRECTOR ELECTIONS ISSUER 133578.000000 0 FOR 133578.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/13/2025 To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Walter M Rosebrough, Jr. DIRECTOR ELECTIONS ISSUER 133578.000000 0 FOR 133578.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/13/2025 To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Sunny S. Sanyal DIRECTOR ELECTIONS ISSUER 133578.000000 0 FOR 133578.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/13/2025 To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Christine A. Tsingos DIRECTOR ELECTIONS ISSUER 133578.000000 0 FOR 133578.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/13/2025 To approve, on an advisory basis, our executive compensation as described in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 133578.000000 0 FOR 133578.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/13/2025 To hold an advisory vote on how frequently we conduct an advisory vote of stockholders on our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 133578.000000 0 ONE YEAR 133578.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/13/2025 To approve the Varex Imaging Corporation 2017 Employee Stock Purchase Plan, as amended. COMPENSATION ISSUER 133578.000000 0 FOR 133578.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/13/2025 To amend the Amended and Restated Certificate of Incorporation of Varex Imaging Corporation to limit the liability of certain officer as permitted by law. CORPORATE GOVERNANCE ISSUER 133578.000000 0 FOR 133578.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/13/2025 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year 2025. AUDIT-RELATED ISSUER 133578.000000 0 FOR 133578.000000 FOR S000004450 Hologic Inc. 436440101 US4364401012 02/26/2025 Election of Directors: Stephen P. MacMillan DIRECTOR ELECTIONS ISSUER 754865.000000 0 FOR 754865.000000 FOR S000004450 Hologic Inc. 436440101 US4364401012 02/26/2025 Election of Directors: Charles J. Dockendorff DIRECTOR ELECTIONS ISSUER 754865.000000 0 FOR 754865.000000 FOR S000004450 Hologic Inc. 436440101 US4364401012 02/26/2025 Election of Directors: Ludwig N. Hantson DIRECTOR ELECTIONS ISSUER 754865.000000 0 FOR 754865.000000 FOR S000004450 Hologic Inc. 436440101 US4364401012 02/26/2025 Election of Directors: Martin Madaus DIRECTOR ELECTIONS ISSUER 754865.000000 0 FOR 754865.000000 FOR S000004450 Hologic Inc. 436440101 US4364401012 02/26/2025 Election of Directors: Nanaz Mohtashami DIRECTOR ELECTIONS ISSUER 754865.000000 0 FOR 754865.000000 FOR S000004450 Hologic Inc. 436440101 US4364401012 02/26/2025 Election of Directors: Christiana Stamoulis DIRECTOR ELECTIONS ISSUER 754865.000000 0 FOR 754865.000000 FOR S000004450 Hologic Inc. 436440101 US4364401012 02/26/2025 Election of Directors: Stacey D. Stewart DIRECTOR ELECTIONS ISSUER 754865.000000 0 FOR 754865.000000 FOR S000004450 Hologic Inc. 436440101 US4364401012 02/26/2025 Election of Directors: Amy M. Wendell DIRECTOR ELECTIONS ISSUER 754865.000000 0 FOR 754865.000000 FOR S000004450 Hologic Inc. 436440101 US4364401012 02/26/2025 A non-binding advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 754865.000000 0 FOR 754865.000000 FOR S000004450 Hologic Inc. 436440101 US4364401012 02/26/2025 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2025. AUDIT-RELATED ISSUER 754865.000000 0 FOR 754865.000000 FOR S000004450 Hologic Inc. 436440101 US4364401012 02/26/2025 Advisory approval of a stockholder proposal to replace the supermajority voting provisions in our charter and bylaws with a simple majority voting standard. CORPORATE GOVERNANCE SECURITY HOLDER 754865.000000 0 AGAINST 754865.000000 NONE S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 02/28/2025 To adopt the Agreement and Plan of Merger, dated as of December 3, 2024 (such agreement, as it may be amended from time to time, the "merger agreement"), among Cross Country Healthcare, Inc., a Delaware corporation ("Cross Country"), Aya Holdings II Inc., a Delaware corporation ("Parent"), Spark Merger Sub One Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Mergers Sub"), and, solely for the purposes of Section 11.14 thereto, Aya Healthcare, Inc., a Delaware corporation ("Aya"), pursuant to which, upon the terms and subject to the conditions of the merger agreement, Merger Sub will merge with and into Cross Country (the "merger"), with Cross Country surviving the merger and becoming a wholly owned indirect subsidiary of Aya (the "merger agreement proposal"); EXTRAORDINARY TRANSACTIONS ISSUER 103612.000000 0 FOR 103612.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 02/28/2025 To approve on an advisory (non-binding) basis the compensation that may be paid or become payable to Cross Country's named executive officers that is based on or otherwise relates to the merger; and SECTION 14A SAY-ON-PAY VOTES ISSUER 103612.000000 0 FOR 103612.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 02/28/2025 To approve the adjournment of the special meeting, if necessary, to solicit additional proxies if there are not sufficient votes to approve the merger agreement proposal. CORPORATE GOVERNANCE ISSUER 103612.000000 0 FOR 103612.000000 FOR S000004450 Outset Medical, Inc. 690145206 US6901452069 03/05/2025 Approval, for purposes of complying with Nasdaq Listing Rule 5635, of the issuance of, or in excess of, 20% of the Company's outstanding common stock upon conversion of the Series A Preferred Stock at less than the "minimum price and which may be deemed a "change of control" under Nasdaq Listing Rule 5635; CAPITAL STRUCTURE ISSUER 152969.000000 0 FOR 152969.000000 FOR S000004450 Outset Medical, Inc. 690145206 US6901452069 03/05/2025 Approval, for purposes of complying with Nasdaq Listing Rule 5635, of the issuance of the Company's Series A Preferred Stock to certain of the Company's directors, officers and employees and any shares of the Company's common stock issuable upon the conversion thereof; CAPITAL STRUCTURE ISSUER 152969.000000 0 FOR 152969.000000 FOR S000004450 Outset Medical, Inc. 690145206 US6901452069 03/05/2025 Approval of an amendment to the Company's amended and restated certificate of incorporation to effect a reverse stock split of the Company's common stock at a ratio ranging from any whole number between 1-for-10 and 1-for-15, inclusive, as determined by the Company's board of directors in its discretion, subject to the Company's board of directors' authority to abandon such amendments; and CAPITAL STRUCTURE ISSUER 152969.000000 0 FOR 152969.000000 FOR S000004450 Outset Medical, Inc. 690145206 US6901452069 03/05/2025 Approval of the adjournment of the Special Meeting, if necessary in the reasonable discretion of the Company's board of directors, the Chair of the Board, the President or the Corporate Secretary to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve any of the other proposals. CORPORATE GOVERNANCE ISSUER 152969.000000 0 FOR 152969.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/06/2025 Election of eleven directors: Ornella Barra DIRECTOR ELECTIONS ISSUER 575960.000000 0 FOR 575960.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/06/2025 Election of eleven directors: Werner Baumann DIRECTOR ELECTIONS ISSUER 575960.000000 0 FOR 575960.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/06/2025 Election of eleven directors: Frank K. Clyburn DIRECTOR ELECTIONS ISSUER 575960.000000 0 FOR 575960.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/06/2025 Election of eleven directors: Steven H. Collis DIRECTOR ELECTIONS ISSUER 575960.000000 0 FOR 575960.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/06/2025 Election of eleven directors: D. Mark Durcan DIRECTOR ELECTIONS ISSUER 575960.000000 0 FOR 575960.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/06/2025 Election of eleven directors: Lon R. Greenberg DIRECTOR ELECTIONS ISSUER 575960.000000 0 FOR 575960.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/06/2025 Election of eleven directors: Lorence H. Kim, M.D. DIRECTOR ELECTIONS ISSUER 575960.000000 0 FOR 575960.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/06/2025 Election of eleven directors: Robert P. Mauch DIRECTOR ELECTIONS ISSUER 575960.000000 0 FOR 575960.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/06/2025 Election of eleven directors: Redonda G. Miller, M.D. DIRECTOR ELECTIONS ISSUER 575960.000000 0 FOR 575960.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/06/2025 Election of eleven directors: Dennis M. Nally DIRECTOR ELECTIONS ISSUER 575960.000000 0 FOR 575960.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/06/2025 Election of eleven directors: Lauren M. Tyler DIRECTOR ELECTIONS ISSUER 575960.000000 0 FOR 575960.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/06/2025 Advisory vote to approve the fiscal 2024 compensation of Cencora, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 575960.000000 0 FOR 575960.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/06/2025 Ratify the appointment of Ernst & Young LLP as Cencora, Inc.'s independent registered public accounting firm for fiscal 2025. AUDIT-RELATED ISSUER 575960.000000 0 FOR 575960.000000 FOR S000004450 Coherus BioSciences, Inc. 19249H103 US19249H1032 03/11/2025 To approve the Transaction, the Asset Purchase Agreement and the other transactions and ancillary documents contemplated by the Asset Purchase Agreement. EXTRAORDINARY TRANSACTIONS ISSUER 321933.000000 0 FOR 321933.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/12/2025 Election of Directors: Hongbo Lu DIRECTOR ELECTIONS ISSUER 361060.000000 0 FOR 361060.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/12/2025 Election of Directors: Michael S. Perry DIRECTOR ELECTIONS ISSUER 361060.000000 0 FOR 361060.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/12/2025 Election of Directors: Christopher Anzalone DIRECTOR ELECTIONS ISSUER 361060.000000 0 FOR 361060.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/12/2025 Election of Directors: Mauro Ferrari DIRECTOR ELECTIONS ISSUER 361060.000000 0 FOR 361060.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/12/2025 Election of Directors: Adeoye Olukotun DIRECTOR ELECTIONS ISSUER 361060.000000 0 FOR 361060.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/12/2025 Election of Directors: William Waddill DIRECTOR ELECTIONS ISSUER 361060.000000 0 FOR 361060.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/12/2025 Election of Directors: Victoria Vakiener DIRECTOR ELECTIONS ISSUER 361060.000000 0 FOR 361060.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/12/2025 Election of Directors: Douglas Ingram DIRECTOR ELECTIONS ISSUER 361060.000000 0 FOR 361060.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/12/2025 Advisory Vote to Approve Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 361060.000000 0 FOR 361060.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/12/2025 Advisory Vote on Frequency of Executive Compensation Advisory Votes. SECTION 14A SAY-ON-PAY VOTES ISSUER 361060.000000 0 ONE YEAR 361060.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/12/2025 To ratify the selection of KPMG LLP as independent auditors of the Company for the fiscal year ending September 30, 2025. AUDIT-RELATED ISSUER 361060.000000 0 FOR 361060.000000 FOR S000004450 Agilent Technologies, Inc. 00846U101 US00846U1016 03/13/2025 Election of Directors: To elect two directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Otis W. Brawley, M.D. DIRECTOR ELECTIONS ISSUER 922484.000000 0 FOR 922484.000000 FOR S000004450 Agilent Technologies, Inc. 00846U101 US00846U1016 03/13/2025 Election of Directors: To elect two directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Mikael Dolsten, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 922484.000000 0 FOR 922484.000000 FOR S000004450 Agilent Technologies, Inc. 00846U101 US00846U1016 03/13/2025 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 922484.000000 0 FOR 922484.000000 FOR S000004450 Agilent Technologies, Inc. 00846U101 US00846U1016 03/13/2025 To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm. AUDIT-RELATED ISSUER 922484.000000 0 FOR 922484.000000 FOR S000004450 Agilent Technologies, Inc. 00846U101 US00846U1016 03/13/2025 To approve the amendments to Agilent's Second Amended and Restated Certificate of Incorporation to remove supermajority voting requirements. CORPORATE GOVERNANCE ISSUER 922484.000000 0 FOR 922484.000000 FOR S000004450 Agilent Technologies, Inc. 00846U101 US00846U1016 03/13/2025 To elect each director annually. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 922484.000000 0 FOR 922484.000000 NONE S000004450 Enanta Pharmaceuticals, Inc. 29251M106 US29251M1062 03/13/2025 To elect two Class III directors to serve until the 2028 Annual Meeting of Stockholders or until their respective successors are elected and qualified: Mark G. Foletta DIRECTOR ELECTIONS ISSUER 64924.000000 0 FOR 64924.000000 FOR S000004450 Enanta Pharmaceuticals, Inc. 29251M106 US29251M1062 03/13/2025 To elect two Class III directors to serve until the 2028 Annual Meeting of Stockholders or until their respective successors are elected and qualified: Lesley Russell DIRECTOR ELECTIONS ISSUER 64924.000000 0 FOR 64924.000000 FOR S000004450 Enanta Pharmaceuticals, Inc. 29251M106 US29251M1062 03/13/2025 To approve an amendment to our 2019 Equity Incentive Plan. COMPENSATION ISSUER 64924.000000 0 FOR 64924.000000 FOR S000004450 Enanta Pharmaceuticals, Inc. 29251M106 US29251M1062 03/13/2025 To approve, on an advisory basis, the frequency of holding an advisory vote on the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 64924.000000 0 ONE YEAR 64924.000000 FOR S000004450 Enanta Pharmaceuticals, Inc. 29251M106 US29251M1062 03/13/2025 To approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 64924.000000 0 FOR 64924.000000 FOR S000004450 Enanta Pharmaceuticals, Inc. 29251M106 US29251M1062 03/13/2025 To ratify the appointment of PricewaterhouseCoopers LLP as Enanta's independent registered public accounting firm for the 2025 fiscal year. AUDIT-RELATED ISSUER 64924.000000 0 FOR 64924.000000 FOR S000004450 ModivCare Inc. 60783X104 US60783X1046 03/13/2025 Coliseum Transactions Proposal CAPITAL STRUCTURE ISSUER 36996.000000 0 FOR 36996.000000 FOR S000004450 ModivCare Inc. 60783X104 US60783X1046 03/13/2025 Adjournment Proposal CORPORATE GOVERNANCE ISSUER 36996.000000 0 FOR 36996.000000 FOR S000004450 Accolade, Inc. 00437E102 US00437E1029 03/27/2025 To adopt the Agreement and Plan of Merger (as it may be amended from time to time), dated January 8, 2025 (the "Merger Agreement"), by and among Accolade, Inc., a Delaware corporation ("Accolade"), Transcarent, Inc., a Delaware corporation ("Parent"), and Acorn Merger Sub, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub will merge with and into Accolade (the "Merger"), and approve the Merger and the transactions contemplated by the Merger Agreement (the "Merger Agreement Proposal"). EXTRAORDINARY TRANSACTIONS ISSUER 243309.000000 0 FOR 243309.000000 FOR S000004450 Accolade, Inc. 00437E102 US00437E1029 03/27/2025 To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Accolade to its named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 243309.000000 0 FOR 243309.000000 FOR S000004450 Accolade, Inc. 00437E102 US00437E1029 03/27/2025 To approve the adjournment of the special meeting of stockholders of Accolade (the "Special Meeting"), from time to time, to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to approve the Merger Agreement Proposal at the time of the Special Meeting. CORPORATE GOVERNANCE ISSUER 243309.000000 0 FOR 243309.000000 FOR S000004450 Intra-Cellular Therapies, Inc. 46116X101 US46116X1019 03/27/2025 To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated January 10, 2025, by and among Intra-Cellular Therapies, Inc. ("ITI"), Johnson & Johnson, a New Jersey corporation ("Johnson & Johnson"), and Fleming Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Johnson & Johnson ("Merger Sub"). Pursuant to the terms of the Merger Agreement, Merger Sub will merge with and into ITI (the "Merger"), with ITI surviving the Merger as a wholly owned subsidiary of Johnson & Johnson. EXTRAORDINARY TRANSACTIONS ISSUER 302613.000000 0 FOR 302613.000000 FOR S000004450 Intra-Cellular Therapies, Inc. 46116X101 US46116X1019 03/27/2025 To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to ITI's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 302613.000000 0 FOR 302613.000000 FOR S000004450 Intra-Cellular Therapies, Inc. 46116X101 US46116X1019 03/27/2025 To adjourn the Company Stockholders' Meeting to a later date or dates as provided in the Merger Agreement, if necessary or appropriate, including to solicit additional votes if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting of Stockholders. CORPORATE GOVERNANCE ISSUER 302613.000000 0 FOR 302613.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 04/01/2025 To adopt and approve the Agreement and Plan of Merger including the transactions contemplated thereby, including the Merger. EXTRAORDINARY TRANSACTIONS ISSUER 266708.000000 0 FOR 266708.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 04/01/2025 To adjourn the special meeting to a later date or dates if necessary to solicit additional proxies if there are insufficient votes to adopt and approve the Merger Agreement and the transactions contemplated thereby, including the Merger, at the time of the special meeting. CORPORATE GOVERNANCE ISSUER 266708.000000 0 FOR 266708.000000 FOR S000004450 Patterson Companies, Inc. 703395103 US7033951036 04/01/2025 To approve, on a non-binding, advisory basis, certain compensation that will or may become payable to our named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 266708.000000 0 FOR 266708.000000 FOR S000004450 Nevro Corp. 64157F103 US64157F1030 04/02/2025 To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated as of February 6, 2025, by and among Globus Medical, Inc., a Delaware corporation ("Globus"), Palmer Merger Sub Inc., a Delaware corporation and a direct wholly owned subsidiary of Globus ("Merger Sub"), and Nevro Corp., a Delaware corporation ("Nevro"), pursuant to which Merger Sub will be merged with and into Nevro, with Nevro surviving as a wholly owned subsidiary of Globus (the "Merger"); EXTRAORDINARY TRANSACTIONS ISSUER 107946.000000 0 FOR 107946.000000 FOR S000004450 Nevro Corp. 64157F103 US64157F1030 04/02/2025 To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or become payable to Nevro's named executive officers that is based on or otherwise relates to the Merger; and SECTION 14A SAY-ON-PAY VOTES ISSUER 107946.000000 0 AGAINST 107946.000000 AGAINST S000004450 Nevro Corp. 64157F103 US64157F1030 04/02/2025 To approve the adjournment of the special meeting to a later date or dates if necessary to solicit additional proxies if there are insufficient votes in person or by proxy to approve the proposal to adopt the Merger Agreement at the time of the special meeting. CORPORATE GOVERNANCE ISSUER 107946.000000 0 FOR 107946.000000 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/02/2025 Election of Directors: Robert S. Weiss DIRECTOR ELECTIONS ISSUER 633960.000000 0 FOR 633960.000000 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/02/2025 Election of Directors: Colleen E. Jay DIRECTOR ELECTIONS ISSUER 633960.000000 0 FOR 633960.000000 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/02/2025 Election of Directors: Lawrence E. Kurzius DIRECTOR ELECTIONS ISSUER 633960.000000 0 FOR 633960.000000 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/02/2025 Election of Directors: Cynthia L. Lucchese DIRECTOR ELECTIONS ISSUER 633960.000000 0 FOR 633960.000000 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/02/2025 Election of Directors: Teresa S. Madden DIRECTOR ELECTIONS ISSUER 633960.000000 0 FOR 633960.000000 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/02/2025 Election of Directors: Maria Rivas, M.D. DIRECTOR ELECTIONS ISSUER 633960.000000 0 FOR 633960.000000 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/02/2025 Election of Directors: Albert G. White III DIRECTOR ELECTIONS ISSUER 633960.000000 0 FOR 633960.000000 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/02/2025 Approve an amendment to our Second Restated Certificate of Incorporation to provide for the exculpation of officers. CORPORATE GOVERNANCE ISSUER 633960.000000 0 FOR 633960.000000 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/02/2025 Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending October 31, 2025. AUDIT-RELATED ISSUER 633960.000000 0 FOR 633960.000000 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/02/2025 Approve, on a non-binding, advisory basis, the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 633960.000000 0 FOR 633960.000000 FOR S000004450 Seres Therapeutics, Inc. 81750R201 US81750R2013 04/10/2025 Election of Directors: Dennis A. Ausiello DIRECTOR ELECTIONS ISSUER 148940.000000 239400.000000 FOR 148940.000000 FOR S000004450 Seres Therapeutics, Inc. 81750R201 US81750R2013 04/10/2025 Election of Directors: Willard H. Dere DIRECTOR ELECTIONS ISSUER 148940.000000 239400.000000 FOR 148940.000000 FOR S000004450 Seres Therapeutics, Inc. 81750R201 US81750R2013 04/10/2025 Election of Directors: Eric D. Shaff DIRECTOR ELECTIONS ISSUER 148940.000000 239400.000000 FOR 148940.000000 FOR S000004450 Seres Therapeutics, Inc. 81750R201 US81750R2013 04/10/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 148940.000000 239400.000000 FOR 148940.000000 FOR S000004450 Seres Therapeutics, Inc. 81750R201 US81750R2013 04/10/2025 Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 148940.000000 239400.000000 FOR 148940.000000 FOR S000004450 Seres Therapeutics, Inc. 81750R201 US81750R2013 04/10/2025 Approval of the Seres Therapeutics, Inc. 2025 Incentive Award Plan as an amendment and restatement of the Seres Therapeutics, Inc. 2015 Incentive Award Plan, which is scheduled to expire in 2025. COMPENSATION ISSUER 148940.000000 239400.000000 FOR 148940.000000 FOR S000004450 Seres Therapeutics, Inc. 81750R201 US81750R2013 04/10/2025 Approval of amendments to our Restated Certificate of Incorporation, as amended, to effect a reverse stock split. CAPITAL STRUCTURE ISSUER 148940.000000 239400.000000 FOR 148940.000000 FOR S000004450 Seres Therapeutics, Inc. 81750R201 US81750R2013 04/10/2025 Approval of amendments to our Restated Certificate of Incorporation, as amended, to clarify voting requirements to amend the number of shares of authorized common stock and preferred stock. CAPITAL STRUCTURE ISSUER 148940.000000 239400.000000 FOR 148940.000000 FOR S000004450 Seres Therapeutics, Inc. 81750R201 US81750R2013 04/10/2025 Approval of amendments to our Restated Certificate of Incorporation, as amended, to eliminate supermajority voting requirements. CORPORATE GOVERNANCE ISSUER 148940.000000 239400.000000 FOR 148940.000000 FOR S000004450 Seres Therapeutics, Inc. 81750R201 US81750R2013 04/10/2025 Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposals 5, 6 or 7. CORPORATE GOVERNANCE ISSUER 148940.000000 239400.000000 FOR 148940.000000 FOR S000004450 Aerovate Therapeutics, Inc. 008064206 US0080642061 04/16/2025 To approve the issuance of shares of common stock of Aerovate Therapeutics, Inc. ("Aerovate") (including the shares of Aerovate common stock issuable upon conversion of the Aerovate Series A Non-Voting Convertible Preferred Stock ("Aerovate Series A Preferred Stock") and exercise of the Aerovate pre-funded warrants) to stockholders of Jade Biosciences, Inc. ("Jade") pursuant to the terms of the Agreement and Plan of Merger among Aerovate, Jade and Caribbean Merger Sub I, Inc. ("Merger Sub I") and Caribbean Merger Sub II, LLC ("Merger Sub II" and together with Merger Sub I, the "Merger Subs"), dated as of October 30, 2024, a copy of which is attached as Annex A to the accompanying proxy statement/prospectus, which is referred to in this notice as the "Merger Agreement," a copy of which is attached as Annex A to the accompanying proxy statement/prospectus, which will (i) represent more than 20% of the shares of Aerovate common stock outstanding immediately prior to the Merger (as defined herein) under Nasdaq Listing Rule 5635(a), and (ii) result in a change of control under Nasdaq Listing Rule 5635(b) (the "Nasdaq Stock Issuance Proposal" or "Proposal No. 1"); EXTRAORDINARY TRANSACTIONS ISSUER 28792.000000 0 FOR 28792.000000 FOR S000004450 Aerovate Therapeutics, Inc. 008064206 US0080642061 04/16/2025 To approve an amendment to the amended and restated certificate of incorporation of Aerovate to effect a reverse stock split of Aerovate's issued and outstanding common stock at a ratio determined by the Aerovate board of directors and agreed to by Jade, of one new share of Aerovate common stock for every 20 to 120 shares (or any number in between) of outstanding Aerovate common stock, in the form attached as Annex B to the accompanying proxy statement/prospectus (the "Reverse Stock Split Proposal" or "Proposal No. 2"); CAPITAL STRUCTURE ISSUER 28792.000000 0 FOR 28792.000000 FOR S000004450 Aerovate Therapeutics, Inc. 008064206 US0080642061 04/16/2025 To approve an amendment to the amended and restated certificate of incorporation of Aerovate to increase the number of shares of Aerovate common stock that Aerovate is authorized to issue from 150,000,000 to 300,000,000, in the form attached as Annex C (the "Authorized Share Increase Proposal" or "Proposal No. 3"); CAPITAL STRUCTURE ISSUER 28792.000000 0 FOR 28792.000000 FOR S000004450 Aerovate Therapeutics, Inc. 008064206 US0080642061 04/16/2025 To approve the redomestication of Aerovate from the State of Delaware to the State of Nevada by conversion (the "Redomestication Proposal" or "Proposal No. 4"); EXTRAORDINARY TRANSACTIONS CORPORATE GOVERNANCE ISSUER 28792.000000 0 AGAINST 28792.000000 AGAINST S000004450 Aerovate Therapeutics, Inc. 008064206 US0080642061 04/16/2025 To approve the Jade Biosciences, Inc. 2025 Stock Incentive Plan (the "Stock Plan Proposal" or "Proposal No. 5"); COMPENSATION ISSUER 28792.000000 0 AGAINST 28792.000000 AGAINST S000004450 Aerovate Therapeutics, Inc. 008064206 US0080642061 04/16/2025 To approve the Jade Biosciences, Inc. 2025 Employee Stock Purchase Plan (the "ESPP Proposal" or "Proposal No. 6"); COMPENSATION ISSUER 28792.000000 0 FOR 28792.000000 FOR S000004450 Aerovate Therapeutics, Inc. 008064206 US0080642061 04/16/2025 Elect the three Class I directors, Mark Iwicki, Timothy P. Noyes, and Donald J. Santel, to Aerovate's board of directors and to hold office until Aerovate's 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal; provided that if the Merger is consummated, the approval of Proposal No. 7 will only have an effect until the completion of the Merger because the composition of Aerovate's board of directors will be reconstituted upon completion of the Merger, in accordance with the Merger Agreement (the "Director Election Proposal" or "Proposal No. 7"): Mark Iwicki DIRECTOR ELECTIONS ISSUER 28792.000000 0 WITHHOLD 28792.000000 AGAINST S000004450 Aerovate Therapeutics, Inc. 008064206 US0080642061 04/16/2025 Elect the three Class I directors, Mark Iwicki, Timothy P. Noyes, and Donald J. Santel, to Aerovate's board of directors and to hold office until Aerovate's 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal; provided that if the Merger is consummated, the approval of Proposal No. 7 will only have an effect until the completion of the Merger because the composition of Aerovate's board of directors will be reconstituted upon completion of the Merger, in accordance with the Merger Agreement (the "Director Election Proposal" or "Proposal No. 7"): Timothy P. Noyes DIRECTOR ELECTIONS ISSUER 28792.000000 0 FOR 28792.000000 FOR S000004450 Aerovate Therapeutics, Inc. 008064206 US0080642061 04/16/2025 Elect the three Class I directors, Mark Iwicki, Timothy P. Noyes, and Donald J. Santel, to Aerovate's board of directors and to hold office until Aerovate's 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal; provided that if the Merger is consummated, the approval of Proposal No. 7 will only have an effect until the completion of the Merger because the composition of Aerovate's board of directors will be reconstituted upon completion of the Merger, in accordance with the Merger Agreement (the "Director Election Proposal" or "Proposal No. 7"): Donald J. Santel DIRECTOR ELECTIONS ISSUER 28792.000000 0 FOR 28792.000000 FOR S000004450 Aerovate Therapeutics, Inc. 008064206 US0080642061 04/16/2025 Ratify the appointment of KPMG LLP as Aerovate's independent registered public accounting firm for fiscal year ending December 31, 2025; provided that PricewaterhouseCoopers LLP is expected to be appointed for that fiscal year if the Merger is completed (the "Auditor Ratification Proposal" or "Proposal No. 8"); AUDIT-RELATED ISSUER 28792.000000 0 FOR 28792.000000 FOR S000004450 Aerovate Therapeutics, Inc. 008064206 US0080642061 04/16/2025 To approve an adjournment of the Aerovate Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal Nos. 1, 2 and 3 (the "Adjournment Proposal" or "Proposal No. 9"); and CORPORATE GOVERNANCE ISSUER 28792.000000 0 FOR 28792.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Raquel C. Bono, M.D. DIRECTOR ELECTIONS ISSUER 382203.000000 0.000000 FOR 382203.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 382203.000000 0.000000 FOR 382203.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: David T. Feinberg, M.D. DIRECTOR ELECTIONS ISSUER 382203.000000 0.000000 FOR 382203.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Wayne A. I. Frederick, M.D. DIRECTOR ELECTIONS ISSUER 382203.000000 0.000000 FOR 382203.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: John W. Garratt DIRECTOR ELECTIONS ISSUER 382203.000000 0.000000 FOR 382203.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Kurt J. Hilzinger DIRECTOR ELECTIONS ISSUER 382203.000000 0.000000 FOR 382203.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Karen W. Katz DIRECTOR ELECTIONS ISSUER 382203.000000 0.000000 FOR 382203.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Marcy S. Klevorn DIRECTOR ELECTIONS ISSUER 382203.000000 0.000000 FOR 382203.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Jorge S. Mesquita DIRECTOR ELECTIONS ISSUER 382203.000000 0.000000 FOR 382203.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: James A. Rechtin DIRECTOR ELECTIONS ISSUER 382203.000000 0.000000 FOR 382203.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Gordon Smith DIRECTOR ELECTIONS ISSUER 382203.000000 0.000000 FOR 382203.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/17/2025 The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm. AUDIT-RELATED ISSUER 382203.000000 0.000000 FOR 382203.000000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/17/2025 Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2025 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 382203.000000 0.000000 FOR 382203.000000 FOR S000004450 Paragon 28, Inc. 69913P105 US69913P1057 04/17/2025 To adopt the Agreement and Plan of Merger, dated as of January 28, 2025 (the "merger agreement"), by and among Paragon 28, Inc. (the "Company"), Zimmer, Inc. ("Zimmer"), Gazelle Merger Sub I, Inc. ("Merger Sub"), and, for certain provisions of the merger agreement, Zimmer Biomet Holdings, Inc., pursuant to which and subject to the terms and conditions thereof, Merger Sub will be merged with and into the Company (the "merger"), with the Company continuing as the surviving corporation in the merger and a wholly owned subsidiary of Zimmer. EXTRAORDINARY TRANSACTIONS ISSUER 119233.000000 0 FOR 119233.000000 FOR S000004450 Paragon 28, Inc. 69913P105 US69913P1057 04/17/2025 To approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the Company's named executive officers in connection with the consummation of the merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 119233.000000 0 AGAINST 119233.000000 AGAINST S000004450 Paragon 28, Inc. 69913P105 US69913P1057 04/17/2025 To approve any adjournment of the special meeting for the purpose of soliciting additional proxies if there are insufficient votes at the special meeting to adopt the merger agreement. CORPORATE GOVERNANCE ISSUER 119233.000000 0 FOR 119233.000000 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 US0905722072 04/22/2025 Nominees: Melinda Litherland DIRECTOR ELECTIONS ISSUER 61510.000000 0 FOR 61510.000000 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 US0905722072 04/22/2025 Nominees: Arnold A. Pinkston DIRECTOR ELECTIONS ISSUER 61510.000000 0 FOR 61510.000000 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 US0905722072 04/22/2025 Proposal to ratify the selection of KPMG LLP to serve as the Company's independent auditors. AUDIT-RELATED ISSUER 61510.000000 0 FOR 61510.000000 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 US0905722072 04/22/2025 Stockholder proposal requesting approval of certain executive severance arrangements. COMPENSATION SECURITY HOLDER 61510.000000 0 AGAINST 61510.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/22/2025 To elect ten nominees for director for terms of one year each: Peter Barrett, PhD DIRECTOR ELECTIONS ISSUER 391850.000000 0 FOR 391850.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/22/2025 To elect ten nominees for director for terms of one year each: Samuel R. Chapin DIRECTOR ELECTIONS ISSUER 391850.000000 0 FOR 391850.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/22/2025 To elect ten nominees for director for terms of one year each: Michael A. Klobuchar DIRECTOR ELECTIONS ISSUER 391850.000000 0 FOR 391850.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/22/2025 To elect ten nominees for director for terms of one year each: Michelle McMurry-Heath, MD, PhD DIRECTOR ELECTIONS ISSUER 391850.000000 0 FOR 391850.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/22/2025 To elect ten nominees for director for terms of one year each: Alexis P. Michas DIRECTOR ELECTIONS ISSUER 391850.000000 0 FOR 391850.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/22/2025 To elect ten nominees for director for terms of one year each: Prahlad R. Singh, PhD DIRECTOR ELECTIONS ISSUER 391850.000000 0 FOR 391850.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/22/2025 To elect ten nominees for director for terms of one year each: Sophie V. Vandebroek, PhD DIRECTOR ELECTIONS ISSUER 391850.000000 0 FOR 391850.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/22/2025 To elect ten nominees for director for terms of one year each: Michel Vounatsos DIRECTOR ELECTIONS ISSUER 391850.000000 0 FOR 391850.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/22/2025 To elect ten nominees for director for terms of one year each: Frank Witney, PhD DIRECTOR ELECTIONS ISSUER 391850.000000 0 FOR 391850.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/22/2025 To elect ten nominees for director for terms of one year each: Pascale Witz DIRECTOR ELECTIONS ISSUER 391850.000000 0 FOR 391850.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/22/2025 To ratify the selection of Deloitte & Touche LLP as Revvity's independent registered public accounting firm for the current fiscal year. AUDIT-RELATED ISSUER 391850.000000 0 FOR 391850.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/22/2025 To approve, by non-binding advisory vote, our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 391850.000000 0 FOR 391850.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/22/2025 To approve amendments to Revvity's Restated Articles of Organization, as amended, and Amended and Restated By-laws to implement a majority voting standard for specified corporate actions. CORPORATE GOVERNANCE ISSUER 391850.000000 0 FOR 391850.000000 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/22/2025 To approve the shareholder proposal regarding ability to call a special shareholder meeting, if properly presented at the annual meeting. CORPORATE GOVERNANCE SECURITY HOLDER 391850.000000 0 FOR 391850.000000 AGAINST S000004450 OPKO Health, Inc. 68375N103 US68375N1037 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: Phillip Frost, M.D. DIRECTOR ELECTIONS ISSUER 578513.000000 533500.000000 FOR 578513.000000 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: Jane H. Hsiao, Ph.D., MBA DIRECTOR ELECTIONS ISSUER 578513.000000 533500.000000 FOR 578513.000000 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: Elias A. Zerhouni, M.D. DIRECTOR ELECTIONS ISSUER 578513.000000 533500.000000 FOR 578513.000000 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: Steven D. Rubin DIRECTOR ELECTIONS ISSUER 578513.000000 533500.000000 FOR 578513.000000 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: Gary J. Nabel, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 578513.000000 533500.000000 FOR 578513.000000 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: Richard M. Krasno, Ph.D. DIRECTOR ELECTIONS ISSUER 578513.000000 533500.000000 FOR 578513.000000 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: Prem A. Lachman, M.D. DIRECTOR ELECTIONS ISSUER 578513.000000 533500.000000 FOR 578513.000000 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: Roger J. Medel, M.D. DIRECTOR ELECTIONS ISSUER 578513.000000 533500.000000 FOR 578513.000000 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: John A. Paganelli DIRECTOR ELECTIONS ISSUER 578513.000000 533500.000000 FOR 578513.000000 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: Richard C. Pfenniger, Jr DIRECTOR ELECTIONS ISSUER 578513.000000 533500.000000 FOR 578513.000000 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: Alice Lin-Tsing Yu, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 578513.000000 533500.000000 FOR 578513.000000 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 04/23/2025 To approve a non-binding resolution regarding the compensation paid to the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 578513.000000 533500.000000 FOR 578513.000000 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 04/23/2025 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 AUDIT-RELATED ISSUER 578513.000000 533500.000000 FOR 578513.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: David M. Cordani DIRECTOR ELECTIONS ISSUER 883576.000000 0.000000 FOR 883576.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: Eric J. Foss DIRECTOR ELECTIONS ISSUER 883576.000000 0.000000 FOR 883576.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: Retired Maj. Gen. Elder Granger, M.D. DIRECTOR ELECTIONS ISSUER 883576.000000 0.000000 FOR 883576.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: Neesha Hathi DIRECTOR ELECTIONS ISSUER 883576.000000 0.000000 FOR 883576.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: George Kurian DIRECTOR ELECTIONS ISSUER 883576.000000 0.000000 FOR 883576.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: Kathleen M. Mazzarella DIRECTOR ELECTIONS ISSUER 883576.000000 0.000000 FOR 883576.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: Mark B. McClellan, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 883576.000000 0.000000 FOR 883576.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: Philip O. Ozuah, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 883576.000000 0.000000 FOR 883576.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: Kimberly A. Ross DIRECTOR ELECTIONS ISSUER 883576.000000 0.000000 FOR 883576.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: Eric C. Wiseman DIRECTOR ELECTIONS ISSUER 883576.000000 0.000000 FOR 883576.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: Donna F. Zarcone DIRECTOR ELECTIONS ISSUER 883576.000000 0.000000 FOR 883576.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/23/2025 Advisory approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 883576.000000 0.000000 FOR 883576.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/23/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2025 AUDIT-RELATED ISSUER 883576.000000 0.000000 FOR 883576.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/23/2025 Shareholder proposal - Support Special Shareholder Meeting Improvement CORPORATE GOVERNANCE SECURITY HOLDER 883576.000000 0.000000 AGAINST 883576.000000 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/24/2025 Election of Directors (to serve until the 2026 Annual Meeting): Gary D. Blackford DIRECTOR ELECTIONS ISSUER 146602.000000 0 FOR 146602.000000 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/24/2025 Election of Directors (to serve until the 2026 Annual Meeting): Dr. Lisa Egbuonu-Davis DIRECTOR ELECTIONS ISSUER 146602.000000 0 FOR 146602.000000 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/24/2025 Election of Directors (to serve until the 2026 Annual Meeting): Indrani L. Franchini DIRECTOR ELECTIONS ISSUER 146602.000000 0 FOR 146602.000000 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/24/2025 Election of Directors (to serve until the 2026 Annual Meeting): Patrick J. O'Leary DIRECTOR ELECTIONS ISSUER 146602.000000 0 FOR 146602.000000 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/24/2025 Election of Directors (to serve until the 2026 Annual Meeting): Dr. Julie Shimer DIRECTOR ELECTIONS ISSUER 146602.000000 0 FOR 146602.000000 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/24/2025 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 146602.000000 0 FOR 146602.000000 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/24/2025 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 146602.000000 0 FOR 146602.000000 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/24/2025 Approval of an amendment to the Company's 2021 Long Term Incentive Plan to increase the number of shares reserved for issuance thereunder by 2,250,000 shares. COMPENSATION ISSUER 146602.000000 0 FOR 146602.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Election of Directors: Thomas F. Frist III DIRECTOR ELECTIONS ISSUER 615710.000000 0 FOR 615710.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Election of Directors: Samuel N. Hazen DIRECTOR ELECTIONS ISSUER 615710.000000 0 FOR 615710.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Election of Directors: Robert J. Dennis DIRECTOR ELECTIONS ISSUER 615710.000000 0 FOR 615710.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Election of Directors: Nancy-Ann DeParle DIRECTOR ELECTIONS ISSUER 615710.000000 0 FOR 615710.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Election of Directors: William R. Frist DIRECTOR ELECTIONS ISSUER 615710.000000 0 FOR 615710.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Election of Directors: Hugh F. Johnston DIRECTOR ELECTIONS ISSUER 615710.000000 0 FOR 615710.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Election of Directors: Michael W. Michelson DIRECTOR ELECTIONS ISSUER 615710.000000 0 FOR 615710.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Election of Directors: Wayne J. Riley M.D. DIRECTOR ELECTIONS ISSUER 615710.000000 0 FOR 615710.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Election of Directors: Andrea B. Smith DIRECTOR ELECTIONS ISSUER 615710.000000 0 FOR 615710.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 615710.000000 0 FOR 615710.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 615710.000000 0 FOR 615710.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 To approve the First Amendment to the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates. COMPENSATION ISSUER 615710.000000 0 FOR 615710.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 To approve an amendment to our amended and restated certificate of incorporation to provide for the exculpation of officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 615710.000000 0 FOR 615710.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Stockholder proposal, if properly presented at the meeting, regarding lavish golden parachutes. COMPENSATION SECURITY HOLDER 615710.000000 0 AGAINST 615710.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Stockholder proposal, if properly presented at the meeting, regarding an amendment to Patient Safety and Quality of Care Committee charter. OTHER SOCIAL ISSUES SECURITY HOLDER 615710.000000 0 AGAINST 615710.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Stockholder proposal, if properly presented at the meeting, regarding report on acquisition strategy. OTHER SOCIAL ISSUES SECURITY HOLDER 615710.000000 0 AGAINST 615710.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 The election of each of the director nominees listed below (a through i): Ari Bousbib DIRECTOR ELECTIONS ISSUER 579637.000000 0 FOR 579637.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 The election of each of the director nominees listed below (a through i): Carol J. Burt DIRECTOR ELECTIONS ISSUER 579637.000000 0 FOR 579637.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 The election of each of the director nominees listed below (a through i): John G. Danhakl DIRECTOR ELECTIONS ISSUER 579637.000000 0 FOR 579637.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 The election of each of the director nominees listed below (a through i): James A. Fasano DIRECTOR ELECTIONS ISSUER 579637.000000 0 FOR 579637.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 The election of each of the director nominees listed below (a through i): Colleen A. Goggins DIRECTOR ELECTIONS ISSUER 579637.000000 0 FOR 579637.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 The election of each of the director nominees listed below (a through i): John M. Leonard, M.D. DIRECTOR ELECTIONS ISSUER 579637.000000 0 FOR 579637.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 The election of each of the director nominees listed below (a through i): Leslie Wims Morris DIRECTOR ELECTIONS ISSUER 579637.000000 0 FOR 579637.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 The election of each of the director nominees listed below (a through i): Todd B. Sisitsky DIRECTOR ELECTIONS ISSUER 579637.000000 0 FOR 579637.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 The election of each of the director nominees listed below (a through i): Sheila A. Stamps DIRECTOR ELECTIONS ISSUER 579637.000000 0 FOR 579637.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 Approve an advisory (non-binding) resolution to approve IQVIA'S executive compensation (say-on-pay). SECTION 14A SAY-ON-PAY VOTES ISSUER 579637.000000 0 FOR 579637.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 579637.000000 0 FOR 579637.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 Approve a Company proposal to amend IQVIA's Certificate of Incorporation regarding officer exculpation. CORPORATE GOVERNANCE ISSUER 579637.000000 0 FOR 579637.000000 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 If properly presented, a stockholder proposal concerning special stockholder meetings. CORPORATE GOVERNANCE SECURITY HOLDER 579637.000000 0 AGAINST 579637.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Darius Adamczyk DIRECTOR ELECTIONS ISSUER 5707835.000000 0 FOR 5707835.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Mary C. Beckerle DIRECTOR ELECTIONS ISSUER 5707835.000000 0 FOR 5707835.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Jennifer A. Doudna DIRECTOR ELECTIONS ISSUER 5707835.000000 0 FOR 5707835.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Joaquin Duato DIRECTOR ELECTIONS ISSUER 5707835.000000 0 FOR 5707835.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Marillyn A. Hewson DIRECTOR ELECTIONS ISSUER 5707835.000000 0 FOR 5707835.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Paula A. Johnson DIRECTOR ELECTIONS ISSUER 5707835.000000 0 FOR 5707835.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Hubert Joly DIRECTOR ELECTIONS ISSUER 5707835.000000 0 FOR 5707835.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Mark B. McClellan DIRECTOR ELECTIONS ISSUER 5707835.000000 0 FOR 5707835.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Mark A. Weinberger DIRECTOR ELECTIONS ISSUER 5707835.000000 0 FOR 5707835.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Nadja Y. West DIRECTOR ELECTIONS ISSUER 5707835.000000 0 FOR 5707835.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Eugene A. Woods DIRECTOR ELECTIONS ISSUER 5707835.000000 0 FOR 5707835.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/24/2025 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 5707835.000000 0 FOR 5707835.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/24/2025 Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 5707835.000000 0 FOR 5707835.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/24/2025 Shareholder opportunity to vote on excessive golden parachutes COMPENSATION SECURITY HOLDER 5707835.000000 0 AGAINST 5707835.000000 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/24/2025 Produce a human rights impact assessment HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 5707835.000000 0 AGAINST 5707835.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Ronald E. Blaylock DIRECTOR ELECTIONS ISSUER 18000499.000000 0 FOR 18000499.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Albert Bourla DIRECTOR ELECTIONS ISSUER 18000499.000000 0 FOR 18000499.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Mortimer J. Buckley DIRECTOR ELECTIONS ISSUER 18000499.000000 0 FOR 18000499.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Susan Desmond-Hellmann DIRECTOR ELECTIONS ISSUER 18000499.000000 0 FOR 18000499.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Joseph J. Echevarria DIRECTOR ELECTIONS ISSUER 18000499.000000 0 FOR 18000499.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Scott Gottlieb DIRECTOR ELECTIONS ISSUER 18000499.000000 0 FOR 18000499.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Susan Hockfield DIRECTOR ELECTIONS ISSUER 18000499.000000 0 FOR 18000499.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Dan R. Littman DIRECTOR ELECTIONS ISSUER 18000499.000000 0 FOR 18000499.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Shantanu Narayen DIRECTOR ELECTIONS ISSUER 18000499.000000 0 FOR 18000499.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Suzanne Nora Johnson DIRECTOR ELECTIONS ISSUER 18000499.000000 0 FOR 18000499.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: James Quincey DIRECTOR ELECTIONS ISSUER 18000499.000000 0 FOR 18000499.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: James C. Smith DIRECTOR ELECTIONS ISSUER 18000499.000000 0 FOR 18000499.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Cyrus Taraporevala DIRECTOR ELECTIONS ISSUER 18000499.000000 0 FOR 18000499.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/24/2025 Ratify the selection of KPMG LLP as our independent registered public accounting firm for 2025 AUDIT-RELATED ISSUER 18000499.000000 0 FOR 18000499.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/24/2025 2025 advisory approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 18000499.000000 0 FOR 18000499.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/24/2025 Shareholder Vote Regarding Golden Parachutes COMPENSATION SECURITY HOLDER 18000499.000000 0 AGAINST 18000499.000000 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/24/2025 Issue a Report Evaluating the Risks Related to Religious Discrimination Against Employees ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 18000499.000000 0 AGAINST 18000499.000000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/24/2025 Vote to elect four Class I directors, each for a term of three years or until their respective successors have been elected and qualified: Russell L. Carson DIRECTOR ELECTIONS ISSUER 351509.000000 0 FOR 351509.000000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/24/2025 Vote to elect four Class I directors, each for a term of three years or until their respective successors have been elected and qualified: Katherine R. Davisson DIRECTOR ELECTIONS ISSUER 351509.000000 0 FOR 351509.000000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/24/2025 Vote to elect four Class I directors, each for a term of three years or until their respective successors have been elected and qualified: William H. Frist DIRECTOR ELECTIONS ISSUER 351509.000000 0 FOR 351509.000000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/24/2025 Vote to elect four Class I directors, each for a term of three years or until their respective successors have been elected and qualified: Marilyn B. Tavenner DIRECTOR ELECTIONS ISSUER 351509.000000 0 FOR 351509.000000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/24/2025 Vote to approve an amendment to the Company's Amended and Restated Certificate of Incorporation to eliminate supermajority voting requirements; CORPORATE GOVERNANCE ISSUER 351509.000000 0 FOR 351509.000000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/24/2025 Vote to approve the Company's Non-Employee Director Compensation Policy; COMPENSATION ISSUER 351509.000000 0 FOR 351509.000000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/24/2025 Vote on a stockholder proposal to amend the Company's Amended and Restated Certificate of Incorporation to elect each director annually, if properly presented at the meeting; SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 351509.000000 0 FOR 351509.000000 NONE S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/24/2025 Non-binding advisory vote on the compensation of our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 351509.000000 0 FOR 351509.000000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/24/2025 Vote to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 351509.000000 0 FOR 351509.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: R. J. Alpern DIRECTOR ELECTIONS ISSUER 5527441.000000 0 FOR 5527441.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: C. Babineaux-Fontenot DIRECTOR ELECTIONS ISSUER 5527441.000000 0 FOR 5527441.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: S. E. Blount DIRECTOR ELECTIONS ISSUER 5527441.000000 0 FOR 5527441.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: R. B. Ford DIRECTOR ELECTIONS ISSUER 5527441.000000 0 FOR 5527441.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: P. Gonzalez DIRECTOR ELECTIONS ISSUER 5527441.000000 0 FOR 5527441.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: M. A. Kumbier DIRECTOR ELECTIONS ISSUER 5527441.000000 0 FOR 5527441.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: D. W. McDew DIRECTOR ELECTIONS ISSUER 5527441.000000 0 FOR 5527441.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: N. McKinstry DIRECTOR ELECTIONS ISSUER 5527441.000000 0 FOR 5527441.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: M. G. O'Grady DIRECTOR ELECTIONS ISSUER 5527441.000000 0 FOR 5527441.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: M. F. Roman DIRECTOR ELECTIONS ISSUER 5527441.000000 0 FOR 5527441.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: D. J. Starks DIRECTOR ELECTIONS ISSUER 5527441.000000 0 FOR 5527441.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: J. G. Stratton DIRECTOR ELECTIONS ISSUER 5527441.000000 0 FOR 5527441.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/25/2025 Ratification of Ernst & Young LLP As Auditors AUDIT-RELATED ISSUER 5527441.000000 0 FOR 5527441.000000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/25/2025 Say on Pay - An Advisory Vote on the Approval of Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 5527441.000000 0 FOR 5527441.000000 FOR S000004450 Masimo Corporation 574795100 US5747951003 04/29/2025 Election of Directors: William Jellison DIRECTOR ELECTIONS ISSUER 144680.000000 0 FOR 144680.000000 FOR S000004450 Masimo Corporation 574795100 US5747951003 04/29/2025 Election of Directors: Wendy Lane DIRECTOR ELECTIONS ISSUER 144680.000000 0 FOR 144680.000000 FOR S000004450 Masimo Corporation 574795100 US5747951003 04/29/2025 Election of Directors: Timothy Scannell DIRECTOR ELECTIONS ISSUER 144680.000000 0 FOR 144680.000000 FOR S000004450 Masimo Corporation 574795100 US5747951003 04/29/2025 Election of Directors: Darlene Solomon DIRECTOR ELECTIONS ISSUER 144680.000000 0 FOR 144680.000000 FOR S000004450 Masimo Corporation 574795100 US5747951003 04/29/2025 Election of Directors: Catherine Szyman DIRECTOR ELECTIONS ISSUER 144680.000000 0 FOR 144680.000000 FOR S000004450 Masimo Corporation 574795100 US5747951003 04/29/2025 To ratify the selection of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending January 3, 2026. AUDIT-RELATED ISSUER 144680.000000 0 FOR 144680.000000 FOR S000004450 Masimo Corporation 574795100 US5747951003 04/29/2025 An advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 144680.000000 0 FOR 144680.000000 FOR S000004450 Claritev Corporation 62548M209 US62548M2098 04/30/2025 Election of the three Class II nominees named in the proxy statement to our Board of Directors: Richard A. Clarke DIRECTOR ELECTIONS ISSUER 20538.000000 0 FOR 20538.000000 FOR S000004450 Claritev Corporation 62548M209 US62548M2098 04/30/2025 Election of the three Class II nominees named in the proxy statement to our Board of Directors: Julie D. Klapstein DIRECTOR ELECTIONS ISSUER 20538.000000 0 FOR 20538.000000 FOR S000004450 Claritev Corporation 62548M209 US62548M2098 04/30/2025 Election of the three Class II nominees named in the proxy statement to our Board of Directors: Jason Kap DIRECTOR ELECTIONS ISSUER 20538.000000 0 FOR 20538.000000 FOR S000004450 Claritev Corporation 62548M209 US62548M2098 04/30/2025 Ratification of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal 2025. AUDIT-RELATED ISSUER 20538.000000 0 FOR 20538.000000 FOR S000004450 Claritev Corporation 62548M209 US62548M2098 04/30/2025 Advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 20538.000000 0 FOR 20538.000000 FOR S000004450 Claritev Corporation 62548M209 US62548M2098 04/30/2025 Approval of the Amendment to the Claritev Corporation 2020 Omnibus Incentive Plan. COMPENSATION ISSUER 20538.000000 0 FOR 20538.000000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 US29089Q1058 04/30/2025 To elect three Class I directors to hold office for a term expiring at our 2028 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Keith Katkin DIRECTOR ELECTIONS ISSUER 171966.000000 0 FOR 171966.000000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 US29089Q1058 04/30/2025 To elect three Class I directors to hold office for a term expiring at our 2028 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Ronald Richard DIRECTOR ELECTIONS ISSUER 171966.000000 0 FOR 171966.000000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 US29089Q1058 04/30/2025 To elect three Class I directors to hold office for a term expiring at our 2028 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Kathryn Zoon Ph.D. DIRECTOR ELECTIONS ISSUER 171966.000000 0 FOR 171966.000000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 US29089Q1058 04/30/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 171966.000000 0 FOR 171966.000000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 US29089Q1058 04/30/2025 To hold, on an advisory basis, a vote to approve the 2024 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 171966.000000 0 FOR 171966.000000 FOR S000004450 Moderna, Inc. 60770K107 US60770K1079 04/30/2025 To elect three Class I director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Noubar B. Afeyan DIRECTOR ELECTIONS ISSUER 1038702.000000 0 FOR 1038702.000000 FOR S000004450 Moderna, Inc. 60770K107 US60770K1079 04/30/2025 To elect three Class I director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Stephane Bancel DIRECTOR ELECTIONS ISSUER 1038702.000000 0 FOR 1038702.000000 FOR S000004450 Moderna, Inc. 60770K107 US60770K1079 04/30/2025 To elect three Class I director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Francois Nader, M.D. DIRECTOR ELECTIONS ISSUER 1038702.000000 0 FOR 1038702.000000 FOR S000004450 Moderna, Inc. 60770K107 US60770K1079 04/30/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1038702.000000 0 FOR 1038702.000000 FOR S000004450 Moderna, Inc. 60770K107 US60770K1079 04/30/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 1038702.000000 0 FOR 1038702.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To elect nine directors to hold office until the 2026 Annual Meeting: Barbara L. Brasier DIRECTOR ELECTIONS ISSUER 181331.000000 0.000000 FOR 181331.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To elect nine directors to hold office until the 2026 Annual Meeting: Leo P. Grohowski DIRECTOR ELECTIONS ISSUER 181331.000000 0.000000 FOR 181331.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To elect nine directors to hold office until the 2026 Annual Meeting: Stephen H. Lockhart DIRECTOR ELECTIONS ISSUER 181331.000000 0.000000 FOR 181331.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To elect nine directors to hold office until the 2026 Annual Meeting: Steven J. Orlando DIRECTOR ELECTIONS ISSUER 181331.000000 0.000000 FOR 181331.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To elect nine directors to hold office until the 2026 Annual Meeting: Ronna E. Romney DIRECTOR ELECTIONS ISSUER 181331.000000 0.000000 FOR 181331.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To elect nine directors to hold office until the 2026 Annual Meeting: Richard M. Schapiro DIRECTOR ELECTIONS ISSUER 181331.000000 0.000000 FOR 181331.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To elect nine directors to hold office until the 2026 Annual Meeting: Dale B. Wolf DIRECTOR ELECTIONS ISSUER 181331.000000 0.000000 FOR 181331.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To elect nine directors to hold office until the 2026 Annual Meeting: Richard C. Zoretic DIRECTOR ELECTIONS ISSUER 181331.000000 0.000000 FOR 181331.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To elect nine directors to hold office until the 2026 Annual Meeting: Joseph M. Zubretsky DIRECTOR ELECTIONS ISSUER 181331.000000 0.000000 FOR 181331.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 181331.000000 0.000000 AGAINST 181331.000000 AGAINST S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 181331.000000 0.000000 FOR 181331.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To consider and approve the Company's 2025 Equity Incentive Plan. COMPENSATION ISSUER 181331.000000 0.000000 FOR 181331.000000 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 Stockholder proposal regarding stockholders ability to call a special stockholders meeting, if properly presented. CORPORATE GOVERNANCE SECURITY HOLDER 181331.000000 0.000000 FOR 181331.000000 AGAINST S000004450 Solventum Corp. 83444M101 US83444M1018 04/30/2025 Election of Directors: Glenn A. Eisenberg DIRECTOR ELECTIONS ISSUER 466112.000000 0 FOR 466112.000000 FOR S000004450 Solventum Corp. 83444M101 US83444M1018 04/30/2025 Election of Directors: Elizabeth A. Mily DIRECTOR ELECTIONS ISSUER 466112.000000 0 FOR 466112.000000 FOR S000004450 Solventum Corp. 83444M101 US83444M1018 04/30/2025 Election of Directors: John H. Weiland DIRECTOR ELECTIONS ISSUER 466112.000000 0 FOR 466112.000000 FOR S000004450 Solventum Corp. 83444M101 US83444M1018 04/30/2025 Election of Directors: Amy A. Wendell DIRECTOR ELECTIONS ISSUER 466112.000000 0 FOR 466112.000000 FOR S000004450 Solventum Corp. 83444M101 US83444M1018 04/30/2025 Advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 466112.000000 0 FOR 466112.000000 FOR S000004450 Solventum Corp. 83444M101 US83444M1018 04/30/2025 Advisory vote on frequency of advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 466112.000000 0 ONE YEAR 466112.000000 FOR S000004450 Solventum Corp. 83444M101 US83444M1018 04/30/2025 Ratification of the appointment of PwC as Solventum's independent registered public accounting firm for the fiscal year ending December 31, 2025 AUDIT-RELATED ISSUER 466112.000000 0 FOR 466112.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 04/30/2025 Election of Directors: Robert L. Zerbe DIRECTOR ELECTIONS ISSUER 156626.000000 0 FOR 156626.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 04/30/2025 Election of Directors: Alan L. Rubino DIRECTOR ELECTIONS ISSUER 156626.000000 0 FOR 156626.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 04/30/2025 Election of Directors: Heidi Hagen DIRECTOR ELECTIONS ISSUER 156626.000000 0 FOR 156626.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 04/30/2025 Election of Directors: Kevin F. McLaughlin DIRECTOR ELECTIONS ISSUER 156626.000000 0 FOR 156626.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 04/30/2025 Election of Directors: Paul K. Wotton DIRECTOR ELECTIONS ISSUER 156626.000000 0 FOR 156626.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 04/30/2025 Election of Directors: Dominick C. Colangelo DIRECTOR ELECTIONS ISSUER 156626.000000 0 FOR 156626.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 04/30/2025 Election of Directors: Lisa Wright DIRECTOR ELECTIONS ISSUER 156626.000000 0 FOR 156626.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 04/30/2025 To approve, on an advisory basis, the compensation of Vericel Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 156626.000000 0 FOR 156626.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 04/30/2025 To ratify the appointment of PricewaterhouseCoopers LLP as Vericel Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 156626.000000 0 FOR 156626.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 04/30/2025 To approve the adoption of Vericel Corporation's Amended and Restated 2022 Omnibus Incentive Plan. COMPENSATION ISSUER 156626.000000 0 FOR 156626.000000 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 04/30/2025 To approve the adoption of Vericel Corporation's Amended and Restated 2015 Employee Stock Purchase Plan. COMPENSATION ISSUER 156626.000000 0 FOR 156626.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: Yoshiaki Fujimori DIRECTOR ELECTIONS ISSUER 4671891.000000 0 FOR 4671891.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: David C. Habiger DIRECTOR ELECTIONS ISSUER 4671891.000000 0 FOR 4671891.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: Edward J. Ludwig DIRECTOR ELECTIONS ISSUER 4671891.000000 0 FOR 4671891.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 4671891.000000 0 FOR 4671891.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: Jessica L. Mega DIRECTOR ELECTIONS ISSUER 4671891.000000 0 FOR 4671891.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: Susan E. Morano DIRECTOR ELECTIONS ISSUER 4671891.000000 0 FOR 4671891.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: Cheryl Pegus DIRECTOR ELECTIONS ISSUER 4671891.000000 0 FOR 4671891.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: John E. Sununu DIRECTOR ELECTIONS ISSUER 4671891.000000 0 FOR 4671891.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: David S. Wichmann DIRECTOR ELECTIONS ISSUER 4671891.000000 0 FOR 4671891.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: Ellen M. Zane DIRECTOR ELECTIONS ISSUER 4671891.000000 0 FOR 4671891.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 4671891.000000 0 FOR 4671891.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2025 fiscal year. AUDIT-RELATED ISSUER 4671891.000000 0 FOR 4671891.000000 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Stockholder proposal titled "Support Simple Majority Vote." CORPORATE GOVERNANCE SECURITY HOLDER 4671891.000000 0 FOR 4671891.000000 NONE S000004450 Concentra Group Holdings Parent, Inc. 20603L102 US20603L1026 05/01/2025 Elect two Class I directors, each for a term of three years or until their respective successors have been elected and qualified: Cheryl B. Pegus DIRECTOR ELECTIONS ISSUER 363382.000000 0 FOR 363382.000000 FOR S000004450 Concentra Group Holdings Parent, Inc. 20603L102 US20603L1026 05/01/2025 Elect two Class I directors, each for a term of three years or until their respective successors have been elected and qualified: Daniel J. Thomas DIRECTOR ELECTIONS ISSUER 363382.000000 0 FOR 363382.000000 FOR S000004450 Concentra Group Holdings Parent, Inc. 20603L102 US20603L1026 05/01/2025 Hold a non-binding advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 363382.000000 0 FOR 363382.000000 FOR S000004450 Concentra Group Holdings Parent, Inc. 20603L102 US20603L1026 05/01/2025 Hold a non-binding advisory vote on the frequency of the advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 363382.000000 0 ONE YEAR 363382.000000 FOR S000004450 Concentra Group Holdings Parent, Inc. 20603L102 US20603L1026 05/01/2025 Ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 363382.000000 0 FOR 363382.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/01/2025 Election of ten nominees to the Board of Directors to serve until our 2026 Annual Meeting of Stockholders: Greg D. Carmichael DIRECTOR ELECTIONS ISSUER 319435.000000 0 FOR 319435.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/01/2025 Election of ten nominees to the Board of Directors to serve until our 2026 Annual Meeting of Stockholders: Edward M. Christie III DIRECTOR ELECTIONS ISSUER 319435.000000 0 FOR 319435.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/01/2025 Election of ten nominees to the Board of Directors to serve until our 2026 Annual Meeting of Stockholders: Joan E. Herman DIRECTOR ELECTIONS ISSUER 319435.000000 0 FOR 319435.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/01/2025 Election of ten nominees to the Board of Directors to serve until our 2026 Annual Meeting of Stockholders: Leslye G. Katz DIRECTOR ELECTIONS ISSUER 319435.000000 0 FOR 319435.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/01/2025 Election of ten nominees to the Board of Directors to serve until our 2026 Annual Meeting of Stockholders: Patricia A. Maryland DIRECTOR ELECTIONS ISSUER 319435.000000 0 FOR 319435.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/01/2025 Election of ten nominees to the Board of Directors to serve until our 2026 Annual Meeting of Stockholders: Kevin J. O'Connor DIRECTOR ELECTIONS ISSUER 319435.000000 0 FOR 319435.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/01/2025 Election of ten nominees to the Board of Directors to serve until our 2026 Annual Meeting of Stockholders: Christopher R. Reidy DIRECTOR ELECTIONS ISSUER 319435.000000 0 FOR 319435.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/01/2025 Election of ten nominees to the Board of Directors to serve until our 2026 Annual Meeting of Stockholders: Nancy M. Schlichting DIRECTOR ELECTIONS ISSUER 319435.000000 0 FOR 319435.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/01/2025 Election of ten nominees to the Board of Directors to serve until our 2026 Annual Meeting of Stockholders: Mark J. Tarr DIRECTOR ELECTIONS ISSUER 319435.000000 0 FOR 319435.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/01/2025 Election of ten nominees to the Board of Directors to serve until our 2026 Annual Meeting of Stockholders: Terrance Williams DIRECTOR ELECTIONS ISSUER 319435.000000 0 FOR 319435.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/01/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 319435.000000 0 FOR 319435.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/01/2025 An advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 319435.000000 0 FOR 319435.000000 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/01/2025 A vote to approve the Company's 2025 Omnibus Performance Incentive Plan. COMPENSATION ISSUER 319435.000000 0 FOR 319435.000000 FOR S000004450 Halozyme Therapeutics, Inc. 40637H109 US40637H1095 05/01/2025 Election of Class III Directors: Jeffrey W. Henderson DIRECTOR ELECTIONS ISSUER 404146.000000 0 FOR 404146.000000 FOR S000004450 Halozyme Therapeutics, Inc. 40637H109 US40637H1095 05/01/2025 Election of Class III Directors: Helen I. Torley DIRECTOR ELECTIONS ISSUER 404146.000000 0 FOR 404146.000000 FOR S000004450 Halozyme Therapeutics, Inc. 40637H109 US40637H1095 05/01/2025 To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 404146.000000 0 FOR 404146.000000 FOR S000004450 Halozyme Therapeutics, Inc. 40637H109 US40637H1095 05/01/2025 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 404146.000000 0 FOR 404146.000000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 US4577301090 05/01/2025 Election of Class I Directors: Cynthia B. Burks DIRECTOR ELECTIONS ISSUER 95193.000000 0 FOR 95193.000000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 US4577301090 05/01/2025 Election of Class I Directors: Timothy P. Herbert DIRECTOR ELECTIONS ISSUER 95193.000000 0 FOR 95193.000000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 US4577301090 05/01/2025 Election of Class I Directors: Shawn T McCormick DIRECTOR ELECTIONS ISSUER 95193.000000 0 FOR 95193.000000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 US4577301090 05/01/2025 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 95193.000000 0 FOR 95193.000000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 US4577301090 05/01/2025 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 95193.000000 0 FOR 95193.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Craig H. Barratt, Ph.D. DIRECTOR ELECTIONS ISSUER 1131797.000000 0 FOR 1131797.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Joseph C. Beery DIRECTOR ELECTIONS ISSUER 1131797.000000 0 FOR 1131797.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Lewis Chew DIRECTOR ELECTIONS ISSUER 1131797.000000 0 FOR 1131797.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Gary S. Guthart, Ph.D. DIRECTOR ELECTIONS ISSUER 1131797.000000 0 FOR 1131797.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Amal M. Johnson DIRECTOR ELECTIONS ISSUER 1131797.000000 0 FOR 1131797.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 1131797.000000 0 FOR 1131797.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Amy L. Ladd, M.D. DIRECTOR ELECTIONS ISSUER 1131797.000000 0 FOR 1131797.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Keith R. Leonard, Jr. DIRECTOR ELECTIONS ISSUER 1131797.000000 0 FOR 1131797.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Jami Dover Nachtsheim DIRECTOR ELECTIONS ISSUER 1131797.000000 0 FOR 1131797.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Monica P. Reed, M.D. DIRECTOR ELECTIONS ISSUER 1131797.000000 0 FOR 1131797.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: David J. Rosa DIRECTOR ELECTIONS ISSUER 1131797.000000 0 FOR 1131797.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 To approve, by advisory vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1131797.000000 0 FOR 1131797.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 1131797.000000 0 FOR 1131797.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 The amendment and restatement of the Amended and Restated 2010 Incentive Award Plan. COMPENSATION ISSUER 1131797.000000 0 FOR 1131797.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 The stockholder proposal purportedly "to improve the executive compensation program," if properly presented at the Annual Meeting. COMPENSATION SECURITY HOLDER 1131797.000000 0 AGAINST 1131797.000000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 The stockholder proposal that is titled "requesting a shareholder approval requirement for excessive golden parachutes," if properly presented at the Annual Meeting. COMPENSATION SECURITY HOLDER 1131797.000000 0 AGAINST 1131797.000000 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 05/01/2025 The election of four Class I directors to our Board of Directors: Ms. Mary Anne Heino DIRECTOR ELECTIONS ISSUER 220935.000000 0 FOR 220935.000000 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 05/01/2025 The election of four Class I directors to our Board of Directors: Dr. Gerard Ber DIRECTOR ELECTIONS ISSUER 220935.000000 0 FOR 220935.000000 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 05/01/2025 The election of four Class I directors to our Board of Directors: Ms. Julie Eastland DIRECTOR ELECTIONS ISSUER 220935.000000 0 FOR 220935.000000 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 05/01/2025 The election of four Class I directors to our Board of Directors: Mr. Samuel Leno DIRECTOR ELECTIONS ISSUER 220935.000000 0 FOR 220935.000000 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 05/01/2025 The approval, on an advisory basis, of the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 220935.000000 0 FOR 220935.000000 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 05/01/2025 The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 220935.000000 0 FOR 220935.000000 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 05/01/2025 The shareholder proposal regarding the declassification of our Board of Directors. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 220935.000000 0 FOR 220935.000000 NONE S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/01/2025 ELECTION OF DIRECTORS: Roland Diggelmann DIRECTOR ELECTIONS ISSUER 67058.000000 0 FOR 67058.000000 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/01/2025 ELECTION OF DIRECTORS: Domitille Doat-Le Bigot DIRECTOR ELECTIONS ISSUER 67058.000000 0 FOR 67058.000000 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/01/2025 ELECTION OF DIRECTORS: Elisha W. Finney DIRECTOR ELECTIONS ISSUER 67058.000000 0 FOR 67058.000000 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/01/2025 ELECTION OF DIRECTORS: Michael A. Kelly DIRECTOR ELECTIONS ISSUER 67058.000000 0 FOR 67058.000000 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/01/2025 ELECTION OF DIRECTORS: Thomas P. Salice DIRECTOR ELECTIONS ISSUER 67058.000000 0 FOR 67058.000000 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/01/2025 ELECTION OF DIRECTORS: Brian Shepherd DIRECTOR ELECTIONS ISSUER 67058.000000 0 FOR 67058.000000 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/01/2025 ELECTION OF DIRECTORS: Wolfgang Wienand DIRECTOR ELECTIONS ISSUER 67058.000000 0 FOR 67058.000000 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/01/2025 ELECTION OF DIRECTORS: Ingrid Zhang DIRECTOR ELECTIONS ISSUER 67058.000000 0 FOR 67058.000000 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/01/2025 RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM AUDIT-RELATED ISSUER 67058.000000 0 FOR 67058.000000 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/01/2025 ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION SECTION 14A SAY-ON-PAY VOTES ISSUER 67058.000000 0 FOR 67058.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Bradley A. Alford DIRECTOR ELECTIONS ISSUER 433826.000000 0 FOR 433826.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Orlando D. Ashford DIRECTOR ELECTIONS ISSUER 433826.000000 0 FOR 433826.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Julia M. Brown DIRECTOR ELECTIONS ISSUER 433826.000000 0 FOR 433826.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Kevin Egan DIRECTOR ELECTIONS ISSUER 433826.000000 0 FOR 433826.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Adriana Karaboutis DIRECTOR ELECTIONS ISSUER 433826.000000 0 FOR 433826.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Jeffrey B. Kindler DIRECTOR ELECTIONS ISSUER 433826.000000 0 FOR 433826.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Patrick Lockwood-Taylor DIRECTOR ELECTIONS ISSUER 433826.000000 0 FOR 433826.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Albert A. Manzone DIRECTOR ELECTIONS ISSUER 433826.000000 0 FOR 433826.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Donal O'Connor DIRECTOR ELECTIONS ISSUER 433826.000000 0 FOR 433826.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Geoffrey M. Parker DIRECTOR ELECTIONS ISSUER 433826.000000 0 FOR 433826.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Jonas Samuelson DIRECTOR ELECTIONS ISSUER 433826.000000 0 FOR 433826.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company's independent auditor, and authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor; AUDIT-RELATED ISSUER 433826.000000 0 FOR 433826.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To provide advisory approval of the Company's executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 433826.000000 0 FOR 433826.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To renew the Board's authority to issue shares under Irish law; CAPITAL STRUCTURE ISSUER 433826.000000 0 FOR 433826.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To renew the Board's authority to opt-out of statutory pre-emption rights under Irish law; CAPITAL STRUCTURE ISSUER 433826.000000 0 FOR 433826.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To approve an increase in the maximum number of directors who may be appointed to the Board; CORPORATE GOVERNANCE ISSUER 433826.000000 0 FOR 433826.000000 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To approve amendments to the Company's Articles of Association; CORPORATE GOVERNANCE ISSUER 433826.000000 0 FOR 433826.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/02/2025 Election of Directors: Jorge A. Caballero DIRECTOR ELECTIONS ISSUER 121070.000000 0 FOR 121070.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/02/2025 Election of Directors: Mark G. Foletta DIRECTOR ELECTIONS ISSUER 121070.000000 0 FOR 121070.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/02/2025 Election of Directors: Teri G. Fontenot DIRECTOR ELECTIONS ISSUER 121070.000000 0 FOR 121070.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/02/2025 Election of Directors: Cary S. Grace DIRECTOR ELECTIONS ISSUER 121070.000000 0 FOR 121070.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/02/2025 Election of Directors: R. Jeffrey Harris DIRECTOR ELECTIONS ISSUER 121070.000000 0 FOR 121070.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/02/2025 Election of Directors: James H. Hinton DIRECTOR ELECTIONS ISSUER 121070.000000 0 FOR 121070.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/02/2025 Election of Directors: Celia P. Huber DIRECTOR ELECTIONS ISSUER 121070.000000 0 FOR 121070.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/02/2025 Election of Directors: Daphne E. Jones DIRECTOR ELECTIONS ISSUER 121070.000000 0 FOR 121070.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/02/2025 Election of Directors: Sylvia D. Trent-Adams DIRECTOR ELECTIONS ISSUER 121070.000000 0 FOR 121070.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/02/2025 To approve, by non-binding advisory vote, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 121070.000000 0 FOR 121070.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/02/2025 To ratify the appointment of KPMG LLP to be our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 121070.000000 0 FOR 121070.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/02/2025 To approve the AMN Healthcare 2025 Equity Plan. COMPENSATION ISSUER 121070.000000 0 FOR 121070.000000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/02/2025 A shareholder proposal entitled: "Special Shareholder Meeting Improvement." CORPORATE GOVERNANCE SECURITY HOLDER 121070.000000 0 AGAINST 121070.000000 FOR S000004450 Biohaven Ltd. G1110E107 VGG1110E1079 05/05/2025 Election of Directors for a term expiring at the 2028 Annual Meeting of shareholders: Vlad Coric, M.D. DIRECTOR ELECTIONS ISSUER 272426.000000 0 FOR 272426.000000 FOR S000004450 Biohaven Ltd. G1110E107 VGG1110E1079 05/05/2025 Election of Directors for a term expiring at the 2028 Annual Meeting of shareholders: Kishan Mehta DIRECTOR ELECTIONS ISSUER 272426.000000 0 FOR 272426.000000 FOR S000004450 Biohaven Ltd. G1110E107 VGG1110E1079 05/05/2025 Ratification of appointment of Ernst & Young LLP as independent auditors for fiscal year 2025. AUDIT-RELATED ISSUER 272426.000000 0 FOR 272426.000000 FOR S000004450 Biohaven Ltd. G1110E107 VGG1110E1079 05/05/2025 A non-binding advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 272426.000000 0 FOR 272426.000000 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/05/2025 Election of the following directors, each to serve a three-year term: Ralph Alvarez DIRECTOR ELECTIONS ISSUER 2566278.000000 0 FOR 2566278.000000 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/05/2025 Election of the following directors, each to serve a three-year term: Mary Lynne Hedley DIRECTOR ELECTIONS ISSUER 2566278.000000 0 FOR 2566278.000000 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/05/2025 Election of the following directors, each to serve a three-year term: Kimberly Johnson DIRECTOR ELECTIONS ISSUER 2566278.000000 0 FOR 2566278.000000 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/05/2025 Election of the following directors, each to serve a three-year term: Juan Luciano DIRECTOR ELECTIONS ISSUER 2566278.000000 0 FOR 2566278.000000 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/05/2025 Approval, on an advisory basis, of the compensation paid to the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2566278.000000 0 FOR 2566278.000000 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/05/2025 Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2025. AUDIT-RELATED ISSUER 2566278.000000 0 FOR 2566278.000000 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/05/2025 Approval of amendments to the company's Articles of Incorporation to eliminate the classified board structure. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 2566278.000000 0 FOR 2566278.000000 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/05/2025 Approval of amendments to the company's Articles of Incorporation to eliminate supermajority voting provisions. CORPORATE GOVERNANCE ISSUER 2566278.000000 0 FOR 2566278.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2025 Election of Directors: Emily Peterson Alva DIRECTOR ELECTIONS ISSUER 440816.000000 0 FOR 440816.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2025 Election of Directors: Deb Autor DIRECTOR ELECTIONS ISSUER 440816.000000 0 FOR 440816.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2025 Election of Directors: J. Kevin Buchi DIRECTOR ELECTIONS ISSUER 440816.000000 0 FOR 440816.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2025 Election of Directors: Jeff George DIRECTOR ELECTIONS ISSUER 440816.000000 0 FOR 440816.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2025 Election of Directors: John Kiely DIRECTOR ELECTIONS ISSUER 440816.000000 0 FOR 440816.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2025 Election of Directors: Paul Meister DIRECTOR ELECTIONS ISSUER 440816.000000 0 FOR 440816.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2025 Election of Directors: Ted Nark DIRECTOR ELECTIONS ISSUER 440816.000000 0 FOR 440816.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2025 Election of Directors: Chintu Patel DIRECTOR ELECTIONS ISSUER 440816.000000 0 FOR 440816.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2025 Election of Directors: Chirag Patel DIRECTOR ELECTIONS ISSUER 440816.000000 0 FOR 440816.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2025 Election of Directors: Gautam Patel DIRECTOR ELECTIONS ISSUER 440816.000000 0 FOR 440816.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2025 Election of Directors: Shlomo Yanai DIRECTOR ELECTIONS ISSUER 440816.000000 0 FOR 440816.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2025 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 440816.000000 0 FOR 440816.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2025 Advisory vote to approve the Frequency of Future "Say on Pay" votes. SECTION 14A SAY-ON-PAY VOTES ISSUER 440816.000000 0 ONE YEAR 440816.000000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2025 Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal 2025. AUDIT-RELATED ISSUER 440816.000000 0 FOR 440816.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/06/2025 Election of Directors: William A. Ampofo II DIRECTOR ELECTIONS ISSUER 1616314.000000 0 FOR 1616314.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/06/2025 Election of Directors: Jeffrey A. Craig DIRECTOR ELECTIONS ISSUER 1616314.000000 0 FOR 1616314.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/06/2025 Election of Directors: Patricia B. Morrison DIRECTOR ELECTIONS ISSUER 1616314.000000 0 FOR 1616314.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/06/2025 Election of Directors: Stephen N. Oesterle, M.D. DIRECTOR ELECTIONS ISSUER 1616314.000000 0 FOR 1616314.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/06/2025 Election of Directors: Stephen H. Rusckowski DIRECTOR ELECTIONS ISSUER 1616314.000000 0 FOR 1616314.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/06/2025 Election of Directors: Nancy M. Schlichting DIRECTOR ELECTIONS ISSUER 1616314.000000 0 FOR 1616314.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/06/2025 Election of Directors: Brent Shafer DIRECTOR ELECTIONS ISSUER 1616314.000000 0 FOR 1616314.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/06/2025 Election of Directors: Cathy R. Smith DIRECTOR ELECTIONS ISSUER 1616314.000000 0 FOR 1616314.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/06/2025 Election of Directors: Amy A. Wendell DIRECTOR ELECTIONS ISSUER 1616314.000000 0 FOR 1616314.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/06/2025 Election of Directors: David S. Wilkes, M.D. DIRECTOR ELECTIONS ISSUER 1616314.000000 0 FOR 1616314.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/06/2025 Advisory Vote to Approve Named Executive Officer Compensation for 2024 SECTION 14A SAY-ON-PAY VOTES ISSUER 1616314.000000 0 FOR 1616314.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/06/2025 Ratification of Appointment of Independent Registered Public Accounting Firm for 2025 AUDIT-RELATED ISSUER 1616314.000000 0 FOR 1616314.000000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/06/2025 Stockholder Proposal - Executives to Retain Significant Stock COMPENSATION SECURITY HOLDER 1616314.000000 0 AGAINST 1616314.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Peter J. Arduini DIRECTOR ELECTIONS ISSUER 6413853.000000 0 FOR 6413853.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Deepak L. Bhatt, M.D., M.P.H., M.B.A. DIRECTOR ELECTIONS ISSUER 6413853.000000 0 FOR 6413853.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Christopher S. Boerner, Ph.D. DIRECTOR ELECTIONS ISSUER 6413853.000000 0 FOR 6413853.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Julia A. Haller, M.D. DIRECTOR ELECTIONS ISSUER 6413853.000000 0 FOR 6413853.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Manuel Hidalgo Medina, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 6413853.000000 0 FOR 6413853.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Michael R. McMullen DIRECTOR ELECTIONS ISSUER 6413853.000000 0 FOR 6413853.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Paula A. Price DIRECTOR ELECTIONS ISSUER 6413853.000000 0 FOR 6413853.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Derica W. Rice DIRECTOR ELECTIONS ISSUER 6413853.000000 0 FOR 6413853.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Theodore R. Samuels DIRECTOR ELECTIONS ISSUER 6413853.000000 0 FOR 6413853.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Karen H. Vousden, Ph.D. DIRECTOR ELECTIONS ISSUER 6413853.000000 0 FOR 6413853.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Phyllis R. Yale DIRECTOR ELECTIONS ISSUER 6413853.000000 0 FOR 6413853.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 6413853.000000 0 FOR 6413853.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Ratification of the Appointment of an Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 6413853.000000 0 FOR 6413853.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Shareholder Proposal on Corporate Financial Sustainability ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 6413853.000000 0 AGAINST 6413853.000000 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Shareholder Proposal on a Request to Cease DEI Efforts ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 6413853.000000 0 AGAINST 6413853.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Rainer M. Blair DIRECTOR ELECTIONS ISSUER 2060658.000000 0 FOR 2060658.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Feroz Dewan DIRECTOR ELECTIONS ISSUER 2060658.000000 0 FOR 2060658.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Linda Filler DIRECTOR ELECTIONS ISSUER 2060658.000000 0 FOR 2060658.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Charles W. Lamanna DIRECTOR ELECTIONS ISSUER 2060658.000000 0 FOR 2060658.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri List DIRECTOR ELECTIONS ISSUER 2060658.000000 0 FOR 2060658.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Jessica L. Mega, MD, MPH DIRECTOR ELECTIONS ISSUER 2060658.000000 0 FOR 2060658.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Mitchell P. Rales DIRECTOR ELECTIONS ISSUER 2060658.000000 0 FOR 2060658.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Steven M. Rales DIRECTOR ELECTIONS ISSUER 2060658.000000 0 FOR 2060658.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane Sanders DIRECTOR ELECTIONS ISSUER 2060658.000000 0 FOR 2060658.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: John T. Schwieters DIRECTOR ELECTIONS ISSUER 2060658.000000 0 FOR 2060658.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Alan G. Spoon DIRECTOR ELECTIONS ISSUER 2060658.000000 0 FOR 2060658.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Raymond C. Stevens, Ph.D. DIRECTOR ELECTIONS ISSUER 2060658.000000 0 FOR 2060658.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Elias A. Zerhouni, MD DIRECTOR ELECTIONS ISSUER 2060658.000000 0 FOR 2060658.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/06/2025 To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 2060658.000000 0 FOR 2060658.000000 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/06/2025 To approve on an advisory basis the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2060658.000000 0 FOR 2060658.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/06/2025 Election of Directors: Mark A. Buthman DIRECTOR ELECTIONS ISSUER 230188.000000 0 FOR 230188.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/06/2025 Election of Directors: William F. Feehery DIRECTOR ELECTIONS ISSUER 230188.000000 0 FOR 230188.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/06/2025 Election of Directors: Robert F. Friel DIRECTOR ELECTIONS ISSUER 230188.000000 0 FOR 230188.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/06/2025 Election of Directors: Eric M. Green DIRECTOR ELECTIONS ISSUER 230188.000000 0 FOR 230188.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/06/2025 Election of Directors: Janet B. Haugen DIRECTOR ELECTIONS ISSUER 230188.000000 0 FOR 230188.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/06/2025 Election of Directors: Thomas W. Hofmann DIRECTOR ELECTIONS ISSUER 230188.000000 0 FOR 230188.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/06/2025 Election of Directors: Molly E. Joseph DIRECTOR ELECTIONS ISSUER 230188.000000 0 FOR 230188.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/06/2025 Election of Directors: Deborah L. V. Keller DIRECTOR ELECTIONS ISSUER 230188.000000 0 FOR 230188.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/06/2025 Election of Directors: Myla P. Lai-Goldman DIRECTOR ELECTIONS ISSUER 230188.000000 0 FOR 230188.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/06/2025 Election of Directors: Stephen H. Lockhart DIRECTOR ELECTIONS ISSUER 230188.000000 0 FOR 230188.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/06/2025 Election of Directors: Douglas A. Michels DIRECTOR ELECTIONS ISSUER 230188.000000 0 FOR 230188.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/06/2025 Election of Directors: Paolo Pucci DIRECTOR ELECTIONS ISSUER 230188.000000 0 FOR 230188.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/06/2025 Advisory vote to approve named executive officer compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 230188.000000 0 FOR 230188.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/06/2025 Amend and Restate Our Amended and Restated Articles of Incorporation to Add a Right For Shareholders to call a Special Meeting; CORPORATE GOVERNANCE ISSUER 230188.000000 0 FOR 230188.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/06/2025 Amend and Restate Our 2016 Omnibus Incentive Compensation Plan; and COMPENSATION ISSUER 230188.000000 0 FOR 230188.000000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/06/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 230188.000000 0 FOR 230188.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jacqueline K. Barton, Ph.D. DIRECTOR ELECTIONS ISSUER 3941127.000000 0 FOR 3941127.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jeffrey A. Bluestone, Ph.D. DIRECTOR ELECTIONS ISSUER 3941127.000000 0 FOR 3941127.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Sandra J. Horning, M.D. DIRECTOR ELECTIONS ISSUER 3941127.000000 0 FOR 3941127.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Kelly A. Kramer DIRECTOR ELECTIONS ISSUER 3941127.000000 0 FOR 3941127.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Ted W. Love, M.D. DIRECTOR ELECTIONS ISSUER 3941127.000000 0 FOR 3941127.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Harish Manwani DIRECTOR ELECTIONS ISSUER 3941127.000000 0 FOR 3941127.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Daniel P. O'Day DIRECTOR ELECTIONS ISSUER 3941127.000000 0 FOR 3941127.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Javier J. Rodriguez DIRECTOR ELECTIONS ISSUER 3941127.000000 0 FOR 3941127.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Anthony Welters DIRECTOR ELECTIONS ISSUER 3941127.000000 0 FOR 3941127.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 3941127.000000 0 FOR 3941127.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 3941127.000000 0 FOR 3941127.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To vote on a stockholder proposal requesting the CEO pay ratio factor be included in the Company's executive compensation programs, if properly presented at the Annual Meeting. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 3941127.000000 0 AGAINST 3941127.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. CORPORATE GOVERNANCE SECURITY HOLDER 3941127.000000 0 AGAINST 3941127.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To vote on a stockholder proposal requesting a comprehensive human rights policy and human rights due diligence process, if properly presented at the Annual Meeting. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 3941127.000000 0 AGAINST 3941127.000000 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To vote on a stockholder proposal requesting a report on the risks of the Company's DEI practices for contractors, if properly presented at the Annual Meeting. ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 3941127.000000 0 AGAINST 3941127.000000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/07/2025 Election of Directors (Proposal One): Stuart M. Essig DIRECTOR ELECTIONS ISSUER 259486.000000 0 FOR 259486.000000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/07/2025 Election of Directors (Proposal One): Jonathan J. Mazelsky DIRECTOR ELECTIONS ISSUER 259486.000000 0 FOR 259486.000000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/07/2025 Election of Directors (Proposal One): M. Anne Szostak DIRECTOR ELECTIONS ISSUER 259486.000000 0 FOR 259486.000000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/07/2025 Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year (Proposal Two). AUDIT-RELATED ISSUER 259486.000000 0 FOR 259486.000000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/07/2025 Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three). SECTION 14A SAY-ON-PAY VOTES ISSUER 259486.000000 0 FOR 259486.000000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/07/2025 Amend Certificate of Incorporation to Remove Supermajority Voting Provisions (Proposal Four). CORPORATE GOVERNANCE ISSUER 259486.000000 0 FOR 259486.000000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/07/2025 Amend Certificate of Incorporation to Reflect New Delaware Law Provisions Allowing for Officer Exculpation (Proposal Five). CORPORATE GOVERNANCE ISSUER 259486.000000 0 FOR 259486.000000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/07/2025 Shareholder Proposal Regarding the Annual Election of Directors (Proposal Six). SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 259486.000000 0 FOR 259486.000000 NONE S000004450 ZimVie Inc. 98888T107 US98888T1079 05/07/2025 Election of Directors: Vafa Jamali DIRECTOR ELECTIONS ISSUER 88391.000000 0 FOR 88391.000000 FOR S000004450 ZimVie Inc. 98888T107 US98888T1079 05/07/2025 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 88391.000000 0 FOR 88391.000000 FOR S000004450 ZimVie Inc. 98888T107 US98888T1079 05/07/2025 Approve, on a non-binding advisory basis, named executive officer compensation ("Say on Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 88391.000000 0 FOR 88391.000000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/08/2025 To elect the following nominees as Class III directors of Alnylam: Carolyn R. Bertozzi, Ph.D. DIRECTOR ELECTIONS ISSUER 408725.000000 0 FOR 408725.000000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/08/2025 To elect the following nominees as Class III directors of Alnylam: Margaret A. Hamburg, M.D. DIRECTOR ELECTIONS ISSUER 408725.000000 0 FOR 408725.000000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/08/2025 To elect the following nominees as Class III directors of Alnylam: Colleen F. Reitan DIRECTOR ELECTIONS ISSUER 408725.000000 0 FOR 408725.000000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/08/2025 To elect the following nominees as Class III directors of Alnylam: Amy W. Schulman DIRECTOR ELECTIONS ISSUER 408725.000000 0 FOR 408725.000000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/08/2025 To approve an Amendment to our Restated Certificate of Incorporation allowing for officer exculpation. CORPORATE GOVERNANCE ISSUER 408725.000000 0 FOR 408725.000000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/08/2025 To approve the second amended and restated 2018 Stock Incentive Plan. COMPENSATION ISSUER 408725.000000 0 FOR 408725.000000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/08/2025 To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 408725.000000 0 FOR 408725.000000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/08/2025 To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 408725.000000 0 FOR 408725.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/08/2025 Election of Directors: Juan Andres DIRECTOR ELECTIONS ISSUER 1990447.000000 0 FOR 1990447.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/08/2025 Election of Directors: John Carethers DIRECTOR ELECTIONS ISSUER 1990447.000000 0 FOR 1990447.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/08/2025 Election of Directors: Lan Kang DIRECTOR ELECTIONS ISSUER 1990447.000000 0 FOR 1990447.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/08/2025 Election of Directors: Dame Louise Makin DIRECTOR ELECTIONS ISSUER 1990447.000000 0 FOR 1990447.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/08/2025 Election of Directors: Joseph Massaro DIRECTOR ELECTIONS ISSUER 1990447.000000 0 FOR 1990447.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/08/2025 Election of Directors: Mala Murthy DIRECTOR ELECTIONS ISSUER 1990447.000000 0 FOR 1990447.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/08/2025 Election of Directors: Jonathan Peacock DIRECTOR ELECTIONS ISSUER 1990447.000000 0 FOR 1990447.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/08/2025 Election of Directors: Michael Severino DIRECTOR ELECTIONS ISSUER 1990447.000000 0 FOR 1990447.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/08/2025 Election of Directors: Michael Stubblefield DIRECTOR ELECTIONS ISSUER 1990447.000000 0 FOR 1990447.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/08/2025 Election of Directors: Gregory Summe DIRECTOR ELECTIONS ISSUER 1990447.000000 0 FOR 1990447.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/08/2025 Ratification of the Appointment of Deloitte & Touche LLP as the Company's independent registered accounting firm for 2025. AUDIT-RELATED ISSUER 1990447.000000 0 FOR 1990447.000000 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/08/2025 Approve, on an Advisory Basis, Named Executive Officer Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1990447.000000 0 FOR 1990447.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/08/2025 To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Kevin R. Sayer DIRECTOR ELECTIONS ISSUER 1236489.000000 0 FOR 1236489.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/08/2025 To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Steven R. Altman DIRECTOR ELECTIONS ISSUER 1236489.000000 0 FOR 1236489.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/08/2025 To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Nicholas Augustinos DIRECTOR ELECTIONS ISSUER 1236489.000000 0 FOR 1236489.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/08/2025 To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Richard A. Collins DIRECTOR ELECTIONS ISSUER 1236489.000000 0 FOR 1236489.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/08/2025 To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Rimma Driscoll DIRECTOR ELECTIONS ISSUER 1236489.000000 0 FOR 1236489.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/08/2025 To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Mark G. Foletta DIRECTOR ELECTIONS ISSUER 1236489.000000 0 FOR 1236489.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/08/2025 To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Renee Gala DIRECTOR ELECTIONS ISSUER 1236489.000000 0 FOR 1236489.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/08/2025 To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Bridgette P. Heller DIRECTOR ELECTIONS ISSUER 1236489.000000 0 FOR 1236489.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/08/2025 To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Kyle Malady DIRECTOR ELECTIONS ISSUER 1236489.000000 0 FOR 1236489.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/08/2025 To ratify the selection by the Audit Committee of our Board of Directors of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 1236489.000000 0 FOR 1236489.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/08/2025 To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2024. SECTION 14A SAY-ON-PAY VOTES ISSUER 1236489.000000 0 FOR 1236489.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/08/2025 To approve our Amended and Restated 2015 Equity Incentive Plan (as amended and restated) to, among other things, increase the number of shares reserved for issuance thereunder by 3,400,000 shares. COMPENSATION ISSUER 1236489.000000 0 FOR 1236489.000000 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/08/2025 To approve our Amended and Restated 2015 Employee Stock Purchase Plan to, among other things, increase the number of shares reserved for issuance thereunder by 8,000,000 shares. COMPENSATION ISSUER 1236489.000000 0 FOR 1236489.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/08/2025 Election of Directors: Leslie C. Davis DIRECTOR ELECTIONS ISSUER 1867721.000000 0 FOR 1867721.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/08/2025 Election of Directors: David T. Feinberg, MD DIRECTOR ELECTIONS ISSUER 1867721.000000 0 FOR 1867721.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/08/2025 Election of Directors: Kieran T. Gallahue DIRECTOR ELECTIONS ISSUER 1867721.000000 0 FOR 1867721.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/08/2025 Election of Directors: Leslie S. Heisz DIRECTOR ELECTIONS ISSUER 1867721.000000 0 FOR 1867721.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/08/2025 Election of Directors: Paul A. LaViolette DIRECTOR ELECTIONS ISSUER 1867721.000000 0 FOR 1867721.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/08/2025 Election of Directors: Steven R. Loranger DIRECTOR ELECTIONS ISSUER 1867721.000000 0 FOR 1867721.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/08/2025 Election of Directors: Ramona Sequeira DIRECTOR ELECTIONS ISSUER 1867721.000000 0 FOR 1867721.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/08/2025 Election of Directors: Nicholas J. Valeriani DIRECTOR ELECTIONS ISSUER 1867721.000000 0 FOR 1867721.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/08/2025 Election of Directors: Bernard J. Zovighian DIRECTOR ELECTIONS ISSUER 1867721.000000 0 FOR 1867721.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/08/2025 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 1867721.000000 0 FOR 1867721.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/08/2025 Ratification of Appointment of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 1867721.000000 0 FOR 1867721.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/08/2025 Approval of the Amendment and Restatement of the Company's 2001 Employee Stock Purchase Plan for United States Employees (the "U.S. ESPP") to Increase the Total Number of Shares of Common Stock Available for Issuance under the U.S. ESPP by 4,200,000 Shares COMPENSATION ISSUER 1867721.000000 0 FOR 1867721.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/08/2025 Approval of the Amendment and Restatement of the Company's 2001 Employee Stock Purchase Plan for International Employees (the "International ESPP") to Increase the Total Number of Shares of Common Stock Available for Issuance under the International ESPP by 1,460,000 Shares COMPENSATION ISSUER 1867721.000000 0 FOR 1867721.000000 FOR S000004450 National HealthCare Corporation 635906100 US6359061008 05/08/2025 The re-election of directors to hold office for a three (3) year term and until their successors have been duly elected and qualified: Stephen F. Flatt DIRECTOR ELECTIONS ISSUER 41606.000000 0 FOR 41606.000000 FOR S000004450 National HealthCare Corporation 635906100 US6359061008 05/08/2025 The re-election of directors to hold office for a three (3) year term and until their successors have been duly elected and qualified: Richard F. LaRoche DIRECTOR ELECTIONS ISSUER 41606.000000 0 FOR 41606.000000 FOR S000004450 National HealthCare Corporation 635906100 US6359061008 05/08/2025 The re-election of directors to hold office for a three (3) year term and until their successors have been duly elected and qualified: Sandra Y. Trail DIRECTOR ELECTIONS ISSUER 41606.000000 0 FOR 41606.000000 FOR S000004450 National HealthCare Corporation 635906100 US6359061008 05/08/2025 To consider an advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 41606.000000 0 FOR 41606.000000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/08/2025 Elect eight Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Laura A. Linynsky DIRECTOR ELECTIONS ISSUER 272491.000000 0 FOR 272491.000000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/08/2025 Elect eight Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Thomas A. McEachin DIRECTOR ELECTIONS ISSUER 272491.000000 0 FOR 272491.000000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/08/2025 Elect eight Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Mark S. Ordan DIRECTOR ELECTIONS ISSUER 272491.000000 0 FOR 272491.000000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/08/2025 Elect eight Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Michael A. Rucker DIRECTOR ELECTIONS ISSUER 272491.000000 0 FOR 272491.000000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/08/2025 Elect eight Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Guy P. Sansone DIRECTOR ELECTIONS ISSUER 272491.000000 0 FOR 272491.000000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/08/2025 Elect eight Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: John M. Starcher, Jr. DIRECTOR ELECTIONS ISSUER 272491.000000 0 FOR 272491.000000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/08/2025 Elect eight Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Shirley A. Weis DIRECTOR ELECTIONS ISSUER 272491.000000 0 FOR 272491.000000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/08/2025 Elect eight Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Sylvia J. Young DIRECTOR ELECTIONS ISSUER 272491.000000 0 FOR 272491.000000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/08/2025 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2025 fiscal year; AUDIT-RELATED ISSUER 272491.000000 0 FOR 272491.000000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/08/2025 Conduct an advisory vote regarding the compensation of our named executive officers for the 2024 fiscal year; and SECTION 14A SAY-ON-PAY VOTES ISSUER 272491.000000 0 FOR 272491.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/08/2025 Election of Ten Directors: Mary K. Brainerd DIRECTOR ELECTIONS ISSUER 1087270.000000 0 FOR 1087270.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/08/2025 Election of Ten Directors: Giovanni Caforio, M.D. DIRECTOR ELECTIONS ISSUER 1087270.000000 0 FOR 1087270.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/08/2025 Election of Ten Directors: Kevin A. Lobo DIRECTOR ELECTIONS ISSUER 1087270.000000 0 FOR 1087270.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/08/2025 Election of Ten Directors: Emmanuel P. Maceda DIRECTOR ELECTIONS ISSUER 1087270.000000 0 FOR 1087270.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/08/2025 Election of Ten Directors: Sherilyn S. McCoy DIRECTOR ELECTIONS ISSUER 1087270.000000 0 FOR 1087270.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/08/2025 Election of Ten Directors: Rachel M. Ruggeri DIRECTOR ELECTIONS ISSUER 1087270.000000 0 FOR 1087270.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/08/2025 Election of Ten Directors: Andrew K. Silvernail DIRECTOR ELECTIONS ISSUER 1087270.000000 0 FOR 1087270.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/08/2025 Election of Ten Directors: Lisa M. Skeete Tatum DIRECTOR ELECTIONS ISSUER 1087270.000000 0 FOR 1087270.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/08/2025 Election of Ten Directors: Ronda E. Stryker DIRECTOR ELECTIONS ISSUER 1087270.000000 0 FOR 1087270.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/08/2025 Election of Ten Directors: Rajeev Suri DIRECTOR ELECTIONS ISSUER 1087270.000000 0 FOR 1087270.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/08/2025 Ratification of Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for 2025. AUDIT-RELATED ISSUER 1087270.000000 0 FOR 1087270.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/08/2025 Approval of the 2011 Long-Term Incentive Plan, as Amended and Restated. COMPENSATION ISSUER 1087270.000000 0 FOR 1087270.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/08/2025 Approval of the 2011 Performance Incentive Award Plan, as Amended and Restated. COMPENSATION ISSUER 1087270.000000 0 FOR 1087270.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/08/2025 Approval of the 2008 Stock Purchase Plan, as Amended and Restated. COMPENSATION ISSUER 1087270.000000 0 FOR 1087270.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/08/2025 Advisory Vote to Approve Named Executive Officer Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1087270.000000 0 FOR 1087270.000000 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/08/2025 Shareholder Proposal to Support Transparency in Political Spending. OTHER SOCIAL ISSUES SECURITY HOLDER 1087270.000000 0 AGAINST 1087270.000000 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Election of Class I Directors: William H.L. Burnside DIRECTOR ELECTIONS ISSUER 5049894.000000 0 FOR 5049894.000000 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Election of Class I Directors: Thomas C. Freyman DIRECTOR ELECTIONS ISSUER 5049894.000000 0 FOR 5049894.000000 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Election of Class I Directors: Brett J. Hart DIRECTOR ELECTIONS ISSUER 5049894.000000 0 FOR 5049894.000000 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Election of Class I Directors: Edward J. Rapp DIRECTOR ELECTIONS ISSUER 5049894.000000 0 FOR 5049894.000000 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2025 AUDIT-RELATED ISSUER 5049894.000000 0 FOR 5049894.000000 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Say on Pay - An advisory vote on the approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 5049894.000000 0 FOR 5049894.000000 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting CORPORATE GOVERNANCE ISSUER 5049894.000000 0 FOR 5049894.000000 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Stockholder Proposal - to Implement Simple Majority Vote CORPORATE GOVERNANCE SECURITY HOLDER 5049894.000000 0 AGAINST 5049894.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2025 Election of Directors: Keith Bradley DIRECTOR ELECTIONS ISSUER 219912.000000 0 FOR 219912.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2025 Election of Directors: Shaundra D. Clay DIRECTOR ELECTIONS ISSUER 219912.000000 0 FOR 219912.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2025 Election of Directors: Stuart M. Essig DIRECTOR ELECTIONS ISSUER 219912.000000 0 FOR 219912.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2025 Election of Directors: Jeffrey A. Graves DIRECTOR ELECTIONS ISSUER 219912.000000 0 FOR 219912.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2025 Election of Directors: Barbara B. Hill DIRECTOR ELECTIONS ISSUER 219912.000000 0 FOR 219912.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2025 Election of Directors: Renee W. Lo DIRECTOR ELECTIONS ISSUER 219912.000000 0 FOR 219912.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2025 Election of Directors: Mojdeh Poul DIRECTOR ELECTIONS ISSUER 219912.000000 0 FOR 219912.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2025 Election of Directors: Christian S. Schade DIRECTOR ELECTIONS ISSUER 219912.000000 0 FOR 219912.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2025 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year 2025. AUDIT-RELATED ISSUER 219912.000000 0 FOR 219912.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2025 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 219912.000000 0 FOR 219912.000000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/09/2025 To approve Amendment No. 2 to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan. COMPENSATION ISSUER 219912.000000 0 FOR 219912.000000 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/09/2025 Election of Directors: Candace H. Duncan DIRECTOR ELECTIONS ISSUER 147064.000000 0 FOR 147064.000000 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/09/2025 Election of Directors: Gretchen R. Haggerty DIRECTOR ELECTIONS ISSUER 147064.000000 0 FOR 147064.000000 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/09/2025 Election of Directors: John C. Heinmiller DIRECTOR ELECTIONS ISSUER 147064.000000 0 FOR 147064.000000 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/09/2025 Election of Directors: Liam J. Kelly DIRECTOR ELECTIONS ISSUER 147064.000000 0 FOR 147064.000000 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/09/2025 Election of Directors: Stephen K. Klasko DIRECTOR ELECTIONS ISSUER 147064.000000 0 FOR 147064.000000 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/09/2025 Election of Directors: Andrew A. Krakauer DIRECTOR ELECTIONS ISSUER 147064.000000 0 FOR 147064.000000 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/09/2025 Election of Directors: Neena M. Patil DIRECTOR ELECTIONS ISSUER 147064.000000 0 FOR 147064.000000 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/09/2025 Election of Directors: Stuart A. Randle DIRECTOR ELECTIONS ISSUER 147064.000000 0 FOR 147064.000000 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/09/2025 Election of Directors: Jaewon Ryu DIRECTOR ELECTIONS ISSUER 147064.000000 0 FOR 147064.000000 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/09/2025 Approval, on an advisory basis, of named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 147064.000000 0 FOR 147064.000000 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/09/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 147064.000000 0 FOR 147064.000000 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/09/2025 Stockholder proposal, if properly presented at the Annual Meeting, regarding continuous holding requirement for calling a special calling a special stockholder meeting. CORPORATE GOVERNANCE SECURITY HOLDER 147064.000000 0 AGAINST 147064.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 Direct the chairman, if he determines that there are insufficient votes cast in favor of Proposal 2 (below), to adjourn the Annual General Meeting and Special Meeting to such time and place that he, in his absolute discretion, considers fit. CORPORATE GOVERNANCE ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 Approve (a) the Membership Interest Purchase Agreement and each other transaction document, (b) grant allotment authority for the issuance of (i) additional Class A ordinary shares of Royalty Pharma plc sufficient to allow for the exchange of a number of Class B ordinary shares of Royalty Pharma Holdings Ltd. equal to the share consideration and (ii) additional Class B ordinary shares of Royalty Pharma plc equal to the share consideration, and (c) adopt amended articles of association of Royalty Pharma plc (special resolution). EXTRAORDINARY TRANSACTIONS ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 A non-binding advisory vote to approve executive compensation that may become payable in connection with the transaction contemplated by the Membership Interest Purchase Agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 Approve the adoption the 2025 Equity Incentive Plan. COMPENSATION ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 Approve the terms of the agreements and counterparties pursuant to which we may purchase our Class A ordinary shares. CAPITAL STRUCTURE ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 Election of Directors: Pablo Legorreta DIRECTOR ELECTIONS ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 Election of Directors: Henry Fernandez DIRECTOR ELECTIONS ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 Election of Directors: Bonnie Bassler, Ph.D. DIRECTOR ELECTIONS ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 Election of Directors: Vlad Coric, M.D. DIRECTOR ELECTIONS ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 Election of Directors: Errol De Souza, Ph.D. DIRECTOR ELECTIONS ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 Election of Directors: Catherine Engelbert DIRECTOR ELECTIONS ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 Election of Directors: David Hodgson DIRECTOR ELECTIONS ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 Election of Directors: Ted Love, M.D. DIRECTOR ELECTIONS ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 Election of Directors: Gregory Norden DIRECTOR ELECTIONS ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 A non-binding advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm. AUDIT-RELATED ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 Approve receipt of our U.K. audited annual report and accounts and related directors' and auditor's reports for the fiscal year ended December 31, 2024. CORPORATE GOVERNANCE ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 Approve on a binding basis our U.K. directors' remuneration policy. COMPENSATION ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 Approve on a non-binding advisory basis our U.K. directors' remuneration report (other than the part containing the directors' remuneration policy) for the fiscal year ended December 31, 2024. COMPENSATION ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 Re-appoint Ernst & Young as our U.K. statutory auditor, to hold office until the conclusion of the next general meeting at which the U.K. annual report and accounts are presented to shareholders. AUDIT-RELATED ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 Authorize the Board to determine the remuneration of Ernst & Young in its capacity as our U.K. statutory auditor. AUDIT-RELATED ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 Authorize the Board to allot shares. CAPITAL STRUCTURE ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 Royalty Pharma Plc G7709Q104 GB00BMVP7Y09 05/12/2025 Authorize the Board to allot shares without rights of pre-emption (special resolution). CAPITAL STRUCTURE ISSUER 1177790.000000 0 FOR 1177790.000000 FOR S000004450 ACELYRIN, Inc. 00445A100 US00445A1007 05/13/2025 To adopt the Agreement and Plan of Merger, dated February 6, 2025, among Alumis Inc., Arrow Merger Sub, Inc. and ACELYRIN, Inc., as may be amended from time to time. We refer to this proposal as the "ACELYRIN merger proposal." EXTRAORDINARY TRANSACTIONS ISSUER 157392.000000 0 FOR 157392.000000 FOR S000004450 ACELYRIN, Inc. 00445A100 US00445A1007 05/13/2025 To approve the adjournment from time to time of the ACELYRIN virtual special meeting, if necessary, to solicit additional proxies if there are not sufficient votes to approve the ACELYRIN merger proposal. We refer to this proposal as the "ACELYRIN adjournment proposal." CORPORATE GOVERNANCE ISSUER 157392.000000 0 FOR 157392.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/13/2025 ELECTION OF DIRECTORS: Thomas F. Ackerman DIRECTOR ELECTIONS ISSUER 120008.000000 0 FOR 120008.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/13/2025 ELECTION OF DIRECTORS: Daniel J. Bevevino DIRECTOR ELECTIONS ISSUER 120008.000000 0 FOR 120008.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/13/2025 ELECTION OF DIRECTORS: Marna P. Borgstrom DIRECTOR ELECTIONS ISSUER 120008.000000 0 FOR 120008.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/13/2025 ELECTION OF DIRECTORS: James W. Bullock DIRECTOR ELECTIONS ISSUER 120008.000000 0 FOR 120008.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/13/2025 ELECTION OF DIRECTORS: Jeffrey H. Burbank DIRECTOR ELECTIONS ISSUER 120008.000000 0 FOR 120008.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/13/2025 ELECTION OF DIRECTORS: Elizabeth A. Hoff DIRECTOR ELECTIONS ISSUER 120008.000000 0 FOR 120008.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/13/2025 ELECTION OF DIRECTORS: J. Patrick Mackin DIRECTOR ELECTIONS ISSUER 120008.000000 0 FOR 120008.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/13/2025 ELECTION OF DIRECTORS: Jon W. Salveson DIRECTOR ELECTIONS ISSUER 120008.000000 0 FOR 120008.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/13/2025 ELECTION OF DIRECTORS: Anthony B. Semedo DIRECTOR ELECTIONS ISSUER 120008.000000 0 FOR 120008.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/13/2025 To approve, by non-binding vote, the compensation paid to Artivion's Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion. SECTION 14A SAY-ON-PAY VOTES ISSUER 120008.000000 0 FOR 120008.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/13/2025 To ratify the preliminary approval of Ernst & Young LLP as the independent registered public accounting firm for the company for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 120008.000000 0 FOR 120008.000000 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/13/2025 To approve additional funding of 3,570,000 shares for the Amended and Restated Artivion, Inc. 2020 Equity and Cash Incentive Plan. COMPENSATION ISSUER 120008.000000 0 FOR 120008.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/13/2025 ELECTION OF DIRECTORS: Jessica L. Blume DIRECTOR ELECTIONS ISSUER 1596607.000000 0.000000 FOR 1596607.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/13/2025 ELECTION OF DIRECTORS: Kenneth A. Burdick DIRECTOR ELECTIONS ISSUER 1596607.000000 0.000000 FOR 1596607.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/13/2025 ELECTION OF DIRECTORS: Christopher J. Coughlin DIRECTOR ELECTIONS ISSUER 1596607.000000 0.000000 FOR 1596607.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/13/2025 ELECTION OF DIRECTORS: H. James Dallas DIRECTOR ELECTIONS ISSUER 1596607.000000 0.000000 FOR 1596607.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/13/2025 ELECTION OF DIRECTORS: Wayne S. DeVeydt DIRECTOR ELECTIONS ISSUER 1596607.000000 0.000000 FOR 1596607.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/13/2025 ELECTION OF DIRECTORS: Frederick H. Eppinger DIRECTOR ELECTIONS ISSUER 1596607.000000 0.000000 FOR 1596607.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/13/2025 ELECTION OF DIRECTORS: Monte E. Ford DIRECTOR ELECTIONS ISSUER 1596607.000000 0.000000 FOR 1596607.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/13/2025 ELECTION OF DIRECTORS: Thomas R. Greco DIRECTOR ELECTIONS ISSUER 1596607.000000 0.000000 FOR 1596607.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/13/2025 ELECTION OF DIRECTORS: Sarah M. London DIRECTOR ELECTIONS ISSUER 1596607.000000 0.000000 FOR 1596607.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/13/2025 ELECTION OF DIRECTORS: Theodore R. Samuels DIRECTOR ELECTIONS ISSUER 1596607.000000 0.000000 FOR 1596607.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/13/2025 ELECTION OF DIRECTORS: Kenneth Y. Tanji DIRECTOR ELECTIONS ISSUER 1596607.000000 0.000000 FOR 1596607.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/13/2025 ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION. SECTION 14A SAY-ON-PAY VOTES ISSUER 1596607.000000 0.000000 FOR 1596607.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/13/2025 RATIFICATION OF APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2025. AUDIT-RELATED ISSUER 1596607.000000 0.000000 FOR 1596607.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/13/2025 APPROVAL OF THE 2025 STOCK INCENTIVE PLAN. COMPENSATION ISSUER 1596607.000000 0.000000 FOR 1596607.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/13/2025 STOCKHOLDER PROPOSAL TO DISCLOSE PLAN TO REDUCE TOTAL CONTRIBUTION TO CLIMATE CHANGE. ENVIRONMENT OR CLIMATE SECURITY HOLDER 1596607.000000 0.000000 AGAINST 1596607.000000 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/13/2025 STOCKHOLDER PROPOSAL FOR REPORT ON CLIMATE RISK TO RETIREMENT INVESTMENTS. ENVIRONMENT OR CLIMATE SECURITY HOLDER 1596607.000000 0.000000 ABSTAIN 1596607.000000 AGAINST S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: Susan W. Brooks DIRECTOR ELECTIONS ISSUER 396799.000000 0 FOR 396799.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: Ronald L. Burgess, Jr. DIRECTOR ELECTIONS ISSUER 396799.000000 0 FOR 396799.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: John A. Clerico DIRECTOR ELECTIONS ISSUER 396799.000000 0 FOR 396799.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: Michael Dinkins DIRECTOR ELECTIONS ISSUER 396799.000000 0 FOR 396799.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: James S. Ely III DIRECTOR ELECTIONS ISSUER 396799.000000 0 FOR 396799.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: John A. Fry DIRECTOR ELECTIONS ISSUER 396799.000000 0 FOR 396799.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: Joseph A. Hastings, D.M.D. DIRECTOR ELECTIONS ISSUER 396799.000000 0 FOR 396799.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: Tim L. Hingtgen DIRECTOR ELECTIONS ISSUER 396799.000000 0 FOR 396799.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: Elizabeth T. Hirsch DIRECTOR ELECTIONS ISSUER 396799.000000 0 FOR 396799.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: William Norris Jennings, M.D. DIRECTOR ELECTIONS ISSUER 396799.000000 0 FOR 396799.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: K. Ranga Krishnan, MBBS DIRECTOR ELECTIONS ISSUER 396799.000000 0 FOR 396799.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: Fawn D. Lopez DIRECTOR ELECTIONS ISSUER 396799.000000 0 FOR 396799.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: Wayne T. Smith DIRECTOR ELECTIONS ISSUER 396799.000000 0 FOR 396799.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: H. James Williams, Ph.D. DIRECTOR ELECTIONS ISSUER 396799.000000 0 FOR 396799.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Proposal to approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 396799.000000 0 FOR 396799.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Proposal to approve the amendment and restatement of the Community Health Systems, Inc. 2009 Stock Option and Award Plan, which was approved by the Board of Directors on March 12, 2025, subject to stockholder approval. COMPENSATION ISSUER 396799.000000 0 FOR 396799.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Proposal to approve the amendment to the Restated Certificate of Incorporation of Community Health Systems, Inc., to permit exculpation of officers. CORPORATE GOVERNANCE ISSUER 396799.000000 0 FOR 396799.000000 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 396799.000000 0 FOR 396799.000000 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2025 Election of Directors: Vivek Jain DIRECTOR ELECTIONS ISSUER 73460.000000 0 FOR 73460.000000 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2025 Election of Directors: David C. Greenberg DIRECTOR ELECTIONS ISSUER 73460.000000 0 FOR 73460.000000 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2025 Election of Directors: Elisha W. Finney DIRECTOR ELECTIONS ISSUER 73460.000000 0 FOR 73460.000000 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2025 Election of Directors: David F. Hoffmeister DIRECTOR ELECTIONS ISSUER 73460.000000 0 FOR 73460.000000 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2025 Election of Directors: Donald M. Abbey DIRECTOR ELECTIONS ISSUER 73460.000000 0 FOR 73460.000000 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2025 Election of Directors: Laurie Hernandez DIRECTOR ELECTIONS ISSUER 73460.000000 0 FOR 73460.000000 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2025 Election of Directors: Kolleen T. Kennedy DIRECTOR ELECTIONS ISSUER 73460.000000 0 FOR 73460.000000 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2025 To approve an amendment to the Amended and Restated ICU Medical, Inc. 2011 Stock Incentive Plan. COMPENSATION ISSUER 73460.000000 0 FOR 73460.000000 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2025 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2025. AUDIT-RELATED ISSUER 73460.000000 0 FOR 73460.000000 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2025 To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 73460.000000 0 FOR 73460.000000 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2025 To approve, on an advisory basis, a stockholder proposal to adopt simple majority voting. CORPORATE GOVERNANCE SECURITY HOLDER 73460.000000 0 FOR 73460.000000 AGAINST S000004450 Prothena Corporation plc G72800108 IE00B91XRN20 05/13/2025 To elect, by separate resolution, three directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2028, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Paula K. Cobb DIRECTOR ELECTIONS ISSUER 111647.000000 0 FOR 111647.000000 FOR S000004450 Prothena Corporation plc G72800108 IE00B91XRN20 05/13/2025 To elect, by separate resolution, three directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2028, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Lars G. Ekman DIRECTOR ELECTIONS ISSUER 111647.000000 0 FOR 111647.000000 FOR S000004450 Prothena Corporation plc G72800108 IE00B91XRN20 05/13/2025 To elect, by separate resolution, three directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2028, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Gene G. Kinney DIRECTOR ELECTIONS ISSUER 111647.000000 0 FOR 111647.000000 FOR S000004450 Prothena Corporation plc G72800108 IE00B91XRN20 05/13/2025 To ratify, on a non-binding vote, the appointment of KPMG LLP as the Company's independent registered public accounting firm for its fiscal year 2025, and to authorize, in a binding vote, the Company's Board of Directors, acting through its Audit Committee, to approve remuneration of that auditor. AUDIT-RELATED ISSUER 111647.000000 0 FOR 111647.000000 FOR S000004450 Prothena Corporation plc G72800108 IE00B91XRN20 05/13/2025 To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 111647.000000 0 FOR 111647.000000 FOR S000004450 Prothena Corporation plc G72800108 IE00B91XRN20 05/13/2025 To approve an amendment to the Company's 2018 Long Term Incentive Plan to increase the number of ordinary shares available for issuance under that Plan by 2,000,000 ordinary shares. COMPENSATION ISSUER 111647.000000 0 FOR 111647.000000 FOR S000004450 Cytokinetics, Incorporated 23282W605 US23282W6057 05/14/2025 To elect the three nominees listed below as Class III Directors, each to serve for a three-year term and until their successors are duly elected and qualified: John T. Henderson DIRECTOR ELECTIONS ISSUER 353863.000000 0 FOR 353863.000000 FOR S000004450 Cytokinetics, Incorporated 23282W605 US23282W6057 05/14/2025 To elect the three nominees listed below as Class III Directors, each to serve for a three-year term and until their successors are duly elected and qualified: B. Lynne Parshall DIRECTOR ELECTIONS ISSUER 353863.000000 0 FOR 353863.000000 FOR S000004450 Cytokinetics, Incorporated 23282W605 US23282W6057 05/14/2025 To elect the three nominees listed below as Class III Directors, each to serve for a three-year term and until their successors are duly elected and qualified: Muna Bhanji DIRECTOR ELECTIONS ISSUER 353863.000000 0 FOR 353863.000000 FOR S000004450 Cytokinetics, Incorporated 23282W605 US23282W6057 05/14/2025 To approve the amendment and restatement of the Cytokinetics Amended and Restated 2004 Equity Incentive Plan to: (i) increase the number of authorized shares reserved for issuance under such plan by 5,000,000 shares of common stock and (ii) provide for limitations on the maximum grant value that non-executive directors may receive under such plan of $1,000,000 for annual grants to continuing directors and $1,250,000 for the initial grant to new directors. COMPENSATION ISSUER 353863.000000 0 FOR 353863.000000 FOR S000004450 Cytokinetics, Incorporated 23282W605 US23282W6057 05/14/2025 To approve an amendment to Cytokinetics, Incorporated's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common available for issuance by Cytokinetics, Incorporated from 163,000,000 to 326,000,000 shares of common stock. CAPITAL STRUCTURE ISSUER 353863.000000 0 FOR 353863.000000 FOR S000004450 Cytokinetics, Incorporated 23282W605 US23282W6057 05/14/2025 To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Cytokinetics, Incorporated's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 353863.000000 0 FOR 353863.000000 FOR S000004450 Cytokinetics, Incorporated 23282W605 US23282W6057 05/14/2025 To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 353863.000000 0 FOR 353863.000000 FOR S000004450 Elevance Health, Inc. 036752103 US0367521038 05/14/2025 Election of Directors: Susan D. DeVore DIRECTOR ELECTIONS ISSUER 733187.000000 0.000000 FOR 733187.000000 FOR S000004450 Elevance Health, Inc. 036752103 US0367521038 05/14/2025 Election of Directors: Bahija Jallal DIRECTOR ELECTIONS ISSUER 733187.000000 0.000000 FOR 733187.000000 FOR S000004450 Elevance Health, Inc. 036752103 US0367521038 05/14/2025 Election of Directors: Ryan M. Schneider DIRECTOR ELECTIONS ISSUER 733187.000000 0.000000 FOR 733187.000000 FOR S000004450 Elevance Health, Inc. 036752103 US0367521038 05/14/2025 Advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 733187.000000 0.000000 FOR 733187.000000 FOR S000004450 Elevance Health, Inc. 036752103 US0367521038 05/14/2025 To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 733187.000000 0.000000 FOR 733187.000000 FOR S000004450 Elevance Health, Inc. 036752103 US0367521038 05/14/2025 Shareholder proposal requesting report on the effectiveness of Diversity, Equity and Inclusion efforts. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 733187.000000 0.000000 AGAINST 733187.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/14/2025 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: James S. Shannon, M.D., MRCP (UK) DIRECTOR ELECTIONS ISSUER 870719.000000 0 FOR 870719.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/14/2025 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Michael E. Castagna, Pharm.D. DIRECTOR ELECTIONS ISSUER 870719.000000 0 FOR 870719.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/14/2025 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Steven B. Binder DIRECTOR ELECTIONS ISSUER 870719.000000 0 FOR 870719.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/14/2025 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Ronald J. Consiglio DIRECTOR ELECTIONS ISSUER 870719.000000 0 FOR 870719.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/14/2025 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Michael A. Friedman, M.D. DIRECTOR ELECTIONS ISSUER 870719.000000 0 FOR 870719.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/14/2025 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Jennifer Grancio DIRECTOR ELECTIONS ISSUER 870719.000000 0 FOR 870719.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/14/2025 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Anthony Hooper DIRECTOR ELECTIONS ISSUER 870719.000000 0 FOR 870719.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/14/2025 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Sabrina Kay, Ed.D. DIRECTOR ELECTIONS ISSUER 870719.000000 0 FOR 870719.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/14/2025 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Christine Mundkur DIRECTOR ELECTIONS ISSUER 870719.000000 0 FOR 870719.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/14/2025 To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in Mannkind's proxy statement for the Annual Meeting; SECTION 14A SAY-ON-PAY VOTES ISSUER 870719.000000 0 FOR 870719.000000 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/14/2025 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2025; and AUDIT-RELATED ISSUER 870719.000000 0 FOR 870719.000000 FOR S000004450 Merit Medical Systems, Inc. 589889104 US5898891040 05/14/2025 The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for a three (3) year term or until their successors are elected and qualified: Thomas J. Gunderson DIRECTOR ELECTIONS ISSUER 184309.000000 0 FOR 184309.000000 FOR S000004450 Merit Medical Systems, Inc. 589889104 US5898891040 05/14/2025 The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for a three (3) year term or until their successors are elected and qualified: Laura S. Kaiser DIRECTOR ELECTIONS ISSUER 184309.000000 0 FOR 184309.000000 FOR S000004450 Merit Medical Systems, Inc. 589889104 US5898891040 05/14/2025 The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for a three (3) year term or until their successors are elected and qualified: Michael R. McDonnell DIRECTOR ELECTIONS ISSUER 184309.000000 0 FOR 184309.000000 FOR S000004450 Merit Medical Systems, Inc. 589889104 US5898891040 05/14/2025 The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for a three (3) year term or until their successors are elected and qualified: F. Ann Millner, Ed.D. DIRECTOR ELECTIONS ISSUER 184309.000000 0 FOR 184309.000000 FOR S000004450 Merit Medical Systems, Inc. 589889104 US5898891040 05/14/2025 Approval of a non-binding, advisory resolution approving the compensation of the Company's named executive officers as described in the Merit Medical Systems, Inc. Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 184309.000000 0 FOR 184309.000000 FOR S000004450 Merit Medical Systems, Inc. 589889104 US5898891040 05/14/2025 Ratification of the Audit Committee's appointment of Deloitte & Touche LLP to serve as the independent registered public accounting firm of the Company for the year ending December 31, 2025. AUDIT-RELATED ISSUER 184309.000000 0 FOR 184309.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/14/2025 To elect eleven nominees identified in the accompanying proxy statement to serve as directors: Elizabeth Q. Betten DIRECTOR ELECTIONS ISSUER 537496.000000 0 FOR 537496.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/14/2025 To elect eleven nominees identified in the accompanying proxy statement to serve as directors: Elizabeth D. Bierbower DIRECTOR ELECTIONS ISSUER 537496.000000 0 FOR 537496.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/14/2025 To elect eleven nominees identified in the accompanying proxy statement to serve as directors: Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 537496.000000 0 FOR 537496.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/14/2025 To elect eleven nominees identified in the accompanying proxy statement to serve as directors: Eric K. Brandt DIRECTOR ELECTIONS ISSUER 537496.000000 0 FOR 537496.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/14/2025 To elect eleven nominees identified in the accompanying proxy statement to serve as directors: Natasha Deckmann DIRECTOR ELECTIONS ISSUER 537496.000000 0 FOR 537496.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/14/2025 To elect eleven nominees identified in the accompanying proxy statement to serve as directors: David W. Golding DIRECTOR ELECTIONS ISSUER 537496.000000 0 FOR 537496.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/14/2025 To elect eleven nominees identified in the accompanying proxy statement to serve as directors: Harry M. Jansen Kraemer, Jr. DIRECTOR ELECTIONS ISSUER 537496.000000 0 FOR 537496.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/14/2025 To elect eleven nominees identified in the accompanying proxy statement to serve as directors: R. Carter Pate DIRECTOR ELECTIONS ISSUER 537496.000000 0 FOR 537496.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/14/2025 To elect eleven nominees identified in the accompanying proxy statement to serve as directors: John C. Rademacher DIRECTOR ELECTIONS ISSUER 537496.000000 0 FOR 537496.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/14/2025 To elect eleven nominees identified in the accompanying proxy statement to serve as directors: Timothy P. Sullivan DIRECTOR ELECTIONS ISSUER 537496.000000 0 FOR 537496.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/14/2025 To elect eleven nominees identified in the accompanying proxy statement to serve as directors: Norman L. Wright DIRECTOR ELECTIONS ISSUER 537496.000000 0 FOR 537496.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/14/2025 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 537496.000000 0 FOR 537496.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/14/2025 To approve, on a non-binding advisory basis, our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 537496.000000 0 FOR 537496.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/14/2025 To amend our Amended and Restated Certificate of Incorporation to provide stockholders holding at least 25% of our voting power (with certain stockholders holding their shares continuously for at least one year) the right to request special meetings of stockholders. CORPORATE GOVERNANCE ISSUER 537496.000000 0 FOR 537496.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/14/2025 To amend our Amended and Restated Certificate of Incorporation to provide for officer exculpation. CORPORATE GOVERNANCE ISSUER 537496.000000 0 FOR 537496.000000 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/14/2025 To amend our Amended and Restated Certificate of Incorporation to remove legacy provisions relating to HC Group. CORPORATE GOVERNANCE ISSUER 537496.000000 0 FOR 537496.000000 FOR S000004450 OraSure Technologies, Inc. 68554V108 US68554V1089 05/14/2025 ELECTION OF DIRECTORS: Class I (Expiring 2028): Carrie Eglinton Manner DIRECTOR ELECTIONS ISSUER 233533.000000 0 FOR 233533.000000 FOR S000004450 OraSure Technologies, Inc. 68554V108 US68554V1089 05/14/2025 ELECTION OF DIRECTORS: Class I (Expiring 2028): John P. Kenny DIRECTOR ELECTIONS ISSUER 233533.000000 0 FOR 233533.000000 FOR S000004450 OraSure Technologies, Inc. 68554V108 US68554V1089 05/14/2025 ELECTION OF DIRECTORS: Class I (Expiring 2028): David J. Shulkin, M.D. DIRECTOR ELECTIONS ISSUER 233533.000000 0 FOR 233533.000000 FOR S000004450 OraSure Technologies, Inc. 68554V108 US68554V1089 05/14/2025 Ratification of Appointment of Grant Thornton LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2025. AUDIT-RELATED ISSUER 233533.000000 0 FOR 233533.000000 FOR S000004450 OraSure Technologies, Inc. 68554V108 US68554V1089 05/14/2025 Advisory (Non-Binding) Vote to Approve Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 233533.000000 0 FOR 233533.000000 FOR S000004450 OraSure Technologies, Inc. 68554V108 US68554V1089 05/14/2025 Approval of Amendment and Restatement of the Company's Stock Award Plan to Increase the Shares Authorized for Issuance Thereunder. COMPENSATION ISSUER 233533.000000 0 FOR 233533.000000 FOR S000004450 SpringWorks Therapeutics, Inc. 85205L107 US85205L1070 05/14/2025 Election of Class III Directors: Alan Fuhrman DIRECTOR ELECTIONS ISSUER 187739.000000 0 FOR 187739.000000 FOR S000004450 SpringWorks Therapeutics, Inc. 85205L107 US85205L1070 05/14/2025 Election of Class III Directors: Julie Hambleton, M.D. DIRECTOR ELECTIONS ISSUER 187739.000000 0 FOR 187739.000000 FOR S000004450 SpringWorks Therapeutics, Inc. 85205L107 US85205L1070 05/14/2025 Election of Class III Directors: Daniel S. Lynch, M.B.A. DIRECTOR ELECTIONS ISSUER 187739.000000 0 FOR 187739.000000 FOR S000004450 SpringWorks Therapeutics, Inc. 85205L107 US85205L1070 05/14/2025 Ratification of the appointment of Ernst & Young LLP as SpringWorks Therapeutics' independent registered public accounting firm for the fiscal year ending December 31, 2025 AUDIT-RELATED ISSUER 187739.000000 0 FOR 187739.000000 FOR S000004450 SpringWorks Therapeutics, Inc. 85205L107 US85205L1070 05/14/2025 Non-binding advisory vote on executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 187739.000000 0 FOR 187739.000000 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 US87164F1057 05/14/2025 Election of Directors: Keith A. Katkin DIRECTOR ELECTIONS ISSUER 242819.000000 0 FOR 242819.000000 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 US87164F1057 05/14/2025 Election of Directors: Dennis G. Podlesak DIRECTOR ELECTIONS ISSUER 242819.000000 0 FOR 242819.000000 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 US87164F1057 05/14/2025 Election of Directors: Aleksandra Rizo, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 242819.000000 0 FOR 242819.000000 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 US87164F1057 05/14/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2025 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 242819.000000 0 FOR 242819.000000 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 US87164F1057 05/14/2025 To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 242819.000000 0 FOR 242819.000000 FOR S000004450 Universal Health Services, Inc. 913903100 US9139031002 05/14/2025 Election of Director: Maria R. Singer DIRECTOR ELECTIONS ISSUER 185581.000000 0 FOR 185581.000000 FOR S000004450 Universal Health Services, Inc. 913903100 US9139031002 05/14/2025 Proposal to ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 185581.000000 0 FOR 185581.000000 FOR S000004450 Universal Health Services, Inc. 913903100 US9139031002 05/14/2025 Stockholder proposal to elect each director annually, if properly presented at the meeting SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 185581.000000 0 FOR 185581.000000 AGAINST S000004450 Vera Therapeutics, Inc. 92337R101 US92337R1014 05/14/2025 To elect the three Class I directors named below to hold office until the Company's 2028 annual meeting of stockholders: Marshall Fordyce, M.D. DIRECTOR ELECTIONS ISSUER 140170.000000 0 FOR 140170.000000 FOR S000004450 Vera Therapeutics, Inc. 92337R101 US92337R1014 05/14/2025 To elect the three Class I directors named below to hold office until the Company's 2028 annual meeting of stockholders: Beth Seidenberg, M.D. DIRECTOR ELECTIONS ISSUER 140170.000000 0 FOR 140170.000000 FOR S000004450 Vera Therapeutics, Inc. 92337R101 US92337R1014 05/14/2025 To elect the three Class I directors named below to hold office until the Company's 2028 annual meeting of stockholders: Kimball Hall DIRECTOR ELECTIONS ISSUER 140170.000000 0 FOR 140170.000000 FOR S000004450 Vera Therapeutics, Inc. 92337R101 US92337R1014 05/14/2025 To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 140170.000000 0 FOR 140170.000000 FOR S000004450 Vera Therapeutics, Inc. 92337R101 US92337R1014 05/14/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 140170.000000 0 FOR 140170.000000 FOR S000004450 Vera Therapeutics, Inc. 92337R101 US92337R1014 05/14/2025 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 140170.000000 0 ONE YEAR 140170.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Sangeeta Bhatia DIRECTOR ELECTIONS ISSUER 814122.000000 0 FOR 814122.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Lloyd Carney DIRECTOR ELECTIONS ISSUER 814122.000000 0 FOR 814122.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Alan Garber DIRECTOR ELECTIONS ISSUER 814122.000000 0 FOR 814122.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Reshma Kewalramani DIRECTOR ELECTIONS ISSUER 814122.000000 0 FOR 814122.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Michel Lagarde DIRECTOR ELECTIONS ISSUER 814122.000000 0 FOR 814122.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Jeffrey Leiden DIRECTOR ELECTIONS ISSUER 814122.000000 0 FOR 814122.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Diana McKenzie DIRECTOR ELECTIONS ISSUER 814122.000000 0 FOR 814122.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Bruce Sachs DIRECTOR ELECTIONS ISSUER 814122.000000 0 FOR 814122.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Jennifer Schneider DIRECTOR ELECTIONS ISSUER 814122.000000 0 FOR 814122.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Nancy Thornberry DIRECTOR ELECTIONS ISSUER 814122.000000 0 FOR 814122.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Suketu Upadhyay DIRECTOR ELECTIONS ISSUER 814122.000000 0 FOR 814122.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 814122.000000 0 FOR 814122.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 814122.000000 0 FOR 814122.000000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Shareholder proposal, if properly presented at the meeting, regarding excessive golden parachutes. COMPENSATION SECURITY HOLDER 814122.000000 0 AGAINST 814122.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/15/2025 Adoption of the Dutch statutory annual accounts for the fiscal year 2024. CORPORATE GOVERNANCE ISSUER 24425.000000 360100.000000 FOR 24425.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/15/2025 Appointment of Deloitte & Touche LLP and Deloitte Accountants B.V. as our external auditor for the fiscal year 2025. AUDIT-RELATED ISSUER 24425.000000 360100.000000 FOR 24425.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/15/2025 Release of each member of our supervisory board and our management board from liability for the exercise of their duties during the fiscal year 2024. CORPORATE GOVERNANCE ISSUER 24425.000000 360100.000000 FOR 24425.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/15/2025 Appointment of John Hoffman as supervisory director of the Company. DIRECTOR ELECTIONS ISSUER 24425.000000 360100.000000 FOR 24425.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/15/2025 Appointment of Dr. Srinivas Rao as managing director of the Company. CORPORATE GOVERNANCE ISSUER 24425.000000 360100.000000 FOR 24425.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/15/2025 Appointment of Anne Johnson as managing director of the Company. CORPORATE GOVERNANCE ISSUER 24425.000000 360100.000000 FOR 24425.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/15/2025 Amendments to revise the Company's governance model to a one-tier board with designation of the Company's managing directors as executive directors and its supervisory directors as non-executive directors; CORPORATE GOVERNANCE ISSUER 24425.000000 360100.000000 FOR 24425.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/15/2025 Amendments to remove certain limitations relating to the Company's German tax residency; and CORPORATE GOVERNANCE ISSUER 24425.000000 360100.000000 FOR 24425.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/15/2025 Amendments to remove the supermajority requirement for a resolution to amend the Company's articles of association. CORPORATE GOVERNANCE ISSUER 24425.000000 360100.000000 FOR 24425.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/15/2025 Contingent adoption of the Company's compensation policy suitable for a unitary board of directors. COMPENSATION ISSUER 24425.000000 360100.000000 AGAINST 24425.000000 AGAINST S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/15/2025 Extension of the authorization of our management board to issue shares and grant rights to subscribe for shares. CAPITAL STRUCTURE ISSUER 24425.000000 360100.000000 AGAINST 24425.000000 AGAINST S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/15/2025 Extension of the authorization of our management board to limit and exclude pre-emption rights. CAPITAL STRUCTURE ISSUER 24425.000000 360100.000000 AGAINST 24425.000000 AGAINST S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 05/15/2025 Extension of the authorization of our management board to acquire shares (or depositary receipts for such shares) in our capital. CAPITAL STRUCTURE ISSUER 24425.000000 360100.000000 FOR 24425.000000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 05/15/2025 Election of Directors: Kevin Tang DIRECTOR ELECTIONS ISSUER 379834.000000 0 FOR 379834.000000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 05/15/2025 Election of Directors: Jeffrey A. Bailey DIRECTOR ELECTIONS ISSUER 379834.000000 0 FOR 379834.000000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 05/15/2025 Election of Directors: Kathy Goetz DIRECTOR ELECTIONS ISSUER 379834.000000 0 FOR 379834.000000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 05/15/2025 Election of Directors: Peter Greenleaf DIRECTOR ELECTIONS ISSUER 379834.000000 0 FOR 379834.000000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 05/15/2025 Election of Directors: Craig Johnson DIRECTOR ELECTIONS ISSUER 379834.000000 0 FOR 379834.000000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 05/15/2025 Election of Directors: Tina S. Nova DIRECTOR ELECTIONS ISSUER 379834.000000 0 FOR 379834.000000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 05/15/2025 Appointment of Auditors Appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm until the close of the 2026 annual general meeting of shareholders or until a successor is appointed. AUDIT-RELATED ISSUER 379834.000000 0 FOR 379834.000000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 05/15/2025 Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation set forth in the Company's Proxy Statement/Circular. SECTION 14A SAY-ON-PAY VOTES ISSUER 379834.000000 0 FOR 379834.000000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 05/15/2025 Amendment to Equity Incentive Plan To approve the amendment to the Company's Equity Incentive Plan to increase the maximum number of common shares of the Company reserved for issuance pursuant to the Equity Incentive Plan, as set forth in the Company's Proxy Statement/Circular. COMPENSATION ISSUER 379834.000000 0 FOR 379834.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/15/2025 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: Rita Balice-Gordon, Ph.D. DIRECTOR ELECTIONS ISSUER 101720.000000 0 FOR 101720.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/15/2025 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: Garen Bohlin DIRECTOR ELECTIONS ISSUER 101720.000000 0 FOR 101720.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/15/2025 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: Carlos Paya DIRECTOR ELECTIONS ISSUER 101720.000000 0 FOR 101720.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/15/2025 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: John Fallon, M.D. DIRECTOR ELECTIONS ISSUER 101720.000000 0 FOR 101720.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/15/2025 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: John Freund, M.D. DIRECTOR ELECTIONS ISSUER 101720.000000 0 FOR 101720.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/15/2025 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: Vikram Karnani DIRECTOR ELECTIONS ISSUER 101720.000000 0 FOR 101720.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/15/2025 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: Nancy Lurker DIRECTOR ELECTIONS ISSUER 101720.000000 0 FOR 101720.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/15/2025 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: Gino Santini DIRECTOR ELECTIONS ISSUER 101720.000000 0 FOR 101720.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/15/2025 Approval of, on an advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 101720.000000 0 FOR 101720.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/15/2025 To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 101720.000000 0 ONE YEAR 101720.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/15/2025 Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025 AUDIT-RELATED ISSUER 101720.000000 0 FOR 101720.000000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/15/2025 To approve the Collegium Pharmaceutical, Inc. 2025 Equity Incentive Plan COMPENSATION ISSUER 101720.000000 0 FOR 101720.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: Fernando Aguirre DIRECTOR ELECTIONS ISSUER 3978188.000000 0.000000 FOR 3978188.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: Jeffrey R. Balser, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 3978188.000000 0.000000 FOR 3978188.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: C. David Brown II DIRECTOR ELECTIONS ISSUER 3978188.000000 0.000000 FOR 3978188.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: Alecia A. DeCoudreaux DIRECTOR ELECTIONS ISSUER 3978188.000000 0.000000 FOR 3978188.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: Roger N. Farah DIRECTOR ELECTIONS ISSUER 3978188.000000 0.000000 FOR 3978188.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: Anne M. Finucane DIRECTOR ELECTIONS ISSUER 3978188.000000 0.000000 FOR 3978188.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: J. David Joyner DIRECTOR ELECTIONS ISSUER 3978188.000000 0.000000 FOR 3978188.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: J. Scott Kirby DIRECTOR ELECTIONS ISSUER 3978188.000000 0.000000 FOR 3978188.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 3978188.000000 0.000000 FOR 3978188.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: Leslie V. Norwalk DIRECTOR ELECTIONS ISSUER 3978188.000000 0.000000 FOR 3978188.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: Larry M. Robbins DIRECTOR ELECTIONS ISSUER 3978188.000000 0.000000 FOR 3978188.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: Guy P. Sansone DIRECTOR ELECTIONS ISSUER 3978188.000000 0.000000 FOR 3978188.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: Douglas H. Shulman DIRECTOR ELECTIONS ISSUER 3978188.000000 0.000000 FOR 3978188.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/15/2025 Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2025. AUDIT-RELATED ISSUER 3978188.000000 0.000000 FOR 3978188.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/15/2025 Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3978188.000000 0.000000 FOR 3978188.000000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/15/2025 Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. CORPORATE GOVERNANCE SECURITY HOLDER 3978188.000000 0.000000 AGAINST 3978188.000000 FOR S000004450 Fulgent Genetics, Inc. 359664109 US3596641098 05/15/2025 Election of Directors: Ming Hsieh DIRECTOR ELECTIONS ISSUER 61969.000000 0 FOR 61969.000000 FOR S000004450 Fulgent Genetics, Inc. 359664109 US3596641098 05/15/2025 Election of Directors: Linda Marsh DIRECTOR ELECTIONS ISSUER 61969.000000 0 FOR 61969.000000 FOR S000004450 Fulgent Genetics, Inc. 359664109 US3596641098 05/15/2025 Election of Directors: Michael Nohaile, Ph.D. DIRECTOR ELECTIONS ISSUER 61969.000000 0 FOR 61969.000000 FOR S000004450 Fulgent Genetics, Inc. 359664109 US3596641098 05/15/2025 Election of Directors: Regina Groves DIRECTOR ELECTIONS ISSUER 61969.000000 0 FOR 61969.000000 FOR S000004450 Fulgent Genetics, Inc. 359664109 US3596641098 05/15/2025 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 61969.000000 0 FOR 61969.000000 FOR S000004450 Fulgent Genetics, Inc. 359664109 US3596641098 05/15/2025 To approve, on an advisory basis, compensation awarded to the Company's named executive officers (Say-on-Pay). SECTION 14A SAY-ON-PAY VOTES ISSUER 61969.000000 0 FOR 61969.000000 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 US4131971040 05/15/2025 To elect three Class II directors to serve until our 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Juan A. Sabater DIRECTOR ELECTIONS ISSUER 135247.000000 0 FOR 135247.000000 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 US4131971040 05/15/2025 To elect three Class II directors to serve until our 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Gary Sender DIRECTOR ELECTIONS ISSUER 135247.000000 0 FOR 135247.000000 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 US4131971040 05/15/2025 To elect three Class II directors to serve until our 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Linda Szyper DIRECTOR ELECTIONS ISSUER 135247.000000 0 FOR 135247.000000 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 US4131971040 05/15/2025 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 135247.000000 0 FOR 135247.000000 FOR S000004450 Insmed Incorporated 457669307 US4576693075 05/15/2025 Election of two Class I directors, Leo Lee and William H. Lewis, to serve until the 2028 Annual Meeting of Shareholders: Leo Lee DIRECTOR ELECTIONS ISSUER 538747.000000 0 FOR 538747.000000 FOR S000004450 Insmed Incorporated 457669307 US4576693075 05/15/2025 Election of two Class I directors, Leo Lee and William H. Lewis, to serve until the 2028 Annual Meeting of Shareholders: William H. Lewis DIRECTOR ELECTIONS ISSUER 538747.000000 0 FOR 538747.000000 FOR S000004450 Insmed Incorporated 457669307 US4576693075 05/15/2025 An advisory vote on the 2024 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 538747.000000 0 FOR 538747.000000 FOR S000004450 Insmed Incorporated 457669307 US4576693075 05/15/2025 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 538747.000000 0 FOR 538747.000000 FOR S000004450 Insmed Incorporated 457669307 US4576693075 05/15/2025 Approval of Amendment No. 2 to the Insmed Incorporated Amended and Restated 2019 Incentive Plan. COMPENSATION ISSUER 538747.000000 0 FOR 538747.000000 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/15/2025 Election of the members of the Company's Board of Directors: Kerrii B. Anderson DIRECTOR ELECTIONS ISSUER 264232.000000 0 FOR 264232.000000 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/15/2025 Election of the members of the Company's Board of Directors: Jeffrey A. Davis DIRECTOR ELECTIONS ISSUER 264232.000000 0 FOR 264232.000000 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/15/2025 Election of the members of the Company's Board of Directors: D. Gary Gilliland, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 264232.000000 0 FOR 264232.000000 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/15/2025 Election of the members of the Company's Board of Directors: Kirsten M. Kliphouse DIRECTOR ELECTIONS ISSUER 264232.000000 0 FOR 264232.000000 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/15/2025 Election of the members of the Company's Board of Directors: Garheng Kong, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 264232.000000 0 FOR 264232.000000 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/15/2025 Election of the members of the Company's Board of Directors: Peter M. Neupert DIRECTOR ELECTIONS ISSUER 264232.000000 0 FOR 264232.000000 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/15/2025 Election of the members of the Company's Board of Directors: Richelle P. Parham DIRECTOR ELECTIONS ISSUER 264232.000000 0 FOR 264232.000000 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/15/2025 Election of the members of the Company's Board of Directors: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 264232.000000 0 FOR 264232.000000 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/15/2025 Election of the members of the Company's Board of Directors: Adam H. Schechter DIRECTOR ELECTIONS ISSUER 264232.000000 0 FOR 264232.000000 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/15/2025 Election of the members of the Company's Board of Directors: Kathryn E. Wengel DIRECTOR ELECTIONS ISSUER 264232.000000 0 FOR 264232.000000 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/15/2025 To approve, by non-binding vote, the compensation of Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 264232.000000 0 FOR 264232.000000 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/15/2025 To approve the Company's 2025 Omnibus Incentive Plan. COMPENSATION ISSUER 264232.000000 0 FOR 264232.000000 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/15/2025 To approve the Company's 2025 Employee Stock Purchase Plan. COMPENSATION ISSUER 264232.000000 0 FOR 264232.000000 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/15/2025 To ratify the appointment of Deloitte & Touche LLP as Labcorp Holdings Inc.'s independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 264232.000000 0 FOR 264232.000000 FOR S000004450 Lyell Immunopharma, Inc. 55083R203 US55083R2031 05/15/2025 Election of Class I Director: Catherine Friedman DIRECTOR ELECTIONS ISSUER 342456.000000 0 FOR 342456.000000 FOR S000004450 Lyell Immunopharma, Inc. 55083R203 US55083R2031 05/15/2025 Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for its fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 342456.000000 0 FOR 342456.000000 FOR S000004450 Lyell Immunopharma, Inc. 55083R203 US55083R2031 05/15/2025 Approval, on a non-binding advisory basis, of the compensation of the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 342456.000000 0 FOR 342456.000000 FOR S000004450 Lyell Immunopharma, Inc. 55083R203 US55083R2031 05/15/2025 Approval of a series of alternate amendments to the company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of its common stock at a ratio in the range of 1-for-10 to 1-for-25, with such ratio to be determined in the discretion of the company's board of directors and with such reverse stock split to be effected at such time and date, if at all, as determined by the company's board of directors in its sole discretion. CAPITAL STRUCTURE ISSUER 342456.000000 0 FOR 342456.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/15/2025 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Mark A. Beck DIRECTOR ELECTIONS ISSUER 231795.000000 0 FOR 231795.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/15/2025 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Gwendolyn M. Bingham DIRECTOR ELECTIONS ISSUER 231795.000000 0 FOR 231795.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/15/2025 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Kenneth Gardner-Smith DIRECTOR ELECTIONS ISSUER 231795.000000 0 FOR 231795.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/15/2025 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Robert J. Henkel DIRECTOR ELECTIONS ISSUER 231795.000000 0 FOR 231795.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/15/2025 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Rita F. Johnson-Mills DIRECTOR ELECTIONS ISSUER 231795.000000 0 FOR 231795.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/15/2025 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Stephen W. Klemash DIRECTOR ELECTIONS ISSUER 231795.000000 0 FOR 231795.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/15/2025 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Teresa L. Kline DIRECTOR ELECTIONS ISSUER 231795.000000 0 FOR 231795.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/15/2025 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Edward A. Pesicka DIRECTOR ELECTIONS ISSUER 231795.000000 0 FOR 231795.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/15/2025 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Carissa L. Rollins DIRECTOR ELECTIONS ISSUER 231795.000000 0 FOR 231795.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/15/2025 Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 231795.000000 0 FOR 231795.000000 FOR S000004450 Owens & Minor, Inc. 690732102 US6907321029 05/15/2025 Advisory vote to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 231795.000000 0 FOR 231795.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/15/2025 Election of Directors: Robert B. Carter DIRECTOR ELECTIONS ISSUER 352847.000000 0 FOR 352847.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/15/2025 Election of Directors: James E. Davis DIRECTOR ELECTIONS ISSUER 352847.000000 0 FOR 352847.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/15/2025 Election of Directors: Luis A. Diaz, Jr., M.D. DIRECTOR ELECTIONS ISSUER 352847.000000 0 FOR 352847.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/15/2025 Election of Directors: Tracey C. Doi DIRECTOR ELECTIONS ISSUER 352847.000000 0 FOR 352847.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/15/2025 Election of Directors: Vicky B. Gregg DIRECTOR ELECTIONS ISSUER 352847.000000 0 FOR 352847.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/15/2025 Election of Directors: Wright L. Lassiter, III DIRECTOR ELECTIONS ISSUER 352847.000000 0 FOR 352847.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/15/2025 Election of Directors: Timothy L. Main DIRECTOR ELECTIONS ISSUER 352847.000000 0 FOR 352847.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/15/2025 Election of Directors: Denise M. Morrison DIRECTOR ELECTIONS ISSUER 352847.000000 0 FOR 352847.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/15/2025 Election of Directors: Gary M. Pfeiffer DIRECTOR ELECTIONS ISSUER 352847.000000 0 FOR 352847.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/15/2025 Election of Directors: Timothy M. Ring DIRECTOR ELECTIONS ISSUER 352847.000000 0 FOR 352847.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/15/2025 An advisory resolution to approve the executive officer compensation disclosed in the Company's 2025 proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 352847.000000 0 FOR 352847.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/15/2025 Ratification of the appointment of our independent registered public accounting firm for 2025 AUDIT-RELATED ISSUER 352847.000000 0 FOR 352847.000000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/15/2025 Stockholder proposal, as described in the accompanying proxy statement, if properly presented at the Annual Meeting CORPORATE GOVERNANCE SECURITY HOLDER 352847.000000 0 AGAINST 352847.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/15/2025 Election of Directors: Olivier Loeillot DIRECTOR ELECTIONS ISSUER 167883.000000 0 FOR 167883.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/15/2025 Election of Directors: Tony J. Hunt DIRECTOR ELECTIONS ISSUER 167883.000000 0 FOR 167883.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/15/2025 Election of Directors: Karen A. Dawes DIRECTOR ELECTIONS ISSUER 167883.000000 0 FOR 167883.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/15/2025 Election of Directors: Nicolas M. Barthelemy DIRECTOR ELECTIONS ISSUER 167883.000000 0 FOR 167883.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/15/2025 Election of Directors: Carrie Eglinton Manner DIRECTOR ELECTIONS ISSUER 167883.000000 0 FOR 167883.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/15/2025 Election of Directors: Konstantin Konstantinov, Ph.D. DIRECTOR ELECTIONS ISSUER 167883.000000 0 FOR 167883.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/15/2025 Election of Directors: Martin D. Madaus, D.V.M., Ph.D. DIRECTOR ELECTIONS ISSUER 167883.000000 0 FOR 167883.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/15/2025 Election of Directors: Rohin Mhatre, Ph.D. DIRECTOR ELECTIONS ISSUER 167883.000000 0 FOR 167883.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/15/2025 Election of Directors: Glenn P. Muir DIRECTOR ELECTIONS ISSUER 167883.000000 0 FOR 167883.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/15/2025 Election of Directors: Margaret A. Pax DIRECTOR ELECTIONS ISSUER 167883.000000 0 FOR 167883.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/15/2025 Ratification of the selection of Ernst & Young LLP as Repligen Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 167883.000000 0 FOR 167883.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/15/2025 Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 167883.000000 0 FOR 167883.000000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/15/2025 Approval of an amendment to the Corporation's certificate of incorporation to limit the liability of certain officers of the company as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 167883.000000 0 FOR 167883.000000 FOR S000004450 The Ensign Group, Inc. 29358P101 US29358P1012 05/15/2025 ELECTION OF CLASS III DIRECTORS EACH FOR A THREE-YEAR TERM as follows: NOMINEE: Dr. Ann S. Blouin DIRECTOR ELECTIONS ISSUER 181014.000000 0 FOR 181014.000000 FOR S000004450 The Ensign Group, Inc. 29358P101 US29358P1012 05/15/2025 ELECTION OF CLASS III DIRECTORS EACH FOR A THREE-YEAR TERM as follows: NOMINEE: Dr. John O. Agwunobi DIRECTOR ELECTIONS ISSUER 181014.000000 0 FOR 181014.000000 FOR S000004450 The Ensign Group, Inc. 29358P101 US29358P1012 05/15/2025 ELECTION OF CLASS III DIRECTORS EACH FOR A THREE-YEAR TERM as follows: NOMINEE: Mr. Barry R. Port DIRECTOR ELECTIONS ISSUER 181014.000000 0 FOR 181014.000000 FOR S000004450 The Ensign Group, Inc. 29358P101 US29358P1012 05/15/2025 ELECTION OF CLASS II DIRECTORS EACH FOR A TWO-YEAR TERM as follows: NOMINEE: Mr. Mark V. Parkinson DIRECTOR ELECTIONS ISSUER 181014.000000 0 FOR 181014.000000 FOR S000004450 The Ensign Group, Inc. 29358P101 US29358P1012 05/15/2025 RATIFICATION OF APPOINTMENT OF DELOITTE & TOUCHE LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2025. AUDIT-RELATED ISSUER 181014.000000 0 FOR 181014.000000 FOR S000004450 The Ensign Group, Inc. 29358P101 US29358P1012 05/15/2025 APPROVAL, ON AN ADVISORY BASIS, OF OUR NAMED EXECUTIVE OFFICER COMPENSATION. SECTION 14A SAY-ON-PAY VOTES ISSUER 181014.000000 0 FOR 181014.000000 FOR S000004450 The Ensign Group, Inc. 29358P101 US29358P1012 05/15/2025 APPROVAL OF THE AMENDMENT TO THE ENSIGN GROUP, INC. 2022 OMNIBUS INCENTIVE PLAN COMPENSATION ISSUER 181014.000000 0 FOR 181014.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/15/2025 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Roy Baynes DIRECTOR ELECTIONS ISSUER 257424.000000 0 FOR 257424.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/15/2025 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Suzanne Bruhn DIRECTOR ELECTIONS ISSUER 257424.000000 0 FOR 257424.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/15/2025 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Timothy Coughlin DIRECTOR ELECTIONS ISSUER 257424.000000 0 FOR 257424.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/15/2025 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Eric Dube DIRECTOR ELECTIONS ISSUER 257424.000000 0 FOR 257424.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/15/2025 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Gary Lyons DIRECTOR ELECTIONS ISSUER 257424.000000 0 FOR 257424.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/15/2025 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Jeffrey Meckler DIRECTOR ELECTIONS ISSUER 257424.000000 0 FOR 257424.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/15/2025 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: John Orwin DIRECTOR ELECTIONS ISSUER 257424.000000 0 FOR 257424.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/15/2025 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Sandra Poole DIRECTOR ELECTIONS ISSUER 257424.000000 0 FOR 257424.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/15/2025 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Ron Squarer DIRECTOR ELECTIONS ISSUER 257424.000000 0 FOR 257424.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/15/2025 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Ruth Williams-Brinkley DIRECTOR ELECTIONS ISSUER 257424.000000 0 FOR 257424.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/15/2025 To approve the Company's 2018 Equity Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 4,000,000 shares. COMPENSATION ISSUER 257424.000000 0 FOR 257424.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/15/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 257424.000000 0 FOR 257424.000000 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/15/2025 To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 257424.000000 0 FOR 257424.000000 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/15/2025 Nominees: Matthew K. Fust DIRECTOR ELECTIONS ISSUER 261857.000000 0 FOR 261857.000000 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/15/2025 Nominees: Amrit Ray, M.D. DIRECTOR ELECTIONS ISSUER 261857.000000 0 FOR 261857.000000 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/15/2025 Approval of the Second Amended and Restated 2023 Incentive Plan. COMPENSATION ISSUER 261857.000000 0 FOR 261857.000000 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/15/2025 Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 261857.000000 0 FOR 261857.000000 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/15/2025 Advisory (non-binding) vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 261857.000000 0 FOR 261857.000000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/16/2025 Election of Director: Kapila Anand DIRECTOR ELECTIONS ISSUER 1561519.000000 0 FOR 1561519.000000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/16/2025 Election of Director: Paul Herendeen DIRECTOR ELECTIONS ISSUER 1561519.000000 0 FOR 1561519.000000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/16/2025 Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 1561519.000000 0 FOR 1561519.000000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/16/2025 Advisory vote on the compensation of the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1561519.000000 0 FOR 1561519.000000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/16/2025 Advisory vote on the frequency with which shareholders vote on the compensation of the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1561519.000000 0 ONE YEAR 1561519.000000 FOR S000004450 Krystal Biotech, Inc. 501147102 US5011471027 05/16/2025 Election of Class II Directors: Daniel S. Janney DIRECTOR ELECTIONS ISSUER 68102.000000 0 FOR 68102.000000 FOR S000004450 Krystal Biotech, Inc. 501147102 US5011471027 05/16/2025 Election of Class II Directors: Dino A. Rossi DIRECTOR ELECTIONS ISSUER 68102.000000 0 FOR 68102.000000 FOR S000004450 Krystal Biotech, Inc. 501147102 US5011471027 05/16/2025 Election of Class II Directors: E. Rand Sutherland DIRECTOR ELECTIONS ISSUER 68102.000000 0 FOR 68102.000000 FOR S000004450 Krystal Biotech, Inc. 501147102 US5011471027 05/16/2025 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 68102.000000 0 FOR 68102.000000 FOR S000004450 Krystal Biotech, Inc. 501147102 US5011471027 05/16/2025 Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 68102.000000 0 FOR 68102.000000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/16/2025 Election of Directors: August J. Troendle DIRECTOR ELECTIONS ISSUER 83465.000000 0 FOR 83465.000000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/16/2025 Election of Directors: Dani S. Zander DIRECTOR ELECTIONS ISSUER 83465.000000 0 FOR 83465.000000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/16/2025 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 83465.000000 0 FOR 83465.000000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/16/2025 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2025 Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 83465.000000 0 FOR 83465.000000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/16/2025 To approve the Medpace Holdings, Inc. 2016 Amended and Restated Incentive Award Plan. COMPENSATION ISSUER 83465.000000 0 FOR 83465.000000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/16/2025 Stockholder proposal regarding implementation of simple majority voting, if properly presented at the meeting. CORPORATE GOVERNANCE SECURITY HOLDER 83465.000000 0 FOR 83465.000000 AGAINST S000004450 The Pennant Group, Inc. 70805E109 US70805E1091 05/16/2025 Election of Directors: Stephen M.R. Covey DIRECTOR ELECTIONS ISSUER 108652.000000 0 FOR 108652.000000 FOR S000004450 The Pennant Group, Inc. 70805E109 US70805E1091 05/16/2025 Election of Directors: Suzanne D. Snapper DIRECTOR ELECTIONS ISSUER 108652.000000 0 FOR 108652.000000 FOR S000004450 The Pennant Group, Inc. 70805E109 US70805E1091 05/16/2025 Approval of amendment to the Company's certificate of incorporation to reflect Delaware Law provisions regarding officer exculpation CORPORATE GOVERNANCE ISSUER 108652.000000 0 FOR 108652.000000 FOR S000004450 The Pennant Group, Inc. 70805E109 US70805E1091 05/16/2025 Approval of Amended and Restated Pennant Group, Inc. 2019 Omnibus Incentive Plan COMPENSATION ISSUER 108652.000000 0 FOR 108652.000000 FOR S000004450 The Pennant Group, Inc. 70805E109 US70805E1091 05/16/2025 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for fiscal year 2025. AUDIT-RELATED ISSUER 108652.000000 0 FOR 108652.000000 FOR S000004450 The Pennant Group, Inc. 70805E109 US70805E1091 05/16/2025 Advisory approval of the Company's named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 108652.000000 0 FOR 108652.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/19/2025 Election of Directors: Michael H. Carrel DIRECTOR ELECTIONS ISSUER 154102.000000 0 FOR 154102.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/19/2025 Election of Directors: Regina E. Groves DIRECTOR ELECTIONS ISSUER 154102.000000 0 FOR 154102.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/19/2025 Election of Directors: B. Kristine Johnson DIRECTOR ELECTIONS ISSUER 154102.000000 0 FOR 154102.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/19/2025 Election of Directors: Shlomo Nachman DIRECTOR ELECTIONS ISSUER 154102.000000 0 FOR 154102.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/19/2025 Election of Directors: Karen N. Prange DIRECTOR ELECTIONS ISSUER 154102.000000 0 FOR 154102.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/19/2025 Election of Directors: Deborah H. Telman DIRECTOR ELECTIONS ISSUER 154102.000000 0 FOR 154102.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/19/2025 Election of Directors: Sven A. Wehrwein DIRECTOR ELECTIONS ISSUER 154102.000000 0 FOR 154102.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/19/2025 Election of Directors: Robert S. White DIRECTOR ELECTIONS ISSUER 154102.000000 0 FOR 154102.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/19/2025 Election of Directors: Maggie Yuen DIRECTOR ELECTIONS ISSUER 154102.000000 0 FOR 154102.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/19/2025 Proposal to ratify the appointment of Deloitte & Touche LLP as Independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 154102.000000 0 FOR 154102.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/19/2025 Proposal to approve an amendment to the AtriCure, Inc. 2023 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 1,700,000. COMPENSATION ISSUER 154102.000000 0 FOR 154102.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/19/2025 Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement for the 2025 Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 154102.000000 0 FOR 154102.000000 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/19/2025 Advisory vote on the frequency of future advisory votes on compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 154102.000000 0 ONE YEAR 154102.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/19/2025 Election of directors: Kevin J. McNamara DIRECTOR ELECTIONS ISSUER 44915.000000 0 FOR 44915.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/19/2025 Election of directors: Ron DeLyons DIRECTOR ELECTIONS ISSUER 44915.000000 0 FOR 44915.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/19/2025 Election of directors: Patrick P. Grace DIRECTOR ELECTIONS ISSUER 44915.000000 0 FOR 44915.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/19/2025 Election of directors: Christopher J. Heaney DIRECTOR ELECTIONS ISSUER 44915.000000 0 FOR 44915.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/19/2025 Election of directors: Thomas C. Hutton DIRECTOR ELECTIONS ISSUER 44915.000000 0 FOR 44915.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/19/2025 Election of directors: Andrea R. Lindell DIRECTOR ELECTIONS ISSUER 44915.000000 0 FOR 44915.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/19/2025 Election of directors: Eileen P. McCarthy DIRECTOR ELECTIONS ISSUER 44915.000000 0 FOR 44915.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/19/2025 Election of directors: John M. Mount, Jr. DIRECTOR ELECTIONS ISSUER 44915.000000 0 FOR 44915.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/19/2025 Election of directors: George J. Walsh III DIRECTOR ELECTIONS ISSUER 44915.000000 0 FOR 44915.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/19/2025 Approval and Adoption of the 2025 Stock Incentive Plan. COMPENSATION ISSUER 44915.000000 0 FOR 44915.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/19/2025 Ratification of Audit Committee's selection of PricewaterhouseCoopers LLP as independent accountants for 2025. AUDIT-RELATED ISSUER 44915.000000 0 FOR 44915.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/19/2025 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 44915.000000 0 FOR 44915.000000 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/19/2025 Stockholder proposal to reduce voting power threshold for calling a special meeting to 10%. CORPORATE GOVERNANCE SECURITY HOLDER 44915.000000 0 AGAINST 44915.000000 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 05/19/2025 Elect five directors to serve until the 2026 Annual Meeting of Stockholders: Mark A. DiPaolo, Esq. DIRECTOR ELECTIONS ISSUER 177661.000000 0 FOR 177661.000000 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 05/19/2025 Elect five directors to serve until the 2026 Annual Meeting of Stockholders: Jules Haimovitz DIRECTOR ELECTIONS ISSUER 177661.000000 0 FOR 177661.000000 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 05/19/2025 Elect five directors to serve until the 2026 Annual Meeting of Stockholders: Sarah J. Schlesinger, M.D. DIRECTOR ELECTIONS ISSUER 177661.000000 0 FOR 177661.000000 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 05/19/2025 Elect five directors to serve until the 2026 Annual Meeting of Stockholders: Derek A. Small DIRECTOR ELECTIONS ISSUER 177661.000000 0 FOR 177661.000000 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 05/19/2025 Elect five directors to serve until the 2026 Annual Meeting of Stockholders: Pavel Raifeld DIRECTOR ELECTIONS ISSUER 177661.000000 0 FOR 177661.000000 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 05/19/2025 Approval of a non-binding advisory resolution regarding executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 177661.000000 0 FOR 177661.000000 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 05/19/2025 Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 177661.000000 0 FOR 177661.000000 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 US67080M1036 05/19/2025 Election of Directors: Judith A. Reinsdorf DIRECTOR ELECTIONS ISSUER 190136.000000 0 FOR 190136.000000 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 US67080M1036 05/19/2025 Election of Directors: Edward C. Saltzman DIRECTOR ELECTIONS ISSUER 190136.000000 0 FOR 190136.000000 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 US67080M1036 05/19/2025 Election of Directors: Roy D. Baynes DIRECTOR ELECTIONS ISSUER 190136.000000 0 FOR 190136.000000 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 US67080M1036 05/19/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending November 30, 2025. AUDIT-RELATED ISSUER 190136.000000 0 FOR 190136.000000 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 US67080M1036 05/19/2025 To approve, a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 190136.000000 0 FOR 190136.000000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 KYG8807B1068 05/19/2025 Election of Directors: Rick E Winningham DIRECTOR ELECTIONS ISSUER 119147.000000 0 FOR 119147.000000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 KYG8807B1068 05/19/2025 Election of Directors: Jeremy T. Grant DIRECTOR ELECTIONS ISSUER 119147.000000 0 FOR 119147.000000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 KYG8807B1068 05/19/2025 Election of Directors: Susannah Gray DIRECTOR ELECTIONS ISSUER 119147.000000 0 FOR 119147.000000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 KYG8807B1068 05/19/2025 Election of Directors: Donal O'Connor DIRECTOR ELECTIONS ISSUER 119147.000000 0 FOR 119147.000000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 KYG8807B1068 05/19/2025 To ratify the appointment of Ernst & Young LLP as Theravance Biopharma, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 119147.000000 0 FOR 119147.000000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 KYG8807B1068 05/19/2025 To vote on a non-binding advisory resolution regarding the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 119147.000000 0 FOR 119147.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/20/2025 Election of Directors: Elizabeth M. Anderson DIRECTOR ELECTIONS ISSUER 601469.000000 0 FOR 601469.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/20/2025 Election of Directors: Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 601469.000000 0 FOR 601469.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/20/2025 Election of Directors: Athena Countouriotis DIRECTOR ELECTIONS ISSUER 601469.000000 0 FOR 601469.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/20/2025 Election of Directors: Willard Dere DIRECTOR ELECTIONS ISSUER 601469.000000 0 FOR 601469.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/20/2025 Election of Directors: Mark J. Enyedy DIRECTOR ELECTIONS ISSUER 601469.000000 0 FOR 601469.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/20/2025 Election of Directors: Alexander Hardy DIRECTOR ELECTIONS ISSUER 601469.000000 0 FOR 601469.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/20/2025 Election of Directors: Maykin Ho DIRECTOR ELECTIONS ISSUER 601469.000000 0 FOR 601469.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/20/2025 Election of Directors: Robert J. Hombach DIRECTOR ELECTIONS ISSUER 601469.000000 0 FOR 601469.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/20/2025 Election of Directors: Richard A. Meier DIRECTOR ELECTIONS ISSUER 601469.000000 0 FOR 601469.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/20/2025 Election of Directors: Timothy P. Walbert DIRECTOR ELECTIONS ISSUER 601469.000000 0 FOR 601469.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/20/2025 To ratify the selection of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 601469.000000 0 FOR 601469.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/20/2025 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 601469.000000 0 FOR 601469.000000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 05/20/2025 To approve an amendment to the Company's 2017 Equity Incentive Plan, as amended. COMPENSATION ISSUER 601469.000000 0 FOR 601469.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/20/2025 To elect Richard J. Daly as a member of the Board of Directors until the 2026 Annual Meeting of Stockholders, or until his earlier death, disability or resignation: DIRECTOR ELECTIONS ISSUER 337149.000000 0 FOR 337149.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/20/2025 To elect Patrick J. McEnany as a member of the Board of Directors until the 2026 Annual Meeting of Stockholders, or until his earlier death, disability or resignation: DIRECTOR ELECTIONS ISSUER 337149.000000 0 FOR 337149.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/20/2025 To elect Donald A. Denkhaus as a member of the Board of Directors until the 2026 Annual Meeting of Stockholders, or until his earlier death, disability or resignation: DIRECTOR ELECTIONS ISSUER 337149.000000 0 FOR 337149.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/20/2025 To elect Molly Harper as a member of the Board of Directors until the 2026 Annual Meeting of Stockholders, or until her earlier death, disability or resignation: DIRECTOR ELECTIONS ISSUER 337149.000000 0 FOR 337149.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/20/2025 To elect Tamar Thompson as a member of the Board of Directors until the 2026 Annual Meeting of Stockholders, or until her earlier death, disability or resignation: DIRECTOR ELECTIONS ISSUER 337149.000000 0 FOR 337149.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/20/2025 To elect David S. Tierney, M.D. as a member of the Board of Directors until the 2026 Annual Meeting of Stockholders, or until his earlier death, disability or resignation: DIRECTOR ELECTIONS ISSUER 337149.000000 0 FOR 337149.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/20/2025 To approve an amendment to our 2018 Stock Incentive Plan to increase the shares available for issuance by 5 million shares. COMPENSATION ISSUER 337149.000000 0 FOR 337149.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/20/2025 To approve, on an advisory basis, the 2024 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 337149.000000 0 FOR 337149.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/20/2025 To ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 337149.000000 0 FOR 337149.000000 FOR S000004450 Catalyst Pharmaceuticals, Inc. 14888U101 US14888U1016 05/20/2025 To transact such other business as may properly come before the meeting. CORPORATE GOVERNANCE ISSUER 337149.000000 0 AGAINST 337149.000000 AGAINST S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/20/2025 Election of Directors: James C. Foster DIRECTOR ELECTIONS ISSUER 161449.000000 0 FOR 161449.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/20/2025 Election of Directors: Nancy C. Andrews DIRECTOR ELECTIONS ISSUER 161449.000000 0 FOR 161449.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/20/2025 Election of Directors: Robert Bertolini DIRECTOR ELECTIONS ISSUER 161449.000000 0 FOR 161449.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/20/2025 Election of Directors: Reshema Kemps-Polanco DIRECTOR ELECTIONS ISSUER 161449.000000 0 FOR 161449.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/20/2025 Election of Directors: Deborah T. Kochevar DIRECTOR ELECTIONS ISSUER 161449.000000 0 FOR 161449.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/20/2025 Election of Directors: George Llado, Sr. DIRECTOR ELECTIONS ISSUER 161449.000000 0 FOR 161449.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/20/2025 Election of Directors: Martin W. Mackay DIRECTOR ELECTIONS ISSUER 161449.000000 0 FOR 161449.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/20/2025 Election of Directors: George E. Massaro DIRECTOR ELECTIONS ISSUER 161449.000000 0 FOR 161449.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/20/2025 Election of Directors: Craig B. Thompson DIRECTOR ELECTIONS ISSUER 161449.000000 0 FOR 161449.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/20/2025 Election of Directors: Richard F. Wallman DIRECTOR ELECTIONS ISSUER 161449.000000 0 FOR 161449.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/20/2025 Election of Directors: Virginia M. Wilson DIRECTOR ELECTIONS ISSUER 161449.000000 0 FOR 161449.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/20/2025 Advisory Approval of 2024 Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 161449.000000 0 FOR 161449.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/20/2025 Ratification of PricewaterhouseCoopers LLC as independent registered public accounting firm for 2025 AUDIT-RELATED ISSUER 161449.000000 0 FOR 161449.000000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/20/2025 Proposal to publish a report on non-human primates imported by Charles River Laboratories International, Inc. OTHER SOCIAL ISSUES SECURITY HOLDER 161449.000000 0 AGAINST 161449.000000 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/20/2025 To elect eight directors to serve on the Company's Board of Directors: Patrick Beyer DIRECTOR ELECTIONS ISSUER 97858.000000 0 FOR 97858.000000 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/20/2025 To elect eight directors to serve on the Company's Board of Directors: David Bronson DIRECTOR ELECTIONS ISSUER 97858.000000 0 FOR 97858.000000 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/20/2025 To elect eight directors to serve on the Company's Board of Directors: Brian P. Concannon DIRECTOR ELECTIONS ISSUER 97858.000000 0 FOR 97858.000000 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/20/2025 To elect eight directors to serve on the Company's Board of Directors: LaVerne Council DIRECTOR ELECTIONS ISSUER 97858.000000 0 FOR 97858.000000 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/20/2025 To elect eight directors to serve on the Company's Board of Directors: Charles M. Farkas DIRECTOR ELECTIONS ISSUER 97858.000000 0 FOR 97858.000000 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/20/2025 To elect eight directors to serve on the Company's Board of Directors: Martha Goldberg Aronson DIRECTOR ELECTIONS ISSUER 97858.000000 0 FOR 97858.000000 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/20/2025 To elect eight directors to serve on the Company's Board of Directors: Mark Kaye DIRECTOR ELECTIONS ISSUER 97858.000000 0 FOR 97858.000000 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/20/2025 To elect eight directors to serve on the Company's Board of Directors: Barbara J. Schwarzentraub DIRECTOR ELECTIONS ISSUER 97858.000000 0 FOR 97858.000000 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/20/2025 Advisory Vote on Named Executive Officer Compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 97858.000000 0 FOR 97858.000000 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/20/2025 To approve the 2025 Long-Term Incentive Plan; COMPENSATION ISSUER 97858.000000 0 FOR 97858.000000 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/20/2025 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025; AUDIT-RELATED ISSUER 97858.000000 0 FOR 97858.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/20/2025 Election of Directors: To be elected for terms expiring in 2026: Brian J. Blaser DIRECTOR ELECTIONS ISSUER 212380.000000 0 FOR 212380.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/20/2025 Election of Directors: To be elected for terms expiring in 2026: Kenneth F. Buechler, Ph.D. DIRECTOR ELECTIONS ISSUER 212380.000000 0 FOR 212380.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/20/2025 Election of Directors: To be elected for terms expiring in 2026: John R. Chiminski DIRECTOR ELECTIONS ISSUER 212380.000000 0 FOR 212380.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/20/2025 Election of Directors: To be elected for terms expiring in 2026: Evelyn S. Dilsaver DIRECTOR ELECTIONS ISSUER 212380.000000 0 FOR 212380.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/20/2025 Election of Directors: To be elected for terms expiring in 2026: R. Scott Huennekens DIRECTOR ELECTIONS ISSUER 212380.000000 0 FOR 212380.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/20/2025 Election of Directors: To be elected for terms expiring in 2026: Edward L. Michael DIRECTOR ELECTIONS ISSUER 212380.000000 0 FOR 212380.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/20/2025 Election of Directors: To be elected for terms expiring in 2026: Mary Lake Polan, M.D., Ph.D., M.P.H. DIRECTOR ELECTIONS ISSUER 212380.000000 0 FOR 212380.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/20/2025 Election of Directors: To be elected for terms expiring in 2026: Ann D. Rhoads DIRECTOR ELECTIONS ISSUER 212380.000000 0 FOR 212380.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/20/2025 Election of Directors: To be elected for terms expiring in 2026: Matthew W. Strobeck Ph.D. DIRECTOR ELECTIONS ISSUER 212380.000000 0 FOR 212380.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/20/2025 Election of Directors: To be elected for terms expiring in 2026: Kenneth J. Widder, M.D. DIRECTOR ELECTIONS ISSUER 212380.000000 0 FOR 212380.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/20/2025 Election of Directors: To be elected for terms expiring in 2026: Joseph D. Wilkins Jr. DIRECTOR ELECTIONS ISSUER 212380.000000 0 FOR 212380.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/20/2025 Approval of the adoption of QuidelOrtho's Second Amended and Restated 2018 Equity Incentive Plan. COMPENSATION ISSUER 212380.000000 0 FOR 212380.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/20/2025 Approval of, on an advisory basis, the compensation of QuidelOrtho's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 212380.000000 0 FOR 212380.000000 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 05/20/2025 Ratification of the selection of KPMG LLP as QuidelOrtho's independent registered public accounting firm for the fiscal year ending December 28, 2025. AUDIT-RELATED ISSUER 212380.000000 0 FOR 212380.000000 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 US89455T1097 05/20/2025 Election of Directors: Lawrence W. Hamilton DIRECTOR ELECTIONS ISSUER 157094.000000 0 FOR 157094.000000 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 US89455T1097 05/20/2025 Election of Directors: Deepti Jain DIRECTOR ELECTIONS ISSUER 157094.000000 0 FOR 157094.000000 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 US89455T1097 05/20/2025 Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 157094.000000 0 FOR 157094.000000 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 US89455T1097 05/20/2025 Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 157094.000000 0 FOR 157094.000000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/20/2025 Election of eight directors to serve until the next annual meeting of stockholders: Christopher J. Reading DIRECTOR ELECTIONS ISSUER 47204.000000 0 FOR 47204.000000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/20/2025 Election of eight directors to serve until the next annual meeting of stockholders: Dr. Bernard A. Harris Jr. DIRECTOR ELECTIONS ISSUER 47204.000000 0 FOR 47204.000000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/20/2025 Election of eight directors to serve until the next annual meeting of stockholders: Kathleen A. Gilmartin DIRECTOR ELECTIONS ISSUER 47204.000000 0 FOR 47204.000000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/20/2025 Election of eight directors to serve until the next annual meeting of stockholders: Regg E. Swanson DIRECTOR ELECTIONS ISSUER 47204.000000 0 FOR 47204.000000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/20/2025 Election of eight directors to serve until the next annual meeting of stockholders: Clayton K. Trier DIRECTOR ELECTIONS ISSUER 47204.000000 0 FOR 47204.000000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/20/2025 Election of eight directors to serve until the next annual meeting of stockholders: Anne B. Motsenbocker DIRECTOR ELECTIONS ISSUER 47204.000000 0 FOR 47204.000000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/20/2025 Election of eight directors to serve until the next annual meeting of stockholders: Nancy J. Ham DIRECTOR ELECTIONS ISSUER 47204.000000 0 FOR 47204.000000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/20/2025 Election of eight directors to serve until the next annual meeting of stockholders: Michael G. Mayrsohn DIRECTOR ELECTIONS ISSUER 47204.000000 0 FOR 47204.000000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/20/2025 Advisory vote to approve the named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 47204.000000 0 FOR 47204.000000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/20/2025 Ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 47204.000000 0 FOR 47204.000000 FOR S000004450 Viking Therapeutics, Inc. 92686J106 US92686J1060 05/20/2025 ELECTION OF DIRECTOR NOMINEES FOR CLASS I (term to expire in 2028): Matthew W. Foehr DIRECTOR ELECTIONS ISSUER 314656.000000 0 FOR 314656.000000 FOR S000004450 Viking Therapeutics, Inc. 92686J106 US92686J1060 05/20/2025 ELECTION OF DIRECTOR NOMINEES FOR CLASS I (term to expire in 2028): Charles A. Rowland, Jr. DIRECTOR ELECTIONS ISSUER 314656.000000 0 FOR 314656.000000 FOR S000004450 Viking Therapeutics, Inc. 92686J106 US92686J1060 05/20/2025 RATIFICATION OF THE SELECTION OF CBIZ CPAS P.C. AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2025. AUDIT-RELATED ISSUER 314656.000000 0 FOR 314656.000000 FOR S000004450 Viking Therapeutics, Inc. 92686J106 US92686J1060 05/20/2025 TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 314656.000000 0 FOR 314656.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/21/2025 Election of Directors: Kevin T. Conroy DIRECTOR ELECTIONS ISSUER 223698.000000 0 FOR 223698.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/21/2025 Election of Directors: Kevin J. Dallas DIRECTOR ELECTIONS ISSUER 223698.000000 0 FOR 223698.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/21/2025 Election of Directors: Joseph M. Hogan DIRECTOR ELECTIONS ISSUER 223698.000000 0 FOR 223698.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/21/2025 Election of Directors: Joseph Lacob DIRECTOR ELECTIONS ISSUER 223698.000000 0 FOR 223698.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/21/2025 Election of Directors: C. Raymond Larkin, Jr. DIRECTOR ELECTIONS ISSUER 223698.000000 0 FOR 223698.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/21/2025 Election of Directors: George J. Morrow DIRECTOR ELECTIONS ISSUER 223698.000000 0 FOR 223698.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/21/2025 Election of Directors: Anne M. Myong DIRECTOR ELECTIONS ISSUER 223698.000000 0 FOR 223698.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/21/2025 Election of Directors: Mojdeh Poul DIRECTOR ELECTIONS ISSUER 223698.000000 0 FOR 223698.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/21/2025 Election of Directors: Andrea L. Saia DIRECTOR ELECTIONS ISSUER 223698.000000 0 FOR 223698.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/21/2025 Election of Directors: Susan E. Siegel DIRECTOR ELECTIONS ISSUER 223698.000000 0 FOR 223698.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/21/2025 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 223698.000000 0 FOR 223698.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/21/2025 Ratification of Appointment of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 223698.000000 0 FOR 223698.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/21/2025 Replacement of Supermajority Provisions in our Charter with a Simple Majority Vote CORPORATE GOVERNANCE ISSUER 223698.000000 0 FOR 223698.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/21/2025 Approval of an Amendment to the Align Technology, Inc. 2005 Incentive Plan COMPENSATION ISSUER 223698.000000 0 FOR 223698.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/21/2025 Advisory Vote to Allow Stockholders Owning 25% of our Stock to Call a Special Meeting CORPORATE GOVERNANCE ISSUER 223698.000000 0 FOR 223698.000000 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/21/2025 Support for Shareholder Ability to Call for a Special Shareholder Meeting CORPORATE GOVERNANCE SECURITY HOLDER 223698.000000 0 AGAINST 223698.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/21/2025 To elect as directors to serve a one-year term until the Company's 2026 annual general meeting of shareholders: Shane M. Cooke DIRECTOR ELECTIONS ISSUER 486116.000000 0 FOR 486116.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/21/2025 To elect as directors to serve a one-year term until the Company's 2026 annual general meeting of shareholders: Richard B. Gaynor, M.D. DIRECTOR ELECTIONS ISSUER 486116.000000 0 FOR 486116.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/21/2025 To elect as directors to serve a one-year term until the Company's 2026 annual general meeting of shareholders: Cato T. Laurencin, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 486116.000000 0 FOR 486116.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/21/2025 To elect as directors to serve a one-year term until the Company's 2026 annual general meeting of shareholders: Nancy S. Lurker DIRECTOR ELECTIONS ISSUER 486116.000000 0 FOR 486116.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/21/2025 To elect as directors to serve a one-year term until the Company's 2026 annual general meeting of shareholders: Brian P. McKeon DIRECTOR ELECTIONS ISSUER 486116.000000 0 FOR 486116.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/21/2025 To elect as directors to serve a one-year term until the Company's 2026 annual general meeting of shareholders: Richard F. Pops DIRECTOR ELECTIONS ISSUER 486116.000000 0 FOR 486116.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/21/2025 To elect as directors to serve a one-year term until the Company's 2026 annual general meeting of shareholders: Nancy L. Snyderman, M.D. DIRECTOR ELECTIONS ISSUER 486116.000000 0 FOR 486116.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/21/2025 To elect as directors to serve a one-year term until the Company's 2026 annual general meeting of shareholders: Frank Anders Wilson DIRECTOR ELECTIONS ISSUER 486116.000000 0 FOR 486116.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/21/2025 To elect as directors to serve a one-year term until the Company's 2026 annual general meeting of shareholders: Christopher I. Wright, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 486116.000000 0 FOR 486116.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/21/2025 To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 486116.000000 0 FOR 486116.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/21/2025 To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize, in a binding vote, the Audit and Risk Committee of the Board to set the independent auditor and accounting firm's remuneration. AUDIT-RELATED ISSUER 486116.000000 0 FOR 486116.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/21/2025 To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended. COMPENSATION ISSUER 486116.000000 0 FOR 486116.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/21/2025 To renew Board authority to allot and issue shares under Irish law. CAPITAL STRUCTURE ISSUER 486116.000000 0 FOR 486116.000000 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/21/2025 To renew Board authority to disapply the statutory pre-emption rights that would otherwise apply under Irish law. CAPITAL STRUCTURE ISSUER 486116.000000 0 FOR 486116.000000 FOR S000004450 Arbutus Biopharma Corporation 03879J100 CA03879J1003 05/21/2025 To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2026 Annual General Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Lindsay Androski, JD, MBA, CFA DIRECTOR ELECTIONS ISSUER 447290.000000 0 FOR 447290.000000 FOR S000004450 Arbutus Biopharma Corporation 03879J100 CA03879J1003 05/21/2025 To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2026 Annual General Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Robert Alan Beardsley DIRECTOR ELECTIONS ISSUER 447290.000000 0 FOR 447290.000000 FOR S000004450 Arbutus Biopharma Corporation 03879J100 CA03879J1003 05/21/2025 To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2026 Annual General Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Joseph Bishop DIRECTOR ELECTIONS ISSUER 447290.000000 0 FOR 447290.000000 FOR S000004450 Arbutus Biopharma Corporation 03879J100 CA03879J1003 05/21/2025 To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2026 Annual General Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Matthew Gline DIRECTOR ELECTIONS ISSUER 447290.000000 0 FOR 447290.000000 FOR S000004450 Arbutus Biopharma Corporation 03879J100 CA03879J1003 05/21/2025 To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2026 Annual General Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Anuj Hasija DIRECTOR ELECTIONS ISSUER 447290.000000 0 FOR 447290.000000 FOR S000004450 Arbutus Biopharma Corporation 03879J100 CA03879J1003 05/21/2025 To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement/Circular; and SECTION 14A SAY-ON-PAY VOTES ISSUER 447290.000000 0 FOR 447290.000000 FOR S000004450 Arbutus Biopharma Corporation 03879J100 CA03879J1003 05/21/2025 To approve the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 447290.000000 0 FOR 447290.000000 FOR S000004450 Certara, Inc. 15687V109 US15687V1098 05/21/2025 To elect the four Class II directors named in our Proxy Statement to hold office until the 2028 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Eran Broshy DIRECTOR ELECTIONS ISSUER 407190.000000 0 FOR 407190.000000 FOR S000004450 Certara, Inc. 15687V109 US15687V1098 05/21/2025 To elect the four Class II directors named in our Proxy Statement to hold office until the 2028 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Cynthia Collins DIRECTOR ELECTIONS ISSUER 407190.000000 0 FOR 407190.000000 FOR S000004450 Certara, Inc. 15687V109 US15687V1098 05/21/2025 To elect the four Class II directors named in our Proxy Statement to hold office until the 2028 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: John Reynders DIRECTOR ELECTIONS ISSUER 407190.000000 0 FOR 407190.000000 FOR S000004450 Certara, Inc. 15687V109 US15687V1098 05/21/2025 To elect the four Class II directors named in our Proxy Statement to hold office until the 2028 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Matthew Walsh DIRECTOR ELECTIONS ISSUER 407190.000000 0 FOR 407190.000000 FOR S000004450 Certara, Inc. 15687V109 US15687V1098 05/21/2025 Ratification of the selection of RSM US LLP as our independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 407190.000000 0 FOR 407190.000000 FOR S000004450 Certara, Inc. 15687V109 US15687V1098 05/21/2025 A non-binding advisory vote to approve the compensation of our named executive officers for the most recently completed fiscal year. SECTION 14A SAY-ON-PAY VOTES ISSUER 407190.000000 0 FOR 407190.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/21/2025 Election of Directors: Michael J. Barber DIRECTOR ELECTIONS ISSUER 627418.000000 0 FOR 627418.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/21/2025 Election of Directors: Simon D. Campion DIRECTOR ELECTIONS ISSUER 627418.000000 0 FOR 627418.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/21/2025 Election of Directors: Willie A. Deese DIRECTOR ELECTIONS ISSUER 627418.000000 0 FOR 627418.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/21/2025 Election of Directors: Brian T. Gladden DIRECTOR ELECTIONS ISSUER 627418.000000 0 FOR 627418.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/21/2025 Election of Directors: Betsy D. Holden DIRECTOR ELECTIONS ISSUER 627418.000000 0 FOR 627418.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/21/2025 Election of Directors: Clyde R. Hosein DIRECTOR ELECTIONS ISSUER 627418.000000 0 FOR 627418.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/21/2025 Election of Directors: Gregory T. Lucier DIRECTOR ELECTIONS ISSUER 627418.000000 0 FOR 627418.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/21/2025 Election of Directors: Jonathan J. Mazelsky DIRECTOR ELECTIONS ISSUER 627418.000000 0 FOR 627418.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/21/2025 Election of Directors: Daniel T. Scavilla DIRECTOR ELECTIONS ISSUER 627418.000000 0 FOR 627418.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/21/2025 Election of Directors: Leslie F. Varon DIRECTOR ELECTIONS ISSUER 627418.000000 0 FOR 627418.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/21/2025 Election of Directors: Janet S. Vergis DIRECTOR ELECTIONS ISSUER 627418.000000 0 FOR 627418.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/21/2025 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accountants for 2025. AUDIT-RELATED ISSUER 627418.000000 0 FOR 627418.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/21/2025 Approval, by non-binding vote, of the Company's executive compensation for 2024. SECTION 14A SAY-ON-PAY VOTES ISSUER 627418.000000 0 FOR 627418.000000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 05/21/2025 Approval of Amendment No. 1 to the 2024 Omnibus Incentive Plan to increase the number of shares of the Company's Common Stock issuable under such Plan. COMPENSATION ISSUER 627418.000000 0 FOR 627418.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/21/2025 Election of Directors: Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 176592.000000 0 FOR 176592.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/21/2025 Election of Directors: Liam J. Kelly DIRECTOR ELECTIONS ISSUER 176592.000000 0 FOR 176592.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/21/2025 Election of Directors: Angela S. Lalor DIRECTOR ELECTIONS ISSUER 176592.000000 0 FOR 176592.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/21/2025 Election of Directors: Philip A. Okala DIRECTOR ELECTIONS ISSUER 176592.000000 0 FOR 176592.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/21/2025 Election of Directors: Christine Ortiz DIRECTOR ELECTIONS ISSUER 176592.000000 0 FOR 176592.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/21/2025 Election of Directors: A. Clayton Perfall DIRECTOR ELECTIONS ISSUER 176592.000000 0 FOR 176592.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/21/2025 Election of Directors: Brady Shirley DIRECTOR ELECTIONS ISSUER 176592.000000 0 FOR 176592.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/21/2025 Election of Directors: Rajiv Vinnakota DIRECTOR ELECTIONS ISSUER 176592.000000 0 FOR 176592.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/21/2025 Election of Directors: Sharon Wienbar DIRECTOR ELECTIONS ISSUER 176592.000000 0 FOR 176592.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/21/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 176592.000000 0 FOR 176592.000000 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/21/2025 To approve on an advisory basis the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 176592.000000 0 FOR 176592.000000 FOR S000004450 Geron Corporation 374163103 US3741631036 05/21/2025 To elect the two nominees for director named below to hold office as Class II members of the Board of Directors until the 2028 annual meeting of stockholders: Dawn C. Bir DIRECTOR ELECTIONS ISSUER 1617956.000000 0 FOR 1617956.000000 FOR S000004450 Geron Corporation 374163103 US3741631036 05/21/2025 To elect the two nominees for director named below to hold office as Class II members of the Board of Directors until the 2028 annual meeting of stockholders: Elizabeth G. O'Farrell DIRECTOR ELECTIONS ISSUER 1617956.000000 0 FOR 1617956.000000 FOR S000004450 Geron Corporation 374163103 US3741631036 05/21/2025 To approve an amendment to our 2018 Equity Incentive Plan to, among other items, increase the total number of shares of our common stock issuable thereunder by 20,000,000 shares. COMPENSATION ISSUER 1617956.000000 0 FOR 1617956.000000 FOR S000004450 Geron Corporation 374163103 US3741631036 05/21/2025 To approve an amendment to our 2014 Employee Stock Purchase Plan to increase the number of shares of our common stock issuable thereunder by 6,000,000 shares. COMPENSATION ISSUER 1617956.000000 0 FOR 1617956.000000 FOR S000004450 Geron Corporation 374163103 US3741631036 05/21/2025 To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1617956.000000 0 FOR 1617956.000000 FOR S000004450 Geron Corporation 374163103 US3741631036 05/21/2025 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 1617956.000000 0 FOR 1617956.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2025 Election of Directors: Frances Arnold, Ph.D. DIRECTOR ELECTIONS ISSUER 499502.000000 0 FOR 499502.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2025 Election of Directors: Caroline D. Dorsa DIRECTOR ELECTIONS ISSUER 499502.000000 0 FOR 499502.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2025 Election of Directors: Robert S. Epstein, M.D. DIRECTOR ELECTIONS ISSUER 499502.000000 0 FOR 499502.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2025 Election of Directors: Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 499502.000000 0 FOR 499502.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2025 Election of Directors: Gary S. Guthart, Ph.D. DIRECTOR ELECTIONS ISSUER 499502.000000 0 FOR 499502.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2025 Election of Directors: Keith A. Meister DIRECTOR ELECTIONS ISSUER 499502.000000 0 FOR 499502.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2025 Election of Directors: Anna Richo DIRECTOR ELECTIONS ISSUER 499502.000000 0 FOR 499502.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2025 Election of Directors: Philip W. Schiller DIRECTOR ELECTIONS ISSUER 499502.000000 0 FOR 499502.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2025 Election of Directors: Susan E. Siegel DIRECTOR ELECTIONS ISSUER 499502.000000 0 FOR 499502.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2025 Election of Directors: Jacob Thaysen, Ph.D. DIRECTOR ELECTIONS ISSUER 499502.000000 0 FOR 499502.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2025 Election of Directors: Scott B. Ullem DIRECTOR ELECTIONS ISSUER 499502.000000 0 FOR 499502.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 28, 2025. AUDIT-RELATED ISSUER 499502.000000 0 FOR 499502.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2025 To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 499502.000000 0 FOR 499502.000000 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2025 To approve the Second Amended and Restated 2015 Stock and Incentive Plan of Illumina, Inc. COMPENSATION ISSUER 499502.000000 0 FOR 499502.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/21/2025 To elect 10 directors for a one-year term or until their successors have been duly elected and qualified: Sheila Antrum DIRECTOR ELECTIONS ISSUER 105825.000000 0 FOR 105825.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/21/2025 To elect 10 directors for a one-year term or until their successors have been duly elected and qualified: Pamela G. Bailey DIRECTOR ELECTIONS ISSUER 105825.000000 0 FOR 105825.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/21/2025 To elect 10 directors for a one-year term or until their successors have been duly elected and qualified: Cheryl C. Capps DIRECTOR ELECTIONS ISSUER 105825.000000 0 FOR 105825.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/21/2025 To elect 10 directors for a one-year term or until their successors have been duly elected and qualified: Joseph W. Dziedzic DIRECTOR ELECTIONS ISSUER 105825.000000 0 FOR 105825.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/21/2025 To elect 10 directors for a one-year term or until their successors have been duly elected and qualified: James F. Hinrichs DIRECTOR ELECTIONS ISSUER 105825.000000 0 FOR 105825.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/21/2025 To elect 10 directors for a one-year term or until their successors have been duly elected and qualified: Jean Hobby DIRECTOR ELECTIONS ISSUER 105825.000000 0 FOR 105825.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/21/2025 To elect 10 directors for a one-year term or until their successors have been duly elected and qualified: Alvin (Tyrone) Jeffers DIRECTOR ELECTIONS ISSUER 105825.000000 0 FOR 105825.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/21/2025 To elect 10 directors for a one-year term or until their successors have been duly elected and qualified: M. Craig Maxwell DIRECTOR ELECTIONS ISSUER 105825.000000 0 FOR 105825.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/21/2025 To elect 10 directors for a one-year term or until their successors have been duly elected and qualified: Filippo Passerini DIRECTOR ELECTIONS ISSUER 105825.000000 0 FOR 105825.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/21/2025 To elect 10 directors for a one-year term or until their successors have been duly elected and qualified: Donald J. Spence DIRECTOR ELECTIONS ISSUER 105825.000000 0 FOR 105825.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/21/2025 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for Integer Holdings Corporation for fiscal year 2025. AUDIT-RELATED ISSUER 105825.000000 0 FOR 105825.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/21/2025 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 105825.000000 0 FOR 105825.000000 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/21/2025 To approve an amendment to the Company's Restated Certificate of Incorporation to include an officer exculpation provision. CORPORATE GOVERNANCE ISSUER 105825.000000 0 FOR 105825.000000 FOR S000004450 MacroGenics, Inc. 556099109 US5560991094 05/21/2025 To elect four Class III directors listed in the proxy materials to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Karen Ferrante, M.D. DIRECTOR ELECTIONS ISSUER 129624.000000 0 FOR 129624.000000 FOR S000004450 MacroGenics, Inc. 556099109 US5560991094 05/21/2025 To elect four Class III directors listed in the proxy materials to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: William Heiden DIRECTOR ELECTIONS ISSUER 129624.000000 0 FOR 129624.000000 FOR S000004450 MacroGenics, Inc. 556099109 US5560991094 05/21/2025 To elect four Class III directors listed in the proxy materials to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Edward Hurwitz DIRECTOR ELECTIONS ISSUER 129624.000000 0 FOR 129624.000000 FOR S000004450 MacroGenics, Inc. 556099109 US5560991094 05/21/2025 To elect four Class III directors listed in the proxy materials to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Meenu Chhabra Karson DIRECTOR ELECTIONS ISSUER 129624.000000 0 FOR 129624.000000 FOR S000004450 MacroGenics, Inc. 556099109 US5560991094 05/21/2025 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 129624.000000 0 FOR 129624.000000 FOR S000004450 MacroGenics, Inc. 556099109 US5560991094 05/21/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy materials. SECTION 14A SAY-ON-PAY VOTES ISSUER 129624.000000 0 FOR 129624.000000 FOR S000004450 MacroGenics, Inc. 556099109 US5560991094 05/21/2025 To approve the amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan, as disclosed in the proxy materials. COMPENSATION ISSUER 129624.000000 0 FOR 129624.000000 FOR S000004450 Merus N.V. N5749R100 NL0011606264 05/21/2025 Adoption of Merus N.V.'s Dutch statutory annual accounts for the financial year 2024. CORPORATE GOVERNANCE ISSUER 149474.000000 0 FOR 149474.000000 FOR S000004450 Merus N.V. N5749R100 NL0011606264 05/21/2025 Appointment of KPMG Accountants N.V. as Merus N.V.'s external auditor for the financial year 2025 for purposes of Dutch law. AUDIT-RELATED ISSUER 149474.000000 0 FOR 149474.000000 FOR S000004450 Merus N.V. N5749R100 NL0011606264 05/21/2025 Release of each member of Merus N.V.'s board of directors from liability for the exercise of their duties during the financial year 2024. CORPORATE GOVERNANCE ISSUER 149474.000000 0 FOR 149474.000000 FOR S000004450 Merus N.V. N5749R100 NL0011606264 05/21/2025 Opportunity to make recommendations for nomination by Merus N.V.'s group of non-executive directors. CORPORATE GOVERNANCE ISSUER 149474.000000 0 FOR 149474.000000 FOR S000004450 Merus N.V. N5749R100 NL0011606264 05/21/2025 Re-appointment of Anand Mehra, M.D. as non-executive director. DIRECTOR ELECTIONS ISSUER 149474.000000 0 FOR 149474.000000 FOR S000004450 Merus N.V. N5749R100 NL0011606264 05/21/2025 Opportunity to make recommendations for nomination by Merus N.V.'s group of non-executive directors. CORPORATE GOVERNANCE ISSUER 149474.000000 0 FOR 149474.000000 FOR S000004450 Merus N.V. N5749R100 NL0011606264 05/21/2025 Re-appointment of Maxine Gowen, Ph.D. as non-executive director. DIRECTOR ELECTIONS ISSUER 149474.000000 0 FOR 149474.000000 FOR S000004450 Merus N.V. N5749R100 NL0011606264 05/21/2025 Granting authorization to Merus N.V.'s board of directors to acquire shares (or depository receipts for such shares) in Merus N.V.'s capital. CAPITAL STRUCTURE ISSUER 149474.000000 0 FOR 149474.000000 FOR S000004450 Merus N.V. N5749R100 NL0011606264 05/21/2025 Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 149474.000000 0 FOR 149474.000000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/21/2025 The election of the four nominees for Class II directors named below to the Board of Directors to serve for a term of three years: Kyle W. Gano, Ph.D. DIRECTOR ELECTIONS ISSUER 319519.000000 0 FOR 319519.000000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/21/2025 The election of the four nominees for Class II directors named below to the Board of Directors to serve for a term of three years: Richard F. Pops DIRECTOR ELECTIONS ISSUER 319519.000000 0 FOR 319519.000000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/21/2025 The election of the four nominees for Class II directors named below to the Board of Directors to serve for a term of three years: Shalini Sharp DIRECTOR ELECTIONS ISSUER 319519.000000 0 FOR 319519.000000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/21/2025 The election of the four nominees for Class II directors named below to the Board of Directors to serve for a term of three years: Stephen A. Sherwin, M.D. DIRECTOR ELECTIONS ISSUER 319519.000000 0 FOR 319519.000000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/21/2025 Advisory vote on the compensation paid to the Company's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 319519.000000 0 FOR 319519.000000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/21/2025 To approve the Company's 2025 Equity Incentive Plan; COMPENSATION ISSUER 319519.000000 0 FOR 319519.000000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/21/2025 To approve an amendment and restatement of the Company's 2018 Employee Stock Purchase Plan; and COMPENSATION ISSUER 319519.000000 0 FOR 319519.000000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/21/2025 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 319519.000000 0 FOR 319519.000000 FOR S000004450 Nuvation Bio Inc. 67080N101 US67080N1019 05/21/2025 Election of Director: Kathryn E. Falberg DIRECTOR ELECTIONS ISSUER 685136.000000 0 FOR 685136.000000 FOR S000004450 Nuvation Bio Inc. 67080N101 US67080N1019 05/21/2025 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm. AUDIT-RELATED ISSUER 685136.000000 0 FOR 685136.000000 FOR S000004450 Nuvation Bio Inc. 67080N101 US67080N1019 05/21/2025 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 685136.000000 0 FOR 685136.000000 FOR S000004450 Omnicell, Inc. 68213N109 US68213N1090 05/21/2025 Proposal to elect Class III Directors to hold office until the 2028 Annual Meeting of Stockholders: Edward P. Bousa DIRECTOR ELECTIONS ISSUER 145248.000000 0 FOR 145248.000000 FOR S000004450 Omnicell, Inc. 68213N109 US68213N1090 05/21/2025 Proposal to elect Class III Directors to hold office until the 2028 Annual Meeting of Stockholders: Mary Garrett DIRECTOR ELECTIONS ISSUER 145248.000000 0 FOR 145248.000000 FOR S000004450 Omnicell, Inc. 68213N109 US68213N1090 05/21/2025 Proposal to elect Class III Directors to hold office until the 2028 Annual Meeting of Stockholders: Bruce E. Scott DIRECTOR ELECTIONS ISSUER 145248.000000 0 FOR 145248.000000 FOR S000004450 Omnicell, Inc. 68213N109 US68213N1090 05/21/2025 Say on Pay - An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 145248.000000 0 FOR 145248.000000 FOR S000004450 Omnicell, Inc. 68213N109 US68213N1090 05/21/2025 Proposal to approve an amendment to the Omnicell, Inc. 2009 Equity Incentive Plan, as amended, to, among other items, add an additional 1,750,000 shares to the number of shares of common stock authorized for issuance under such plan. COMPENSATION ISSUER 145248.000000 0 FOR 145248.000000 FOR S000004450 Omnicell, Inc. 68213N109 US68213N1090 05/21/2025 Proposal to ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2025. AUDIT-RELATED ISSUER 145248.000000 0 FOR 145248.000000 FOR S000004450 Privia Health Group, Inc. 74276R102 US74276R1023 05/21/2025 To elect the three nominees listed in the accompanying proxy statement as Class III directors to the Board of Directors ("Board") to serve until our 2028 annual meeting and until their respective successors have been duly elected and qualified: Pamela Kimmet DIRECTOR ELECTIONS ISSUER 302645.000000 0 FOR 302645.000000 FOR S000004450 Privia Health Group, Inc. 74276R102 US74276R1023 05/21/2025 To elect the three nominees listed in the accompanying proxy statement as Class III directors to the Board of Directors ("Board") to serve until our 2028 annual meeting and until their respective successors have been duly elected and qualified: Patricia Maryland DIRECTOR ELECTIONS ISSUER 302645.000000 0 FOR 302645.000000 FOR S000004450 Privia Health Group, Inc. 74276R102 US74276R1023 05/21/2025 To elect the three nominees listed in the accompanying proxy statement as Class III directors to the Board of Directors ("Board") to serve until our 2028 annual meeting and until their respective successors have been duly elected and qualified: Shawn Morris DIRECTOR ELECTIONS ISSUER 302645.000000 0 FOR 302645.000000 FOR S000004450 Privia Health Group, Inc. 74276R102 US74276R1023 05/21/2025 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers ("NEOs"). SECTION 14A SAY-ON-PAY VOTES ISSUER 302645.000000 0 FOR 302645.000000 FOR S000004450 Privia Health Group, Inc. 74276R102 US74276R1023 05/21/2025 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 302645.000000 0 FOR 302645.000000 FOR S000004450 Sotera Health Company 83601L102 US83601L1026 05/21/2025 Elect the three following Class II director nominees to serve until the 2028 Annual Meeting of Stockholders: Ruoxi Chen DIRECTOR ELECTIONS ISSUER 492319.000000 0 FOR 492319.000000 FOR S000004450 Sotera Health Company 83601L102 US83601L1026 05/21/2025 Elect the three following Class II director nominees to serve until the 2028 Annual Meeting of Stockholders: Karen A. Flynn DIRECTOR ELECTIONS ISSUER 492319.000000 0 FOR 492319.000000 FOR S000004450 Sotera Health Company 83601L102 US83601L1026 05/21/2025 Elect the three following Class II director nominees to serve until the 2028 Annual Meeting of Stockholders: Ann R. Klee DIRECTOR ELECTIONS ISSUER 492319.000000 0 FOR 492319.000000 FOR S000004450 Sotera Health Company 83601L102 US83601L1026 05/21/2025 Approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 492319.000000 0 FOR 492319.000000 FOR S000004450 Sotera Health Company 83601L102 US83601L1026 05/21/2025 Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 492319.000000 0 FOR 492319.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/21/2025 To elect eight directors for a one-year term expiring at the 2026 annual meeting of stockholders: Rebecca Robertson DIRECTOR ELECTIONS ISSUER 206772.000000 0 FOR 206772.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/21/2025 To elect eight directors for a one-year term expiring at the 2026 annual meeting of stockholders: Myoungil Cha DIRECTOR ELECTIONS ISSUER 206772.000000 0 FOR 206772.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/21/2025 To elect eight directors for a one-year term expiring at the 2026 annual meeting of stockholders: Peyton Howell DIRECTOR ELECTIONS ISSUER 206772.000000 0 FOR 206772.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/21/2025 To elect eight directors for a one-year term expiring at the 2026 annual meeting of stockholders: Joao Malagueira DIRECTOR ELECTIONS ISSUER 206772.000000 0 FOR 206772.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/21/2025 To elect eight directors for a one-year term expiring at the 2026 annual meeting of stockholders: Kathleen McGroddy-Goetz DIRECTOR ELECTIONS ISSUER 206772.000000 0 FOR 206772.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/21/2025 To elect eight directors for a one-year term expiring at the 2026 annual meeting of stockholders: John Sheridan DIRECTOR ELECTIONS ISSUER 206772.000000 0 FOR 206772.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/21/2025 To elect eight directors for a one-year term expiring at the 2026 annual meeting of stockholders: Rajwant Sodhi DIRECTOR ELECTIONS ISSUER 206772.000000 0 FOR 206772.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/21/2025 To elect eight directors for a one-year term expiring at the 2026 annual meeting of stockholders: Christopher Twomey DIRECTOR ELECTIONS ISSUER 206772.000000 0 FOR 206772.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/21/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 206772.000000 0 FOR 206772.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/21/2025 To approve, on a non-binding, advisory basis, the frequency of future stockholder advisory votes to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 206772.000000 0 ONE YEAR 206772.000000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/21/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 206772.000000 0 FOR 206772.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Marc N. Casper DIRECTOR ELECTIONS ISSUER 1207093.000000 0 FOR 1207093.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Nelson J. Chai DIRECTOR ELECTIONS ISSUER 1207093.000000 0 FOR 1207093.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Ruby R. Chandy DIRECTOR ELECTIONS ISSUER 1207093.000000 0 FOR 1207093.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: C. Martin Harris DIRECTOR ELECTIONS ISSUER 1207093.000000 0 FOR 1207093.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Tyler Jacks DIRECTOR ELECTIONS ISSUER 1207093.000000 0 FOR 1207093.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Jennifer M. Johnson DIRECTOR ELECTIONS ISSUER 1207093.000000 0 FOR 1207093.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: R. Alexandra Keith DIRECTOR ELECTIONS ISSUER 1207093.000000 0 FOR 1207093.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Karen S. Lynch DIRECTOR ELECTIONS ISSUER 1207093.000000 0 FOR 1207093.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: James C. Mullen DIRECTOR ELECTIONS ISSUER 1207093.000000 0 FOR 1207093.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Debora L. Spar DIRECTOR ELECTIONS ISSUER 1207093.000000 0 FOR 1207093.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Scott M. Sperling DIRECTOR ELECTIONS ISSUER 1207093.000000 0 FOR 1207093.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Dion J. Weisler DIRECTOR ELECTIONS ISSUER 1207093.000000 0 FOR 1207093.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1207093.000000 0 FOR 1207093.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2025. AUDIT-RELATED ISSUER 1207093.000000 0 FOR 1207093.000000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Shareholder proposal. CORPORATE GOVERNANCE SECURITY HOLDER 1207093.000000 0 AGAINST 1207093.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Paul M. Bisaro DIRECTOR ELECTIONS ISSUER 1420777.000000 0 FOR 1420777.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Vanessa Broadhurst DIRECTOR ELECTIONS ISSUER 1420777.000000 0 FOR 1420777.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 1420777.000000 0 FOR 1420777.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Gavin D.K. Hattersley DIRECTOR ELECTIONS ISSUER 1420777.000000 0 FOR 1420777.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Sanjay Khosla DIRECTOR ELECTIONS ISSUER 1420777.000000 0 FOR 1420777.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Antoinette R. Leatherberry DIRECTOR ELECTIONS ISSUER 1420777.000000 0 FOR 1420777.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Michael B. McCallister DIRECTOR ELECTIONS ISSUER 1420777.000000 0 FOR 1420777.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Gregory Norden DIRECTOR ELECTIONS ISSUER 1420777.000000 0 FOR 1420777.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Louise M. Parent DIRECTOR ELECTIONS ISSUER 1420777.000000 0 FOR 1420777.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Kristin C. Peck DIRECTOR ELECTIONS ISSUER 1420777.000000 0 FOR 1420777.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Willie M. Reed DIRECTOR ELECTIONS ISSUER 1420777.000000 0 FOR 1420777.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Mark Stetter DIRECTOR ELECTIONS ISSUER 1420777.000000 0 FOR 1420777.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1420777.000000 0 FOR 1420777.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 1420777.000000 0 FOR 1420777.000000 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Shareholder proposal regarding a special shareholder meeting improvement. CORPORATE GOVERNANCE SECURITY HOLDER 1420777.000000 0 AGAINST 1420777.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/22/2025 Election of Directors: Thomas J. Haughey DIRECTOR ELECTIONS ISSUER 52731.000000 0 FOR 52731.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/22/2025 Election of Directors: Nikhil Lalwani DIRECTOR ELECTIONS ISSUER 52731.000000 0 FOR 52731.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/22/2025 Election of Directors: Matthew J. Leonard, R.Ph. DIRECTOR ELECTIONS ISSUER 52731.000000 0 FOR 52731.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/22/2025 Election of Directors: Antonio R. Pera DIRECTOR ELECTIONS ISSUER 52731.000000 0 FOR 52731.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/22/2025 Election of Directors: Muthusamy Shanmugam DIRECTOR ELECTIONS ISSUER 52731.000000 0 FOR 52731.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/22/2025 Election of Directors: Renee P. Tannenbaum, Pharm.D. DIRECTOR ELECTIONS ISSUER 52731.000000 0 FOR 52731.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/22/2025 Election of Directors: Jeanne A Thoma DIRECTOR ELECTIONS ISSUER 52731.000000 0 FOR 52731.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/22/2025 Election of Directors: Patrick D. Wash DIRECTOR ELECTIONS ISSUER 52731.000000 0 FOR 52731.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/22/2025 To ratify the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 52731.000000 0 FOR 52731.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/22/2025 To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 52731.000000 0 FOR 52731.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/22/2025 To approve an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of common stock. CAPITAL STRUCTURE ISSUER 52731.000000 0 FOR 52731.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/22/2025 To approve the Amended and Restated 2022 Stock Incentive Plan. COMPENSATION ISSUER 52731.000000 0 FOR 52731.000000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/22/2025 To approve the Amended and Restated 2016 Employee Stock Purchase Plan. COMPENSATION ISSUER 52731.000000 0 FOR 52731.000000 FOR S000004450 Castle Biosciences, Inc. 14843C105 US14843C1053 05/22/2025 To elect the three Class III directors listed below to hold office until the 2028 Annual Meeting of Stockholders: Kimberlee S. Caple DIRECTOR ELECTIONS ISSUER 88323.000000 0 FOR 88323.000000 FOR S000004450 Castle Biosciences, Inc. 14843C105 US14843C1053 05/22/2025 To elect the three Class III directors listed below to hold office until the 2028 Annual Meeting of Stockholders: G. Bradley Cole DIRECTOR ELECTIONS ISSUER 88323.000000 0 FOR 88323.000000 FOR S000004450 Castle Biosciences, Inc. 14843C105 US14843C1053 05/22/2025 To elect the three Class III directors listed below to hold office until the 2028 Annual Meeting of Stockholders: G. Bradley Cole DIRECTOR ELECTIONS ISSUER 88323.000000 0 FOR 88323.000000 FOR S000004450 Castle Biosciences, Inc. 14843C105 US14843C1053 05/22/2025 To ratify the selection of KPMG LLP by the Audit Committee of our Board of Directors as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 88323.000000 0 FOR 88323.000000 FOR S000004450 Castle Biosciences, Inc. 14843C105 US14843C1053 05/22/2025 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 88323.000000 0 FOR 88323.000000 FOR S000004450 Castle Biosciences, Inc. 14843C105 US14843C1053 05/22/2025 To approve the amendment and restatement of the Company's Amended and Restated Certificate of Incorporation to limit the liability of certain officers of the Company to the maximum extent permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 88323.000000 0 FOR 88323.000000 FOR S000004450 Dianthus Therapeutics, Inc. 252828108 US2528281080 05/22/2025 To elect Class I directors to our Board of Directors, to serve until the 2028 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Marino Garcia DIRECTOR ELECTIONS ISSUER 23214.000000 0 FOR 23214.000000 FOR S000004450 Dianthus Therapeutics, Inc. 252828108 US2528281080 05/22/2025 To elect Class I directors to our Board of Directors, to serve until the 2028 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Paula Soteropoulos DIRECTOR ELECTIONS ISSUER 23214.000000 0 FOR 23214.000000 FOR S000004450 Dianthus Therapeutics, Inc. 252828108 US2528281080 05/22/2025 To approve, on an advisory basis, the compensation paid to our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 23214.000000 0 AGAINST 23214.000000 AGAINST S000004450 Dianthus Therapeutics, Inc. 252828108 US2528281080 05/22/2025 To ratify the appointment of Deloitte & Touche, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 23214.000000 0 FOR 23214.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/22/2025 Election of Incumbent Directors: Mohamad Ali DIRECTOR ELECTIONS ISSUER 393505.000000 0 FOR 393505.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/22/2025 Election of Incumbent Directors: Stanley M. Bergman DIRECTOR ELECTIONS ISSUER 393505.000000 0 FOR 393505.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/22/2025 Election of Incumbent Directors: Deborah Derby DIRECTOR ELECTIONS ISSUER 393505.000000 0 FOR 393505.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/22/2025 Election of Incumbent Directors: Carole T. Faig DIRECTOR ELECTIONS ISSUER 393505.000000 0 FOR 393505.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/22/2025 Election of Incumbent Directors: Joseph L. Herring DIRECTOR ELECTIONS ISSUER 393505.000000 0 FOR 393505.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/22/2025 Election of Incumbent Directors: Robert J. Hombach DIRECTOR ELECTIONS ISSUER 393505.000000 0 FOR 393505.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/22/2025 Election of Incumbent Directors: Kurt P. Kuehn DIRECTOR ELECTIONS ISSUER 393505.000000 0 FOR 393505.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/22/2025 Election of Incumbent Directors: Philip A. Laskawy DIRECTOR ELECTIONS ISSUER 393505.000000 0 FOR 393505.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/22/2025 Election of Incumbent Directors: Anne H. Margulies DIRECTOR ELECTIONS ISSUER 393505.000000 0 FOR 393505.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/22/2025 Election of Incumbent Directors: Scott Serota DIRECTOR ELECTIONS ISSUER 393505.000000 0 FOR 393505.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/22/2025 Election of Incumbent Directors: Bradley T. Sheares, Ph.D. DIRECTOR ELECTIONS ISSUER 393505.000000 0 FOR 393505.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/22/2025 Election of Incumbent Directors: Reed V. Tuckson, M.D., FACP DIRECTOR ELECTIONS ISSUER 393505.000000 0 FOR 393505.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/22/2025 Election of Max Lin as a director, provided certain conditions are satisfied. DIRECTOR ELECTIONS ISSUER 393505.000000 0 FOR 393505.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/22/2025 Election of William K. "Dan" Daniel as a director, provided certain conditions are satisfied. DIRECTOR ELECTIONS ISSUER 393505.000000 0 FOR 393505.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/22/2025 Proposal to approve, by non-binding vote, the 2024 compensation paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 393505.000000 0 FOR 393505.000000 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/22/2025 Proposal to ratify the selection of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 27, 2025. AUDIT-RELATED ISSUER 393505.000000 0 FOR 393505.000000 FOR S000004450 Insulet Corporation 45784P101 US45784P1012 05/22/2025 Election of Directors: Jessica Hopfield DIRECTOR ELECTIONS ISSUER 220988.000000 0 FOR 220988.000000 FOR S000004450 Insulet Corporation 45784P101 US45784P1012 05/22/2025 Election of Directors: Ashley A. McEvoy DIRECTOR ELECTIONS ISSUER 220988.000000 0 FOR 220988.000000 FOR S000004450 Insulet Corporation 45784P101 US45784P1012 05/22/2025 Election of Directors: Elizabeth H. Weatherman DIRECTOR ELECTIONS ISSUER 220988.000000 0 FOR 220988.000000 FOR S000004450 Insulet Corporation 45784P101 US45784P1012 05/22/2025 To approve, on a non-binding, advisory basis, the compensation of certain executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 220988.000000 0 FOR 220988.000000 FOR S000004450 Insulet Corporation 45784P101 US45784P1012 05/22/2025 To approve the Insulet Corporation 2025 Stock Option and Incentive Plan. COMPENSATION ISSUER 220988.000000 0 FOR 220988.000000 FOR S000004450 Insulet Corporation 45784P101 US45784P1012 05/22/2025 To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 220988.000000 0 FOR 220988.000000 FOR S000004450 Maravai Lifesciences Holdings, Inc. 56600D107 US56600D1072 05/22/2025 To elect four nominees to the Board of Directors (3-year term expiring in 2028): Sean Cunningham DIRECTOR ELECTIONS ISSUER 358778.000000 0 FOR 358778.000000 FOR S000004450 Maravai Lifesciences Holdings, Inc. 56600D107 US56600D1072 05/22/2025 To elect four nominees to the Board of Directors (3-year term expiring in 2028): John DeFord, PhD DIRECTOR ELECTIONS ISSUER 358778.000000 0 FOR 358778.000000 FOR S000004450 Maravai Lifesciences Holdings, Inc. 56600D107 US56600D1072 05/22/2025 To elect four nominees to the Board of Directors (3-year term expiring in 2028): Jessica Hopfield, PhD DIRECTOR ELECTIONS ISSUER 358778.000000 0 FOR 358778.000000 FOR S000004450 Maravai Lifesciences Holdings, Inc. 56600D107 US56600D1072 05/22/2025 To elect four nominees to the Board of Directors (3-year term expiring in 2028): Murali K. Prahalad, PhD DIRECTOR ELECTIONS ISSUER 358778.000000 0 FOR 358778.000000 FOR S000004450 Maravai Lifesciences Holdings, Inc. 56600D107 US56600D1072 05/22/2025 To ratify the appointment of Ernst & Young LLP as Maravai's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 358778.000000 0 FOR 358778.000000 FOR S000004450 Maravai Lifesciences Holdings, Inc. 56600D107 US56600D1072 05/22/2025 To approve, on a non-binding advisory basis, the compensation of Maravai's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 358778.000000 0 FOR 358778.000000 FOR S000004450 Mineralys Therapeutics, Inc. 603170101 US6031701013 05/22/2025 Election of Class II directors for a three-year term to expire at the 2028 annual meeting of stockholders: Glenn P. Sblendorio DIRECTOR ELECTIONS ISSUER 105098.000000 0 FOR 105098.000000 FOR S000004450 Mineralys Therapeutics, Inc. 603170101 US6031701013 05/22/2025 Election of Class II directors for a three-year term to expire at the 2028 annual meeting of stockholders: Derek DiRocco, Ph.D. DIRECTOR ELECTIONS ISSUER 105098.000000 0 FOR 105098.000000 FOR S000004450 Mineralys Therapeutics, Inc. 603170101 US6031701013 05/22/2025 Ratify the appointment of Ernst & Young LLP as Mineralys Therapeutics, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 105098.000000 0 FOR 105098.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/22/2025 Election of the directors named in the proxy statement as set forth below: Lynn A. Tetrault DIRECTOR ELECTIONS ISSUER 403179.000000 0 FOR 403179.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/22/2025 Election of the directors named in the proxy statement as set forth below: Elizabeth A. Floegel DIRECTOR ELECTIONS ISSUER 403179.000000 0 FOR 403179.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/22/2025 Election of the directors named in the proxy statement as set forth below: Dr. Neil Gunn DIRECTOR ELECTIONS ISSUER 403179.000000 0 FOR 403179.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/22/2025 Election of the directors named in the proxy statement as set forth below: Dr. Alison L. Hannah DIRECTOR ELECTIONS ISSUER 403179.000000 0 FOR 403179.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/22/2025 Election of the directors named in the proxy statement as set forth below: Stephen M. Kanovsky DIRECTOR ELECTIONS ISSUER 403179.000000 0 FOR 403179.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/22/2025 Election of the directors named in the proxy statement as set forth below: Michael A. Kelly DIRECTOR ELECTIONS ISSUER 403179.000000 0 FOR 403179.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/22/2025 Election of the directors named in the proxy statement as set forth below: David B. Perez DIRECTOR ELECTIONS ISSUER 403179.000000 0 FOR 403179.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/22/2025 Election of the directors named in the proxy statement as set forth below: Felicia Williams DIRECTOR ELECTIONS ISSUER 403179.000000 0 FOR 403179.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/22/2025 Election of the directors named in the proxy statement as set forth below: Anthony P. Zook DIRECTOR ELECTIONS ISSUER 403179.000000 0 FOR 403179.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/22/2025 Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 403179.000000 0 FOR 403179.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/22/2025 Recommend, on a non-binding advisory basis, the Frequency of Future Advisory Votes on Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 403179.000000 0 ONE YEAR 403179.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/22/2025 Approval of the First Amendment of the NeoGenomics, Inc. 2023 Equity Incentive Plan. COMPENSATION ISSUER 403179.000000 0 FOR 403179.000000 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/22/2025 Ratification of the Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm. AUDIT-RELATED ISSUER 403179.000000 0 FOR 403179.000000 FOR S000004450 Progyny, Inc. 74340E103 US74340E1038 05/22/2025 Election of Directors: Norman Payson, M.D. DIRECTOR ELECTIONS ISSUER 228665.000000 0 FOR 228665.000000 FOR S000004450 Progyny, Inc. 74340E103 US74340E1038 05/22/2025 Election of Directors: Debra Morris DIRECTOR ELECTIONS ISSUER 228665.000000 0 FOR 228665.000000 FOR S000004450 Progyny, Inc. 74340E103 US74340E1038 05/22/2025 Election of Directors: Elizabeth Bierbower DIRECTOR ELECTIONS ISSUER 228665.000000 0 FOR 228665.000000 FOR S000004450 Progyny, Inc. 74340E103 US74340E1038 05/22/2025 Ratification of the selection of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025 AUDIT-RELATED ISSUER 228665.000000 0 FOR 228665.000000 FOR S000004450 Progyny, Inc. 74340E103 US74340E1038 05/22/2025 Approval, on an advisory (non-binding basis), of the compensation of the company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 228665.000000 0 FOR 228665.000000 FOR S000004450 Pulmonx Corporation 745848101 US7458481014 05/22/2025 Election of Directors: Richard M. Ferrari DIRECTOR ELECTIONS ISSUER 114518.000000 0 FOR 114518.000000 FOR S000004450 Pulmonx Corporation 745848101 US7458481014 05/22/2025 Election of Directors: Daniel P. Florin DIRECTOR ELECTIONS ISSUER 114518.000000 0 FOR 114518.000000 FOR S000004450 Pulmonx Corporation 745848101 US7458481014 05/22/2025 Election of Directors: Steve Williamson DIRECTOR ELECTIONS ISSUER 114518.000000 0 FOR 114518.000000 FOR S000004450 Pulmonx Corporation 745848101 US7458481014 05/22/2025 To ratify the selection by the Audit Committee of our Board of Directors of BDO USA, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 114518.000000 0 FOR 114518.000000 FOR S000004450 Pulmonx Corporation 745848101 US7458481014 05/22/2025 To conduct a non-binding advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 114518.000000 0 FOR 114518.000000 FOR S000004450 SCHOLAR ROCK HOLDING CORPORATION 80706P103 US80706P1030 05/22/2025 To elect three Class I directors to our Board of Directors, each to serve until the 2028 Annual Meeting of stockholders and until his successor has been duly elected and qualified, or until his earlier death, resignation, or removal: Srinivas Akkaraju, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 206997.000000 0 FOR 206997.000000 FOR S000004450 SCHOLAR ROCK HOLDING CORPORATION 80706P103 US80706P1030 05/22/2025 To elect three Class I directors to our Board of Directors, each to serve until the 2028 Annual Meeting of stockholders and until his successor has been duly elected and qualified, or until his earlier death, resignation, or removal: Joshua Reed DIRECTOR ELECTIONS ISSUER 206997.000000 0 FOR 206997.000000 FOR S000004450 SCHOLAR ROCK HOLDING CORPORATION 80706P103 US80706P1030 05/22/2025 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 206997.000000 0 FOR 206997.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/22/2025 Elect nine directors, each for a term of one year: Charles Divita, III DIRECTOR ELECTIONS ISSUER 542103.000000 0 FOR 542103.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/22/2025 Elect nine directors, each for a term of one year: J. Eric Evans DIRECTOR ELECTIONS ISSUER 542103.000000 0 FOR 542103.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/22/2025 Elect nine directors, each for a term of one year: Sandra L. Fenwick DIRECTOR ELECTIONS ISSUER 542103.000000 0 FOR 542103.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/22/2025 Elect nine directors, each for a term of one year: Catherine A. Jacobson DIRECTOR ELECTIONS ISSUER 542103.000000 0 FOR 542103.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/22/2025 Elect nine directors, each for a term of one year: Thomas G. McKinley DIRECTOR ELECTIONS ISSUER 542103.000000 0 FOR 542103.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/22/2025 Elect nine directors, each for a term of one year: Kenneth H. Paulus DIRECTOR ELECTIONS ISSUER 542103.000000 0 FOR 542103.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/22/2025 Elect nine directors, each for a term of one year: David L. Shedlarz DIRECTOR ELECTIONS ISSUER 542103.000000 0 FOR 542103.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/22/2025 Elect nine directors, each for a term of one year: Mark Douglas Smith DIRECTOR ELECTIONS ISSUER 542103.000000 0 FOR 542103.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/22/2025 Elect nine directors, each for a term of one year: David B. Snow, Jr. DIRECTOR ELECTIONS ISSUER 542103.000000 0 FOR 542103.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/22/2025 Approve, on an advisory basis, the compensation of Teladoc Health's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 542103.000000 0 FOR 542103.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/22/2025 Approve an amendment to the Teladoc Health, Inc. 2023 Incentive Award Plan. COMPENSATION ISSUER 542103.000000 0 FOR 542103.000000 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/22/2025 Ratify the appointment of Ernst & Young LLP as Teladoc Health's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 542103.000000 0 FOR 542103.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2025 Election of Directors: Saumya Sutaria DIRECTOR ELECTIONS ISSUER 299529.000000 0 FOR 299529.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2025 Election of Directors: J. Robert Kerrey DIRECTOR ELECTIONS ISSUER 299529.000000 0 FOR 299529.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2025 Election of Directors: Vineeta Agarwala DIRECTOR ELECTIONS ISSUER 299529.000000 0 FOR 299529.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2025 Election of Directors: James L. Bierman DIRECTOR ELECTIONS ISSUER 299529.000000 0 FOR 299529.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2025 Election of Directors: Roy Blunt DIRECTOR ELECTIONS ISSUER 299529.000000 0 FOR 299529.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2025 Election of Directors: Richard W. Fisher DIRECTOR ELECTIONS ISSUER 299529.000000 0 FOR 299529.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2025 Election of Directors: Meghan M. FitzGerald DIRECTOR ELECTIONS ISSUER 299529.000000 0 FOR 299529.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2025 Election of Directors: Cecil D. Haney DIRECTOR ELECTIONS ISSUER 299529.000000 0 FOR 299529.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2025 Election of Directors: Christopher S. Lynch DIRECTOR ELECTIONS ISSUER 299529.000000 0 FOR 299529.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2025 Election of Directors: Richard J. Mark DIRECTOR ELECTIONS ISSUER 299529.000000 0 FOR 299529.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2025 Election of Directors: Tammy Romo DIRECTOR ELECTIONS ISSUER 299529.000000 0 FOR 299529.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2025 Election of Directors: Stephen H. Rusckowski DIRECTOR ELECTIONS ISSUER 299529.000000 0 FOR 299529.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2025 Election of Directors: Nadja Y. West DIRECTOR ELECTIONS ISSUER 299529.000000 0 FOR 299529.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2025 To approve, on an advisory basis, the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 299529.000000 0 FOR 299529.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2025 To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accountants for the year ending December 31, 2025. AUDIT-RELATED ISSUER 299529.000000 0 FOR 299529.000000 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/22/2025 To report on strategies and programs for improving maternal health outcomes. OTHER SOCIAL ISSUES SECURITY HOLDER 299529.000000 0 AGAINST 299529.000000 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/22/2025 Election of Directors: Waleed H. Hassanein, M.D. DIRECTOR ELECTIONS ISSUER 106029.000000 0 FOR 106029.000000 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/22/2025 Election of Directors: James R. Tobin DIRECTOR ELECTIONS ISSUER 106029.000000 0 FOR 106029.000000 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/22/2025 Election of Directors: Edward M. Basile DIRECTOR ELECTIONS ISSUER 106029.000000 0 FOR 106029.000000 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/22/2025 Election of Directors: Thomas J. Gunderson DIRECTOR ELECTIONS ISSUER 106029.000000 0 FOR 106029.000000 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/22/2025 Election of Directors: Edwin M. Kania, Jr. DIRECTOR ELECTIONS ISSUER 106029.000000 0 FOR 106029.000000 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/22/2025 Election of Directors: Stephanie Lovell DIRECTOR ELECTIONS ISSUER 106029.000000 0 FOR 106029.000000 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/22/2025 Election of Directors: Merilee Raines DIRECTOR ELECTIONS ISSUER 106029.000000 0 FOR 106029.000000 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/22/2025 Election of Directors: David Weill, M.D. DIRECTOR ELECTIONS ISSUER 106029.000000 0 FOR 106029.000000 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/22/2025 To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 106029.000000 0 FOR 106029.000000 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/22/2025 To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 106029.000000 0 FOR 106029.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/22/2025 To elect directors to serve for the ensuing year and until their successors are elected: Dr. Flemming Ornskov, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 187378.000000 0 FOR 187378.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/22/2025 To elect directors to serve for the ensuing year and until their successors are elected: Linda Baddour DIRECTOR ELECTIONS ISSUER 187378.000000 0 FOR 187378.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/22/2025 To elect directors to serve for the ensuing year and until their successors are elected: Udit Batra, Ph.D. DIRECTOR ELECTIONS ISSUER 187378.000000 0 FOR 187378.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/22/2025 To elect directors to serve for the ensuing year and until their successors are elected: Dan Brennan DIRECTOR ELECTIONS ISSUER 187378.000000 0 FOR 187378.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/22/2025 To elect directors to serve for the ensuing year and until their successors are elected: Richard Fearon DIRECTOR ELECTIONS ISSUER 187378.000000 0 FOR 187378.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/22/2025 To elect directors to serve for the ensuing year and until their successors are elected: Pearl S. Huang, Ph.D. DIRECTOR ELECTIONS ISSUER 187378.000000 0 FOR 187378.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/22/2025 To elect directors to serve for the ensuing year and until their successors are elected: Wei Jiang DIRECTOR ELECTIONS ISSUER 187378.000000 0 FOR 187378.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/22/2025 To elect directors to serve for the ensuing year and until their successors are elected: Heather Knight DIRECTOR ELECTIONS ISSUER 187378.000000 0 FOR 187378.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/22/2025 To elect directors to serve for the ensuing year and until their successors are elected: Christopher A. Kuebler DIRECTOR ELECTIONS ISSUER 187378.000000 0 FOR 187378.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/22/2025 To elect directors to serve for the ensuing year and until their successors are elected: Mark Vergnano DIRECTOR ELECTIONS ISSUER 187378.000000 0 FOR 187378.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/22/2025 To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025; AUDIT-RELATED ISSUER 187378.000000 0 FOR 187378.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/22/2025 To approve, on a non-binding, advisory basis, the compensation of the Company's executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 187378.000000 0 FOR 187378.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/22/2025 To approve the Company's Amended and Restated 2009 Employee Stock Purchase Plan. COMPENSATION ISSUER 187378.000000 0 FOR 187378.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Wanda M. Austin DIRECTOR ELECTIONS ISSUER 1696346.000000 0 FOR 1696346.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Bradway DIRECTOR ELECTIONS ISSUER 1696346.000000 0 FOR 1696346.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Michael V. Drake DIRECTOR ELECTIONS ISSUER 1696346.000000 0 FOR 1696346.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Brian J. Druker DIRECTOR ELECTIONS ISSUER 1696346.000000 0 FOR 1696346.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Eckert DIRECTOR ELECTIONS ISSUER 1696346.000000 0 FOR 1696346.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Greg C. Garland DIRECTOR ELECTIONS ISSUER 1696346.000000 0 FOR 1696346.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Charles M. Holley, Jr. DIRECTOR ELECTIONS ISSUER 1696346.000000 0 FOR 1696346.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. S. Omar Ishrak DIRECTOR ELECTIONS ISSUER 1696346.000000 0 FOR 1696346.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Tyler Jacks DIRECTOR ELECTIONS ISSUER 1696346.000000 0 FOR 1696346.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Mary E. Klotman DIRECTOR ELECTIONS ISSUER 1696346.000000 0 FOR 1696346.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Ellen J. Kullman DIRECTOR ELECTIONS ISSUER 1696346.000000 0 FOR 1696346.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Amy E. Miles DIRECTOR ELECTIONS ISSUER 1696346.000000 0 FOR 1696346.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/23/2025 Advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1696346.000000 0 FOR 1696346.000000 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/23/2025 To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 1696346.000000 0 FOR 1696346.000000 FOR S000004450 Cassava Sciences, Inc. 14817C107 US14817C1071 05/23/2025 Re-elect two (2) Class I Directors to serve for three-year terms as of the date of the Annual Meeting of Stockholders and until their successors are duly elected and qualified: Robert Anderson, Jr. DIRECTOR ELECTIONS ISSUER 60325.000000 83400.000000 FOR 60325.000000 FOR S000004450 Cassava Sciences, Inc. 14817C107 US14817C1071 05/23/2025 Re-elect two (2) Class I Directors to serve for three-year terms as of the date of the Annual Meeting of Stockholders and until their successors are duly elected and qualified: Michael J. O'Donnell DIRECTOR ELECTIONS ISSUER 60325.000000 83400.000000 FOR 60325.000000 FOR S000004450 Cassava Sciences, Inc. 14817C107 US14817C1071 05/23/2025 To approve an amendment to the Company's Non-employee Director Compensation Program. COMPENSATION ISSUER 60325.000000 83400.000000 FOR 60325.000000 FOR S000004450 Cassava Sciences, Inc. 14817C107 US14817C1071 05/23/2025 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to reduce the Company's Board classification from three to two. CORPORATE GOVERNANCE ISSUER 60325.000000 83400.000000 FOR 60325.000000 FOR S000004450 Cassava Sciences, Inc. 14817C107 US14817C1071 05/23/2025 To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 60325.000000 83400.000000 FOR 60325.000000 FOR S000004450 Cassava Sciences, Inc. 14817C107 US14817C1071 05/23/2025 To approve, by a non-binding advisory vote, 2024 executive compensation for the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 60325.000000 83400.000000 FOR 60325.000000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 VGG312491084 05/23/2025 To elect five directors to serve for a one-year term: Juan Jose Chacon Quiros DIRECTOR ELECTIONS ISSUER 853.000000 62800.000000 FOR 853.000000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 VGG312491084 05/23/2025 To elect five directors to serve for a one-year term: Ann Custin DIRECTOR ELECTIONS ISSUER 853.000000 62800.000000 FOR 853.000000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 VGG312491084 05/23/2025 To elect five directors to serve for a one-year term: Nicholas Lewin DIRECTOR ELECTIONS ISSUER 853.000000 62800.000000 FOR 853.000000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 VGG312491084 05/23/2025 To elect five directors to serve for a one-year term: Edward J. Schutter DIRECTOR ELECTIONS ISSUER 853.000000 62800.000000 FOR 853.000000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 VGG312491084 05/23/2025 To elect five directors to serve for a one-year term: Bryan Slotkin DIRECTOR ELECTIONS ISSUER 853.000000 62800.000000 FOR 853.000000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 VGG312491084 05/23/2025 To approve, on an advisory basis, the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 853.000000 62800.000000 FOR 853.000000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 VGG312491084 05/23/2025 To ratify the appointment of CBIZ, Inc. as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 853.000000 62800.000000 FOR 853.000000 FOR S000004450 OrthoPediatrics Corp. 68752L100 US68752L1008 05/23/2025 To elect four (4) directors, each to serve until the 2028 annual meeting of our stockholders: DIRECTOR ELECTIONS ISSUER 49714.000000 0 FOR 49714.000000 FOR S000004450 OrthoPediatrics Corp. 68752L100 US68752L1008 05/23/2025 To elect four (4) directors, each to serve until the 2028 annual meeting of our stockholders: Bryan W. Hughes DIRECTOR ELECTIONS ISSUER 49714.000000 0 FOR 49714.000000 FOR S000004450 OrthoPediatrics Corp. 68752L100 US68752L1008 05/23/2025 To elect four (4) directors, each to serve until the 2028 annual meeting of our stockholders: Samuel D. Riccitelli DIRECTOR ELECTIONS ISSUER 49714.000000 0 FOR 49714.000000 FOR S000004450 OrthoPediatrics Corp. 68752L100 US68752L1008 05/23/2025 To elect four (4) directors, each to serve until the 2028 annual meeting of our stockholders: Mark C. Throdahl DIRECTOR ELECTIONS ISSUER 49714.000000 0 FOR 49714.000000 FOR S000004450 OrthoPediatrics Corp. 68752L100 US68752L1008 05/23/2025 To approve, on an advisory basis, the resolution approving the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 49714.000000 0 FOR 49714.000000 FOR S000004450 OrthoPediatrics Corp. 68752L100 US68752L1008 05/23/2025 To approve, on an advisory basis, the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 49714.000000 0 FOR 49714.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Douglas M. Baker, Jr. DIRECTOR ELECTIONS ISSUER 7591481.000000 0 FOR 7591481.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Mary Ellen Coe DIRECTOR ELECTIONS ISSUER 7591481.000000 0 FOR 7591481.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Pamela J. Craig DIRECTOR ELECTIONS ISSUER 7591481.000000 0 FOR 7591481.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Robert M. Davis DIRECTOR ELECTIONS ISSUER 7591481.000000 0 FOR 7591481.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Thomas H. Glocer DIRECTOR ELECTIONS ISSUER 7591481.000000 0 FOR 7591481.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Surendralal L. Karsanbhai DIRECTOR ELECTIONS ISSUER 7591481.000000 0 FOR 7591481.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Risa J. Lavizzo-Mourey, M.D. DIRECTOR ELECTIONS ISSUER 7591481.000000 0 FOR 7591481.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Stephen L. Mayo, Ph.D. DIRECTOR ELECTIONS ISSUER 7591481.000000 0 FOR 7591481.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 7591481.000000 0 FOR 7591481.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Patricia F. Russo DIRECTOR ELECTIONS ISSUER 7591481.000000 0 FOR 7591481.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Christine E. Seidman, M.D. DIRECTOR ELECTIONS ISSUER 7591481.000000 0 FOR 7591481.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Inge G. Thulin DIRECTOR ELECTIONS ISSUER 7591481.000000 0 FOR 7591481.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Kathy J. Warden DIRECTOR ELECTIONS ISSUER 7591481.000000 0 FOR 7591481.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 7591481.000000 0 FOR 7591481.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Ratification of the appointment of the Company's independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 7591481.000000 0 FOR 7591481.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Shareholder proposal regarding a human rights impact assessment. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 7591481.000000 0 AGAINST 7591481.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Shareholder proposal regarding a tax transparency report. OTHER SOCIAL ISSUES SECURITY HOLDER 7591481.000000 0 AGAINST 7591481.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Shareholder proposal to revisit DEl goals in executive pay incentives. ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 7591481.000000 0 AGAINST 7591481.000000 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Shareholder proposal regarding a report on civil liberties in advertising services. ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 7591481.000000 0 AGAINST 7591481.000000 FOR S000004450 89bio, Inc. 282559103 US2825591033 05/28/2025 Election of Directors: To be elected for terms expiring in 2028: Martin Babler DIRECTOR ELECTIONS ISSUER 335187.000000 0 FOR 335187.000000 FOR S000004450 89bio, Inc. 282559103 US2825591033 05/28/2025 Election of Directors: To be elected for terms expiring in 2028: Derek DiRocco, Ph.D. DIRECTOR ELECTIONS ISSUER 335187.000000 0 FOR 335187.000000 FOR S000004450 89bio, Inc. 282559103 US2825591033 05/28/2025 Election of Directors: To be elected for terms expiring in 2028: Lota Zoth, C.P.A. DIRECTOR ELECTIONS ISSUER 335187.000000 0 FOR 335187.000000 FOR S000004450 89bio, Inc. 282559103 US2825591033 05/28/2025 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 335187.000000 0 FOR 335187.000000 FOR S000004450 89bio, Inc. 282559103 US2825591033 05/28/2025 Approval of, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 335187.000000 0 FOR 335187.000000 FOR S000004450 agilon health, inc. 00857U107 US00857U1079 05/28/2025 Election of Class I Directors: Silvana Battaglia DIRECTOR ELECTIONS ISSUER 977090.000000 0 FOR 977090.000000 FOR S000004450 agilon health, inc. 00857U107 US00857U1079 05/28/2025 Election of Class I Directors: Sharad Mansukani, M.D. DIRECTOR ELECTIONS ISSUER 977090.000000 0 FOR 977090.000000 FOR S000004450 agilon health, inc. 00857U107 US00857U1079 05/28/2025 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 977090.000000 0 FOR 977090.000000 FOR S000004450 agilon health, inc. 00857U107 US00857U1079 05/28/2025 To approve, by advisory vote, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 977090.000000 0 FOR 977090.000000 FOR S000004450 Arcellx, Inc. 03940C100 US03940C1009 05/28/2025 To elect three Class III directors to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: Rami Elghandour DIRECTOR ELECTIONS ISSUER 101850.000000 0 FOR 101850.000000 FOR S000004450 Arcellx, Inc. 03940C100 US03940C1009 05/28/2025 To elect three Class III directors to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: David Lubner DIRECTOR ELECTIONS ISSUER 101850.000000 0 FOR 101850.000000 FOR S000004450 Arcellx, Inc. 03940C100 US03940C1009 05/28/2025 To elect three Class III directors to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: Kristin Myers DIRECTOR ELECTIONS ISSUER 101850.000000 0 FOR 101850.000000 FOR S000004450 Arcellx, Inc. 03940C100 US03940C1009 05/28/2025 To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 101850.000000 0 FOR 101850.000000 FOR S000004450 Arcellx, Inc. 03940C100 US03940C1009 05/28/2025 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 101850.000000 0 FOR 101850.000000 FOR S000004450 BrightSpring Health Services, Inc. 10950A106 US10950A1060 05/28/2025 Election of Class I directors: Johnny Kim DIRECTOR ELECTIONS ISSUER 192318.000000 0 FOR 192318.000000 FOR S000004450 BrightSpring Health Services, Inc. 10950A106 US10950A1060 05/28/2025 Election of Class I directors: Timothy A. Wicks DIRECTOR ELECTIONS ISSUER 192318.000000 0 FOR 192318.000000 FOR S000004450 BrightSpring Health Services, Inc. 10950A106 US10950A1060 05/28/2025 Ratification of the appointment of KPMG LLP as the independent accounting firm for the year ending December 31, 2025 AUDIT-RELATED ISSUER 192318.000000 0 FOR 192318.000000 FOR S000004450 BrightSpring Health Services, Inc. 10950A106 US10950A1060 05/28/2025 Advisory vote on executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 192318.000000 0 FOR 192318.000000 FOR S000004450 BrightSpring Health Services, Inc. 10950A106 US10950A1060 05/28/2025 Advisory vote on the frequency of holding an advisory vote on executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 192318.000000 0 ONE YEAR 192318.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/28/2025 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Mary C. Beckerle, Ph.D. DIRECTOR ELECTIONS ISSUER 808232.000000 0 FOR 808232.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/28/2025 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: S. Gail Eckhardt, M.D. DIRECTOR ELECTIONS ISSUER 808232.000000 0 FOR 808232.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/28/2025 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Maria C. Freire, Ph.D. DIRECTOR ELECTIONS ISSUER 808232.000000 0 FOR 808232.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/28/2025 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Tomas J. Heyman DIRECTOR ELECTIONS ISSUER 808232.000000 0 FOR 808232.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/28/2025 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: David E. Johnson DIRECTOR ELECTIONS ISSUER 808232.000000 0 FOR 808232.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/28/2025 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Michael M. Morrissey, Ph.D. DIRECTOR ELECTIONS ISSUER 808232.000000 0 FOR 808232.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/28/2025 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Robert L. Oliver, Jr. DIRECTOR ELECTIONS ISSUER 808232.000000 0 FOR 808232.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/28/2025 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Stelios Papadopoulos, Ph.D. DIRECTOR ELECTIONS ISSUER 808232.000000 0 FOR 808232.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/28/2025 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: George Poste, DVM, Ph.D., FRS DIRECTOR ELECTIONS ISSUER 808232.000000 0 FOR 808232.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/28/2025 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Julie Anne Smith DIRECTOR ELECTIONS ISSUER 808232.000000 0 FOR 808232.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/28/2025 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Jack L. Wyszomierski DIRECTOR ELECTIONS ISSUER 808232.000000 0 FOR 808232.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/28/2025 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Exelixis' independent registered public accounting firm for the fiscal year ending January 2, 2026. AUDIT-RELATED ISSUER 808232.000000 0 FOR 808232.000000 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/28/2025 To approve, on an advisory basis, the compensation of Exelixis' named executive officers, as disclosed in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 808232.000000 0 FOR 808232.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/28/2025 Election of Directors: Peter J. Arduini DIRECTOR ELECTIONS ISSUER 1436837.000000 0 FOR 1436837.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/28/2025 Election of Directors: H. Lawrence Culp, Jr. DIRECTOR ELECTIONS ISSUER 1436837.000000 0 FOR 1436837.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/28/2025 Election of Directors: Rodney F. Hochman DIRECTOR ELECTIONS ISSUER 1436837.000000 0 FOR 1436837.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/28/2025 Election of Directors: Lloyd W. Howell, Jr. DIRECTOR ELECTIONS ISSUER 1436837.000000 0 FOR 1436837.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/28/2025 Election of Directors: Risa Lavizzo-Mourey DIRECTOR ELECTIONS ISSUER 1436837.000000 0 FOR 1436837.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/28/2025 Election of Directors: Catherine Lesjak DIRECTOR ELECTIONS ISSUER 1436837.000000 0 FOR 1436837.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/28/2025 Election of Directors: Anne T. Madden DIRECTOR ELECTIONS ISSUER 1436837.000000 0 FOR 1436837.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/28/2025 Election of Directors: Tomislav Mihaljevic DIRECTOR ELECTIONS ISSUER 1436837.000000 0 FOR 1436837.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/28/2025 Election of Directors: William J. Stromberg DIRECTOR ELECTIONS ISSUER 1436837.000000 0 FOR 1436837.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/28/2025 Election of Directors: Phoebe L. Yang DIRECTOR ELECTIONS ISSUER 1436837.000000 0 FOR 1436837.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/28/2025 Approval of our named executive officers' compensation in an advisory vote. SECTION 14A SAY-ON-PAY VOTES ISSUER 1436837.000000 0 FOR 1436837.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/28/2025 Ratification of the appointment of Deloitte & Touche LLP as our independent auditor for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 1436837.000000 0 FOR 1436837.000000 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/28/2025 Stockholder proposal regarding stockholder ratification of certain termination pay arrangements, if properly presented. COMPENSATION SECURITY HOLDER 1436837.000000 0 AGAINST 1436837.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/28/2025 To elect eight directors to serve until our 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified: C. Noel Bairey Merz, M.D. DIRECTOR ELECTIONS ISSUER 98771.000000 0 FOR 98771.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/28/2025 To elect eight directors to serve until our 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Quentin Blackford DIRECTOR ELECTIONS ISSUER 98771.000000 0 FOR 98771.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/28/2025 To elect eight directors to serve until our 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Bruce Bodaken DIRECTOR ELECTIONS ISSUER 98771.000000 0 FOR 98771.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/28/2025 To elect eight directors to serve until our 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Karen Ling DIRECTOR ELECTIONS ISSUER 98771.000000 0 FOR 98771.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/28/2025 To elect eight directors to serve until our 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Mark Rubash DIRECTOR ELECTIONS ISSUER 98771.000000 0 FOR 98771.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/28/2025 To elect eight directors to serve until our 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Ralph Snyderman, M.D. DIRECTOR ELECTIONS ISSUER 98771.000000 0 FOR 98771.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/28/2025 To elect eight directors to serve until our 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Abhijit Talwalkar DIRECTOR ELECTIONS ISSUER 98771.000000 0 FOR 98771.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/28/2025 To elect eight directors to serve until our 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Brian Yoor DIRECTOR ELECTIONS ISSUER 98771.000000 0 FOR 98771.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/28/2025 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 98771.000000 0 FOR 98771.000000 FOR S000004450 iRhythm Technologies, Inc. 450056106 US4500561067 05/28/2025 To approve, on a non-binding advisory basis, the named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 98771.000000 0 FOR 98771.000000 FOR S000004450 Neumora Therapeutics, Inc. 640979100 US6409791000 05/28/2025 To elect two Class II directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Alaa Halawa DIRECTOR ELECTIONS ISSUER 175316.000000 0 FOR 175316.000000 FOR S000004450 Neumora Therapeutics, Inc. 640979100 US6409791000 05/28/2025 To elect two Class II directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Maykin Ho, Ph.D. DIRECTOR ELECTIONS ISSUER 175316.000000 0 FOR 175316.000000 FOR S000004450 Neumora Therapeutics, Inc. 640979100 US6409791000 05/28/2025 To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of Ernst & Young LLP, as the independent registered public accounting firm and independent auditor of the Company for the year ending December 31, 2025. AUDIT-RELATED ISSUER 175316.000000 0 FOR 175316.000000 FOR S000004450 Neumora Therapeutics, Inc. 640979100 US6409791000 05/28/2025 To approve the repricing of certain stock options outstanding under the 2023 Incentive Award Plan and the 2020 Equity Incentive Plan. COMPENSATION ISSUER 175316.000000 0 AGAINST 175316.000000 AGAINST S000004450 Neumora Therapeutics, Inc. 640979100 US6409791000 05/28/2025 To approve amendments to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock at a ratio ranging from any whole number between 1-for-5 and 1-for-30, as determined by the Company's Board of Directors in its discretion. CAPITAL STRUCTURE ISSUER 175316.000000 0 FOR 175316.000000 FOR S000004450 Penumbra, Inc. 70975L107 US70975L1070 05/28/2025 To elect the nominees for Class I director to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Janet Leeds DIRECTOR ELECTIONS ISSUER 114648.000000 0 FOR 114648.000000 FOR S000004450 Penumbra, Inc. 70975L107 US70975L1070 05/28/2025 To elect the nominees for Class I director to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Thomas Wilder DIRECTOR ELECTIONS ISSUER 114648.000000 0 FOR 114648.000000 FOR S000004450 Penumbra, Inc. 70975L107 US70975L1070 05/28/2025 To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Penumbra, Inc. for the fiscal year ending December 31, 2025; AUDIT-RELATED ISSUER 114648.000000 0 FOR 114648.000000 FOR S000004450 Penumbra, Inc. 70975L107 US70975L1070 05/28/2025 To approve, on an advisory basis, the compensation of Penumbra, Inc.'s named executive officers as disclosed in the proxy statement; SECTION 14A SAY-ON-PAY VOTES ISSUER 114648.000000 0 FOR 114648.000000 FOR S000004450 Penumbra, Inc. 70975L107 US70975L1070 05/28/2025 To approve an amendment to Penumbra, Inc.'s Restated Certificate of Incorporation to phase in the declassification of Penumbra, Inc.'s Board of Directors, and SHAREHOLDER RIGHTS AND DEFENSES ISSUER 114648.000000 0 FOR 114648.000000 FOR S000004450 Penumbra, Inc. 70975L107 US70975L1070 05/28/2025 To approve an amendment to Penumbra, Inc.'s Restated Certificate of Incorporation to eliminate the supermajority voting requirements. CORPORATE GOVERNANCE ISSUER 114648.000000 0 FOR 114648.000000 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 US46489V3024 05/28/2025 To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office until the Company's 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified: Lori A. Woods DIRECTOR ELECTIONS ISSUER 138633.000000 0 FOR 138633.000000 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 US46489V3024 05/28/2025 To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office until the Company's 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified: Heidi Henson DIRECTOR ELECTIONS ISSUER 138633.000000 0 FOR 138633.000000 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 US46489V3024 05/28/2025 To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office until the Company's 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified: Robert Froman Williamson, III DIRECTOR ELECTIONS ISSUER 138633.000000 0 FOR 138633.000000 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 US46489V3024 05/28/2025 To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office until the Company's 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified: Frank Morich, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 138633.000000 0 FOR 138633.000000 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 US46489V3024 05/28/2025 To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office until the Company's 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified: Johan (Thijs) Spoor DIRECTOR ELECTIONS ISSUER 138633.000000 0 FOR 138633.000000 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 US46489V3024 05/28/2025 To consider and vote on a proposal to ratify the appointment of WithumSmith+Brown, PC as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 138633.000000 0 FOR 138633.000000 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 US46489V3024 05/28/2025 To consider and vote on a proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 138633.000000 0 FOR 138633.000000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/29/2025 Election of Directors: Jason R. Bernhard DIRECTOR ELECTIONS ISSUER 292673.000000 0 FOR 292673.000000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/29/2025 Election of Directors: William F. Grieco DIRECTOR ELECTIONS ISSUER 292673.000000 0 FOR 292673.000000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/29/2025 Election of Directors: R. David Kelly DIRECTOR ELECTIONS ISSUER 292673.000000 0 FOR 292673.000000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/29/2025 Election of Directors: Reeve B. Waud DIRECTOR ELECTIONS ISSUER 292673.000000 0 FOR 292673.000000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/29/2025 Approve an amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan. COMPENSATION ISSUER 292673.000000 0 FOR 292673.000000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/29/2025 Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 292673.000000 0 FOR 292673.000000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/29/2025 Advisory vote on the frequency of a non-binding advisory vote on the Compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 292673.000000 0 ONE YEAR 292673.000000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/29/2025 Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 292673.000000 0 FOR 292673.000000 FOR S000004450 Acadia Pharmaceuticals Inc. 004225108 US0042251084 05/29/2025 To elect three Class III directors to hold office until the Company's 2028 Annual Meeting of Stockholders: Laura A. Brege DIRECTOR ELECTIONS ISSUER 336943.000000 0 FOR 336943.000000 FOR S000004450 Acadia Pharmaceuticals Inc. 004225108 US0042251084 05/29/2025 To elect three Class III directors to hold office until the Company's 2028 Annual Meeting of Stockholders: Elizabeth A. Garofalo, M.D. DIRECTOR ELECTIONS ISSUER 336943.000000 0 FOR 336943.000000 FOR S000004450 Acadia Pharmaceuticals Inc. 004225108 US0042251084 05/29/2025 To elect three Class III directors to hold office until the Company's 2028 Annual Meeting of Stockholders: Catherine Owen Adams DIRECTOR ELECTIONS ISSUER 336943.000000 0 FOR 336943.000000 FOR S000004450 Acadia Pharmaceuticals Inc. 004225108 US0042251084 05/29/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 336943.000000 0 FOR 336943.000000 FOR S000004450 Acadia Pharmaceuticals Inc. 004225108 US0042251084 05/29/2025 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 336943.000000 0 FOR 336943.000000 FOR S000004450 Bruker Corporation 116794108 US1167941087 05/29/2025 Election of four Class I directors to serve for a three-year term expiring in 2028: Bonnie H. Anderson DIRECTOR ELECTIONS ISSUER 333040.000000 0 FOR 333040.000000 FOR S000004450 Bruker Corporation 116794108 US1167941087 05/29/2025 Election of four Class I directors to serve for a three-year term expiring in 2028: Frank H. Laukien, Ph.D. DIRECTOR ELECTIONS ISSUER 333040.000000 0 FOR 333040.000000 FOR S000004450 Bruker Corporation 116794108 US1167941087 05/29/2025 Election of four Class I directors to serve for a three-year term expiring in 2028: John A. Ornell DIRECTOR ELECTIONS ISSUER 333040.000000 0 FOR 333040.000000 FOR S000004450 Bruker Corporation 116794108 US1167941087 05/29/2025 Election of four Class I directors to serve for a three-year term expiring in 2028: Richard A. Packer DIRECTOR ELECTIONS ISSUER 333040.000000 0 FOR 333040.000000 FOR S000004450 Bruker Corporation 116794108 US1167941087 05/29/2025 Approval on an advisory basis of the 2024 compensation of our named executive officers, as discussed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 333040.000000 0 FOR 333040.000000 FOR S000004450 Bruker Corporation 116794108 US1167941087 05/29/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 333040.000000 0 FOR 333040.000000 FOR S000004450 Bruker Corporation 116794108 US1167941087 05/29/2025 Approval of the adoption of the Bruker Corporation 2026 Incentive Compensation Plan. COMPENSATION ISSUER 333040.000000 0 FOR 333040.000000 FOR S000004450 Editas Medicine, Inc. 28106W103 US28106W1036 05/29/2025 Election of two Class III Directors, each to serve until the 2028 annual meeting of stockholders: Jessica Hopfield, Ph.D. DIRECTOR ELECTIONS ISSUER 248762.000000 0 FOR 248762.000000 FOR S000004450 Editas Medicine, Inc. 28106W103 US28106W1036 05/29/2025 Election of two Class III Directors, each to serve until the 2028 annual meeting of stockholders: David T. Scadden, M.D. DIRECTOR ELECTIONS ISSUER 248762.000000 0 FOR 248762.000000 FOR S000004450 Editas Medicine, Inc. 28106W103 US28106W1036 05/29/2025 To approve, on an advisory basis, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 248762.000000 0 FOR 248762.000000 FOR S000004450 Editas Medicine, Inc. 28106W103 US28106W1036 05/29/2025 To approve, on an advisory basis, the frequency of future advisory votes on the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 248762.000000 0 ONE YEAR 248762.000000 FOR S000004450 Editas Medicine, Inc. 28106W103 US28106W1036 05/29/2025 To approve an amendment and restatement of the Company's 2015 Stock Incentive Plan. COMPENSATION ISSUER 248762.000000 0 FOR 248762.000000 FOR S000004450 Editas Medicine, Inc. 28106W103 US28106W1036 05/29/2025 To adopt and approve an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of the Company's capital stock from 200,000,000 to 395,000,000 and the number of authorized shares of the Company's common stock from 195,000,000 to 390,000,000. CAPITAL STRUCTURE ISSUER 248762.000000 0 FOR 248762.000000 FOR S000004450 Editas Medicine, Inc. 28106W103 US28106W1036 05/29/2025 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 248762.000000 0 FOR 248762.000000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 05/29/2025 Election of Class III Directors: Dr. Shefali Agarwal DIRECTOR ELECTIONS ISSUER 273448.000000 0 FOR 273448.000000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 05/29/2025 Election of Class III Directors: Dr. Bahram Valamehr DIRECTOR ELECTIONS ISSUER 273448.000000 0 FOR 273448.000000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 05/29/2025 Election of Class III Directors: Matthew C. Abernethy DIRECTOR ELECTIONS ISSUER 273448.000000 0 FOR 273448.000000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 05/29/2025 To approve the ratification of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 273448.000000 0 FOR 273448.000000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 05/29/2025 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 273448.000000 0 FOR 273448.000000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 05/29/2025 To recommend, on a non-binding advisory basis, the frequency of future non-binding stockholder advisory votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 273448.000000 0 ONE YEAR 273448.000000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 05/29/2025 To approve the amendment of our Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 250,000,000 to 350,000,000. CAPITAL STRUCTURE ISSUER 273448.000000 0 FOR 273448.000000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 05/29/2025 To approve the amendment and restatement of the Company's 2022 Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder. COMPENSATION ISSUER 273448.000000 0 FOR 273448.000000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 05/29/2025 To approve the adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve any of the above proposals. CORPORATE GOVERNANCE ISSUER 273448.000000 0 FOR 273448.000000 FOR S000004450 Glaukos Corporation 377322102 US3773221029 05/29/2025 Election of Directors: Mark J. Foley DIRECTOR ELECTIONS ISSUER 173581.000000 0 FOR 173581.000000 FOR S000004450 Glaukos Corporation 377322102 US3773221029 05/29/2025 Election of Directors: David F. Hoffmeister DIRECTOR ELECTIONS ISSUER 173581.000000 0 FOR 173581.000000 FOR S000004450 Glaukos Corporation 377322102 US3773221029 05/29/2025 Election of Directors: Gilbert H. Kliman, M.D. DIRECTOR ELECTIONS ISSUER 173581.000000 0 FOR 173581.000000 FOR S000004450 Glaukos Corporation 377322102 US3773221029 05/29/2025 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 173581.000000 0 FOR 173581.000000 FOR S000004450 Glaukos Corporation 377322102 US3773221029 05/29/2025 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 173581.000000 0 FOR 173581.000000 FOR S000004450 GRAIL, Inc. 384747101 US3847471014 05/29/2025 Election of Class I Director to serve until the 2028 Annual Meeting of Stockholders, and until their respective successor has been duly elected and qualified: William (Bill) Chase DIRECTOR ELECTIONS ISSUER 57580.000000 37800.000000 FOR 57580.000000 FOR S000004450 GRAIL, Inc. 384747101 US3847471014 05/29/2025 The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 57580.000000 37800.000000 FOR 57580.000000 FOR S000004450 HealthStream, Inc. 42222N103 US42222N1037 05/29/2025 To elect three Class I directors (Charles E. Beard, Jr., Thompson S. Dent, and Deborah Taylor Tate) to hold office for a term of three (3) years and until their successors have been duly elected and qualified: Charles E. Beard, Jr. DIRECTOR ELECTIONS ISSUER 76932.000000 0 FOR 76932.000000 FOR S000004450 HealthStream, Inc. 42222N103 US42222N1037 05/29/2025 To elect three Class I directors (Charles E. Beard, Jr., Thompson S. Dent, and Deborah Taylor Tate) to hold office for a term of three (3) years and until their successors have been duly elected and qualified: Thompson S. Dent DIRECTOR ELECTIONS ISSUER 76932.000000 0 FOR 76932.000000 FOR S000004450 HealthStream, Inc. 42222N103 US42222N1037 05/29/2025 To elect three Class I directors (Charles E. Beard, Jr., Thompson S. Dent, and Deborah Taylor Tate) to hold office for a term of three (3) years and until their successors have been duly elected and qualified: Deborah Taylor Tate DIRECTOR ELECTIONS ISSUER 76932.000000 0 FOR 76932.000000 FOR S000004450 HealthStream, Inc. 42222N103 US42222N1037 05/29/2025 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 76932.000000 0 FOR 76932.000000 FOR S000004450 HealthStream, Inc. 42222N103 US42222N1037 05/29/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers as described in the Company's proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 76932.000000 0 FOR 76932.000000 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 US6047491013 05/29/2025 To elect the Board's three Class III nominees for director to hold office until the Company's 2028 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Christopher Peetz DIRECTOR ELECTIONS ISSUER 113822.000000 0 FOR 113822.000000 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 US6047491013 05/29/2025 To elect the Board's three Class III nominees for director to hold office until the Company's 2028 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Laura Brege DIRECTOR ELECTIONS ISSUER 113822.000000 0 FOR 113822.000000 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 US6047491013 05/29/2025 To elect the Board's three Class III nominees for director to hold office until the Company's 2028 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Michael Grey DIRECTOR ELECTIONS ISSUER 113822.000000 0 FOR 113822.000000 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 US6047491013 05/29/2025 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 113822.000000 0 FOR 113822.000000 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 US6047491013 05/29/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 113822.000000 0 FOR 113822.000000 FOR S000004450 Spyre Therapeutics, Inc. 00773J202 US00773J2024 05/29/2025 Election of Class III Directors for terms expiring in 2028: Peter Harwin DIRECTOR ELECTIONS ISSUER 110561.000000 0 FOR 110561.000000 FOR S000004450 Spyre Therapeutics, Inc. 00773J202 US00773J2024 05/29/2025 Election of Class III Directors for terms expiring in 2028: Michael Henderson, M.D. DIRECTOR ELECTIONS ISSUER 110561.000000 0 FOR 110561.000000 FOR S000004450 Spyre Therapeutics, Inc. 00773J202 US00773J2024 05/29/2025 Election of Class III Directors for terms expiring in 2028: Sandra Milligan, M.D., J.D. DIRECTOR ELECTIONS ISSUER 110561.000000 0 FOR 110561.000000 FOR S000004450 Spyre Therapeutics, Inc. 00773J202 US00773J2024 05/29/2025 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 110561.000000 0 FOR 110561.000000 FOR S000004450 Spyre Therapeutics, Inc. 00773J202 US00773J2024 05/29/2025 To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 110561.000000 0 FOR 110561.000000 FOR S000004450 Tyra Biosciences, Inc. 90240B106 US90240B1061 05/29/2025 To elect three directors to serve as Class I directors for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Todd Harris, Ph.D. DIRECTOR ELECTIONS ISSUER 48015.000000 0 FOR 48015.000000 FOR S000004450 Tyra Biosciences, Inc. 90240B106 US90240B1061 05/29/2025 To elect three directors to serve as Class I directors for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Adele M. Gulfo DIRECTOR ELECTIONS ISSUER 48015.000000 0 FOR 48015.000000 FOR S000004450 Tyra Biosciences, Inc. 90240B106 US90240B1061 05/29/2025 To elect three directors to serve as Class I directors for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: S. Michael Rothenberg, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 48015.000000 0 FOR 48015.000000 FOR S000004450 Tyra Biosciences, Inc. 90240B106 US90240B1061 05/29/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 48015.000000 0 FOR 48015.000000 FOR S000004450 Vir Biotechnology, Inc. 92764N102 US92764N1028 05/29/2025 To elect the following two nominees for director to hold office until the 2028 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Jeffrey S. Hatfield DIRECTOR ELECTIONS ISSUER 279928.000000 0 FOR 279928.000000 FOR S000004450 Vir Biotechnology, Inc. 92764N102 US92764N1028 05/29/2025 To elect the following two nominees for director to hold office until the 2028 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Saira Ramasastry DIRECTOR ELECTIONS ISSUER 279928.000000 0 FOR 279928.000000 FOR S000004450 Vir Biotechnology, Inc. 92764N102 US92764N1028 05/29/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 279928.000000 0 FOR 279928.000000 FOR S000004450 Vir Biotechnology, Inc. 92764N102 US92764N1028 05/29/2025 To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 279928.000000 0 FOR 279928.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/29/2025 Election of Directors: Betsy J. Bernard DIRECTOR ELECTIONS ISSUER 626241.000000 0 FOR 626241.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/29/2025 Election of Directors: Michael J. Farrell DIRECTOR ELECTIONS ISSUER 626241.000000 0 FOR 626241.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/29/2025 Election of Directors: Robert A. Hagemann DIRECTOR ELECTIONS ISSUER 626241.000000 0 FOR 626241.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/29/2025 Election of Directors: Arthur J. Higgins DIRECTOR ELECTIONS ISSUER 626241.000000 0 FOR 626241.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/29/2025 Election of Directors: Maria Teresa Hilado DIRECTOR ELECTIONS ISSUER 626241.000000 0 FOR 626241.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/29/2025 Election of Directors: Syed Jafry DIRECTOR ELECTIONS ISSUER 626241.000000 0 FOR 626241.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/29/2025 Election of Directors: Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 626241.000000 0 FOR 626241.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/29/2025 Election of Directors: Devdatt Kurdikar DIRECTOR ELECTIONS ISSUER 626241.000000 0 FOR 626241.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/29/2025 Election of Directors: Louis A. Shapiro DIRECTOR ELECTIONS ISSUER 626241.000000 0 FOR 626241.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/29/2025 Election of Directors: Ivan Tornos DIRECTOR ELECTIONS ISSUER 626241.000000 0 FOR 626241.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/29/2025 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 626241.000000 0 FOR 626241.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/29/2025 Approve, on a non-binding advisory basis, named executive officer compensation ("Say on Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 626241.000000 0 FOR 626241.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/29/2025 Approve the amended 2009 Stock Incentive Plan. COMPENSATION ISSUER 626241.000000 0 FOR 626241.000000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/29/2025 Approve an amendment to our Restated Certificate of Incorporation to allow for exculpation of officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 626241.000000 0 FOR 626241.000000 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 US26818M1080 05/30/2025 To elect two Class II directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Edward Hurwitz DIRECTOR ELECTIONS ISSUER 192994.000000 0 FOR 192994.000000 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 US26818M1080 05/30/2025 To elect two Class II directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Dirk Kersten DIRECTOR ELECTIONS ISSUER 192994.000000 0 FOR 192994.000000 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 US26818M1080 05/30/2025 To vote, on an advisory basis, to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 192994.000000 0 FOR 192994.000000 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 US26818M1080 05/30/2025 To hold an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 192994.000000 0 ONE YEAR 192994.000000 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 US26818M1080 05/30/2025 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 192994.000000 0 FOR 192994.000000 FOR S000004450 REGENXBIO Inc. 75901B107 US75901B1070 05/30/2025 Election of Four Class I Directors: Allan M. Fox DIRECTOR ELECTIONS ISSUER 132204.000000 0 FOR 132204.000000 FOR S000004450 REGENXBIO Inc. 75901B107 US75901B1070 05/30/2025 Election of Four Class I Directors: Alexandra Glucksmann, Ph.D. DIRECTOR ELECTIONS ISSUER 132204.000000 0 FOR 132204.000000 FOR S000004450 REGENXBIO Inc. 75901B107 US75901B1070 05/30/2025 Election of Four Class I Directors: Curran Simpson DIRECTOR ELECTIONS ISSUER 132204.000000 0 FOR 132204.000000 FOR S000004450 REGENXBIO Inc. 75901B107 US75901B1070 05/30/2025 Election of Four Class I Directors: Jennifer Zachary DIRECTOR ELECTIONS ISSUER 132204.000000 0 FOR 132204.000000 FOR S000004450 REGENXBIO Inc. 75901B107 US75901B1070 05/30/2025 To ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 132204.000000 0 FOR 132204.000000 FOR S000004450 REGENXBIO Inc. 75901B107 US75901B1070 05/30/2025 Advisory vote on the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 132204.000000 0 FOR 132204.000000 FOR S000004450 REGENXBIO Inc. 75901B107 US75901B1070 05/30/2025 Advisory vote on the frequency of future stockholder advisory votes on the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 132204.000000 0 ONE YEAR 132204.000000 FOR S000004450 REGENXBIO Inc. 75901B107 US75901B1070 05/30/2025 To approve the REGENXBIO Inc. 2025 Equity Incentive Plan. COMPENSATION ISSUER 132204.000000 0 FOR 132204.000000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/02/2025 To elect three Class III directors to serve until the Company's 2028 annual meeting of stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: Jack Y. Zhang DIRECTOR ELECTIONS ISSUER 121592.000000 0 FOR 121592.000000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/02/2025 To elect three Class III directors to serve until the Company's 2028 annual meeting of stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: Richard Prins DIRECTOR ELECTIONS ISSUER 121592.000000 0 FOR 121592.000000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/02/2025 To elect three Class III directors to serve until the Company's 2028 annual meeting of stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: Diane G. Gerst DIRECTOR ELECTIONS ISSUER 121592.000000 0 FOR 121592.000000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/02/2025 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2025; AUDIT-RELATED ISSUER 121592.000000 0 FOR 121592.000000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/02/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 121592.000000 0 FOR 121592.000000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/02/2025 To approve the amendment of our Amended and Restated Certificate of Incorporation to reflect Delaware law provisions regarding officer exculpation; and CORPORATE GOVERNANCE ISSUER 121592.000000 0 FOR 121592.000000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/02/2025 To approve the amendment of our Amended and Restated Certificate of Incorporation to remove forum selection provision. CORPORATE GOVERNANCE ISSUER 121592.000000 0 FOR 121592.000000 FOR S000004450 Day One Biopharmaceuticals, Inc. 23954D109 US23954D1090 06/02/2025 Election of Class I Directors: Natalie Holles DIRECTOR ELECTIONS ISSUER 175350.000000 0 FOR 175350.000000 FOR S000004450 Day One Biopharmaceuticals, Inc. 23954D109 US23954D1090 06/02/2025 Election of Class I Directors: Garry Nicholson DIRECTOR ELECTIONS ISSUER 175350.000000 0 FOR 175350.000000 FOR S000004450 Day One Biopharmaceuticals, Inc. 23954D109 US23954D1090 06/02/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 175350.000000 0 FOR 175350.000000 FOR S000004450 Day One Biopharmaceuticals, Inc. 23954D109 US23954D1090 06/02/2025 Approval, on a non-binding advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 175350.000000 0 FOR 175350.000000 FOR S000004450 LeMaitre Vascular, Inc. 525558201 US5255582018 06/02/2025 Election of Directors: George W. LeMaitre DIRECTOR ELECTIONS ISSUER 62885.000000 0 FOR 62885.000000 FOR S000004450 LeMaitre Vascular, Inc. 525558201 US5255582018 06/02/2025 Election of Directors: David B. Roberts DIRECTOR ELECTIONS ISSUER 62885.000000 0 FOR 62885.000000 FOR S000004450 LeMaitre Vascular, Inc. 525558201 US5255582018 06/02/2025 Election of Directors: Martha Shadan DIRECTOR ELECTIONS ISSUER 62885.000000 0 FOR 62885.000000 FOR S000004450 LeMaitre Vascular, Inc. 525558201 US5255582018 06/02/2025 To approve, by a non-binding, advisory vote, the 2024 compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 62885.000000 0 FOR 62885.000000 FOR S000004450 LeMaitre Vascular, Inc. 525558201 US5255582018 06/02/2025 To provide a non-binding, advisory vote on the frequency of future stockholder advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 62885.000000 0 ONE YEAR 62885.000000 AGAINST S000004450 LeMaitre Vascular, Inc. 525558201 US5255582018 06/02/2025 To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 62885.000000 0 FOR 62885.000000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 06/02/2025 Election of Directors: Raymond Debbane DIRECTOR ELECTIONS ISSUER 110122.000000 462700.000000 FOR 110122.000000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 06/02/2025 Election of Directors: Ivan H. Cheung DIRECTOR ELECTIONS ISSUER 110122.000000 462700.000000 FOR 110122.000000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 06/02/2025 Ratification and approval of the amendment to the Company's 2017 Equity Incentive Plan COMPENSATION ISSUER 110122.000000 462700.000000 FOR 110122.000000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 06/02/2025 Ratification and approval of the amendment to the Company's 2017 Non-Employee Directors' Equity Incentive Plan COMPENSATION ISSUER 110122.000000 462700.000000 FOR 110122.000000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 06/02/2025 Approval of an amendment to the Company's Sixth Amended and Restated Certificate of Incorporation to effect, at the discretion of the Company's board of directors, a reverse split of its common stock, at a ratio within a range of 1-for-10 to 1-for-50, at any time prior to the Company's 2026 annual meeting of stockholders and with the actual ratio to be determined within that range at the discretion of the Company's board of directors CAPITAL STRUCTURE ISSUER 110122.000000 462700.000000 FOR 110122.000000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 06/02/2025 Advisory vote to approve the compensation paid to the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 110122.000000 462700.000000 FOR 110122.000000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 06/02/2025 Ratification and approval of the appointment of Ernst & Young LLP as the Company's independent auditors for the fiscal year ending December 31, 2025 AUDIT-RELATED ISSUER 110122.000000 462700.000000 FOR 110122.000000 FOR S000004450 Outset Medical, Inc. 690145206 US6901452069 06/02/2025 Election of Class II Directors: D. Keith Grossman DIRECTOR ELECTIONS ISSUER 10006.000000 0 FOR 10006.000000 FOR S000004450 Outset Medical, Inc. 690145206 US6901452069 06/02/2025 Election of Class II Directors: Patrick T. Hackett DIRECTOR ELECTIONS ISSUER 10006.000000 0 FOR 10006.000000 FOR S000004450 Outset Medical, Inc. 690145206 US6901452069 06/02/2025 To approve, on a non-binding basis, the 2024 compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 10006.000000 0 FOR 10006.000000 FOR S000004450 Outset Medical, Inc. 690145206 US6901452069 06/02/2025 To approve an amendment to our 2020 Equity Incentive Plan to increase the number of shares of common stock available for issuance under the plan by 1,950,000 shares COMPENSATION ISSUER 10006.000000 0 AGAINST 10006.000000 AGAINST S000004450 Outset Medical, Inc. 690145206 US6901452069 06/02/2025 To approve an amendment to our Employee Stock Purchase Plan to increase the number of shares of common stock available for issuance under the plan by 255,000 shares COMPENSATION ISSUER 10006.000000 0 FOR 10006.000000 FOR S000004450 Outset Medical, Inc. 690145206 US6901452069 06/02/2025 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2025 AUDIT-RELATED ISSUER 10006.000000 0 FOR 10006.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: Charles Baker DIRECTOR ELECTIONS ISSUER 2900479.000000 0 FOR 2900479.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: Timothy Flynn DIRECTOR ELECTIONS ISSUER 2900479.000000 0 FOR 2900479.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: Paul Garcia DIRECTOR ELECTIONS ISSUER 2900479.000000 0 FOR 2900479.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: Kristen Gil DIRECTOR ELECTIONS ISSUER 2900479.000000 0 FOR 2900479.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: Stephen Hemsley DIRECTOR ELECTIONS ISSUER 2900479.000000 0 FOR 2900479.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: Michele Hooper DIRECTOR ELECTIONS ISSUER 2900479.000000 0 FOR 2900479.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: F. William McNabb III DIRECTOR ELECTIONS ISSUER 2900479.000000 0 FOR 2900479.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: Valerie Montgomery Rice, M.D. DIRECTOR ELECTIONS ISSUER 2900479.000000 0 FOR 2900479.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: John Noseworthy, M.D. DIRECTOR ELECTIONS ISSUER 2900479.000000 0 FOR 2900479.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2900479.000000 0 FOR 2900479.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2025. AUDIT-RELATED ISSUER 2900479.000000 0 FOR 2900479.000000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 If properly presented at the 2025 Annual Meeting of Shareholders, the shareholder proposal requesting a shareholder vote regarding excessive golden parachutes. COMPENSATION SECURITY HOLDER 2900479.000000 0 AGAINST 2900479.000000 FOR S000004450 10X Genomics, Inc. 88025U109 US88025U1097 06/03/2025 Election of the Class III directors, each to serve a three-year term expiring at the 2028 annual meeting of stockholders or until such director's successors are duly elected and qualified or until such director's earlier death, resignation, disqualification or removal: Sri Kosaraju DIRECTOR ELECTIONS ISSUER 300080.000000 0 FOR 300080.000000 FOR S000004450 10X Genomics, Inc. 88025U109 US88025U1097 06/03/2025 Election of the Class III directors, each to serve a three-year term expiring at the 2028 annual meeting of stockholders or until such director's successors are duly elected and qualified or until such director's earlier death, resignation, disqualification or removal: Shehnaaz Suliman DIRECTOR ELECTIONS ISSUER 300080.000000 0 FOR 300080.000000 FOR S000004450 10X Genomics, Inc. 88025U109 US88025U1097 06/03/2025 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025; and AUDIT-RELATED ISSUER 300080.000000 0 FOR 300080.000000 FOR S000004450 10X Genomics, Inc. 88025U109 US88025U1097 06/03/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 300080.000000 0 FOR 300080.000000 FOR S000004450 Akero Therapeutics, Inc. 00973Y108 US00973Y1082 06/03/2025 To elect two class III directors, Judy Chou, Ph.D. and Tomas Heyman, to our board of directors, to serve until the 2028 Annual Meeting of stockholders and until her or his successor has been duly elected and qualified, or until her or his earlier death, resignation or removal: Judy Chou, Ph.D. DIRECTOR ELECTIONS ISSUER 152192.000000 0 FOR 152192.000000 FOR S000004450 Akero Therapeutics, Inc. 00973Y108 US00973Y1082 06/03/2025 To elect two class III directors, Judy Chou, Ph.D. and Tomas Heyman, to our board of directors, to serve until the 2028 Annual Meeting of stockholders and until her or his successor has been duly elected and qualified, or until her or his earlier death, resignation or removal: Tomas Heyman DIRECTOR ELECTIONS ISSUER 152192.000000 0 FOR 152192.000000 FOR S000004450 Akero Therapeutics, Inc. 00973Y108 US00973Y1082 06/03/2025 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 152192.000000 0 FOR 152192.000000 FOR S000004450 Akero Therapeutics, Inc. 00973Y108 US00973Y1082 06/03/2025 To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 152192.000000 0 FOR 152192.000000 FOR S000004450 Apellis Pharmaceuticals, Inc. 03753U106 US03753U1060 06/03/2025 Election of three Class II directors to hold office until the 2028 Annual Meeting of Stockholders: A. Sinclair Dunlop DIRECTOR ELECTIONS ISSUER 216158.000000 0 FOR 216158.000000 FOR S000004450 Apellis Pharmaceuticals, Inc. 03753U106 US03753U1060 06/03/2025 Election of three Class II directors to hold office until the 2028 Annual Meeting of Stockholders: Alec Machiels DIRECTOR ELECTIONS ISSUER 216158.000000 0 FOR 216158.000000 FOR S000004450 Apellis Pharmaceuticals, Inc. 03753U106 US03753U1060 06/03/2025 Election of three Class II directors to hold office until the 2028 Annual Meeting of Stockholders: Keli Walbert DIRECTOR ELECTIONS ISSUER 216158.000000 0 FOR 216158.000000 FOR S000004450 Apellis Pharmaceuticals, Inc. 03753U106 US03753U1060 06/03/2025 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025; AUDIT-RELATED ISSUER 216158.000000 0 FOR 216158.000000 FOR S000004450 Apellis Pharmaceuticals, Inc. 03753U106 US03753U1060 06/03/2025 To hold an advisory vote to approve the compensation paid to our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 216158.000000 0 FOR 216158.000000 FOR S000004450 Apellis Pharmaceuticals, Inc. 03753U106 US03753U1060 06/03/2025 To hold an advisory vote on the frequency of future advisory votes on the compensation paid to our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 216158.000000 0 ONE YEAR 216158.000000 FOR S000004450 Bioventus Inc. 09075A108 US09075A1088 06/03/2025 To elect the following nominees to serve as Class I directors until the 2026 annual meeting of stockholders of Bioventus Inc. (the "Company"), and until their respective successors have been duly elected and qualified: Robert E. Claypoole DIRECTOR ELECTIONS ISSUER 113467.000000 0 FOR 113467.000000 FOR S000004450 Bioventus Inc. 09075A108 US09075A1088 06/03/2025 To elect the following nominees to serve as Class I directors until the 2026 annual meeting of stockholders of Bioventus Inc. (the "Company"), and until their respective successors have been duly elected and qualified: Philip G. Cowdy DIRECTOR ELECTIONS ISSUER 113467.000000 0 FOR 113467.000000 FOR S000004450 Bioventus Inc. 09075A108 US09075A1088 06/03/2025 To elect the following nominees to serve as Class I directors until the 2026 annual meeting of stockholders of Bioventus Inc. (the "Company"), and until their respective successors have been duly elected and qualified: Michelle McMurry-Heath DIRECTOR ELECTIONS ISSUER 113467.000000 0 FOR 113467.000000 FOR S000004450 Bioventus Inc. 09075A108 US09075A1088 06/03/2025 To elect the following nominees to serve as Class I directors until the 2026 annual meeting of stockholders of Bioventus Inc. (the "Company"), and until their respective successors have been duly elected and qualified: Guido J. Neels DIRECTOR ELECTIONS ISSUER 113467.000000 0 FOR 113467.000000 FOR S000004450 Bioventus Inc. 09075A108 US09075A1088 06/03/2025 To elect the following nominees to serve as Class I directors until the 2026 annual meeting of stockholders of Bioventus Inc. (the "Company"), and until their respective successors have been duly elected and qualified: Guy P. Nohra DIRECTOR ELECTIONS ISSUER 113467.000000 0 FOR 113467.000000 FOR S000004450 Bioventus Inc. 09075A108 US09075A1088 06/03/2025 To elect the following nominees to serve as Class I directors until the 2026 annual meeting of stockholders of Bioventus Inc. (the "Company"), and until their respective successors have been duly elected and qualified: Martin P. Sutter DIRECTOR ELECTIONS ISSUER 113467.000000 0 FOR 113467.000000 FOR S000004450 Bioventus Inc. 09075A108 US09075A1088 06/03/2025 To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 113467.000000 0 FOR 113467.000000 FOR S000004450 Cerus Corporation 157085101 US1570851014 06/03/2025 The election of the two nominees for director named in the Proxy Statement to hold office until the 2028 Annual Meeting of Stockholders: Jami Dover Nachtsheim DIRECTOR ELECTIONS ISSUER 586251.000000 0 FOR 586251.000000 FOR S000004450 Cerus Corporation 157085101 US1570851014 06/03/2025 The election of the two nominees for director named in the Proxy Statement to hold office until the 2028 Annual Meeting of Stockholders: Hua Shan, MD, Ph.D. DIRECTOR ELECTIONS ISSUER 586251.000000 0 FOR 586251.000000 FOR S000004450 Cerus Corporation 157085101 US1570851014 06/03/2025 The approval of an amendment and restatement of the Company's 2024 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance thereunder by 10 million shares and to make certain other changes thereto as described further in the accompanying Proxy Statement. COMPENSATION ISSUER 586251.000000 0 FOR 586251.000000 FOR S000004450 Cerus Corporation 157085101 US1570851014 06/03/2025 The approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 586251.000000 0 FOR 586251.000000 FOR S000004450 Cerus Corporation 157085101 US1570851014 06/03/2025 The ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 586251.000000 0 FOR 586251.000000 FOR S000004450 Denali Therapeutics Inc. 24823R105 US24823R1059 06/03/2025 ELECTION OF DIRECTORS: Julian Baker DIRECTOR ELECTIONS ISSUER 402246.000000 0 FOR 402246.000000 FOR S000004450 Denali Therapeutics Inc. 24823R105 US24823R1059 06/03/2025 ELECTION OF DIRECTORS: Peter Klein DIRECTOR ELECTIONS ISSUER 402246.000000 0 FOR 402246.000000 FOR S000004450 Denali Therapeutics Inc. 24823R105 US24823R1059 06/03/2025 ELECTION OF DIRECTORS: Steve Krognes DIRECTOR ELECTIONS ISSUER 402246.000000 0 WITHHOLD 402246.000000 AGAINST S000004450 Denali Therapeutics Inc. 24823R105 US24823R1059 06/03/2025 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025 AUDIT-RELATED ISSUER 402246.000000 0 FOR 402246.000000 FOR S000004450 Denali Therapeutics Inc. 24823R105 US24823R1059 06/03/2025 Advisory vote on executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 402246.000000 0 FOR 402246.000000 FOR S000004450 GoodRx Holdings, Inc. 38246G108 US38246G1085 06/03/2025 Election of Directors: Christopher Adams DIRECTOR ELECTIONS ISSUER 277633.000000 0 FOR 277633.000000 FOR S000004450 GoodRx Holdings, Inc. 38246G108 US38246G1085 06/03/2025 Election of Directors: Trevor Bezdek DIRECTOR ELECTIONS ISSUER 277633.000000 0 FOR 277633.000000 FOR S000004450 GoodRx Holdings, Inc. 38246G108 US38246G1085 06/03/2025 Election of Directors: Scott Wagner DIRECTOR ELECTIONS ISSUER 277633.000000 0 FOR 277633.000000 FOR S000004450 GoodRx Holdings, Inc. 38246G108 US38246G1085 06/03/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 277633.000000 0 FOR 277633.000000 FOR S000004450 GoodRx Holdings, Inc. 38246G108 US38246G1085 06/03/2025 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 277633.000000 0 FOR 277633.000000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 06/03/2025 Election of Class I Directors to serve until the 2028 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Sanj K. Patel DIRECTOR ELECTIONS ISSUER 117256.000000 0 FOR 117256.000000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 06/03/2025 Election of Class I Directors to serve until the 2028 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Thomas R. Malley DIRECTOR ELECTIONS ISSUER 117256.000000 0 FOR 117256.000000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 06/03/2025 Election of Class I Directors to serve until the 2028 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Richard S. Levy DIRECTOR ELECTIONS ISSUER 117256.000000 0 FOR 117256.000000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 06/03/2025 Election of Class II Directors to serve until the 2026 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Stephen R. Biggar DIRECTOR ELECTIONS ISSUER 117256.000000 0 FOR 117256.000000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 06/03/2025 Election of Class II Directors to serve until the 2026 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: G. Bradley Cole DIRECTOR ELECTIONS ISSUER 117256.000000 0 FOR 117256.000000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 06/03/2025 Election of Class II Directors to serve until the 2026 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Barry D. Quart DIRECTOR ELECTIONS ISSUER 117256.000000 0 FOR 117256.000000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 06/03/2025 Election of Class III Directors to serve until the 2027 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Felix J. Baker, Ph.D. DIRECTOR ELECTIONS ISSUER 117256.000000 0 FOR 117256.000000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 06/03/2025 Election of Class III Directors to serve until the 2027 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: M. Cantey Boyd DIRECTOR ELECTIONS ISSUER 117256.000000 0 FOR 117256.000000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 06/03/2025 Election of Class III Directors to serve until the 2027 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Tracey L. McCain DIRECTOR ELECTIONS ISSUER 117256.000000 0 FOR 117256.000000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 06/03/2025 Election of Class III Directors to serve until the 2027 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Kimberly J. Popovits DIRECTOR ELECTIONS ISSUER 117256.000000 0 FOR 117256.000000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 06/03/2025 To approve the appointment of PricewaterhouseCoopers LLP ("PwC") as the Company's UK statutory auditors until the close of our next Annual General Meeting of Shareholders. AUDIT-RELATED ISSUER 117256.000000 0 FOR 117256.000000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 06/03/2025 To ratify the appointment of PwC as the Company's US independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 117256.000000 0 FOR 117256.000000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 06/03/2025 To authorize the Company's Board of Directors, through its Audit Committee, the authority to determine PwC's remuneration in its capacity as our UK statutory auditors until the close of our next Annual General Meeting of Shareholders. AUDIT-RELATED ISSUER 117256.000000 0 FOR 117256.000000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 06/03/2025 To receive the Company's UK statutory annual accounts and report for the period ended December 31, 2024. CORPORATE GOVERNANCE ISSUER 117256.000000 0 FOR 117256.000000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 06/03/2025 To approve, on an advisory (non-binding) basis, the Company's UK Statutory Directors' Annual Remuneration Report for the period ended December 31, 2024. COMPENSATION ISSUER 117256.000000 0 FOR 117256.000000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 06/03/2025 To approve the Company's UK Statutory Directors' Remuneration Policy. COMPENSATION ISSUER 117256.000000 0 FOR 117256.000000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 06/03/2025 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 117256.000000 0 FOR 117256.000000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 06/03/2025 To authorize the Board of Directors, generally and unconditionally for the purpose of section 551 of the UK Companies Act 2006 (the "Companies Act") to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the company ("Rights") up to a maximum aggregate nominal amount of $6,976.33, which represents approximately 35% of the issued ordinary share capital of the Company on the record date for the 2025 Annual General Meeting of Shareholders. This authority shall expire (unless previously renewed, varied or revoked) on June 2, 2030, but we may at any time before the expiration of this authority make an offer or agreement which would or might require shares to be allotted, or Rights to be granted, pursuant to this authority after its expiration, and the Board of Directors may allot shares or grant Rights in pursuance of that offer or agreement as if the authority conferred by this resolution had not expired. The authority granted by this resolution shall replace all of our existing authorities to allot any shares and to grant Rights previously granted in connection with the adoption of the Articles in June 2024, but without prejudice to any allotment of shares or grant of Rights already made or agreed or offered to be made pursuant to such authorities. CAPITAL STRUCTURE ISSUER 117256.000000 0 FOR 117256.000000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 06/03/2025 Subject to the passing of Proposal No. 11, to empower the Board of Directors generally pursuant to section 570(1) and section 573 of the Companies Act to allot equity securities (as defined in section 560 of the Companies Act) for cash pursuant to the general authority conferred on them by Proposal No. 11 as if section 561(1) of the Companies Act did not apply to that allotment. This power (a) shall be limited to the allotment of equity securities up to a maximum aggregate of $6,976.33; (b) will expire (unless previously renewed, varied or revoked) on June 2, 2030, but we may at any time before the expiration of this power make an offer or agreement which would or might require equity securities to be allotted after that expiry and the Board of Directors may allot equity securities pursuant to any of those offers or agreements as if the power had not expired; and (c) will apply in relation to a sale of shares which is an allotment of equity securities by virtue of section 560(3) of the Companies Act as if in the first paragraph of this proposal the words "pursuant to the general authority conferred on them by Proposal No. 11" were omitted. For purposes of this resolution, references to the allotment of equity securities shall be interpreted in accordance with section 560 of the Companies Act. This resolution replaces all unexercised powers previously granted to the Board of Directors, pursuant to the adoption of the Articles in June 2024, to allot equity securities as if section 561 of the Companies Act did not apply but shall be without prejudice to any allotment of equity securities already made or agreed or agreed to be made pursuant to such authorities. CAPITAL STRUCTURE ISSUER 117256.000000 0 FOR 117256.000000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 06/03/2025 To authorize the Board of Directors to conduct a transaction with the Company's wholly-owned subsidiary, Kiniksa Pharmaceuticals, Ltd. ("Kiniksa Bermuda"), whereby the Company will redeem the preference shares previously issued to Kiniksa Bermuda through the capitalization of the Company's merger reserve account and subsequently cancelling the merger reserve bonus share issued as part of such capitalization via a court-approved process, thus creating distributable reserves to be utilized to redeem such preference shares and thereby allowing for the liquidation of Kiniksa Bermuda. EXTRAORDINARY TRANSACTIONS ISSUER 117256.000000 0 FOR 117256.000000 FOR S000004450 LifeStance Health Group, Inc. 53228F101 US53228F1012 06/03/2025 Election of the three director nominees named in the Proxy Statement to serve until the 2028 annual meeting of stockholders: Teresa DeLuca, M.D. DIRECTOR ELECTIONS ISSUER 419089.000000 0 FOR 419089.000000 FOR S000004450 LifeStance Health Group, Inc. 53228F101 US53228F1012 06/03/2025 Election of the three director nominees named in the Proxy Statement to serve until the 2028 annual meeting of stockholders: Katherine Wood DIRECTOR ELECTIONS ISSUER 419089.000000 0 FOR 419089.000000 FOR S000004450 LifeStance Health Group, Inc. 53228F101 US53228F1012 06/03/2025 Election of the three director nominees named in the Proxy Statement to serve until the 2028 annual meeting of stockholders: Eric Palmer DIRECTOR ELECTIONS ISSUER 419089.000000 0 FOR 419089.000000 FOR S000004450 LifeStance Health Group, Inc. 53228F101 US53228F1012 06/03/2025 Ratification of the appointment of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for the year ended December 31, 2025; AUDIT-RELATED ISSUER 419089.000000 0 FOR 419089.000000 FOR S000004450 LifeStance Health Group, Inc. 53228F101 US53228F1012 06/03/2025 Approval, on an advisory basis, of the compensation of the Company's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 419089.000000 0 FOR 419089.000000 FOR S000004450 Phathom Pharmaceuticals, Inc. 71722W107 US71722W1071 06/03/2025 To elect two class II directors to hold office until the 2026 Annual Meeting of Stockholders: Heidi Kunz DIRECTOR ELECTIONS ISSUER 118886.000000 0 FOR 118886.000000 FOR S000004450 Phathom Pharmaceuticals, Inc. 71722W107 US71722W1071 06/03/2025 To elect two class II directors to hold office until the 2026 Annual Meeting of Stockholders: James Topper, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 118886.000000 0 FOR 118886.000000 FOR S000004450 Phathom Pharmaceuticals, Inc. 71722W107 US71722W1071 06/03/2025 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 118886.000000 0 FOR 118886.000000 FOR S000004450 Phathom Pharmaceuticals, Inc. 71722W107 US71722W1071 06/03/2025 To approve the compensation of the named executive officers on a non-binding advisory basis ("say-on-pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 118886.000000 0 FOR 118886.000000 FOR S000004450 Phathom Pharmaceuticals, Inc. 71722W107 US71722W1071 06/03/2025 To approve a proposal for the frequency of future non-binding advisory votes on the compensation of the named executive officers ("say-on-frequency"). SECTION 14A SAY-ON-PAY VOTES ISSUER 118886.000000 0 ONE YEAR 118886.000000 FOR S000004450 RxSight, Inc. 78349D107 US78349D1072 06/03/2025 To elect three Class I directors to serve until the 2028 annual meeting of stockholders or until their successors are duly elected and qualified: Ron Kurtz, M.D. DIRECTOR ELECTIONS ISSUER 107383.000000 0 FOR 107383.000000 FOR S000004450 RxSight, Inc. 78349D107 US78349D1072 06/03/2025 To elect three Class I directors to serve until the 2028 annual meeting of stockholders or until their successors are duly elected and qualified: J. Andy Corley DIRECTOR ELECTIONS ISSUER 107383.000000 0 FOR 107383.000000 FOR S000004450 RxSight, Inc. 78349D107 US78349D1072 06/03/2025 To elect three Class I directors to serve until the 2028 annual meeting of stockholders or until their successors are duly elected and qualified: Juliet Tammenoms Bakker DIRECTOR ELECTIONS ISSUER 107383.000000 0 FOR 107383.000000 FOR S000004450 RxSight, Inc. 78349D107 US78349D1072 06/03/2025 To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 107383.000000 0 FOR 107383.000000 FOR S000004450 RxSight, Inc. 78349D107 US78349D1072 06/03/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 107383.000000 0 FOR 107383.000000 FOR S000004450 Stoke Therapeutics, Inc. 86150R107 US86150R1077 06/03/2025 Election of Class III Directors to serve until the 2028 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Edward M. Kaye, M.D. DIRECTOR ELECTIONS ISSUER 108206.000000 0 FOR 108206.000000 FOR S000004450 Stoke Therapeutics, Inc. 86150R107 US86150R1077 06/03/2025 Election of Class III Directors to serve until the 2028 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Seth L. Harrison, M.D. DIRECTOR ELECTIONS ISSUER 108206.000000 0 FOR 108206.000000 FOR S000004450 Stoke Therapeutics, Inc. 86150R107 US86150R1077 06/03/2025 Election of Class III Directors to serve until the 2028 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Arthur O. Tzianabos, Ph.D. DIRECTOR ELECTIONS ISSUER 108206.000000 0 FOR 108206.000000 FOR S000004450 Stoke Therapeutics, Inc. 86150R107 US86150R1077 06/03/2025 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 108206.000000 0 FOR 108206.000000 FOR S000004450 Stoke Therapeutics, Inc. 86150R107 US86150R1077 06/03/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 108206.000000 0 FOR 108206.000000 FOR S000004450 Stoke Therapeutics, Inc. 86150R107 US86150R1077 06/03/2025 To indicate, on an advisory basis, the preferred frequency of future stockholder advisory votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 108206.000000 0 ONE YEAR 108206.000000 FOR S000004450 ADMA Biologics, Inc. 000899104 US0008991046 06/04/2025 To elect the following Class III directors for a term expiring at the 2028 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Jerrold B. Grossman D.P.S. DIRECTOR ELECTIONS ISSUER 737305.000000 0 FOR 737305.000000 FOR S000004450 ADMA Biologics, Inc. 000899104 US0008991046 06/04/2025 To elect the following Class III directors for a term expiring at the 2028 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Lawrence P. Guiheen DIRECTOR ELECTIONS ISSUER 737305.000000 0 FOR 737305.000000 FOR S000004450 ADMA Biologics, Inc. 000899104 US0008991046 06/04/2025 To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 737305.000000 0 FOR 737305.000000 FOR S000004450 ADMA Biologics, Inc. 000899104 US0008991046 06/04/2025 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 737305.000000 0 FOR 737305.000000 FOR S000004450 ADMA Biologics, Inc. 000899104 US0008991046 06/04/2025 To determine, on a non-binding, advisory basis, the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 737305.000000 0 ONE YEAR 737305.000000 FOR S000004450 Beam Therapeutics Inc. 07373V105 US07373V1052 06/04/2025 Election of the following nominees as Class II directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2028: Mark Fishman, M.D. DIRECTOR ELECTIONS ISSUER 278668.000000 0 FOR 278668.000000 FOR S000004450 Beam Therapeutics Inc. 07373V105 US07373V1052 06/04/2025 Election of the following nominees as Class II directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2028: Carole Ho, M.D. DIRECTOR ELECTIONS ISSUER 278668.000000 0 FOR 278668.000000 FOR S000004450 Beam Therapeutics Inc. 07373V105 US07373V1052 06/04/2025 Election of the following nominees as Class II directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2028: Kathleen Walsh DIRECTOR ELECTIONS ISSUER 278668.000000 0 FOR 278668.000000 FOR S000004450 Beam Therapeutics Inc. 07373V105 US07373V1052 06/04/2025 Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 278668.000000 0 FOR 278668.000000 FOR S000004450 Beam Therapeutics Inc. 07373V105 US07373V1052 06/04/2025 Approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 278668.000000 0 FOR 278668.000000 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 US19240Q2012 06/04/2025 Election of the two Class I director nominees to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dr. Karen Ferrante DIRECTOR ELECTIONS ISSUER 224476.000000 0 FOR 224476.000000 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 US19240Q2012 06/04/2025 Election of the two Class I director nominees to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Matthew E. Ros DIRECTOR ELECTIONS ISSUER 224476.000000 0 FOR 224476.000000 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 US19240Q2012 06/04/2025 Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 224476.000000 0 FOR 224476.000000 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 US19240Q2012 06/04/2025 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 224476.000000 0 FOR 224476.000000 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 US19240Q2012 06/04/2025 Approval of an amendment of the Company's Certificate of Incorporation to provide for officer exculpation. CORPORATE GOVERNANCE ISSUER 224476.000000 0 FOR 224476.000000 FOR S000004450 FibroGen, Inc. 31572Q881 US31572Q8814 06/04/2025 To elect a Class II director to hold office until the 2028 Annual Meeting of Stockholders: Jeffrey L. Edwards DIRECTOR ELECTIONS ISSUER 303893.000000 0 FOR 303893.000000 FOR S000004450 FibroGen, Inc. 31572Q881 US31572Q8814 06/04/2025 To approve a reverse stock split of FibroGen, Inc's common stock, including granting our board of directors discretion to determine the final ratio and timing. CAPITAL STRUCTURE ISSUER 303893.000000 0 FOR 303893.000000 FOR S000004450 FibroGen, Inc. 31572Q881 US31572Q8814 06/04/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 303893.000000 0 FOR 303893.000000 FOR S000004450 FibroGen, Inc. 31572Q881 US31572Q8814 06/04/2025 To ratify the selection, by the Audit Committee of the Board, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2025. AUDIT-RELATED ISSUER 303893.000000 0 FOR 303893.000000 FOR S000004450 Globus Medical, Inc. 379577208 US3795772082 06/04/2025 Election of Directors: David C. Paul DIRECTOR ELECTIONS ISSUER 254521.000000 0 FOR 254521.000000 FOR S000004450 Globus Medical, Inc. 379577208 US3795772082 06/04/2025 Election of Directors: Daniel T. Lemaitre DIRECTOR ELECTIONS ISSUER 254521.000000 0 FOR 254521.000000 FOR S000004450 Globus Medical, Inc. 379577208 US3795772082 06/04/2025 Election of Directors: Leslie V. Norwalk, Esq. DIRECTOR ELECTIONS ISSUER 254521.000000 0 FOR 254521.000000 FOR S000004450 Globus Medical, Inc. 379577208 US3795772082 06/04/2025 Election of Directors: Ann D. Rhoads DIRECTOR ELECTIONS ISSUER 254521.000000 0 FOR 254521.000000 FOR S000004450 Globus Medical, Inc. 379577208 US3795772082 06/04/2025 The approval of the amendment to the 2021 Equity Incentive Plan; COMPENSATION ISSUER 254521.000000 0 AGAINST 254521.000000 AGAINST S000004450 Globus Medical, Inc. 379577208 US3795772082 06/04/2025 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025; and AUDIT-RELATED ISSUER 254521.000000 0 FOR 254521.000000 FOR S000004450 Globus Medical, Inc. 379577208 US3795772082 06/04/2025 To approve, in an advisory vote, the compensation of the Company's named executive officers (the Say-on-Pay Vote). SECTION 14A SAY-ON-PAY VOTES ISSUER 254521.000000 0 FOR 254521.000000 FOR S000004450 Globus Medical, Inc. 379577208 US3795772082 06/04/2025 To approve, in an advisory vote, the frequency of the approval, on an advisory basis, of the compensation of our named executive officers (the Frequency Vote). SECTION 14A SAY-ON-PAY VOTES ISSUER 254521.000000 0 ONE YEAR 254521.000000 FOR S000004450 Keros Therapeutics, Inc. 492327101 US4923271013 06/04/2025 To elect the three (3) nominees for Class II director named below to hold office until the 2028 Annual Meeting of Stockholders: Mary Ann Gray, Ph.D. DIRECTOR ELECTIONS ISSUER 102662.000000 0 FOR 102662.000000 FOR S000004450 Keros Therapeutics, Inc. 492327101 US4923271013 06/04/2025 To elect the three (3) nominees for Class II director named below to hold office until the 2028 Annual Meeting of Stockholders: Ran Nussbaum DIRECTOR ELECTIONS ISSUER 102662.000000 0 FOR 102662.000000 FOR S000004450 Keros Therapeutics, Inc. 492327101 US4923271013 06/04/2025 To elect the three (3) nominees for Class II director named below to hold office until the 2028 Annual Meeting of Stockholders: Alpna Seth, Ph.D. DIRECTOR ELECTIONS ISSUER 102662.000000 0 FOR 102662.000000 FOR S000004450 Keros Therapeutics, Inc. 492327101 US4923271013 06/04/2025 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 102662.000000 0 FOR 102662.000000 FOR S000004450 Keros Therapeutics, Inc. 492327101 US4923271013 06/04/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 102662.000000 0 FOR 102662.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/04/2025 Election of Directors: Ashley Cordova DIRECTOR ELECTIONS ISSUER 323296.000000 0 FOR 323296.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/04/2025 Election of Directors: Asaf Danziger DIRECTOR ELECTIONS ISSUER 323296.000000 0 FOR 323296.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/04/2025 Election of Directors: William Doyle DIRECTOR ELECTIONS ISSUER 323296.000000 0 FOR 323296.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/04/2025 Election of Directors: Jeryl Hilleman DIRECTOR ELECTIONS ISSUER 323296.000000 0 FOR 323296.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/04/2025 Election of Directors: David Hung DIRECTOR ELECTIONS ISSUER 323296.000000 0 FOR 323296.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/04/2025 Election of Directors: Kinyip Gabriel Leung DIRECTOR ELECTIONS ISSUER 323296.000000 0 FOR 323296.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/04/2025 Election of Directors: Martin Madden DIRECTOR ELECTIONS ISSUER 323296.000000 0 FOR 323296.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/04/2025 Election of Directors: Allyson Ocean DIRECTOR ELECTIONS ISSUER 323296.000000 0 FOR 323296.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/04/2025 Election of Directors: Timothy Scannell DIRECTOR ELECTIONS ISSUER 323296.000000 0 FOR 323296.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/04/2025 Election of Directors: Kristin Stafford DIRECTOR ELECTIONS ISSUER 323296.000000 0 FOR 323296.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/04/2025 Election of Directors: William Vernon DIRECTOR ELECTIONS ISSUER 323296.000000 0 FOR 323296.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/04/2025 The approval and ratification of the appointment, by the Audit Committee of our Board of Directors, of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the auditor and independent registered public accounting firm of the Company for the Company's fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 323296.000000 0 FOR 323296.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/04/2025 A non-binding advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 323296.000000 0 FOR 323296.000000 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/04/2025 The approval of our 2025 Employee Share Purchase Plan. COMPENSATION ISSUER 323296.000000 0 FOR 323296.000000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/04/2025 Election of Directors: William Ericson DIRECTOR ELECTIONS ISSUER 282561.000000 484763.000000 FOR 282561.000000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/04/2025 Election of Directors: Kathy Ordonez DIRECTOR ELECTIONS ISSUER 282561.000000 484763.000000 FOR 282561.000000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/04/2025 Election of Directors: Christopher M. Smith DIRECTOR ELECTIONS ISSUER 282561.000000 484763.000000 FOR 282561.000000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/04/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 282561.000000 484763.000000 FOR 282561.000000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/04/2025 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 282561.000000 484763.000000 FOR 282561.000000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/04/2025 To approve the amendment of our 2020 Equity Incentive Plan. COMPENSATION ISSUER 282561.000000 484763.000000 FOR 282561.000000 FOR S000004450 Prime Medicine, Inc. 74168J101 US74168J1016 06/04/2025 To elect Thomas Cahill, M.D., Ph.D. and Robert Nelsen as Class III Directors: Thomas Cahill, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 20787.000000 105800.000000 FOR 20787.000000 FOR S000004450 Prime Medicine, Inc. 74168J101 US74168J1016 06/04/2025 To elect Thomas Cahill, M.D., Ph.D. and Robert Nelsen as Class III Directors: Robert Nelsen DIRECTOR ELECTIONS ISSUER 20787.000000 105800.000000 WITHHOLD 20787.000000 AGAINST S000004450 Prime Medicine, Inc. 74168J101 US74168J1016 06/04/2025 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 20787.000000 105800.000000 FOR 20787.000000 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/04/2025 To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected: R. Jeffrey Bailly DIRECTOR ELECTIONS ISSUER 23812.000000 0 FOR 23812.000000 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/04/2025 To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected: Thomas Oberdorf DIRECTOR ELECTIONS ISSUER 23812.000000 0 FOR 23812.000000 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/04/2025 To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected: Marc Kozin DIRECTOR ELECTIONS ISSUER 23812.000000 0 FOR 23812.000000 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/04/2025 To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected: Daniel C. Croteau DIRECTOR ELECTIONS ISSUER 23812.000000 0 FOR 23812.000000 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/04/2025 To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected: Cynthia L. Feldmann DIRECTOR ELECTIONS ISSUER 23812.000000 0 FOR 23812.000000 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/04/2025 To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected: Joseph John Hassett DIRECTOR ELECTIONS ISSUER 23812.000000 0 FOR 23812.000000 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/04/2025 To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected: Symeria Hudson DIRECTOR ELECTIONS ISSUER 23812.000000 0 FOR 23812.000000 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/04/2025 To vote on a non-binding advisory resolution to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 23812.000000 0 FOR 23812.000000 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/04/2025 To vote on a non-binding advisory resolution on the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 23812.000000 0 ONE YEAR 23812.000000 AGAINST S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/04/2025 To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 23812.000000 0 FOR 23812.000000 FOR S000004450 Ventyx Biosciences, Inc. 92332V107 US92332V1070 06/04/2025 To elect two Class I directors to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: Somasundaram Subramaniam, M.B.A. DIRECTOR ELECTIONS ISSUER 155731.000000 0 FOR 155731.000000 FOR S000004450 Ventyx Biosciences, Inc. 92332V107 US92332V1070 06/04/2025 To elect two Class I directors to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: Sheila Gujrathi, M.D. DIRECTOR ELECTIONS ISSUER 155731.000000 0 FOR 155731.000000 FOR S000004450 Ventyx Biosciences, Inc. 92332V107 US92332V1070 06/04/2025 To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote"). SECTION 14A SAY-ON-PAY VOTES ISSUER 155731.000000 0 FOR 155731.000000 FOR S000004450 Ventyx Biosciences, Inc. 92332V107 US92332V1070 06/04/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 155731.000000 0 FOR 155731.000000 FOR S000004450 Waystar Holding Corp. 946784105 US9467841055 06/04/2025 Elect three Class I directors to hold office until our 2028 Annual Meeting of stockholders and until their respective successors have been duly elected and qualified: Samuel Blaichman DIRECTOR ELECTIONS ISSUER 214189.000000 0 FOR 214189.000000 FOR S000004450 Waystar Holding Corp. 946784105 US9467841055 06/04/2025 Elect three Class I directors to hold office until our 2028 Annual Meeting of stockholders and until their respective successors have been duly elected and qualified: Priscilla Hung DIRECTOR ELECTIONS ISSUER 214189.000000 0 FOR 214189.000000 FOR S000004450 Waystar Holding Corp. 946784105 US9467841055 06/04/2025 Elect three Class I directors to hold office until our 2028 Annual Meeting of stockholders and until their respective successors have been duly elected and qualified: Vivian Riefberg DIRECTOR ELECTIONS ISSUER 214189.000000 0 FOR 214189.000000 FOR S000004450 Waystar Holding Corp. 946784105 US9467841055 06/04/2025 Approve an amendment to our Amended and Restated Certificate of Incorporation to remove the existing limit on the maximum size of our board of directors. CORPORATE GOVERNANCE ISSUER 214189.000000 0 AGAINST 214189.000000 AGAINST S000004450 Waystar Holding Corp. 946784105 US9467841055 06/04/2025 Ratify the appointment of KPMG LLP as our independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 214189.000000 0 FOR 214189.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2025 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Dawn Svoronos DIRECTOR ELECTIONS ISSUER 203358.000000 0 FOR 203358.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2025 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Gillian Cannon DIRECTOR ELECTIONS ISSUER 203358.000000 0 FOR 203358.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2025 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Steven Gannon DIRECTOR ELECTIONS ISSUER 203358.000000 0 FOR 203358.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2025 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Elizabeth Garofalo DIRECTOR ELECTIONS ISSUER 203358.000000 0 FOR 203358.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2025 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Justin Gover DIRECTOR ELECTIONS ISSUER 203358.000000 0 FOR 203358.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2025 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Patrick Machado DIRECTOR ELECTIONS ISSUER 203358.000000 0 FOR 203358.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2025 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Ian Mortimer DIRECTOR ELECTIONS ISSUER 203358.000000 0 FOR 203358.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2025 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Gary Patou DIRECTOR ELECTIONS ISSUER 203358.000000 0 FOR 203358.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2025 To approve, on an advisory basis, the compensation of the Corporation's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 203358.000000 0 FOR 203358.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2025 To appoint PricewaterhouseCoopers LLP ("PwC") as the Corporation's auditor to hold office until the next annual meeting of the Corporation; AUDIT-RELATED ISSUER 203358.000000 0 FOR 203358.000000 FOR S000004450 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/04/2025 To authorize the Audit Committee of the board of directors of the Corporation to fix the remuneration to be paid to the auditors of the Corporation; AUDIT-RELATED ISSUER 203358.000000 0 FOR 203358.000000 FOR S000004450 Alignment Healthcare, Inc. 01625V104 US01625V1044 06/05/2025 Election of Directors: Margaret McCarthy DIRECTOR ELECTIONS ISSUER 302520.000000 0 FOR 302520.000000 FOR S000004450 Alignment Healthcare, Inc. 01625V104 US01625V1044 06/05/2025 Election of Directors: Mark McClellan DIRECTOR ELECTIONS ISSUER 302520.000000 0 WITHHOLD 302520.000000 AGAINST S000004450 Alignment Healthcare, Inc. 01625V104 US01625V1044 06/05/2025 Election of Directors: Robbert Vorhoff DIRECTOR ELECTIONS ISSUER 302520.000000 0 FOR 302520.000000 FOR S000004450 Alignment Healthcare, Inc. 01625V104 US01625V1044 06/05/2025 Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2025 AUDIT-RELATED ISSUER 302520.000000 0 FOR 302520.000000 FOR S000004450 Alignment Healthcare, Inc. 01625V104 US01625V1044 06/05/2025 Approve, on an advisory basis, the compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 302520.000000 0 FOR 302520.000000 FOR S000004450 Amicus Therapeutics, Inc. 03152W109 US03152W1099 06/05/2025 Election of Directors: Michael A. Kelly DIRECTOR ELECTIONS ISSUER 694992.000000 0 FOR 694992.000000 FOR S000004450 Amicus Therapeutics, Inc. 03152W109 US03152W1099 06/05/2025 Election of Directors: Margaret G. McGlynn DIRECTOR ELECTIONS ISSUER 694992.000000 0 FOR 694992.000000 FOR S000004450 Amicus Therapeutics, Inc. 03152W109 US03152W1099 06/05/2025 Election of Directors: Michael G. Raab DIRECTOR ELECTIONS ISSUER 694992.000000 0 FOR 694992.000000 FOR S000004450 Amicus Therapeutics, Inc. 03152W109 US03152W1099 06/05/2025 Election of Directors: Glenn P. Sblendorio DIRECTOR ELECTIONS ISSUER 694992.000000 0 FOR 694992.000000 FOR S000004450 Amicus Therapeutics, Inc. 03152W109 US03152W1099 06/05/2025 Approval of the 2025 Equity Incentive Plan. COMPENSATION ISSUER 694992.000000 0 FOR 694992.000000 FOR S000004450 Amicus Therapeutics, Inc. 03152W109 US03152W1099 06/05/2025 Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 694992.000000 0 FOR 694992.000000 FOR S000004450 Amicus Therapeutics, Inc. 03152W109 US03152W1099 06/05/2025 Approval, on an advisory basis, the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 694992.000000 0 FOR 694992.000000 FOR S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 US03237H1014 06/05/2025 Election of Directors: To elect the following persons to our board of directors, each to serve as a Class I director until the 2028 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Karen Firestone DIRECTOR ELECTIONS ISSUER 186392.000000 0 FOR 186392.000000 FOR S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 US03237H1014 06/05/2025 Election of Directors: To elect the following persons to our board of directors, each to serve as a Class I director until the 2028 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Justin Klee DIRECTOR ELECTIONS ISSUER 186392.000000 0 FOR 186392.000000 FOR S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 US03237H1014 06/05/2025 Election of Directors: To elect the following persons to our board of directors, each to serve as a Class I director until the 2028 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Bernhardt Zeiher, M.D. DIRECTOR ELECTIONS ISSUER 186392.000000 0 FOR 186392.000000 FOR S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 US03237H1014 06/05/2025 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 186392.000000 0 FOR 186392.000000 FOR S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 US03237H1014 06/05/2025 To approve, on a non-binding, advisory basis, the compensation of our named executives officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 186392.000000 0 FOR 186392.000000 FOR S000004450 Annexon, Inc. 03589W102 US03589W1027 06/05/2025 To elect the two nominees for director to serve as Class II directors to hold office until the 2028 annual meeting of stockholders: Jung E. Choi DIRECTOR ELECTIONS ISSUER 215218.000000 0 FOR 215218.000000 FOR S000004450 Annexon, Inc. 03589W102 US03589W1027 06/05/2025 To elect the two nominees for director to serve as Class II directors to hold office until the 2028 annual meeting of stockholders: William D. Waddill DIRECTOR ELECTIONS ISSUER 215218.000000 0 FOR 215218.000000 FOR S000004450 Annexon, Inc. 03589W102 US03589W1027 06/05/2025 To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 215218.000000 0 FOR 215218.000000 FOR S000004450 Annexon, Inc. 03589W102 US03589W1027 06/05/2025 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 215218.000000 0 FOR 215218.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/05/2025 Election of Directors: Anthony S. Marucci DIRECTOR ELECTIONS ISSUER 186786.000000 0 FOR 186786.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/05/2025 Election of Directors: Keith L. Brownlie DIRECTOR ELECTIONS ISSUER 186786.000000 0 FOR 186786.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/05/2025 Election of Directors: Cheryl L. Cohen DIRECTOR ELECTIONS ISSUER 186786.000000 0 FOR 186786.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/05/2025 Election of Directors: Herbert J. Conrad DIRECTOR ELECTIONS ISSUER 186786.000000 0 FOR 186786.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/05/2025 Election of Directors: Rita I. Jain, M.D. DIRECTOR ELECTIONS ISSUER 186786.000000 0 FOR 186786.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/05/2025 Election of Directors: James J. Marino DIRECTOR ELECTIONS ISSUER 186786.000000 0 FOR 186786.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/05/2025 Election of Directors: Garry Neil, M.D. DIRECTOR ELECTIONS ISSUER 186786.000000 0 FOR 186786.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/05/2025 Election of Directors: Harry H. Penner, Jr. DIRECTOR ELECTIONS ISSUER 186786.000000 0 FOR 186786.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/05/2025 Election of Directors: Denice Torres DIRECTOR ELECTIONS ISSUER 186786.000000 0 FOR 186786.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/05/2025 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 186786.000000 0 FOR 186786.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/05/2025 To approve an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of shares reserved for issuance thereunder by 2,000,000 shares to 9,500,000 shares. COMPENSATION ISSUER 186786.000000 0 FOR 186786.000000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/05/2025 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in this Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 186786.000000 0 FOR 186786.000000 FOR S000004450 CG Oncology, Inc. 156944100 US1569441009 06/05/2025 To elect the Board's three nominees for Class I director named as nominees to hold office until the 2028 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Arthur Kuan DIRECTOR ELECTIONS ISSUER 131065.000000 0 FOR 131065.000000 FOR S000004450 CG Oncology, Inc. 156944100 US1569441009 06/05/2025 To elect the Board's three nominees for Class I director named as nominees to hold office until the 2028 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: James J. Mule DIRECTOR ELECTIONS ISSUER 131065.000000 0 WITHHOLD 131065.000000 AGAINST S000004450 CG Oncology, Inc. 156944100 US1569441009 06/05/2025 To elect the Board's three nominees for Class I director named as nominees to hold office until the 2028 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Leonard Post DIRECTOR ELECTIONS ISSUER 131065.000000 0 FOR 131065.000000 FOR S000004450 CG Oncology, Inc. 156944100 US1569441009 06/05/2025 To ratify the appointment by the Audit Committee of the Board of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 131065.000000 0 FOR 131065.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 Approval of the Swiss management report, the consolidated financial statements and the statutory financial statements of the Company for the year ended December 31, 2024. CORPORATE GOVERNANCE ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 Approval of the appropriation of financial results. CAPITAL STRUCTURE ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 Discharge of the members of the Board of Directors and the Executive Committee. CORPORATE GOVERNANCE ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 Election or re-election of the members to the Board of Directors and the Chairman: 4.a Re-election of Samarth Kulkarni, Ph.D., as member and Chairman DIRECTOR ELECTIONS ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 4.b Re-election of Ali Behbahani, M.D. DIRECTOR ELECTIONS ISSUER 2661.000000 250300.000000 AGAINST 2661.000000 AGAINST S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 4.c Re-election of Maria Fardis, Ph.D. DIRECTOR ELECTIONS ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 4.d Re-election of H. Edward Fleming, Jr., M.D. DIRECTOR ELECTIONS ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 4.e Re-election of Simeon J. George, M.D. DIRECTOR ELECTIONS ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 4.f Re-election of John T. Greene DIRECTOR ELECTIONS ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 4.g Re-election of Katherine A. High, M.D. DIRECTOR ELECTIONS ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 4.h Re-election of Sandesh Mahatme, LL.M. DIRECTOR ELECTIONS ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 4.i Re-election of Christian Rommel, Ph.D. DIRECTOR ELECTIONS ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 4.j Re-election of Douglas A. Treco, Ph.D. DIRECTOR ELECTIONS ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 4.k Election of Briggs W. Morrison, M.D. DIRECTOR ELECTIONS ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 Election or Re-election of the members of the Compensation Committee: 5.a Re-election of Ali Behbahani, M.D. DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 2661.000000 250300.000000 AGAINST 2661.000000 AGAINST S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 5.b Re-election of H. Edward Fleming, Jr., M.D. DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 5.c Re-election of John T. Greene DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 5.d Election of Briggs W. Morrison, M.D. DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 Approval of the compensation for the Board of Directors and the Executive Committee and non-binding advisory vote on the 2024 Compensation Report: 6.a Binding vote on maximum non-performance-related compensation for members of the Board of Directors from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders. COMPENSATION ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 6.b Binding vote on maximum equity for members of the Board of Directors from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders. COMPENSATION ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 6.c Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2025 to June 30, 2026. COMPENSATION ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 6.d Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2025. COMPENSATION ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 6.e Binding vote on maximum equity for members of the Executive Committee from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders. COMPENSATION ISSUER 2661.000000 250300.000000 AGAINST 2661.000000 AGAINST S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 6.f Non-binding advisory vote on the 2024 Compensation Report. COMPENSATION ISSUER 2661.000000 250300.000000 AGAINST 2661.000000 AGAINST S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements. SECTION 14A SAY-ON-PAY VOTES ISSUER 2661.000000 250300.000000 AGAINST 2661.000000 AGAINST S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 Approval of increasing the maximum size of the Board of Directors. CORPORATE GOVERNANCE ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 Re-election of the independent voting rights representative. CORPORATE GOVERNANCE ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 Re-election of the auditors. AUDIT-RELATED ISSUER 2661.000000 250300.000000 FOR 2661.000000 FOR S000004450 CRISPR Therapeutics AG H17182108 CH0334081137 06/05/2025 Transact any other business that may properly come before the 2025 Annual General Meeting or any adjournment or postponement thereof. CORPORATE GOVERNANCE ISSUER 2661.000000 250300.000000 AGAINST 2661.000000 AGAINST S000004450 DaVita Inc. 23918K108 US23918K1088 06/05/2025 Election of Directors: Pamela M. Arway DIRECTOR ELECTIONS ISSUER 140524.000000 0 FOR 140524.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/05/2025 Election of Directors: Barbara J. Desoer DIRECTOR ELECTIONS ISSUER 140524.000000 0 FOR 140524.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/05/2025 Election of Directors: Jason M. Hollar DIRECTOR ELECTIONS ISSUER 140524.000000 0 FOR 140524.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/05/2025 Election of Directors: Gregory J. Moore, MD, PhD DIRECTOR ELECTIONS ISSUER 140524.000000 0 FOR 140524.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/05/2025 Election of Directors: Dennis W. Pullin DIRECTOR ELECTIONS ISSUER 140524.000000 0 FOR 140524.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/05/2025 Election of Directors: Javier J. Rodriguez DIRECTOR ELECTIONS ISSUER 140524.000000 0 FOR 140524.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/05/2025 Election of Directors: Adam H. Schechter DIRECTOR ELECTIONS ISSUER 140524.000000 0 FOR 140524.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/05/2025 Election of Directors: Wendy L. Schoppert DIRECTOR ELECTIONS ISSUER 140524.000000 0 FOR 140524.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/05/2025 Election of Directors: Phyllis R. Yale DIRECTOR ELECTIONS ISSUER 140524.000000 0 FOR 140524.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/05/2025 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2025. AUDIT-RELATED ISSUER 140524.000000 0 FOR 140524.000000 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/05/2025 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 140524.000000 0 FOR 140524.000000 FOR S000004450 Definitive Healthcare Corp. 24477E103 US24477E1038 06/05/2025 To elect the three Class I directors of Definitive Healthcare Corp. named below, each to serve a three-year term expiring at the 2028 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Kevin Coop DIRECTOR ELECTIONS ISSUER 145590.000000 0 FOR 145590.000000 FOR S000004450 Definitive Healthcare Corp. 24477E103 US24477E1038 06/05/2025 To elect the three Class I directors of Definitive Healthcare Corp. named below, each to serve a three-year term expiring at the 2028 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Jason Krantz DIRECTOR ELECTIONS ISSUER 145590.000000 0 FOR 145590.000000 FOR S000004450 Definitive Healthcare Corp. 24477E103 US24477E1038 06/05/2025 To elect the three Class I directors of Definitive Healthcare Corp. named below, each to serve a three-year term expiring at the 2028 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Lauren Young DIRECTOR ELECTIONS ISSUER 145590.000000 0 FOR 145590.000000 FOR S000004450 Definitive Healthcare Corp. 24477E103 US24477E1038 06/05/2025 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 145590.000000 0 FOR 145590.000000 FOR S000004450 Definitive Healthcare Corp. 24477E103 US24477E1038 06/05/2025 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 145590.000000 0 FOR 145590.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/05/2025 Election of Directors: Toyin Ajayi, MD DIRECTOR ELECTIONS ISSUER 309383.000000 0 FOR 309383.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/05/2025 Election of Directors: Craig Barbarosh DIRECTOR ELECTIONS ISSUER 309383.000000 0 FOR 309383.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/05/2025 Election of Directors: Seth Blackley DIRECTOR ELECTIONS ISSUER 309383.000000 0 FOR 309383.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/05/2025 Election of Directors: Russell Glass DIRECTOR ELECTIONS ISSUER 309383.000000 0 FOR 309383.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/05/2025 Election of Directors: Peter Grua DIRECTOR ELECTIONS ISSUER 309383.000000 0 FOR 309383.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/05/2025 Election of Directors: Shawn Guertin DIRECTOR ELECTIONS ISSUER 309383.000000 0 FOR 309383.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/05/2025 Election of Directors: Richard Jelinek DIRECTOR ELECTIONS ISSUER 309383.000000 0 FOR 309383.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/05/2025 Election of Directors: Kim Keck DIRECTOR ELECTIONS ISSUER 309383.000000 0 FOR 309383.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/05/2025 Election of Directors: Cheryl Scott DIRECTOR ELECTIONS ISSUER 309383.000000 0 FOR 309383.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/05/2025 Election of Directors: Brendan Springstubb DIRECTOR ELECTIONS ISSUER 309383.000000 0 FOR 309383.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/05/2025 Proposal to ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 309383.000000 0 FOR 309383.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/05/2025 Proposal to approve the compensation of our named executive officers for 2024 on an advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 309383.000000 0 FOR 309383.000000 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/05/2025 Proposal to approve an amendment to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. COMPENSATION ISSUER 309383.000000 0 FOR 309383.000000 FOR S000004450 Evolus, Inc. 30052C107 US30052C1071 06/05/2025 Election of Class I directors for a three-year term: David Gill DIRECTOR ELECTIONS ISSUER 147945.000000 0 FOR 147945.000000 FOR S000004450 Evolus, Inc. 30052C107 US30052C1071 06/05/2025 Election of Class I directors for a three-year term: Albert White III DIRECTOR ELECTIONS ISSUER 147945.000000 0 FOR 147945.000000 FOR S000004450 Evolus, Inc. 30052C107 US30052C1071 06/05/2025 Ratification of the appointment of Ernst & Young LLP as Evolus' independent auditor for the year ending December 31, 2025. AUDIT-RELATED ISSUER 147945.000000 0 FOR 147945.000000 FOR S000004450 Evolus, Inc. 30052C107 US30052C1071 06/05/2025 Approval of, on an advisory basis, the compensation of Evolus' named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 147945.000000 0 FOR 147945.000000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/05/2025 Election of Directors: Allene M. Diaz DIRECTOR ELECTIONS ISSUER 447094.000000 0 FOR 447094.000000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/05/2025 Election of Directors: Michael Hayden DIRECTOR ELECTIONS ISSUER 447094.000000 0 FOR 447094.000000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/05/2025 Election of Directors: Joseph Klein, III DIRECTOR ELECTIONS ISSUER 447094.000000 0 FOR 447094.000000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/05/2025 Election of Directors: Joseph Loscalzo DIRECTOR ELECTIONS ISSUER 447094.000000 0 FOR 447094.000000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/05/2025 To make an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 447094.000000 0 FOR 447094.000000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/05/2025 To approve an amendment of the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan by 4,000,000 shares to an aggregate of 42,500,000 shares. COMPENSATION ISSUER 447094.000000 0 FOR 447094.000000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/05/2025 To ratify the Audit Committee's selection of Ernst & Young LLP as independent auditors for the 2025 fiscal year. AUDIT-RELATED ISSUER 447094.000000 0 FOR 447094.000000 FOR S000004450 Kura Oncology, Inc. 50127T109 US50127T1097 06/05/2025 Election of three Class II directors for three-year terms: Helen Collins, M.D. DIRECTOR ELECTIONS ISSUER 145658.000000 0 FOR 145658.000000 FOR S000004450 Kura Oncology, Inc. 50127T109 US50127T1097 06/05/2025 Election of three Class II directors for three-year terms: Thomas Malley DIRECTOR ELECTIONS ISSUER 145658.000000 0 FOR 145658.000000 FOR S000004450 Kura Oncology, Inc. 50127T109 US50127T1097 06/05/2025 Election of three Class II directors for three-year terms: Carol Schafer DIRECTOR ELECTIONS ISSUER 145658.000000 0 FOR 145658.000000 FOR S000004450 Kura Oncology, Inc. 50127T109 US50127T1097 06/05/2025 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 145658.000000 0 FOR 145658.000000 FOR S000004450 Kura Oncology, Inc. 50127T109 US50127T1097 06/05/2025 Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 145658.000000 0 FOR 145658.000000 FOR S000004450 Kura Oncology, Inc. 50127T109 US50127T1097 06/05/2025 Approval of an amendment to our Amended and Restated 2014 Equity Incentive Plan. COMPENSATION ISSUER 145658.000000 0 FOR 145658.000000 FOR S000004450 MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/05/2025 Election of the three Class III director nominees to serve until the 2028 Annual General Meeting of Shareholders and until their successors are duly elected and qualified: Dr. Jorge Santos da Silva DIRECTOR ELECTIONS ISSUER 68160.000000 0 FOR 68160.000000 FOR S000004450 MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/05/2025 Election of the three Class III director nominees to serve until the 2028 Annual General Meeting of Shareholders and until their successors are duly elected and qualified: Simon Sturge DIRECTOR ELECTIONS ISSUER 68160.000000 0 FOR 68160.000000 FOR S000004450 MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/05/2025 Election of the three Class III director nominees to serve until the 2028 Annual General Meeting of Shareholders and until their successors are duly elected and qualified: Dr. Andrew Phillips DIRECTOR ELECTIONS ISSUER 68160.000000 0 FOR 68160.000000 FOR S000004450 MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/05/2025 Ratification, by ordinary resolution, of the selection of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 68160.000000 0 FOR 68160.000000 FOR S000004450 MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/05/2025 Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 68160.000000 0 FOR 68160.000000 FOR S000004450 Myriad Genetics, Inc. 62855J104 US62855J1043 06/05/2025 Election of three Class II Directors to serve until the 2028 Annual Meeting of Stockholders: Samraat S. Raha DIRECTOR ELECTIONS ISSUER 284474.000000 0 FOR 284474.000000 FOR S000004450 Myriad Genetics, Inc. 62855J104 US62855J1043 06/05/2025 Election of three Class II Directors to serve until the 2028 Annual Meeting of Stockholders: Heiner Dreismann, Ph.D. DIRECTOR ELECTIONS ISSUER 284474.000000 0 FOR 284474.000000 FOR S000004450 Myriad Genetics, Inc. 62855J104 US62855J1043 06/05/2025 Election of three Class II Directors to serve until the 2028 Annual Meeting of Stockholders: Colleen F. Reitan DIRECTOR ELECTIONS ISSUER 284474.000000 0 FOR 284474.000000 FOR S000004450 Myriad Genetics, Inc. 62855J104 US62855J1043 06/05/2025 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 284474.000000 0 FOR 284474.000000 FOR S000004450 Myriad Genetics, Inc. 62855J104 US62855J1043 06/05/2025 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 284474.000000 0 FOR 284474.000000 FOR S000004450 Myriad Genetics, Inc. 62855J104 US62855J1043 06/05/2025 To approve the proposed amendment to the 2017 Employee, Director and Consultant Equity Incentive Plan, as Amended, to replenish the share pool for equity incentive grants. COMPENSATION ISSUER 284474.000000 0 FOR 284474.000000 FOR S000004450 Ocugen, Inc. 67577C105 US67577C1053 06/05/2025 The election of (i) Uday Kompella, Ph.D. and Blaise Coleman as Class II Directors to hold office until the 2028 Annual Meeting and (ii) Satish Chandran, Ph.D. as a Class III Director to hold office until the 2026 Annual Meeting: Uday Kompella, Ph.D. DIRECTOR ELECTIONS ISSUER 90468.000000 808700.000000 FOR 90468.000000 FOR S000004450 Ocugen, Inc. 67577C105 US67577C1053 06/05/2025 The election of (i) Uday Kompella, Ph.D. and Blaise Coleman as Class II Directors to hold office until the 2028 Annual Meeting and (ii) Satish Chandran, Ph.D. as a Class III Director to hold office until the 2026 Annual Meeting: Blaise Coleman DIRECTOR ELECTIONS ISSUER 90468.000000 808700.000000 FOR 90468.000000 FOR S000004450 Ocugen, Inc. 67577C105 US67577C1053 06/05/2025 The election of (i) Uday Kompella, Ph.D. and Blaise Coleman as Class II Directors to hold office until the 2028 Annual Meeting and (ii) Satish Chandran, Ph.D. as a Class III Director to hold office until the 2026 Annual Meeting: Satish Chandran, Ph.D. DIRECTOR ELECTIONS ISSUER 90468.000000 808700.000000 FOR 90468.000000 FOR S000004450 Ocugen, Inc. 67577C105 US67577C1053 06/05/2025 Ratification of Appointment of PricewaterhouseCoopers LLP as Ocugen, Inc.'s Independent Registered Public Accounting Firm for 2025. AUDIT-RELATED ISSUER 90468.000000 808700.000000 FOR 90468.000000 FOR S000004450 Ocugen, Inc. 67577C105 US67577C1053 06/05/2025 Approval, on an advisory basis, of the compensation of Ocugen, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 90468.000000 808700.000000 FOR 90468.000000 FOR S000004450 Pliant Therapeutics, Inc. 729139105 US7291391057 06/05/2025 To elect three class II directors named in the proxy statement to our Board of Directors: John Curnutte, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 152205.000000 0 FOR 152205.000000 FOR S000004450 Pliant Therapeutics, Inc. 729139105 US7291391057 06/05/2025 To elect three class II directors named in the proxy statement to our Board of Directors: Katharine Knobil, M.D. DIRECTOR ELECTIONS ISSUER 152205.000000 0 FOR 152205.000000 FOR S000004450 Pliant Therapeutics, Inc. 729139105 US7291391057 06/05/2025 To elect three class II directors named in the proxy statement to our Board of Directors: Thomas McCourt DIRECTOR ELECTIONS ISSUER 152205.000000 0 FOR 152205.000000 FOR S000004450 Pliant Therapeutics, Inc. 729139105 US7291391057 06/05/2025 To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 152205.000000 0 FOR 152205.000000 FOR S000004450 Pliant Therapeutics, Inc. 729139105 US7291391057 06/05/2025 To approve an amendment to our Amended and Restated Certificate of Incorporation to limit the liability of certain officers of Pliant Therapeutics, Inc. as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 152205.000000 0 FOR 152205.000000 FOR S000004450 Pliant Therapeutics, Inc. 729139105 US7291391057 06/05/2025 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 152205.000000 0 FOR 152205.000000 FOR S000004450 Sana Biotechnology, Inc. 799566104 US7995661045 06/05/2025 To elect three Class I directors to our Board of Directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Steven D. Harr, M.D. DIRECTOR ELECTIONS ISSUER 168310.000000 219800.000000 FOR 168310.000000 FOR S000004450 Sana Biotechnology, Inc. 799566104 US7995661045 06/05/2025 To elect three Class I directors to our Board of Directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Robert L. Rosiello DIRECTOR ELECTIONS ISSUER 168310.000000 219800.000000 FOR 168310.000000 FOR S000004450 Sana Biotechnology, Inc. 799566104 US7995661045 06/05/2025 To elect three Class I directors to our Board of Directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Michelle Seitz, CFA DIRECTOR ELECTIONS ISSUER 168310.000000 219800.000000 FOR 168310.000000 FOR S000004450 Sana Biotechnology, Inc. 799566104 US7995661045 06/05/2025 To elect three Class I directors to our Board of Directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Patrick Y. Yang, Ph.D. DIRECTOR ELECTIONS ISSUER 168310.000000 219800.000000 FOR 168310.000000 FOR S000004450 Sana Biotechnology, Inc. 799566104 US7995661045 06/05/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 168310.000000 219800.000000 FOR 168310.000000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/05/2025 TO ELECT, AS CLASS II DIRECTORS TO HOLD OFFICE UNTIL THE 2027 ANNUAL MEETING OF STOCKHOLDERS, OR UNTIL THEIR SUCCESSORS ARE EARLIER ELECTED, THE FOLLOWING DIRECTOR NOMINEES: RICHARD J. BARRY DIRECTOR ELECTIONS ISSUER 203481.000000 0 FOR 203481.000000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/05/2025 TO ELECT, AS CLASS II DIRECTORS TO HOLD OFFICE UNTIL THE 2027 ANNUAL MEETING OF STOCKHOLDERS, OR UNTIL THEIR SUCCESSORS ARE EARLIER ELECTED, THE FOLLOWING DIRECTOR NOMINEES: M. KATHLEEN BEHRENS, PH.D. DIRECTOR ELECTIONS ISSUER 203481.000000 0 FOR 203481.000000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/05/2025 TO ELECT, AS CLASS II DIRECTORS TO HOLD OFFICE UNTIL THE 2027 ANNUAL MEETING OF STOCKHOLDERS, OR UNTIL THEIR SUCCESSORS ARE EARLIER ELECTED, THE FOLLOWING DIRECTOR NOMINEES: STEPHEN L. MAYO, PH.D. DIRECTOR ELECTIONS ISSUER 203481.000000 0 FOR 203481.000000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/05/2025 TO ELECT, AS CLASS II DIRECTORS TO HOLD OFFICE UNTIL THE 2027 ANNUAL MEETING OF STOCKHOLDERS, OR UNTIL THEIR SUCCESSORS ARE EARLIER ELECTED, THE FOLLOWING DIRECTOR NOMINEES: CLAUDE NICAISE, M.D. DIRECTOR ELECTIONS ISSUER 203481.000000 0 FOR 203481.000000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/05/2025 ADVISORY VOTE TO APPROVE, ON A NON-BINDING BASIS, NAMED EXECUTIVE OFFICER COMPENSATION SECTION 14A SAY-ON-PAY VOTES ISSUER 203481.000000 0 FOR 203481.000000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/05/2025 APPROVE AN AMENDMENT TO THE COMPANY'S 2018 EQUITY INCENTIVE PLAN (THE "2018 PLAN") TO INCREASE THE MAXIMUM AGGREGATE NUMBER OF SHARES OF COMMON STOCK THAT MAY BE ISSUED PURSUANT TO AWARDS GRANTED UNDER THE 2018 PLAN BY 4,300,000 SHARES TO 17,487,596 SHARES COMPENSATION ISSUER 203481.000000 0 FOR 203481.000000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/05/2025 APPROVE AN AMENDMENT TO THE AMENDED AND RESTATED 2013 EMPLOYEE STOCK PURCHASE PLAN (AS AMENDED AND RESTATED ON JUNE 27, 2016, AND AMENDED ON JUNE 6, 2019 AND ON JUNE 8, 2023) (THE "2016 ESPP") TO INCREASE THE NUMBER OF SHARES OF THE COMPANY'S COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE 2016 ESPP BY 300,000 SHARES TO 1,700,000 SHARES COMPENSATION ISSUER 203481.000000 0 FOR 203481.000000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/05/2025 RATIFY THE SELECTION OF KPMG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT YEAR ENDING DECEMBER 31, 2025 AUDIT-RELATED ISSUER 203481.000000 0 FOR 203481.000000 FOR S000004450 Savara Inc. 805111101 US8051111016 06/05/2025 To elect six directors to hold office until the next Annual Meeting of Stockholders: Matthew Pauls DIRECTOR ELECTIONS ISSUER 288002.000000 0 FOR 288002.000000 FOR S000004450 Savara Inc. 805111101 US8051111016 06/05/2025 To elect six directors to hold office until the next Annual Meeting of Stockholders: Nevan Elam DIRECTOR ELECTIONS ISSUER 288002.000000 0 FOR 288002.000000 FOR S000004450 Savara Inc. 805111101 US8051111016 06/05/2025 To elect six directors to hold office until the next Annual Meeting of Stockholders: Richard J. Hawkins DIRECTOR ELECTIONS ISSUER 288002.000000 0 FOR 288002.000000 FOR S000004450 Savara Inc. 805111101 US8051111016 06/05/2025 To elect six directors to hold office until the next Annual Meeting of Stockholders: Joseph S. McCracken DIRECTOR ELECTIONS ISSUER 288002.000000 0 FOR 288002.000000 FOR S000004450 Savara Inc. 805111101 US8051111016 06/05/2025 To elect six directors to hold office until the next Annual Meeting of Stockholders: David A. Ramsay DIRECTOR ELECTIONS ISSUER 288002.000000 0 FOR 288002.000000 FOR S000004450 Savara Inc. 805111101 US8051111016 06/05/2025 To elect six directors to hold office until the next Annual Meeting of Stockholders: An van Es-Johansson DIRECTOR ELECTIONS ISSUER 288002.000000 0 FOR 288002.000000 FOR S000004450 Savara Inc. 805111101 US8051111016 06/05/2025 To ratify the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 288002.000000 0 FOR 288002.000000 FOR S000004450 Savara Inc. 805111101 US8051111016 06/05/2025 To approve, on an advisory basis, the compensation of our named executives. SECTION 14A SAY-ON-PAY VOTES ISSUER 288002.000000 0 FOR 288002.000000 FOR S000004450 Savara Inc. 805111101 US8051111016 06/05/2025 To indicate, on an advisory basis, the preferred frequency of holding an advisory vote on the compensation of our named executives. SECTION 14A SAY-ON-PAY VOTES ISSUER 288002.000000 0 ONE YEAR 288002.000000 FOR S000004450 SI-BONE, Inc. 825704109 US8257041090 06/05/2025 Election of Directors: Timothy E. Davis, Jr. DIRECTOR ELECTIONS ISSUER 118120.000000 0 FOR 118120.000000 FOR S000004450 SI-BONE, Inc. 825704109 US8257041090 06/05/2025 Election of Directors: Laura Francis DIRECTOR ELECTIONS ISSUER 118120.000000 0 FOR 118120.000000 FOR S000004450 SI-BONE, Inc. 825704109 US8257041090 06/05/2025 Election of Directors: Jeryl L. Hilleman DIRECTOR ELECTIONS ISSUER 118120.000000 0 FOR 118120.000000 FOR S000004450 SI-BONE, Inc. 825704109 US8257041090 06/05/2025 To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as SI-BONE, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 118120.000000 0 FOR 118120.000000 FOR S000004450 SI-BONE, Inc. 825704109 US8257041090 06/05/2025 Advisory vote to approve executive compensation "Say-on-Pay". SECTION 14A SAY-ON-PAY VOTES ISSUER 118120.000000 0 FOR 118120.000000 FOR S000004450 Soleno Therapeutics, Inc. 834203309 US8342033094 06/05/2025 To elect two Class II directors to each serve until the 2028 Annual Meeting of stockholders or until his successor is duly elected and qualified: Anish Bhatnagar, M.D. DIRECTOR ELECTIONS ISSUER 80864.000000 0 FOR 80864.000000 FOR S000004450 Soleno Therapeutics, Inc. 834203309 US8342033094 06/05/2025 To elect two Class II directors to each serve until the 2028 Annual Meeting of stockholders or until his successor is duly elected and qualified: William G. Harris DIRECTOR ELECTIONS ISSUER 80864.000000 0 FOR 80864.000000 FOR S000004450 Soleno Therapeutics, Inc. 834203309 US8342033094 06/05/2025 To ratify the appointment of CBIZ CPAs P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 80864.000000 0 FOR 80864.000000 FOR S000004450 Tango Therapeutics, Inc. 87583X109 US87583X1090 06/05/2025 Election of Class I Director: Lesley Ann Calhoun DIRECTOR ELECTIONS ISSUER 118123.000000 0 FOR 118123.000000 FOR S000004450 Tango Therapeutics, Inc. 87583X109 US87583X1090 06/05/2025 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 118123.000000 0 FOR 118123.000000 FOR S000004450 Tango Therapeutics, Inc. 87583X109 US87583X1090 06/05/2025 To approve an amendment to our Second Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 200,000,000 to 400,000,000. CAPITAL STRUCTURE ISSUER 118123.000000 0 FOR 118123.000000 FOR S000004450 Tango Therapeutics, Inc. 87583X109 US87583X1090 06/05/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 118123.000000 0 FOR 118123.000000 FOR S000004450 Tango Therapeutics, Inc. 87583X109 US87583X1090 06/05/2025 Non-binding, advisory vote on the frequency of future non-binding, advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 118123.000000 0 ONE YEAR 118123.000000 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 US9216591084 06/05/2025 To elect two Class I Directors: Stephen Ray Mitchell, M.D. DIRECTOR ELECTIONS ISSUER 183277.000000 0 FOR 183277.000000 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 US9216591084 06/05/2025 To elect two Class I Directors: Tage Honore, Ph.D., D.Sc. DIRECTOR ELECTIONS ISSUER 183277.000000 0 FOR 183277.000000 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 US9216591084 06/05/2025 To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2025. AUDIT-RELATED ISSUER 183277.000000 0 FOR 183277.000000 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 US9216591084 06/05/2025 To approve, on an advisory basis, the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 183277.000000 0 FOR 183277.000000 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 US9216591084 06/05/2025 To approve an amendment to the Company's amended and restated 2016 Equity Incentive Plan, as amended to (i) increase the aggregate number of shares authorized for issuance thereunder and (ii) eliminate its term. COMPENSATION ISSUER 183277.000000 0 FOR 183277.000000 FOR S000004450 Verve Therapeutics, Inc. 92539P101 US92539P1012 06/05/2025 Election of three Class I directors to our board of directors, each to serve until the 2028 annual meeting of stockholders: Lonnel Coats DIRECTOR ELECTIONS ISSUER 198488.000000 0 FOR 198488.000000 FOR S000004450 Verve Therapeutics, Inc. 92539P101 US92539P1012 06/05/2025 Election of three Class I directors to our board of directors, each to serve until the 2028 annual meeting of stockholders: Jodie Morrison DIRECTOR ELECTIONS ISSUER 198488.000000 0 FOR 198488.000000 FOR S000004450 Verve Therapeutics, Inc. 92539P101 US92539P1012 06/05/2025 Election of three Class I directors to our board of directors, each to serve until the 2028 annual meeting of stockholders: Krishna Yeshwant, M.D. DIRECTOR ELECTIONS ISSUER 198488.000000 0 FOR 198488.000000 FOR S000004450 Verve Therapeutics, Inc. 92539P101 US92539P1012 06/05/2025 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025 AUDIT-RELATED ISSUER 198488.000000 0 FOR 198488.000000 FOR S000004450 Verve Therapeutics, Inc. 92539P101 US92539P1012 06/05/2025 Approval, on an advisory basis, of the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 198488.000000 0 FOR 198488.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/06/2025 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Peter Farrell DIRECTOR ELECTIONS ISSUER 76432.000000 0 FOR 76432.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/06/2025 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Joseph E. Payne DIRECTOR ELECTIONS ISSUER 76432.000000 0 FOR 76432.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/06/2025 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Andy Sassine DIRECTOR ELECTIONS ISSUER 76432.000000 0 FOR 76432.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/06/2025 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: James Barlow DIRECTOR ELECTIONS ISSUER 76432.000000 0 FOR 76432.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/06/2025 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Edward W. Holmes DIRECTOR ELECTIONS ISSUER 76432.000000 0 FOR 76432.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/06/2025 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Magda Marquet DIRECTOR ELECTIONS ISSUER 76432.000000 0 FOR 76432.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/06/2025 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Jing L. Marantz DIRECTOR ELECTIONS ISSUER 76432.000000 0 FOR 76432.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/06/2025 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. John Markels DIRECTOR ELECTIONS ISSUER 76432.000000 0 FOR 76432.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/06/2025 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Moncef Slaoui DIRECTOR ELECTIONS ISSUER 76432.000000 0 FOR 76432.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/06/2025 Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 76432.000000 0 FOR 76432.000000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/06/2025 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 76432.000000 0 FOR 76432.000000 FOR S000004450 Axsome Therapeutics, Inc. 05464T104 US05464T1043 06/06/2025 Election of Director: Roger Jeffs, Ph.D. DIRECTOR ELECTIONS ISSUER 98005.000000 0 FOR 98005.000000 FOR S000004450 Axsome Therapeutics, Inc. 05464T104 US05464T1043 06/06/2025 To approve the Company's 2025 Long-Term Incentive Plan. COMPENSATION ISSUER 98005.000000 0 FOR 98005.000000 FOR S000004450 Axsome Therapeutics, Inc. 05464T104 US05464T1043 06/06/2025 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 98005.000000 0 FOR 98005.000000 FOR S000004450 Axsome Therapeutics, Inc. 05464T104 US05464T1043 06/06/2025 To approve, by non-binding advisory vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 98005.000000 0 FOR 98005.000000 FOR S000004450 Cryoport, Inc. 229050307 US2290503075 06/06/2025 To elect six directors: Linda Baddour DIRECTOR ELECTIONS ISSUER 154735.000000 0 FOR 154735.000000 FOR S000004450 Cryoport, Inc. 229050307 US2290503075 06/06/2025 To elect six directors: Daniel Hancock DIRECTOR ELECTIONS ISSUER 154735.000000 0 FOR 154735.000000 FOR S000004450 Cryoport, Inc. 229050307 US2290503075 06/06/2025 To elect six directors: Robert Hariri, MD, PhD DIRECTOR ELECTIONS ISSUER 154735.000000 0 FOR 154735.000000 FOR S000004450 Cryoport, Inc. 229050307 US2290503075 06/06/2025 To elect six directors: Ram M. Jagannath DIRECTOR ELECTIONS ISSUER 154735.000000 0 FOR 154735.000000 FOR S000004450 Cryoport, Inc. 229050307 US2290503075 06/06/2025 To elect six directors: Ramkumar Mandalam, PhD DIRECTOR ELECTIONS ISSUER 154735.000000 0 FOR 154735.000000 FOR S000004450 Cryoport, Inc. 229050307 US2290503075 06/06/2025 To elect six directors: Jerrell W. Shelton DIRECTOR ELECTIONS ISSUER 154735.000000 0 FOR 154735.000000 FOR S000004450 Cryoport, Inc. 229050307 US2290503075 06/06/2025 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company and its subsidiaries for the year ending December 31, 2025; AUDIT-RELATED ISSUER 154735.000000 0 FOR 154735.000000 FOR S000004450 Cryoport, Inc. 229050307 US2290503075 06/06/2025 To approve, on an advisory basis, the compensation of the named executive officers, as disclosed in the Proxy Statement; SECTION 14A SAY-ON-PAY VOTES ISSUER 154735.000000 0 FOR 154735.000000 FOR S000004450 Cryoport, Inc. 229050307 US2290503075 06/06/2025 To approve, on an advisory basis, the preferred frequency of future advisory votes on the compensation of named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 154735.000000 0 ONE YEAR 154735.000000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/06/2025 Election of Directors: Jason M. Aryeh DIRECTOR ELECTIONS ISSUER 58960.000000 0 FOR 58960.000000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/06/2025 Election of Directors: Todd C. Davis DIRECTOR ELECTIONS ISSUER 58960.000000 0 FOR 58960.000000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/06/2025 Election of Directors: Nancy R. Gray, Ph.D. DIRECTOR ELECTIONS ISSUER 58960.000000 0 FOR 58960.000000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/06/2025 Election of Directors: Jason Haas DIRECTOR ELECTIONS ISSUER 58960.000000 0 FOR 58960.000000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/06/2025 Election of Directors: John W. Kozarich, Ph.D. DIRECTOR ELECTIONS ISSUER 58960.000000 0 FOR 58960.000000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/06/2025 Election of Directors: John L. LaMattina, Ph.D. DIRECTOR ELECTIONS ISSUER 58960.000000 0 FOR 58960.000000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/06/2025 Election of Directors: Stephen L. Sabba, M.D. DIRECTOR ELECTIONS ISSUER 58960.000000 0 FOR 58960.000000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/06/2025 Election of Directors: Martine Zimmermann, Pharm.D. DIRECTOR ELECTIONS ISSUER 58960.000000 0 FOR 58960.000000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/06/2025 Ratification of Ernst & Young LLP as Ligand's independent registered accounting firm for the fiscal year ending December 31, 2025 AUDIT-RELATED ISSUER 58960.000000 0 FOR 58960.000000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/06/2025 Approval, on an advisory basis, of the compensation of the named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 58960.000000 0 FOR 58960.000000 FOR S000004450 Relay Therapeutics, Inc. 75943R102 US75943R1023 06/06/2025 To elect the two class II directors to our board of directors, to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Alexis Borisy DIRECTOR ELECTIONS ISSUER 368400.000000 0 FOR 368400.000000 FOR S000004450 Relay Therapeutics, Inc. 75943R102 US75943R1023 06/06/2025 To elect the two class II directors to our board of directors, to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Mark Murcko, Ph.D. DIRECTOR ELECTIONS ISSUER 368400.000000 0 FOR 368400.000000 FOR S000004450 Relay Therapeutics, Inc. 75943R102 US75943R1023 06/06/2025 To consider and act upon an advisory vote on the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 368400.000000 0 AGAINST 368400.000000 AGAINST S000004450 Relay Therapeutics, Inc. 75943R102 US75943R1023 06/06/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025; and AUDIT-RELATED ISSUER 368400.000000 0 FOR 368400.000000 FOR S000004450 Surgery Partners, Inc. 86881A100 US86881A1007 06/06/2025 Election of Class I Directors: John A. Deane DIRECTOR ELECTIONS ISSUER 217296.000000 0 FOR 217296.000000 FOR S000004450 Surgery Partners, Inc. 86881A100 US86881A1007 06/06/2025 Election of Class I Directors: Teresa DeLuca, M.D. DIRECTOR ELECTIONS ISSUER 217296.000000 0 FOR 217296.000000 FOR S000004450 Surgery Partners, Inc. 86881A100 US86881A1007 06/06/2025 Election of Class I Directors: Wayne S. DeVeydt DIRECTOR ELECTIONS ISSUER 217296.000000 0 FOR 217296.000000 FOR S000004450 Surgery Partners, Inc. 86881A100 US86881A1007 06/06/2025 Approval, on an advisory basis, of the compensation paid by the Company to its named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 217296.000000 0 FOR 217296.000000 FOR S000004450 Surgery Partners, Inc. 86881A100 US86881A1007 06/06/2025 Approval of the Surgery Partners, Inc. 2025 Omnibus Incentive Plan. COMPENSATION ISSUER 217296.000000 0 FOR 217296.000000 FOR S000004450 Surgery Partners, Inc. 86881A100 US86881A1007 06/06/2025 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 217296.000000 0 FOR 217296.000000 FOR S000004450 Applied Therapeutics, Inc. 03828A101 US03828A1016 06/09/2025 Election of Director: Teena Lerner DIRECTOR ELECTIONS ISSUER 233542.000000 0 FOR 233542.000000 FOR S000004450 Applied Therapeutics, Inc. 03828A101 US03828A1016 06/09/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year 2025. AUDIT-RELATED ISSUER 233542.000000 0 FOR 233542.000000 FOR S000004450 Applied Therapeutics, Inc. 03828A101 US03828A1016 06/09/2025 To approve (on a non-binding advisory basis) the compensation of our named executive officers as described in the accompanying materials. SECTION 14A SAY-ON-PAY VOTES ISSUER 233542.000000 0 FOR 233542.000000 FOR S000004450 Applied Therapeutics, Inc. 03828A101 US03828A1016 06/09/2025 To approve (on a non-binding advisory basis) the frequency of an advisory vote on the compensation of our named executive officers in future years. SECTION 14A SAY-ON-PAY VOTES ISSUER 233542.000000 0 ONE YEAR 233542.000000 FOR S000004450 Applied Therapeutics, Inc. 03828A101 US03828A1016 06/09/2025 To approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, to combine the outstanding shares of our common stock, par value $0.0001 per share, into a lesser number of outstanding shares, by a ratio of not less than one-for-5 and not more than one-for-40, with the exact ratio to be set within this range by our board of directors in its sole discretion (the "Reverse Stock Split Proposal"). CAPITAL STRUCTURE ISSUER 233542.000000 0 FOR 233542.000000 FOR S000004450 Applied Therapeutics, Inc. 03828A101 US03828A1016 06/09/2025 To authorize the adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are insufficient votes in favor of the Reverse Stock Split Proposal. CORPORATE GOVERNANCE ISSUER 233542.000000 0 FOR 233542.000000 FOR S000004450 Cabaletta Bio, Inc. 12674W109 US12674W1099 06/09/2025 To elect two class III directors to our board of directors, to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Steven Nichtberger, M.D. DIRECTOR ELECTIONS ISSUER 121805.000000 0 FOR 121805.000000 FOR S000004450 Cabaletta Bio, Inc. 12674W109 US12674W1099 06/09/2025 To elect two class III directors to our board of directors, to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Mark Simon, MBA DIRECTOR ELECTIONS ISSUER 121805.000000 0 FOR 121805.000000 FOR S000004450 Cabaletta Bio, Inc. 12674W109 US12674W1099 06/09/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 121805.000000 0 FOR 121805.000000 FOR S000004450 Cabaletta Bio, Inc. 12674W109 US12674W1099 06/09/2025 To approve an amendment to our Third Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Common Stock from 150,000,000 to 300,000,000. CAPITAL STRUCTURE ISSUER 121805.000000 0 FOR 121805.000000 FOR S000004450 Cabaletta Bio, Inc. 12674W109 US12674W1099 06/09/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 121805.000000 0 AGAINST 121805.000000 AGAINST S000004450 Cabaletta Bio, Inc. 12674W109 US12674W1099 06/09/2025 Non-binding, advisory vote on the frequency of future non-binding, advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 121805.000000 0 ONE YEAR 121805.000000 FOR S000004450 Cabaletta Bio, Inc. 12674W109 US12674W1099 06/09/2025 To approve a proposal to adjourn the Annual Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal 3. CORPORATE GOVERNANCE ISSUER 121805.000000 0 FOR 121805.000000 FOR S000004450 Adaptive Biotechnologies Corporation 00650F109 US00650F1093 06/10/2025 To elect one Class III director nominee to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2028 annual meeting of shareholders: Chad Robins DIRECTOR ELECTIONS ISSUER 322708.000000 0 FOR 322708.000000 FOR S000004450 Adaptive Biotechnologies Corporation 00650F109 US00650F1093 06/10/2025 To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement; SECTION 14A SAY-ON-PAY VOTES ISSUER 322708.000000 0 FOR 322708.000000 FOR S000004450 Adaptive Biotechnologies Corporation 00650F109 US00650F1093 06/10/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2025; and AUDIT-RELATED ISSUER 322708.000000 0 FOR 322708.000000 FOR S000004450 Aldeyra Therapeutics, Inc. 01438T106 US01438T1060 06/10/2025 Election of three Class II Directors: Richard H. Douglas, Ph.D. DIRECTOR ELECTIONS ISSUER 138424.000000 0 FOR 138424.000000 FOR S000004450 Aldeyra Therapeutics, Inc. 01438T106 US01438T1060 06/10/2025 Election of three Class II Directors: Gary M. Phillips, M.D. DIRECTOR ELECTIONS ISSUER 138424.000000 0 FOR 138424.000000 FOR S000004450 Aldeyra Therapeutics, Inc. 01438T106 US01438T1060 06/10/2025 Election of three Class II Directors: Neal S. Walker, D.O. DIRECTOR ELECTIONS ISSUER 138424.000000 0 FOR 138424.000000 FOR S000004450 Aldeyra Therapeutics, Inc. 01438T106 US01438T1060 06/10/2025 To ratify the appointment of BDO USA, P.C. as Aldeyra Therapeutics, Inc.'s independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 138424.000000 0 FOR 138424.000000 FOR S000004450 Aldeyra Therapeutics, Inc. 01438T106 US01438T1060 06/10/2025 To approve, on a non-binding, advisory basis, the compensation of Aldeyra Therapeutics, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 138424.000000 0 FOR 138424.000000 FOR S000004450 Anavex Life Sciences Corp. 032797300 US0327973006 06/10/2025 To elect six (6) members of our Board, each to hold office until the next annual meeting of stockholders or until such director's successor shall have been duly elected and qualified: Christopher Missling DIRECTOR ELECTIONS ISSUER 59532.000000 202600.000000 FOR 59532.000000 FOR S000004450 Anavex Life Sciences Corp. 032797300 US0327973006 06/10/2025 To elect six (6) members of our Board, each to hold office until the next annual meeting of stockholders or until such director's successor shall have been duly elected and qualified: Jiong Ma DIRECTOR ELECTIONS ISSUER 59532.000000 202600.000000 FOR 59532.000000 FOR S000004450 Anavex Life Sciences Corp. 032797300 US0327973006 06/10/2025 To elect six (6) members of our Board, each to hold office until the next annual meeting of stockholders or until such director's successor shall have been duly elected and qualified: Claus van der Velden DIRECTOR ELECTIONS ISSUER 59532.000000 202600.000000 FOR 59532.000000 FOR S000004450 Anavex Life Sciences Corp. 032797300 US0327973006 06/10/2025 To elect six (6) members of our Board, each to hold office until the next annual meeting of stockholders or until such director's successor shall have been duly elected and qualified: Athanasios Skarpelos DIRECTOR ELECTIONS ISSUER 59532.000000 202600.000000 FOR 59532.000000 FOR S000004450 Anavex Life Sciences Corp. 032797300 US0327973006 06/10/2025 To elect six (6) members of our Board, each to hold office until the next annual meeting of stockholders or until such director's successor shall have been duly elected and qualified: Steffen Thomas DIRECTOR ELECTIONS ISSUER 59532.000000 202600.000000 FOR 59532.000000 FOR S000004450 Anavex Life Sciences Corp. 032797300 US0327973006 06/10/2025 To elect six (6) members of our Board, each to hold office until the next annual meeting of stockholders or until such director's successor shall have been duly elected and qualified: Peter Donhauser, D.O. DIRECTOR ELECTIONS ISSUER 59532.000000 202600.000000 FOR 59532.000000 FOR S000004450 Anavex Life Sciences Corp. 032797300 US0327973006 06/10/2025 To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm. AUDIT-RELATED ISSUER 59532.000000 202600.000000 FOR 59532.000000 FOR S000004450 Anavex Life Sciences Corp. 032797300 US0327973006 06/10/2025 To approve an amendment to the Company's 2022 Omnibus Incentive Plan. COMPENSATION ISSUER 59532.000000 202600.000000 FOR 59532.000000 FOR S000004450 Arcus Biosciences, Inc. 03969F109 US03969F1093 06/10/2025 Election of Directors: Yasunori Kaneko, M.D. DIRECTOR ELECTIONS ISSUER 213514.000000 0 FOR 213514.000000 FOR S000004450 Arcus Biosciences, Inc. 03969F109 US03969F1093 06/10/2025 Election of Directors: Patrick Machado, J.D. DIRECTOR ELECTIONS ISSUER 213514.000000 0 FOR 213514.000000 FOR S000004450 Arcus Biosciences, Inc. 03969F109 US03969F1093 06/10/2025 Election of Directors: Andrew Perlman, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 213514.000000 0 FOR 213514.000000 FOR S000004450 Arcus Biosciences, Inc. 03969F109 US03969F1093 06/10/2025 Election of Directors: Antoni Ribas, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 213514.000000 0 FOR 213514.000000 FOR S000004450 Arcus Biosciences, Inc. 03969F109 US03969F1093 06/10/2025 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 213514.000000 0 FOR 213514.000000 FOR S000004450 Arcus Biosciences, Inc. 03969F109 US03969F1093 06/10/2025 To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 213514.000000 0 FOR 213514.000000 FOR S000004450 Avidity Biosciences, Inc. 05370A108 US05370A1088 06/10/2025 To elect Class II directors for a three-year term that expires at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Arthur Levin, Ph.D. DIRECTOR ELECTIONS ISSUER 259353.000000 0 FOR 259353.000000 FOR S000004450 Avidity Biosciences, Inc. 05370A108 US05370A1088 06/10/2025 To elect Class II directors for a three-year term that expires at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Simona Skerjanec DIRECTOR ELECTIONS ISSUER 259353.000000 0 FOR 259353.000000 FOR S000004450 Avidity Biosciences, Inc. 05370A108 US05370A1088 06/10/2025 To elect Class II directors for a three-year term that expires at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Tamar Thompson DIRECTOR ELECTIONS ISSUER 259353.000000 0 FOR 259353.000000 FOR S000004450 Avidity Biosciences, Inc. 05370A108 US05370A1088 06/10/2025 To ratify the appointment of Deloitte & Touche LLP as our independent public accounting firm for the fiscal year ending December 31, 2025; AUDIT-RELATED ISSUER 259353.000000 0 FOR 259353.000000 FOR S000004450 Avidity Biosciences, Inc. 05370A108 US05370A1088 06/10/2025 To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; and SECTION 14A SAY-ON-PAY VOTES ISSUER 259353.000000 0 FOR 259353.000000 FOR S000004450 Clover Health Investments, Corp. 18914F103 US18914F1030 06/10/2025 ELECTION OF DIRECTORS: Anna U. Loengard, M.D. DIRECTOR ELECTIONS ISSUER 1222524.000000 0 FOR 1222524.000000 FOR S000004450 Clover Health Investments, Corp. 18914F103 US18914F1030 06/10/2025 ELECTION OF DIRECTORS: William G. Robinson, Jr. DIRECTOR ELECTIONS ISSUER 1222524.000000 0 FOR 1222524.000000 FOR S000004450 Clover Health Investments, Corp. 18914F103 US18914F1030 06/10/2025 Non-binding advisory proposal to approve the compensation paid to our named executive officers for 2024. SECTION 14A SAY-ON-PAY VOTES ISSUER 1222524.000000 0 FOR 1222524.000000 FOR S000004450 Clover Health Investments, Corp. 18914F103 US18914F1030 06/10/2025 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm. AUDIT-RELATED ISSUER 1222524.000000 0 FOR 1222524.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 06/10/2025 Election of Directors: Gregg Alton DIRECTOR ELECTIONS ISSUER 293832.000000 0 FOR 293832.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 06/10/2025 Election of Directors: G. Leonard Baker, Jr. DIRECTOR ELECTIONS ISSUER 293832.000000 0 FOR 293832.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 06/10/2025 Election of Directors: Joseph K. Belanoff, M.D. DIRECTOR ELECTIONS ISSUER 293832.000000 0 FOR 293832.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 06/10/2025 Election of Directors: Gillian M. Cannon, Ph.D. DIRECTOR ELECTIONS ISSUER 293832.000000 0 FOR 293832.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 06/10/2025 Election of Directors: David L. Mahoney DIRECTOR ELECTIONS ISSUER 293832.000000 0 FOR 293832.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 06/10/2025 Election of Directors: Joshua M. Murray DIRECTOR ELECTIONS ISSUER 293832.000000 0 FOR 293832.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 06/10/2025 Election of Directors: Kimberly Park DIRECTOR ELECTIONS ISSUER 293832.000000 0 FOR 293832.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 06/10/2025 Election of Directors: Daniel N. Swisher, Jr. DIRECTOR ELECTIONS ISSUER 293832.000000 0 FOR 293832.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 06/10/2025 Election of Directors: James N. Wilson DIRECTOR ELECTIONS ISSUER 293832.000000 0 FOR 293832.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 06/10/2025 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 293832.000000 0 FOR 293832.000000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 06/10/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 293832.000000 0 FOR 293832.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 06/10/2025 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2026 annual meeting: Paul Keel DIRECTOR ELECTIONS ISSUER 534679.000000 0 FOR 534679.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 06/10/2025 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2026 annual meeting: Wendy Carruthers DIRECTOR ELECTIONS ISSUER 534679.000000 0 FOR 534679.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 06/10/2025 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2026 annual meeting: Kieran Gallahue DIRECTOR ELECTIONS ISSUER 534679.000000 0 FOR 534679.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 06/10/2025 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2026 annual meeting: Scott Huennekens DIRECTOR ELECTIONS ISSUER 534679.000000 0 FOR 534679.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 06/10/2025 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2026 annual meeting: Barbara Hulit DIRECTOR ELECTIONS ISSUER 534679.000000 0 FOR 534679.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 06/10/2025 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2026 annual meeting: Vivek Jain DIRECTOR ELECTIONS ISSUER 534679.000000 0 FOR 534679.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 06/10/2025 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2026 annual meeting: Daniel Raskas DIRECTOR ELECTIONS ISSUER 534679.000000 0 FOR 534679.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 06/10/2025 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2026 annual meeting: Christine Tsingos DIRECTOR ELECTIONS ISSUER 534679.000000 0 FOR 534679.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 06/10/2025 To ratify the selection of Ernst and Young LLP as Envista's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 534679.000000 0 FOR 534679.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 06/10/2025 To approve on an advisory basis Envista's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 534679.000000 0 FOR 534679.000000 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 06/10/2025 To approve an amendment to Envista's 2019 Omnibus Incentive Plan, as amended. COMPENSATION ISSUER 534679.000000 0 FOR 534679.000000 FOR S000004450 Fortrea Holdings Inc. 34965K107 US34965K1079 06/10/2025 Election of Directors: Dr. Amrit Ray DIRECTOR ELECTIONS ISSUER 266644.000000 0 FOR 266644.000000 FOR S000004450 Fortrea Holdings Inc. 34965K107 US34965K1079 06/10/2025 Election of Directors: Erin L. Russell DIRECTOR ELECTIONS ISSUER 266644.000000 0 FOR 266644.000000 FOR S000004450 Fortrea Holdings Inc. 34965K107 US34965K1079 06/10/2025 Election of Directors: Machelle Sanders DIRECTOR ELECTIONS ISSUER 266644.000000 0 FOR 266644.000000 FOR S000004450 Fortrea Holdings Inc. 34965K107 US34965K1079 06/10/2025 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ended December 31, 2025. AUDIT-RELATED ISSUER 266644.000000 0 FOR 266644.000000 FOR S000004450 Fortrea Holdings Inc. 34965K107 US34965K1079 06/10/2025 Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 266644.000000 0 FOR 266644.000000 FOR S000004450 Fortrea Holdings Inc. 34965K107 US34965K1079 06/10/2025 Approval of the Fortrea Holdings Inc. 2023 Omnibus Incentive Plan, as amended and restated. COMPENSATION ISSUER 266644.000000 0 FOR 266644.000000 FOR S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/10/2025 Election of four Class I directors to serve until the 2028 annual meeting of stockholders: Brady W. Dougan DIRECTOR ELECTIONS ISSUER 153206.000000 230000.000000 FOR 153206.000000 FOR S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/10/2025 Election of four Class I directors to serve until the 2028 annual meeting of stockholders: C. Bruce Green DIRECTOR ELECTIONS ISSUER 153206.000000 230000.000000 FOR 153206.000000 FOR S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/10/2025 Election of four Class I directors to serve until the 2028 annual meeting of stockholders: Diane Seimetz DIRECTOR ELECTIONS ISSUER 153206.000000 230000.000000 FOR 153206.000000 FOR S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/10/2025 Election of four Class I directors to serve until the 2028 annual meeting of stockholders: Max Wallace DIRECTOR ELECTIONS ISSUER 153206.000000 230000.000000 FOR 153206.000000 FOR S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/10/2025 Ratification of the selection of PricewaterhouseCoopers LLP by the Board of Directors as Humacyte, Inc.'s Independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 153206.000000 230000.000000 FOR 153206.000000 FOR S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/10/2025 Approval of an amendment to Humacyte, Inc.'s Second Amended and Restated Certificate of Incorporation to increase the total number of authorized shares of common stock from 250,000,000 shares to 350,000,000 shares. CAPITAL STRUCTURE ISSUER 153206.000000 230000.000000 FOR 153206.000000 FOR S000004450 Immunome, Inc. 45257U108 US45257U1088 06/10/2025 To elect the two nominees named in this Proxy Statement to serve as Class II directors, to hold office until the 2028 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal: Isaac Barchas DIRECTOR ELECTIONS ISSUER 204352.000000 0 FOR 204352.000000 FOR S000004450 Immunome, Inc. 45257U108 US45257U1088 06/10/2025 To elect the two nominees named in this Proxy Statement to serve as Class II directors, to hold office until the 2028 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal: Jean-Jacques Bienaime DIRECTOR ELECTIONS ISSUER 204352.000000 0 FOR 204352.000000 FOR S000004450 Immunome, Inc. 45257U108 US45257U1088 06/10/2025 To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as Immunome, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 204352.000000 0 FOR 204352.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/10/2025 Election of Directors: Julian C. Baker DIRECTOR ELECTIONS ISSUER 510283.000000 0 FOR 510283.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/10/2025 Election of Directors: Jean-Jacques Bienaime DIRECTOR ELECTIONS ISSUER 510283.000000 0 FOR 510283.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/10/2025 Election of Directors: Otis W. Brawley DIRECTOR ELECTIONS ISSUER 510283.000000 0 FOR 510283.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/10/2025 Election of Directors: Paul J. Clancy DIRECTOR ELECTIONS ISSUER 510283.000000 0 FOR 510283.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/10/2025 Election of Directors: Jacqualyn A. Fouse DIRECTOR ELECTIONS ISSUER 510283.000000 0 FOR 510283.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/10/2025 Election of Directors: Edmund P. Harrigan DIRECTOR ELECTIONS ISSUER 510283.000000 0 FOR 510283.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/10/2025 Election of Directors: Katherine A. High DIRECTOR ELECTIONS ISSUER 510283.000000 0 FOR 510283.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/10/2025 Election of Directors: Herve Hoppenot DIRECTOR ELECTIONS ISSUER 510283.000000 0 FOR 510283.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/10/2025 Election of Directors: Susanne Schaffert DIRECTOR ELECTIONS ISSUER 510283.000000 0 FOR 510283.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/10/2025 Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 510283.000000 0 FOR 510283.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/10/2025 Approve amendments of the Company's Amended and Restated 2010 Stock Incentive Plan. COMPENSATION ISSUER 510283.000000 0 FOR 510283.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/10/2025 Approve an amendment of the Company's 1997 Employee Stock Purchase Plan. COMPENSATION ISSUER 510283.000000 0 FOR 510283.000000 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/10/2025 Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 510283.000000 0 FOR 510283.000000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2025 To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: lain Dukes, D. Phil. DIRECTOR ELECTIONS ISSUER 664477.000000 0 FOR 664477.000000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2025 To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Athena Countouriotis, M.D. DIRECTOR ELECTIONS ISSUER 664477.000000 0 AGAINST 664477.000000 AGAINST S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2025 To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Ryan Maynard DIRECTOR ELECTIONS ISSUER 664477.000000 0 FOR 664477.000000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2025 To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Wayne P. Rothbaum DIRECTOR ELECTIONS ISSUER 664477.000000 0 FOR 664477.000000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2025 To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Frederick G. Vogt, Ph.D., J.D. DIRECTOR ELECTIONS ISSUER 664477.000000 0 FOR 664477.000000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2025 To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Michael Weiser, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 664477.000000 0 FOR 664477.000000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2025 To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Wendy Yarno DIRECTOR ELECTIONS ISSUER 664477.000000 0 FOR 664477.000000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2025 To approve, by non-binding advisory vote, the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 664477.000000 0 FOR 664477.000000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025; AUDIT-RELATED ISSUER 664477.000000 0 FOR 664477.000000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2025 To approve an amendment to our 2018 Equity Incentive Plan to increase the number of shares of the Company's common stock authorized for issuance thereunder by 12,500,000 shares; and COMPENSATION ISSUER 664477.000000 0 FOR 664477.000000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2025 To approve an amendment to our 2020 Employee Stock Purchase Plan to increase the number of shares of the Company's common stock authorized for issuance thereunder by 1,000,000 shares. COMPENSATION ISSUER 664477.000000 0 FOR 664477.000000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/10/2025 Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2026 annual meeting of stockholders and their successors are duly elected and qualified: Mark Currie, Ph.D. DIRECTOR ELECTIONS ISSUER 450164.000000 0 FOR 450164.000000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/10/2025 Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2026 annual meeting of stockholders and their successors are duly elected and qualified: Alexander Denner, Ph.D. DIRECTOR ELECTIONS ISSUER 450164.000000 0 FOR 450164.000000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/10/2025 Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2026 annual meeting of stockholders and their successors are duly elected and qualified: Andrew Dreyfus DIRECTOR ELECTIONS ISSUER 450164.000000 0 FOR 450164.000000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/10/2025 Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2026 annual meeting of stockholders and their successors are duly elected and qualified: Jon Duane DIRECTOR ELECTIONS ISSUER 450164.000000 0 FOR 450164.000000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/10/2025 Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2026 annual meeting of stockholders and their successors are duly elected and qualified: Marla Kessler DIRECTOR ELECTIONS ISSUER 450164.000000 0 FOR 450164.000000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/10/2025 Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2026 annual meeting of stockholders and their successors are duly elected and qualified: Thomas McCourt DIRECTOR ELECTIONS ISSUER 450164.000000 0 FOR 450164.000000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/10/2025 Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2026 annual meeting of stockholders and their successors are duly elected and qualified: Julie McHugh DIRECTOR ELECTIONS ISSUER 450164.000000 0 FOR 450164.000000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/10/2025 Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2026 annual meeting of stockholders and their successors are duly elected and qualified: Catherine Moukheibir DIRECTOR ELECTIONS ISSUER 450164.000000 0 FOR 450164.000000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/10/2025 Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2026 annual meeting of stockholders and their successors are duly elected and qualified: Jay Shepard DIRECTOR ELECTIONS ISSUER 450164.000000 0 FOR 450164.000000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/10/2025 Approval, by non-binding advisory vote, of the compensation paid to the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 450164.000000 0 FOR 450164.000000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/10/2025 Ratification of the selection of Ernst & Young LLP as Ironwood Pharmaceuticals, Inc.'s independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 450164.000000 0 FOR 450164.000000 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 US68062P1066 06/10/2025 Election of the three nominees for Class II director named in the accompanying proxy statement to hold office until the Company's 2028 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Cynthia Butitta DIRECTOR ELECTIONS ISSUER 105642.000000 0 FOR 105642.000000 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 US68062P1066 06/10/2025 Election of the three nominees for Class II director named in the accompanying proxy statement to hold office until the Company's 2028 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Cyrus Harmon, Ph.D. DIRECTOR ELECTIONS ISSUER 105642.000000 0 FOR 105642.000000 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 US68062P1066 06/10/2025 Election of the three nominees for Class II director named in the accompanying proxy statement to hold office until the Company's 2028 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Graham Walmsley, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 105642.000000 0 FOR 105642.000000 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 US68062P1066 06/10/2025 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 105642.000000 0 FOR 105642.000000 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 US68062P1066 06/10/2025 Ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 105642.000000 0 FOR 105642.000000 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/10/2025 Election of Directors: Kevin Ali DIRECTOR ELECTIONS ISSUER 801056.000000 0 FOR 801056.000000 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/10/2025 Election of Directors: Carrie S. Cox DIRECTOR ELECTIONS ISSUER 801056.000000 0 FOR 801056.000000 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/10/2025 Election of Directors: Robert Essner DIRECTOR ELECTIONS ISSUER 801056.000000 0 FOR 801056.000000 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/10/2025 Election of Directors: Alan Ezekowitz, M.D., Ph. D. DIRECTOR ELECTIONS ISSUER 801056.000000 0 FOR 801056.000000 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/10/2025 Election of Directors: Helene Gayle, M.D. DIRECTOR ELECTIONS ISSUER 801056.000000 0 FOR 801056.000000 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/10/2025 Election of Directors: Rochelle B. Lazarus DIRECTOR ELECTIONS ISSUER 801056.000000 0 FOR 801056.000000 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/10/2025 Election of Directors: Deborah Leone DIRECTOR ELECTIONS ISSUER 801056.000000 0 FOR 801056.000000 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/10/2025 Election of Directors: Philip Ozuah, M.D., Ph. D. DIRECTOR ELECTIONS ISSUER 801056.000000 0 FOR 801056.000000 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/10/2025 Election of Directors: Cynthia M. Patton DIRECTOR ELECTIONS ISSUER 801056.000000 0 FOR 801056.000000 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/10/2025 Election of Directors: Grace Puma DIRECTOR ELECTIONS ISSUER 801056.000000 0 FOR 801056.000000 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/10/2025 Election of Directors: Shalini Sharp DIRECTOR ELECTIONS ISSUER 801056.000000 0 FOR 801056.000000 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/10/2025 Approve, on a non-binding advisory basis, the compensation of Organon's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 801056.000000 0 FOR 801056.000000 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/10/2025 Approval of an amendment and restatement of the Organon & Co. 2021 Incentive Stock Plan. COMPENSATION ISSUER 801056.000000 0 FOR 801056.000000 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/10/2025 Ratify the appointment of PricewaterhouseCoopers LLP as Organon's independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 801056.000000 0 FOR 801056.000000 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/10/2025 Shareholder proposal requesting adoption of a director election resignation guideline. CORPORATE GOVERNANCE SECURITY HOLDER 801056.000000 0 AGAINST 801056.000000 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/10/2025 Election of three Class II directors to our board of directors to serve until the 2028 annual meeting of stockholders and until their successors are duly elected and qualified: Marcelo Bigal DIRECTOR ELECTIONS ISSUER 143968.000000 0 FOR 143968.000000 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/10/2025 Election of three Class II directors to our board of directors to serve until the 2028 annual meeting of stockholders and until their successors are duly elected and qualified: Frank D. Lee DIRECTOR ELECTIONS ISSUER 143968.000000 0 FOR 143968.000000 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/10/2025 Election of three Class II directors to our board of directors to serve until the 2028 annual meeting of stockholders and until their successors are duly elected and qualified: Alethia Young DIRECTOR ELECTIONS ISSUER 143968.000000 0 FOR 143968.000000 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/10/2025 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 143968.000000 0 FOR 143968.000000 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/10/2025 Approval, on an advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 143968.000000 0 FOR 143968.000000 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/10/2025 Advisory vote to approve the frequency of future advisory votes to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 143968.000000 0 ONE YEAR 143968.000000 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/10/2025 Approval of our Amended and Restated 2011 Stock Incentive Plan. COMPENSATION ISSUER 143968.000000 0 FOR 143968.000000 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 US74276L1052 06/10/2025 Election of Class I directors to serve until 2028 annual meeting of shareholders and until their successors are duly elected and qualified: Elisabeth Little DIRECTOR ELECTIONS ISSUER 159660.000000 0 FOR 159660.000000 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 US74276L1052 06/10/2025 Election of Class I directors to serve until 2028 annual meeting of shareholders and until their successors are duly elected and qualified: Thomas M. Prescott DIRECTOR ELECTIONS ISSUER 159660.000000 0 FOR 159660.000000 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 US74276L1052 06/10/2025 Election of Class I directors to serve until 2028 annual meeting of shareholders and until their successors are duly elected and qualified: Larry Wood DIRECTOR ELECTIONS ISSUER 159660.000000 0 FOR 159660.000000 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 US74276L1052 06/10/2025 Ratification of the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for PROCEPT for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 159660.000000 0 FOR 159660.000000 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 US74276L1052 06/10/2025 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 159660.000000 0 FOR 159660.000000 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/10/2025 Election of Directors until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified: Howard G. Berger, M.D. DIRECTOR ELECTIONS ISSUER 195601.000000 0 FOR 195601.000000 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/10/2025 Election of Directors until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified: A. Gregory Sorensen, M.D. DIRECTOR ELECTIONS ISSUER 195601.000000 0 FOR 195601.000000 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/10/2025 Election of Directors until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified: Laura P. Jacobs DIRECTOR ELECTIONS ISSUER 195601.000000 0 FOR 195601.000000 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/10/2025 Election of Directors until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified: Lawrence L. Levitt DIRECTOR ELECTIONS ISSUER 195601.000000 0 FOR 195601.000000 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/10/2025 Election of Directors until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified: Gregory E. Spurlock DIRECTOR ELECTIONS ISSUER 195601.000000 0 FOR 195601.000000 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/10/2025 Election of Directors until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified: David L. Swartz DIRECTOR ELECTIONS ISSUER 195601.000000 0 FOR 195601.000000 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/10/2025 The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 195601.000000 0 FOR 195601.000000 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/10/2025 An advisory vote to approve the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 195601.000000 0 FOR 195601.000000 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/10/2025 Election of Directors: Jaymie A. Durnan DIRECTOR ELECTIONS ISSUER 134573.000000 0 FOR 134573.000000 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/10/2025 Election of Directors: Harold E. Ford, Jr. DIRECTOR ELECTIONS ISSUER 134573.000000 0 FOR 134573.000000 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/10/2025 Election of Directors: General John M. Keane (Ret.) DIRECTOR ELECTIONS ISSUER 134573.000000 0 FOR 134573.000000 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/10/2025 Election of Directors: Joseph W. Marshall, III DIRECTOR ELECTIONS ISSUER 134573.000000 0 FOR 134573.000000 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/10/2025 Election of Directors: Gary J. Nabel DIRECTOR ELECTIONS ISSUER 134573.000000 0 FOR 134573.000000 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/10/2025 Election of Directors: Julian Nemirovsky DIRECTOR ELECTIONS ISSUER 134573.000000 0 FOR 134573.000000 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/10/2025 Election of Directors: Diem Nguyen DIRECTOR ELECTIONS ISSUER 134573.000000 0 FOR 134573.000000 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/10/2025 Election of Directors: Holly L. Phillips DIRECTOR ELECTIONS ISSUER 134573.000000 0 FOR 134573.000000 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/10/2025 To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of SIGA Technologies, Inc. for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 134573.000000 0 FOR 134573.000000 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/10/2025 To approve an Amendment to the Company's Amended and Restated Certificate of Incorporation to limit the liability of certain officers of the Company. CORPORATE GOVERNANCE ISSUER 134573.000000 0 FOR 134573.000000 FOR S000004450 Tilray Brands, Inc. 88688T100 US88688T1007 06/10/2025 Approval of an amendment to the Company's Fifth Amended and Restated Certificate of Incorporation to effect a reverse split of the Company's common stock by a ratio of not less than one-for-ten and not more than one-for-twenty. CAPITAL STRUCTURE ISSUER 2930932.000000 0 FOR 2930932.000000 FOR S000004450 Tilray Brands, Inc. 88688T100 US88688T1007 06/10/2025 Approval of the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies. CORPORATE GOVERNANCE ISSUER 2930932.000000 0 FOR 2930932.000000 FOR S000004450 Alector, Inc. 014442107 US0144421072 06/11/2025 ELECTION OF DIRECTORS: Arnon Rosenthal, Ph.D. DIRECTOR ELECTIONS ISSUER 209594.000000 0 FOR 209594.000000 FOR S000004450 Alector, Inc. 014442107 US0144421072 06/11/2025 ELECTION OF DIRECTORS: Paula Hammond, Ph.D. DIRECTOR ELECTIONS ISSUER 209594.000000 0 FOR 209594.000000 FOR S000004450 Alector, Inc. 014442107 US0144421072 06/11/2025 Ratification of the appointment of Ernst & Young, LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 209594.000000 0 FOR 209594.000000 FOR S000004450 Alector, Inc. 014442107 US0144421072 06/11/2025 Advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 209594.000000 0 FOR 209594.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/11/2025 To elect nine persons to our Board of Directors: Mortimer Berkowitz III DIRECTOR ELECTIONS ISSUER 329848.000000 0 FOR 329848.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/11/2025 To elect nine persons to our Board of Directors: Quentin Blackford DIRECTOR ELECTIONS ISSUER 329848.000000 0 FOR 329848.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/11/2025 To elect nine persons to our Board of Directors: David Demski DIRECTOR ELECTIONS ISSUER 329848.000000 0 FOR 329848.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/11/2025 To elect nine persons to our Board of Directors: Karen K. McGinnis DIRECTOR ELECTIONS ISSUER 329848.000000 0 FOR 329848.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/11/2025 To elect nine persons to our Board of Directors: Patrick S. Miles DIRECTOR ELECTIONS ISSUER 329848.000000 0 FOR 329848.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/11/2025 To elect nine persons to our Board of Directors: David R. Pelizzon DIRECTOR ELECTIONS ISSUER 329848.000000 0 FOR 329848.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/11/2025 To elect nine persons to our Board of Directors: Jeffery P. Rydin DIRECTOR ELECTIONS ISSUER 329848.000000 0 FOR 329848.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/11/2025 To elect nine persons to our Board of Directors: Keith Valentine DIRECTOR ELECTIONS ISSUER 329848.000000 0 FOR 329848.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/11/2025 To elect nine persons to our Board of Directors: Ward W. Woods DIRECTOR ELECTIONS ISSUER 329848.000000 0 FOR 329848.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/11/2025 To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 329848.000000 0 FOR 329848.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/11/2025 Approval of an amendment to our 2016 Equity Incentive Plan. COMPENSATION ISSUER 329848.000000 0 FOR 329848.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/11/2025 Approval of an amendment to our Certificate of Incorporation. CAPITAL STRUCTURE ISSUER 329848.000000 0 FOR 329848.000000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/11/2025 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 329848.000000 0 FOR 329848.000000 FOR S000004450 ALX Oncology Holdings Inc. 00166B105 US00166B1052 06/11/2025 Election of Directors: Scott Garland DIRECTOR ELECTIONS ISSUER 78911.000000 0 FOR 78911.000000 FOR S000004450 ALX Oncology Holdings Inc. 00166B105 US00166B1052 06/11/2025 Election of Directors: Barbara Klencke, M.D. DIRECTOR ELECTIONS ISSUER 78911.000000 0 FOR 78911.000000 FOR S000004450 ALX Oncology Holdings Inc. 00166B105 US00166B1052 06/11/2025 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 78911.000000 0 FOR 78911.000000 FOR S000004450 ALX Oncology Holdings Inc. 00166B105 US00166B1052 06/11/2025 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 78911.000000 0 FOR 78911.000000 FOR S000004450 American Well Corporation 03044L204 US03044L2043 06/11/2025 To elect three Class II directors to serve until the 2028 annual meeting of stockholders: Mr. Stephen Schlegel DIRECTOR ELECTIONS ISSUER 38863.000000 0 FOR 38863.000000 FOR S000004450 American Well Corporation 03044L204 US03044L2043 06/11/2025 To elect three Class II directors to serve until the 2028 annual meeting of stockholders: Dr. Delos (Toby) Cosgrove DIRECTOR ELECTIONS ISSUER 38863.000000 0 FOR 38863.000000 FOR S000004450 American Well Corporation 03044L204 US03044L2043 06/11/2025 To elect three Class II directors to serve until the 2028 annual meeting of stockholders: Ms. Rivka Goldwasser DIRECTOR ELECTIONS ISSUER 38863.000000 0 FOR 38863.000000 FOR S000004450 American Well Corporation 03044L204 US03044L2043 06/11/2025 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025 AUDIT-RELATED ISSUER 38863.000000 0 FOR 38863.000000 FOR S000004450 American Well Corporation 03044L204 US03044L2043 06/11/2025 To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the compensation discussion and analysis and the related compensation tables and narrative disclosure in the Company's proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 38863.000000 0 FOR 38863.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/11/2025 To elect nine directors to the Board of Directors, each to hold office until the 2026 annual meeting of stockholders of the Company: Kenneth Sim, M.D. DIRECTOR ELECTIONS ISSUER 140503.000000 0 FOR 140503.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/11/2025 To elect nine directors to the Board of Directors, each to hold office until the 2026 annual meeting of stockholders of the Company: Thomas S. Lam, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 140503.000000 0 FOR 140503.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/11/2025 To elect nine directors to the Board of Directors, each to hold office until the 2026 annual meeting of stockholders of the Company: Mitchell W. Kitayama DIRECTOR ELECTIONS ISSUER 140503.000000 0 FOR 140503.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/11/2025 To elect nine directors to the Board of Directors, each to hold office until the 2026 annual meeting of stockholders of the Company: David G. Schmidt DIRECTOR ELECTIONS ISSUER 140503.000000 0 FOR 140503.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/11/2025 To elect nine directors to the Board of Directors, each to hold office until the 2026 annual meeting of stockholders of the Company: Linda Marsh DIRECTOR ELECTIONS ISSUER 140503.000000 0 FOR 140503.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/11/2025 To elect nine directors to the Board of Directors, each to hold office until the 2026 annual meeting of stockholders of the Company: John Chiang DIRECTOR ELECTIONS ISSUER 140503.000000 0 FOR 140503.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/11/2025 To elect nine directors to the Board of Directors, each to hold office until the 2026 annual meeting of stockholders of the Company: Matthew Mazdyasni DIRECTOR ELECTIONS ISSUER 140503.000000 0 FOR 140503.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/11/2025 To elect nine directors to the Board of Directors, each to hold office until the 2026 annual meeting of stockholders of the Company: J. Lorraine Estradas, R.N., B.S.N., M.P.H. DIRECTOR ELECTIONS ISSUER 140503.000000 0 FOR 140503.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/11/2025 To elect nine directors to the Board of Directors, each to hold office until the 2026 annual meeting of stockholders of the Company: Weili Dai DIRECTOR ELECTIONS ISSUER 140503.000000 0 WITHHOLD 140503.000000 AGAINST S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/11/2025 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 140503.000000 0 FOR 140503.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/11/2025 To approve, on a non-binding advisory basis, the compensation program for the Company's named executive officers as disclosed in the Company's O proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 140503.000000 0 FOR 140503.000000 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/11/2025 To approve the Astrana Health, Inc. Amended and Restated 2024 Equity Incentive Plan. COMPENSATION ISSUER 140503.000000 0 FOR 140503.000000 FOR S000004450 Astria Therapeutics, Inc. 04635X102 US04635X1028 06/11/2025 The election of three Class I Directors to our Board of Directors, to serve for a three-year term until the 2028 annual meeting of stockholders: Fred Callori DIRECTOR ELECTIONS ISSUER 79851.000000 0 FOR 79851.000000 FOR S000004450 Astria Therapeutics, Inc. 04635X102 US04635X1028 06/11/2025 The election of three Class I Directors to our Board of Directors, to serve for a three-year term until the 2028 annual meeting of stockholders: Michael Kishbauch DIRECTOR ELECTIONS ISSUER 79851.000000 0 FOR 79851.000000 FOR S000004450 Astria Therapeutics, Inc. 04635X102 US04635X1028 06/11/2025 The election of three Class I Directors to our Board of Directors, to serve for a three-year term until the 2028 annual meeting of stockholders: Jill C. Milne DIRECTOR ELECTIONS ISSUER 79851.000000 0 FOR 79851.000000 FOR S000004450 Astria Therapeutics, Inc. 04635X102 US04635X1028 06/11/2025 The approval of the first amendment to our Second Amended and Restated 2015 Stock Incentive Plan, to increase the number of shares of our common stock available for grant under the plan by 5,500,000 shares. COMPENSATION ISSUER 79851.000000 0 FOR 79851.000000 FOR S000004450 Astria Therapeutics, Inc. 04635X102 US04635X1028 06/11/2025 The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 79851.000000 0 FOR 79851.000000 FOR S000004450 Astria Therapeutics, Inc. 04635X102 US04635X1028 06/11/2025 The approval, by non-binding advisory vote, of our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 79851.000000 0 FOR 79851.000000 FOR S000004450 Biomea Fusion, Inc. 09077A106 US09077A1060 06/11/2025 The election of Bihua Chen, Elizabeth Faust, Ph.D., and Sumita Ray, J.D., as Class I Directors, to serve for a three-year term ending at the Annual Meeting of Stockholders to be held in 2028: Bihua Chen DIRECTOR ELECTIONS ISSUER 1414.000000 77650.000000 FOR 1414.000000 FOR S000004450 Biomea Fusion, Inc. 09077A106 US09077A1060 06/11/2025 The election of Bihua Chen, Elizabeth Faust, Ph.D., and Sumita Ray, J.D., as Class I Directors, to serve for a three-year term ending at the Annual Meeting of Stockholders to be held in 2028: Elizabeth Faust, Ph.D. DIRECTOR ELECTIONS ISSUER 1414.000000 77650.000000 FOR 1414.000000 FOR S000004450 Biomea Fusion, Inc. 09077A106 US09077A1060 06/11/2025 The election of Bihua Chen, Elizabeth Faust, Ph.D., and Sumita Ray, J.D., as Class I Directors, to serve for a three-year term ending at the Annual Meeting of Stockholders to be held in 2028: Sumita Ray, J.D. DIRECTOR ELECTIONS ISSUER 1414.000000 77650.000000 FOR 1414.000000 FOR S000004450 Biomea Fusion, Inc. 09077A106 US09077A1060 06/11/2025 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 1414.000000 77650.000000 FOR 1414.000000 FOR S000004450 Biomea Fusion, Inc. 09077A106 US09077A1060 06/11/2025 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to include an officer exculpation provision that limits the liability of certain of the Company's officers as permitted under current Delaware law. CORPORATE GOVERNANCE ISSUER 1414.000000 77650.000000 FOR 1414.000000 FOR S000004450 Biomea Fusion, Inc. 09077A106 US09077A1060 06/11/2025 To approve the adjournment of the Annual Meeting to solicit additional proxies to the extent that there are insufficient votes at the Annual Meeting to approve Proposal No. 3. CORPORATE GOVERNANCE ISSUER 1414.000000 77650.000000 FOR 1414.000000 FOR S000004450 Coherus BioSciences, Inc. 19249H103 US19249H1032 06/11/2025 To elect three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Jill O'Donnell-Tormey, Ph.D. DIRECTOR ELECTIONS ISSUER 362089.000000 0 FOR 362089.000000 FOR S000004450 Coherus BioSciences, Inc. 19249H103 US19249H1032 06/11/2025 To elect three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Michael Ryan DIRECTOR ELECTIONS ISSUER 362089.000000 0 FOR 362089.000000 FOR S000004450 Coherus BioSciences, Inc. 19249H103 US19249H1032 06/11/2025 To elect three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Ali J. Satvat DIRECTOR ELECTIONS ISSUER 362089.000000 0 FOR 362089.000000 FOR S000004450 Coherus BioSciences, Inc. 19249H103 US19249H1032 06/11/2025 To ratify the selection, by the Audit Committee of our Board of Directors, of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 362089.000000 0 FOR 362089.000000 FOR S000004450 Coherus BioSciences, Inc. 19249H103 US19249H1032 06/11/2025 To vote on a non-binding, advisory basis to approve the compensation of the Company's named executive officers (a "Say-on-Pay" vote). SECTION 14A SAY-ON-PAY VOTES ISSUER 362089.000000 0 FOR 362089.000000 FOR S000004450 Coherus BioSciences, Inc. 19249H103 US19249H1032 06/11/2025 To approve the amendment to the Company's 2014 Employee Stock Purchase Plan (the "ESPP Amendment"). COMPENSATION ISSUER 362089.000000 0 FOR 362089.000000 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 US22663K1079 06/11/2025 To elect three directors to serve as Class I directors for a three-year term to expire at the 2028 annual meeting of stockholders: Matthew K. Fust DIRECTOR ELECTIONS ISSUER 259336.000000 0 FOR 259336.000000 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 US22663K1079 06/11/2025 To elect three directors to serve as Class I directors for a three-year term to expire at the 2028 annual meeting of stockholders: R. Scott Struthers, Ph.D. DIRECTOR ELECTIONS ISSUER 259336.000000 0 FOR 259336.000000 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 US22663K1079 06/11/2025 To elect three directors to serve as Class I directors for a three-year term to expire at the 2028 annual meeting of stockholders: Rogerio Vivaldi Coelho, M.D. DIRECTOR ELECTIONS ISSUER 259336.000000 0 FOR 259336.000000 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 US22663K1079 06/11/2025 To consider and vote upon the ratification of the selection of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2025; AUDIT-RELATED ISSUER 259336.000000 0 FOR 259336.000000 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 US22663K1079 06/11/2025 To consider and vote upon, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; SECTION 14A SAY-ON-PAY VOTES ISSUER 259336.000000 0 FOR 259336.000000 FOR S000004450 Disc Medicine, Inc. 254604101 US2546041011 06/11/2025 To elect each of the following Class II nominees to the Board of Directors as set forth below: Georges Gemayel, Ph.D. DIRECTOR ELECTIONS ISSUER 57788.000000 0 FOR 57788.000000 FOR S000004450 Disc Medicine, Inc. 254604101 US2546041011 06/11/2025 To elect each of the following Class II nominees to the Board of Directors as set forth below: Mark Chin, M.S., M.B.A. DIRECTOR ELECTIONS ISSUER 57788.000000 0 FOR 57788.000000 FOR S000004450 Disc Medicine, Inc. 254604101 US2546041011 06/11/2025 To elect each of the following Class II nominees to the Board of Directors as set forth below: Liam Ratcliffe, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 57788.000000 0 FOR 57788.000000 FOR S000004450 Disc Medicine, Inc. 254604101 US2546041011 06/11/2025 To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 57788.000000 0 FOR 57788.000000 FOR S000004450 Disc Medicine, Inc. 254604101 US2546041011 06/11/2025 To recommend, by a non-binding advisory vote, the frequency of future advisory votes on the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 57788.000000 0 ONE YEAR 57788.000000 FOR S000004450 Disc Medicine, Inc. 254604101 US2546041011 06/11/2025 To ratify the appointment of Emst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 57788.000000 0 FOR 57788.000000 FOR S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To elect four (4) nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: BOARD NOMINEES: Brent MacGrego DIRECTOR ELECTIONS ISSUER 369207.000000 0 FOR 369207.000000 FOR S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To elect four (4) nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: BOARD NOMINEES: Scott Myers DIRECTOR ELECTIONS ISSUER 369207.000000 0 FOR 369207.000000 FOR S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To elect four (4) nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: BOARD NOMINEES: Lauren Silvernail DIRECTOR ELECTIONS ISSUER 369207.000000 0 FOR 369207.000000 FOR S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To elect four (4) nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: BOARD NOMINEES: Elaine Sun DIRECTOR ELECTIONS ISSUER 369207.000000 0 FOR 369207.000000 FOR S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To elect four (4) nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: DEEP TRACK NOMINEES OPPOSED BY THE COMPANY: Brett Erkman DIRECTOR ELECTIONS SECURITY HOLDER 369207.000000 0 WITHHOLD 369207.000000 FOR S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To elect four (4) nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: DEEP TRACK NOMINEES OPPOSED BY THE COMPANY: Jeffrey Farrow DIRECTOR ELECTIONS SECURITY HOLDER 369207.000000 0 WITHHOLD 369207.000000 FOR S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To elect four (4) nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: DEEP TRACK NOMINEES OPPOSED BY THE COMPANY: Michael Mullette DIRECTOR ELECTIONS SECURITY HOLDER 369207.000000 0 WITHHOLD 369207.000000 FOR S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To elect four (4) nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: DEEP TRACK NOMINEES OPPOSED BY THE COMPANY: Donald Santel DIRECTOR ELECTIONS SECURITY HOLDER 369207.000000 0 WITHHOLD 369207.000000 FOR S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To approve, on an advisory basis, executive compensation for certain of our executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 369207.000000 0 FOR 369207.000000 FOR S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 369207.000000 0 FOR 369207.000000 FOR S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To approve an amendment and restatement of the Company's Restated Certificate of Incorporation to declassify on a phased basis the Company's Board of Directors and to implement certain other changes. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 369207.000000 0 FOR 369207.000000 FOR S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 Stockholder proposal to amend the Company's Amended and Restated Bylaws to repeal each provision of, or amendment to, the Company's Amended and Restated Bylaws adopted by the Board without stockholder approval subsequent to November 6, 2018, if properly presented by Deep Track at the Annual Meeting. CORPORATE GOVERNANCE SECURITY HOLDER 369207.000000 0 AGAINST 369207.000000 FOR S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To elect four nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: DEEP TRACK NOMINEES: Brett A. Erkman DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To elect four nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: DEEP TRACK NOMINEES: Jeffrey S. Farrow DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To elect four nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: DEEP TRACK NOMINEES: Michael Mullette DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To elect four nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: DEEP TRACK NOMINEES: Donald J. Santel DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To elect four nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: COMPANY NOMINEES OPPOSED BY DEEP TRACK CAPITAL: Brent MacGregor DIRECTOR ELECTIONS ISSUER 0.000000 0 S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To elect four nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: COMPANY NOMINEES OPPOSED BY DEEP TRACK CAPITAL: Scott Myers DIRECTOR ELECTIONS ISSUER 0.000000 0 S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To elect four nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: COMPANY NOMINEES OPPOSED BY DEEP TRACK CAPITAL: Lauren Silvernail DIRECTOR ELECTIONS ISSUER 0.000000 0 S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To elect four nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: COMPANY NOMINEES OPPOSED BY DEEP TRACK CAPITAL: Elaine Sun DIRECTOR ELECTIONS ISSUER 0.000000 0 S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 0.000000 0 S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 0.000000 0 S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 To approve an amendment and restatement of the Company's Restated Certificate of Incorporation to declassify the Company's Board of Directors on a phased. basis and implement certain other changes. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 0.000000 0 S000004450 Dynavax Technologies Corporation 268158201 US2681582019 06/11/2025 Deep Track's proposal to amend the Company's Amended and Restated Bylaws to repeal each provision of, or amendment to, the Company's Amended and Restated Bylaws adopted by the Board without stockholder approval subsequent to November 6, 2018. CORPORATE GOVERNANCE SECURITY HOLDER 0.000000 0 S000004450 Entrada Therapeutics, Inc. 29384C108 US29384C1080 06/11/2025 Election of Directors: Dipal Doshi DIRECTOR ELECTIONS ISSUER 52600.000000 0 FOR 52600.000000 FOR S000004450 Entrada Therapeutics, Inc. 29384C108 US29384C1080 06/11/2025 Election of Directors: Kush M. Parmar, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 52600.000000 0 FOR 52600.000000 FOR S000004450 Entrada Therapeutics, Inc. 29384C108 US29384C1080 06/11/2025 Election of Directors: Mary Thistle DIRECTOR ELECTIONS ISSUER 52600.000000 0 FOR 52600.000000 FOR S000004450 Entrada Therapeutics, Inc. 29384C108 US29384C1080 06/11/2025 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 52600.000000 0 FOR 52600.000000 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 US45826J1051 06/11/2025 Election of three class III directors to our board of directors, each to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: William Chase DIRECTOR ELECTIONS ISSUER 301566.000000 0 FOR 301566.000000 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 US45826J1051 06/11/2025 Election of three class III directors to our board of directors, each to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Georgia Keresty, Ph.D., M.P.H. DIRECTOR ELECTIONS ISSUER 301566.000000 0 FOR 301566.000000 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 US45826J1051 06/11/2025 Election of three class III directors to our board of directors, each to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: John M. Leonard, M.D. DIRECTOR ELECTIONS ISSUER 301566.000000 0 FOR 301566.000000 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 US45826J1051 06/11/2025 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 301566.000000 0 FOR 301566.000000 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 US45826J1051 06/11/2025 Approval, on a non-binding advisory basis, of the compensation of our named executive officers ("NEOS"). SECTION 14A SAY-ON-PAY VOTES ISSUER 301566.000000 0 FOR 301566.000000 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 US45826J1051 06/11/2025 A non-binding advisory vote on the frequency of future non-binding advisory votes on the compensation of our NEOS. SECTION 14A SAY-ON-PAY VOTES ISSUER 301566.000000 0 ONE YEAR 301566.000000 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 US45826J1051 06/11/2025 Approval of the Intellia Therapeutics, Inc. 2025 Equity Incentive Plan. COMPENSATION ISSUER 301566.000000 0 FOR 301566.000000 FOR S000004450 Janux Therapeutics, Inc. 47103J105 US47103J1051 06/11/2025 To elect the three nominees for Class I director named in the accompanying proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Ronald Barrett, Ph.D. DIRECTOR ELECTIONS ISSUER 128198.000000 0 FOR 128198.000000 FOR S000004450 Janux Therapeutics, Inc. 47103J105 US47103J1051 06/11/2025 To elect the three nominees for Class I director named in the accompanying proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: David Campbell, Ph.D. DIRECTOR ELECTIONS ISSUER 128198.000000 0 FOR 128198.000000 FOR S000004450 Janux Therapeutics, Inc. 47103J105 US47103J1051 06/11/2025 To elect the three nominees for Class I director named in the accompanying proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Winston Kung DIRECTOR ELECTIONS ISSUER 128198.000000 0 FOR 128198.000000 FOR S000004450 Janux Therapeutics, Inc. 47103J105 US47103J1051 06/11/2025 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 128198.000000 0 FOR 128198.000000 FOR S000004450 Janux Therapeutics, Inc. 47103J105 US47103J1051 06/11/2025 Approval, on an advisory basis, of the compensation of our named executive officers ("Say-On-Pay"), as disclosed in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 128198.000000 0 FOR 128198.000000 FOR S000004450 Janux Therapeutics, Inc. 47103J105 US47103J1051 06/11/2025 Indication, on an advisory basis, of the preferred frequency of holding future Say-On-Pay votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 128198.000000 0 ONE YEAR 128198.000000 FOR S000004450 Korro Bio, Inc. 500946108 US5009461089 06/11/2025 Election of three Class III directors nominated by our board of directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Ram Aiyar DIRECTOR ELECTIONS ISSUER 14128.000000 0 FOR 14128.000000 FOR S000004450 Korro Bio, Inc. 500946108 US5009461089 06/11/2025 Election of three Class III directors nominated by our board of directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Jean-Francois Formela DIRECTOR ELECTIONS ISSUER 14128.000000 0 FOR 14128.000000 FOR S000004450 Korro Bio, Inc. 500946108 US5009461089 06/11/2025 Election of three Class III directors nominated by our board of directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Katharine Knobil DIRECTOR ELECTIONS ISSUER 14128.000000 0 FOR 14128.000000 FOR S000004450 Korro Bio, Inc. 500946108 US5009461089 06/11/2025 Non-Binding Advisory Vote to Approve the Compensation of our Named Executive Officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 14128.000000 0 FOR 14128.000000 FOR S000004450 Korro Bio, Inc. 500946108 US5009461089 06/11/2025 Non-Binding Advisory Vote on the Frequency of Future Non-Binding Advisory Votes to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 14128.000000 0 ONE YEAR 14128.000000 FOR S000004450 Korro Bio, Inc. 500946108 US5009461089 06/11/2025 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 14128.000000 0 FOR 14128.000000 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 ("2026 AGM"): J. Christopher Barry DIRECTOR ELECTIONS ISSUER 168725.000000 0 FOR 168725.000000 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 ("2026 AGM"): Francesco Bianchi DIRECTOR ELECTIONS ISSUER 168725.000000 0 FOR 168725.000000 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 ("2026 AGM"): Stacy Enxing Seng DIRECTOR ELECTIONS ISSUER 168725.000000 0 FOR 168725.000000 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 ("2026 AGM"): William Kozy DIRECTOR ELECTIONS ISSUER 168725.000000 0 FOR 168725.000000 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 ("2026 AGM"): Vladimir Makatsaria DIRECTOR ELECTIONS ISSUER 168725.000000 0 FOR 168725.000000 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 ("2026 AGM"): Dr. Sharon O'Kane DIRECTOR ELECTIONS ISSUER 168725.000000 0 FOR 168725.000000 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 ("2026 AGM"): Susan Podlogar DIRECTOR ELECTIONS ISSUER 168725.000000 0 FOR 168725.000000 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 ("2026 AGM"): Todd Schermerhorn DIRECTOR ELECTIONS ISSUER 168725.000000 0 FOR 168725.000000 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 ("2026 AGM"): Brooke Story DIRECTOR ELECTIONS ISSUER 168725.000000 0 FOR 168725.000000 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 ("2026 AGM"): Peter Wilver DIRECTOR ELECTIONS ISSUER 168725.000000 0 FOR 168725.000000 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To approve, on an advisory basis, the Company's compensation of its named executive officers ("US Say on Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 168725.000000 0 FOR 168725.000000 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To ratify the appointment of PricewaterhouseCoopers LLP, a Delaware limited liability partnership ("PwC-US"), as the Company's independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 168725.000000 0 FOR 168725.000000 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To approve the Second Amended and Restated LivaNova PLC 2022 Incentive Award Plan. COMPENSATION ISSUER 168725.000000 0 FOR 168725.000000 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To approve the LivaNova PLC 2025 Director Incentive Award Plan. COMPENSATION ISSUER 168725.000000 0 FOR 168725.000000 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To generally and unconditionally authorize the directors, for the purposes of section 551 of the Companies Act 2006 (the "Companies Act"), to exercise all powers of the Company to allot shares in the Company and to grant rights to subscribe for, or to convert any security into, shares in the Company up to an aggregate nominal amount of pounds10,904,831, provided that: (A) (unless previously revoked, varied or renewed by the Company) this authority will expire at the end of the next annual general meeting of the Company or, if earlier, the close of business on the date that is fifteen (15) months after the date on which this resolution is passed, save that the directors may, before this authority expires, make offers or agreements which would or might require shares in the Company to be allotted, or rights to subscribe for, or convert securities into, shares to be granted, after its expiry and the directors may allot shares or grant rights to subscribe for, or convert securities into, shares pursuant to such offers or agreements as if this authority had not expired; and (B) this authority replaces all subsisting authorities previously granted to the directors for the purposes of section 551 of the Companies Act which, to the extent unused at the date of this resolution, are revoked with immediate effect without prejudice to any allotment of shares or grant of rights already made, offered or agreed to be made under such authorities. CAPITAL STRUCTURE ISSUER 168725.000000 0 FOR 168725.000000 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Special Resolution: Subject to the passing of resolution 6 and in accordance with sections 570 and 573 of the Companies Act, to empower the directors generally to allot equity securities (as defined in section 560 of the Companies Act) for cash pursuant to the authority conferred by resolution 6, and/or to sell Ordinary Shares (as defined in section 560 of the Companies Act) held by the Company as treasury shares for cash, in each case as if section 561 of the Companies Act (existing shareholders' pre-emption rights) did not apply to any such allotment or sale, provided that this power is limited to the allotment of equity securities or sale of treasury shares for cash up to an aggregate nominal amount of pounds10,904,831, provided that: (A) (unless previously revoked, varied or renewed by the Company) this power will expire at the end of the next annual general meeting of the Company or, if earlier, the close of business on the date that is fifteen (15) months after the date on which this resolution is passed, save that the directors may, before this power expires, make offers or agreements which would or might require equity securities to be allotted and/or treasury shares to be sold after its expiry and the directors may allot equity securities and/or sell treasury shares pursuant to such offers or agreement as if this power had not expired; and (B) this power replaces (except for any power conferred by resolution 6) all subsisting powers previously granted to the directors for the purposes of section 570 of the Companies Act which, to the extent unused at the date of this resolution, are revoked with immediate effect, without prejudice to any allotment of equity securities already made, offered or agreed to be made under such powers. CAPITAL STRUCTURE ISSUER 168725.000000 0 FOR 168725.000000 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To approve, on an advisory basis, the United Kingdom ("UK") directors' remuneration report in the form set out in the Company's UK annual report (the "UK Annual Report") for the period ended December 31, 2024. COMPENSATION ISSUER 168725.000000 0 FOR 168725.000000 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To approve the directors' remuneration policy contained in the directors' remuneration report as set forth in the UK Annual Report for the period ended December 31, 2024. COMPENSATION ISSUER 168725.000000 0 FOR 168725.000000 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To receive and adopt the Company's audited UK statutory accounts for the year ended December 31, 2024, together with the reports of the directors and auditors thereon. CORPORATE GOVERNANCE ISSUER 168725.000000 0 FOR 168725.000000 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England ("PwC-UK"), as the Company's UK statutory auditor for 2025. AUDIT-RELATED ISSUER 168725.000000 0 FOR 168725.000000 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To authorize the directors and/or the Audit and Compliance Committee to determine the remuneration of the Company's UK statutory auditor. AUDIT-RELATED ISSUER 168725.000000 0 FOR 168725.000000 FOR S000004450 Mural Oncology plc G63365103 IE000LK2BOB4 06/11/2025 To elect, by separate resolutions, the following six director nominees named in this proxy statement to the board of directors, to serve until the Company's 2026 annual general meeting: Francis Cuss DIRECTOR ELECTIONS ISSUER 47550.000000 0 FOR 47550.000000 FOR S000004450 Mural Oncology plc G63365103 IE000LK2BOB4 06/11/2025 To elect, by separate resolutions, the following six director nominees named in this proxy statement to the board of directors, to serve until the Company's 2026 annual general meeting: George Golumbeski DIRECTOR ELECTIONS ISSUER 47550.000000 0 FOR 47550.000000 FOR S000004450 Mural Oncology plc G63365103 IE000LK2BOB4 06/11/2025 To elect, by separate resolutions, the following six director nominees named in this proxy statement to the board of directors, to serve until the Company's 2026 annual general meeting: Benjamin Hickey DIRECTOR ELECTIONS ISSUER 47550.000000 0 FOR 47550.000000 FOR S000004450 Mural Oncology plc G63365103 IE000LK2BOB4 06/11/2025 To elect, by separate resolutions, the following six director nominees named in this proxy statement to the board of directors, to serve until the Company's 2026 annual general meeting: Scott Jackson DIRECTOR ELECTIONS ISSUER 47550.000000 0 FOR 47550.000000 FOR S000004450 Mural Oncology plc G63365103 IE000LK2BOB4 06/11/2025 To elect, by separate resolutions, the following six director nominees named in this proxy statement to the board of directors, to serve until the Company's 2026 annual general meeting: Caroline Loew DIRECTOR ELECTIONS ISSUER 47550.000000 0 FOR 47550.000000 FOR S000004450 Mural Oncology plc G63365103 IE000LK2BOB4 06/11/2025 To elect, by separate resolutions, the following six director nominees named in this proxy statement to the board of directors, to serve until the Company's 2026 annual general meeting: Sachiyo Minegishi DIRECTOR ELECTIONS ISSUER 47550.000000 0 FOR 47550.000000 FOR S000004450 Mural Oncology plc G63365103 IE000LK2BOB4 06/11/2025 To ratify, in a non-binding advisory vote, the selection of PricewaterhouseCoopers LLP as the Company's independent auditor for the fiscal year ending December 31, 2025 and to authorize, in a binding vote, the board of directors, acting through the audit committee, to set the independent auditor's remuneration; AUDIT-RELATED ISSUER 47550.000000 0 FOR 47550.000000 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 US67576A1007 06/11/2025 To elect three Class II directors, each to serve until the 2028 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Seung Suh Hong, Ph.D. DIRECTOR ELECTIONS ISSUER 292941.000000 0 FOR 292941.000000 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 US67576A1007 06/11/2025 To elect three Class II directors, each to serve until the 2028 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Richard L. Lindstrom, M.D. DIRECTOR ELECTIONS ISSUER 292941.000000 0 FOR 292941.000000 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 US67576A1007 06/11/2025 To elect three Class II directors, each to serve until the 2028 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Leslie J. Williams DIRECTOR ELECTIONS ISSUER 292941.000000 0 FOR 292941.000000 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 US67576A1007 06/11/2025 To approve an advisory vote on named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 292941.000000 0 FOR 292941.000000 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 US67576A1007 06/11/2025 To approve an amendment to the Ocular Therapeutix, Inc. 2021 Stock Incentive Plan, as amended, to increase the number of shares of common stock issuable thereunder by 8,750,000 shares. COMPENSATION ISSUER 292941.000000 0 FOR 292941.000000 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 US67576A1007 06/11/2025 To approve an amendment and restatement of the Ocular Therapeutix, Inc. 2014 Employee Stock Purchase Plan to increase the number of shares of common stock issuable thereunder by 2,000,000 shares and to remove the annual "evergreen" provision. COMPENSATION ISSUER 292941.000000 0 FOR 292941.000000 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 US67576A1007 06/11/2025 To approve an amendment of our Restated Certificate of Incorporation, as amended, to provide for officer exculpation. CORPORATE GOVERNANCE ISSUER 292941.000000 0 FOR 292941.000000 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 US67576A1007 06/11/2025 To ratify the appointment of PricewaterhouseCoopers LLP as Ocular Therapeutix's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 292941.000000 0 FOR 292941.000000 FOR S000004450 ORIC Pharmaceuticals, Inc. 68622P109 US68622P1093 06/11/2025 Election of Directors: Steven L. Hoerter DIRECTOR ELECTIONS ISSUER 110271.000000 0 FOR 110271.000000 FOR S000004450 ORIC Pharmaceuticals, Inc. 68622P109 US68622P1093 06/11/2025 Election of Directors: Angie You, Ph.D. DIRECTOR ELECTIONS ISSUER 110271.000000 0 FOR 110271.000000 FOR S000004450 ORIC Pharmaceuticals, Inc. 68622P109 US68622P1093 06/11/2025 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 110271.000000 0 FOR 110271.000000 FOR S000004450 Sage Therapeutics, Inc. 78667J108 US78667J1088 06/11/2025 To elect two directors, James M. Frates and George Golumbeski, Ph.D., each to serve as a Class II director until the 2028 Annual Meeting of Stockholders and until his successor is duly elected and qualified, subject to his earlier death, resignation, or removal: James M. Frates DIRECTOR ELECTIONS ISSUER 142040.000000 0 FOR 142040.000000 FOR S000004450 Sage Therapeutics, Inc. 78667J108 US78667J1088 06/11/2025 To elect two directors, James M. Frates and George Golumbeski, Ph.D., each to serve as a Class II director until the 2028 Annual Meeting of Stockholders and until his successor is duly elected and qualified, subject to his earlier death, resignation, or removal: George Golumbeski, Ph.D. DIRECTOR ELECTIONS ISSUER 142040.000000 0 FOR 142040.000000 FOR S000004450 Sage Therapeutics, Inc. 78667J108 US78667J1088 06/11/2025 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 142040.000000 0 FOR 142040.000000 FOR S000004450 Sage Therapeutics, Inc. 78667J108 US78667J1088 06/11/2025 To hold a non-binding advisory vote to approve the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 142040.000000 0 FOR 142040.000000 FOR S000004450 Sage Therapeutics, Inc. 78667J108 US78667J1088 06/11/2025 To approve an amendment to our 2014 Employee Stock Purchase Plan, as amended, or the 2014 ESPP, to increase the number of shares of our common stock authorized for issuance under the 2014 ESPP by 500,000 shares. COMPENSATION ISSUER 142040.000000 0 FOR 142040.000000 FOR S000004450 Terns Pharmaceuticals, Inc. 880881107 US8808811074 06/11/2025 Election of Class I Directors for a three-year term: Robert Azelby DIRECTOR ELECTIONS ISSUER 158346.000000 0 FOR 158346.000000 FOR S000004450 Terns Pharmaceuticals, Inc. 880881107 US8808811074 06/11/2025 Election of Class I Directors for a three-year term: Hongbo Lu DIRECTOR ELECTIONS ISSUER 158346.000000 0 FOR 158346.000000 FOR S000004450 Terns Pharmaceuticals, Inc. 880881107 US8808811074 06/11/2025 Election of Class I Directors for a three-year term: Heather Turner DIRECTOR ELECTIONS ISSUER 158346.000000 0 FOR 158346.000000 FOR S000004450 Terns Pharmaceuticals, Inc. 880881107 US8808811074 06/11/2025 To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025 AUDIT-RELATED ISSUER 158346.000000 0 FOR 158346.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 06/11/2025 Adoption of the 2024 Dutch statutory annual accounts for the fiscal year ended December 31, 2024. CORPORATE GOVERNANCE ISSUER 137554.000000 0 FOR 137554.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 06/11/2025 Discharge of liability of the members of the Board for their management during the fiscal year ended December 31, 2024. CORPORATE GOVERNANCE ISSUER 137554.000000 0 FOR 137554.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 06/11/2025 Reappointment of Robert Gut, M.D., Ph.D. as non-executive director. DIRECTOR ELECTIONS ISSUER 137554.000000 0 FOR 137554.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 06/11/2025 Reappointment of Matthew Kapusta as executive director. DIRECTOR ELECTIONS ISSUER 137554.000000 0 FOR 137554.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 06/11/2025 Reappointment of Jeremy Springhorn, Ph.D. as non-executive director. DIRECTOR ELECTIONS ISSUER 137554.000000 0 FOR 137554.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 06/11/2025 Authorization of the Board to issue Ordinary Shares and grant rights to subscribe for Ordinary Shares. CAPITAL STRUCTURE ISSUER 137554.000000 0 FOR 137554.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 06/11/2025 Authorization of the Board to exclude or limit preemptive rights upon the issuance of Ordinary Shares. CAPITAL STRUCTURE ISSUER 137554.000000 0 FOR 137554.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 06/11/2025 Authorization of the Board to repurchase Ordinary Shares. CAPITAL STRUCTURE ISSUER 137554.000000 0 FOR 137554.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 06/11/2025 Appointment of KPMG as external auditor of the Company for the financial year 2025. AUDIT-RELATED ISSUER 137554.000000 0 FOR 137554.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 06/11/2025 Approval, on an advisory basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 137554.000000 0 FOR 137554.000000 FOR S000004450 uniQure N.V. N90064101 NL0010696654 06/11/2025 Resolution to adopt the Amendment and Restatement of the 2014 Share Incentive Plan. COMPENSATION ISSUER 137554.000000 0 FOR 137554.000000 FOR S000004450 Arcutis Biotherapeutics, Inc. 03969K108 US03969K1088 06/12/2025 Election of Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Bhaskar Chaudhuri, Ph.D. DIRECTOR ELECTIONS ISSUER 327479.000000 0 FOR 327479.000000 FOR S000004450 Arcutis Biotherapeutics, Inc. 03969K108 US03969K1088 06/12/2025 Election of Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Sue-Jean Lin DIRECTOR ELECTIONS ISSUER 327479.000000 0 FOR 327479.000000 FOR S000004450 Arcutis Biotherapeutics, Inc. 03969K108 US03969K1088 06/12/2025 Election of Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Howard G. Welgus, M.D. DIRECTOR ELECTIONS ISSUER 327479.000000 0 FOR 327479.000000 FOR S000004450 Arcutis Biotherapeutics, Inc. 03969K108 US03969K1088 06/12/2025 To ratify the selection, by the Audit Committee of the Company's Board of Directors, of Ernst & Young LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 327479.000000 0 FOR 327479.000000 FOR S000004450 Arcutis Biotherapeutics, Inc. 03969K108 US03969K1088 06/12/2025 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 327479.000000 0 FOR 327479.000000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/12/2025 Election of Directors (each to serve until the 2028 Annual Meeting of Stockholders): Steven Galson, M.D., MPH DIRECTOR ELECTIONS ISSUER 614828.000000 0 FOR 614828.000000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/12/2025 Election of Directors (each to serve until the 2028 Annual Meeting of Stockholders): Alan Levin DIRECTOR ELECTIONS ISSUER 614828.000000 0 FOR 614828.000000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/12/2025 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accountants for 2025. AUDIT-RELATED ISSUER 614828.000000 0 FOR 614828.000000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/12/2025 To hold a non-binding, advisory vote regarding executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 614828.000000 0 FOR 614828.000000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/12/2025 To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. COMPENSATION ISSUER 614828.000000 0 FOR 614828.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/12/2025 To elect seven directors to serve one-year terms expiring in 2026: Joseph DeVivo DIRECTOR ELECTIONS ISSUER 436390.000000 0 FOR 436390.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/12/2025 To elect seven directors to serve one-year terms expiring in 2026: Jonathan M. Rothberg, Ph.D. DIRECTOR ELECTIONS ISSUER 436390.000000 0 FOR 436390.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/12/2025 To elect seven directors to serve one-year terms expiring in 2026: Larry Robbins DIRECTOR ELECTIONS ISSUER 436390.000000 0 FOR 436390.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/12/2025 To elect seven directors to serve one-year terms expiring in 2026: Dawn Carfora DIRECTOR ELECTIONS ISSUER 436390.000000 0 FOR 436390.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/12/2025 To elect seven directors to serve one-year terms expiring in 2026: Elazer Edelman, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 436390.000000 0 FOR 436390.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/12/2025 To elect seven directors to serve one-year terms expiring in 2026: S. Louise Phanstiel DIRECTOR ELECTIONS ISSUER 436390.000000 0 FOR 436390.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/12/2025 To elect seven directors to serve one-year terms expiring in 2026: Erica Schwartz, M.D., J.D., M.P.H. DIRECTOR ELECTIONS ISSUER 436390.000000 0 FOR 436390.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/12/2025 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 436390.000000 0 FOR 436390.000000 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/12/2025 To approve by a non-binding advisory vote the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 436390.000000 0 FOR 436390.000000 FOR S000004450 CareDx, Inc. 14167L103 US14167L1035 06/12/2025 Election of Directors: Fred E. Cohen, ME, D. Phil DIRECTOR ELECTIONS ISSUER 159106.000000 0 FOR 159106.000000 FOR S000004450 CareDx, Inc. 14167L103 US14167L1035 06/12/2025 Election of Directors: R. Bryan Riggsbee DIRECTOR ELECTIONS ISSUER 159106.000000 0 FOR 159106.000000 FOR S000004450 CareDx, Inc. 14167L103 US14167L1035 06/12/2025 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 159106.000000 0 FOR 159106.000000 FOR S000004450 CareDx, Inc. 14167L103 US14167L1035 06/12/2025 Approval, on an advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 159106.000000 0 FOR 159106.000000 FOR S000004450 CareDx, Inc. 14167L103 US14167L1035 06/12/2025 Approval of an amendment to 2024 Equity incentive Plan. COMPENSATION ISSUER 159106.000000 0 FOR 159106.000000 FOR S000004450 Cullinan Therapeutics, Inc. 230031106 US2300311063 06/12/2025 Election of the following individuals nominated to serve as Class II directors, for a three-year term ending at the annual meeting of stockholders to be held in 2028: Anthony Rosenberg DIRECTOR ELECTIONS ISSUER 99529.000000 0 FOR 99529.000000 FOR S000004450 Cullinan Therapeutics, Inc. 230031106 US2300311063 06/12/2025 Election of the following individuals nominated to serve as Class II directors, for a three-year term ending at the annual meeting of stockholders to be held in 2028: David P. Ryan, M.D. DIRECTOR ELECTIONS ISSUER 99529.000000 0 FOR 99529.000000 FOR S000004450 Cullinan Therapeutics, Inc. 230031106 US2300311063 06/12/2025 Election of the following individuals nominated to serve as Class II directors, for a three-year term ending at the annual meeting of stockholders to be held in 2028: Mary Thistle DIRECTOR ELECTIONS ISSUER 99529.000000 0 FOR 99529.000000 FOR S000004450 Cullinan Therapeutics, Inc. 230031106 US2300311063 06/12/2025 Proposal to ratify the appointment of KPMG LLP as Cullinan Therapeutics' independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 99529.000000 0 FOR 99529.000000 FOR S000004450 Cullinan Therapeutics, Inc. 230031106 US2300311063 06/12/2025 Proposal to vote, on an advisory basis, to approve our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 99529.000000 0 FOR 99529.000000 FOR S000004450 Cullinan Therapeutics, Inc. 230031106 US2300311063 06/12/2025 Proposal to vote, on an advisory basis, on the frequency of future advisory votes on our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 99529.000000 0 ONE YEAR 99529.000000 FOR S000004450 Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To elect seven members of the Board of Directors to serve for one-year terms (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Michael Barber DIRECTOR ELECTIONS ISSUER 576705.000000 0 FOR 576705.000000 FOR S000004450 Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To elect seven members of the Board of Directors to serve for one-year terms (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Paul Clancy DIRECTOR ELECTIONS ISSUER 576705.000000 0 FOR 576705.000000 FOR S000004450 Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To elect seven members of the Board of Directors to serve for one-year terms (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Daniel Levangie DIRECTOR ELECTIONS ISSUER 576705.000000 0 FOR 576705.000000 FOR S000004450 Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To elect seven members of the Board of Directors to serve for one-year terms (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Kevin Conroy DIRECTOR ELECTIONS ISSUER 576705.000000 0 FOR 576705.000000 FOR S000004450 Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To elect seven members of the Board of Directors to serve for one-year terms (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Shacey Petrovic DIRECTOR ELECTIONS ISSUER 576705.000000 0 FOR 576705.000000 FOR S000004450 Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To elect seven members of the Board of Directors to serve for one-year terms (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Kimberly Popovits DIRECTOR ELECTIONS ISSUER 576705.000000 0 FOR 576705.000000 FOR S000004450 Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To elect seven members of the Board of Directors to serve for one-year terms (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Katherine Zanotti DIRECTOR ELECTIONS ISSUER 576705.000000 0 FOR 576705.000000 FOR S000004450 Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 576705.000000 0 FOR 576705.000000 FOR S000004450 Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 576705.000000 0 FOR 576705.000000 FOR S000004450 Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To approve the 2025 Omnibus Long-Term Incentive Plan. COMPENSATION ISSUER 576705.000000 0 FOR 576705.000000 FOR S000004450 Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To approve an Amendment to the 2010 Employee Stock Purchase Plan to add 4,000,000 shares of stock to the pool of shares available for purchase by employees. COMPENSATION ISSUER 576705.000000 0 FOR 576705.000000 FOR S000004450 Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To vote on a shareholder proposal concerning the adoption of a director election resignation governance policy, if properly presented. CORPORATE GOVERNANCE SECURITY HOLDER 576705.000000 0 AGAINST 576705.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/12/2025 To elect six director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Craig Collard DIRECTOR ELECTIONS ISSUER 380595.000000 0 FOR 380595.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/12/2025 To elect six director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Sharmila Dissanaike, M.D., FACS, FCCM DIRECTOR ELECTIONS ISSUER 380595.000000 0 FOR 380595.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/12/2025 To elect six director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Craig Johnson DIRECTOR ELECTIONS ISSUER 380595.000000 0 FOR 380595.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/12/2025 To elect six director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Michael Kaseta DIRECTOR ELECTIONS ISSUER 380595.000000 0 FOR 380595.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/12/2025 To elect six director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Adam Morgan DIRECTOR ELECTIONS ISSUER 380595.000000 0 FOR 380595.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/12/2025 To elect six director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Christian Waage DIRECTOR ELECTIONS ISSUER 380595.000000 0 FOR 380595.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/12/2025 To ratify the appointment of Withum as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 380595.000000 0 FOR 380595.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/12/2025 To approve, on a nonbinding advisory basis, compensation paid to our Named Executive Officers for the fiscal year ended December 31, 2024. SECTION 14A SAY-ON-PAY VOTES ISSUER 380595.000000 0 FOR 380595.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/12/2025 To approve, on a nonbinding advisory basis, the frequency of future advisory votes on the compensation paid to our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 380595.000000 0 ONE YEAR 380595.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/12/2025 Election of Directors: Andrew Dudum DIRECTOR ELECTIONS ISSUER 556480.000000 0 FOR 556480.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/12/2025 Election of Directors: Deborah Autor DIRECTOR ELECTIONS ISSUER 556480.000000 0 FOR 556480.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/12/2025 Election of Directors: Patrick Carroll, M.D. DIRECTOR ELECTIONS ISSUER 556480.000000 0 FOR 556480.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/12/2025 Election of Directors: Delos Cosgrove, M.D. DIRECTOR ELECTIONS ISSUER 556480.000000 0 FOR 556480.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/12/2025 Election of Directors: Anja Manuel DIRECTOR ELECTIONS ISSUER 556480.000000 0 FOR 556480.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/12/2025 Election of Directors: Christopher Payne DIRECTOR ELECTIONS ISSUER 556480.000000 0 FOR 556480.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/12/2025 Election of Directors: Christiane Pendarvis DIRECTOR ELECTIONS ISSUER 556480.000000 0 FOR 556480.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/12/2025 Election of Directors: Andrea Perez DIRECTOR ELECTIONS ISSUER 556480.000000 0 FOR 556480.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/12/2025 Election of Directors: Kare Schultz DIRECTOR ELECTIONS ISSUER 556480.000000 0 FOR 556480.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/12/2025 Election of Directors: David Wells DIRECTOR ELECTIONS ISSUER 556480.000000 0 FOR 556480.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/12/2025 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 556480.000000 0 FOR 556480.000000 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/12/2025 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 556480.000000 0 FOR 556480.000000 FOR S000004450 MeiraGTx Holdings Plc G59665102 KYG596651029 06/12/2025 Election of Director: Thomas E. Shenk, Ph.D. DIRECTOR ELECTIONS ISSUER 146607.000000 0 WITHHOLD 146607.000000 AGAINST S000004450 MeiraGTx Holdings Plc G59665102 KYG596651029 06/12/2025 To ratify, by ordinary resolution, the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 146607.000000 0 AGAINST 146607.000000 AGAINST S000004450 Mind Medicine (MindMed) Inc. 60255C885 CA60255C8850 06/12/2025 Election of Directors to hold office until the 2026 annual general meeting of shareholders: Robert Barrow DIRECTOR ELECTIONS ISSUER 141714.000000 30200.000000 FOR 141714.000000 FOR S000004450 Mind Medicine (MindMed) Inc. 60255C885 CA60255C8850 06/12/2025 Election of Directors to hold office until the 2026 annual general meeting of shareholders: Suzanne Bruhn, Ph.D. DIRECTOR ELECTIONS ISSUER 141714.000000 30200.000000 FOR 141714.000000 FOR S000004450 Mind Medicine (MindMed) Inc. 60255C885 CA60255C8850 06/12/2025 Election of Directors to hold office until the 2026 annual general meeting of shareholders: Roger Crystal, M.D. DIRECTOR ELECTIONS ISSUER 141714.000000 30200.000000 FOR 141714.000000 FOR S000004450 Mind Medicine (MindMed) Inc. 60255C885 CA60255C8850 06/12/2025 Election of Directors to hold office until the 2026 annual general meeting of shareholders: David Gryska DIRECTOR ELECTIONS ISSUER 141714.000000 30200.000000 FOR 141714.000000 FOR S000004450 Mind Medicine (MindMed) Inc. 60255C885 CA60255C8850 06/12/2025 Election of Directors to hold office until the 2026 annual general meeting of shareholders: Andreas Krebs DIRECTOR ELECTIONS ISSUER 141714.000000 30200.000000 FOR 141714.000000 FOR S000004450 Mind Medicine (MindMed) Inc. 60255C885 CA60255C8850 06/12/2025 Election of Directors to hold office until the 2026 annual general meeting of shareholders: Carol A. Vallone DIRECTOR ELECTIONS ISSUER 141714.000000 30200.000000 FOR 141714.000000 FOR S000004450 Mind Medicine (MindMed) Inc. 60255C885 CA60255C8850 06/12/2025 To appoint KPMG LLP as independent registered public accounting firm (auditor) for the Company until the 2026 annual general meeting of shareholders. AUDIT-RELATED ISSUER 141714.000000 30200.000000 FOR 141714.000000 FOR S000004450 Mind Medicine (MindMed) Inc. 60255C885 CA60255C8850 06/12/2025 To consider, and if deemed advisable, approve, the Mind Medicine (MindMed) Inc. 2025 Equity Incentive Plan. COMPENSATION ISSUER 141714.000000 30200.000000 FOR 141714.000000 FOR S000004450 Natera, Inc. 632307104 US6323071042 06/12/2025 To elect the three directors named below and in the proxy statement to serve as Class I directors until the annual meeting of stockholders to be held in 2028 and until their successors are duly elected and qualified: Roy Baynes DIRECTOR ELECTIONS ISSUER 390829.000000 0 FOR 390829.000000 FOR S000004450 Natera, Inc. 632307104 US6323071042 06/12/2025 To elect the three directors named below and in the proxy statement to serve as Class I directors until the annual meeting of stockholders to be held in 2028 and until their successors are duly elected and qualified: Gail Marcus DIRECTOR ELECTIONS ISSUER 390829.000000 0 FOR 390829.000000 FOR S000004450 Natera, Inc. 632307104 US6323071042 06/12/2025 To elect the three directors named below and in the proxy statement to serve as Class I directors until the annual meeting of stockholders to be held in 2028 and until their successors are duly elected and qualified: Ruth Williams-Brinkley DIRECTOR ELECTIONS ISSUER 390829.000000 0 FOR 390829.000000 FOR S000004450 Natera, Inc. 632307104 US6323071042 06/12/2025 To ratify the appointment of Ernst & Young LLP as Natera, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 390829.000000 0 FOR 390829.000000 FOR S000004450 Natera, Inc. 632307104 US6323071042 06/12/2025 To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 390829.000000 0 FOR 390829.000000 FOR S000004450 Natera, Inc. 632307104 US6323071042 06/12/2025 To approve an amendment to Natera's Amended and Restated 2015 Equity Incentive Plan. COMPENSATION ISSUER 390829.000000 0 FOR 390829.000000 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/12/2025 ELECTION OF DIRECTORS: Robert W. Duggan DIRECTOR ELECTIONS ISSUER 266312.000000 192800.000000 FOR 266312.000000 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/12/2025 ELECTION OF DIRECTORS: Mahkam Zanganeh DIRECTOR ELECTIONS ISSUER 266312.000000 192800.000000 FOR 266312.000000 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/12/2025 ELECTION OF DIRECTORS: Manmeet S. Soni DIRECTOR ELECTIONS ISSUER 266312.000000 192800.000000 FOR 266312.000000 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/12/2025 ELECTION OF DIRECTORS: Kenneth A. Clark DIRECTOR ELECTIONS ISSUER 266312.000000 192800.000000 FOR 266312.000000 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/12/2025 ELECTION OF DIRECTORS: Robert Booth DIRECTOR ELECTIONS ISSUER 266312.000000 192800.000000 FOR 266312.000000 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/12/2025 ELECTION OF DIRECTORS: Alessandra Cesano DIRECTOR ELECTIONS ISSUER 266312.000000 192800.000000 AGAINST 266312.000000 AGAINST S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/12/2025 ELECTION OF DIRECTORS: Yu (Michelle) Xia DIRECTOR ELECTIONS ISSUER 266312.000000 192800.000000 FOR 266312.000000 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/12/2025 ELECTION OF DIRECTORS: Mostafa Ronaghi DIRECTOR ELECTIONS ISSUER 266312.000000 192800.000000 FOR 266312.000000 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/12/2025 ELECTION OF DIRECTORS: Jeff Huber DIRECTOR ELECTIONS ISSUER 266312.000000 192800.000000 FOR 266312.000000 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/12/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 266312.000000 192800.000000 FOR 266312.000000 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/12/2025 Approval, by a non-binding advisory vote, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 266312.000000 192800.000000 FOR 266312.000000 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 US87650L1035 06/12/2025 To elect Class II directors, to serve until the 2028 annual meeting of stockholders or until their respective successor have been elected or appointed: Bobak Azamian DIRECTOR ELECTIONS ISSUER 89631.000000 0 FOR 89631.000000 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 US87650L1035 06/12/2025 To elect Class II directors, to serve until the 2028 annual meeting of stockholders or until their respective successor have been elected or appointed: Katherine Goodrich DIRECTOR ELECTIONS ISSUER 89631.000000 0 FOR 89631.000000 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 US87650L1035 06/12/2025 To hold an advisory vote to approve, on a non-binding basis, named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 89631.000000 0 FOR 89631.000000 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 US87650L1035 06/12/2025 To hold an advisory vote to approve, on a non-binding basis, the frequency with which future stockholder votes on the compensation of our named executive officers will be conducted of one, two or three years. SECTION 14A SAY-ON-PAY VOTES ISSUER 89631.000000 0 ONE YEAR 89631.000000 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 US87650L1035 06/12/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 89631.000000 0 FOR 89631.000000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/12/2025 Election of Directors: Laurence Charney DIRECTOR ELECTIONS ISSUER 460796.000000 0 FOR 460796.000000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/12/2025 Election of Directors: Yann Echelard DIRECTOR ELECTIONS ISSUER 460796.000000 0 FOR 460796.000000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/12/2025 Election of Directors: Kenneth Hoberman DIRECTOR ELECTIONS ISSUER 460796.000000 0 FOR 460796.000000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/12/2025 Election of Directors: Daniel Hume DIRECTOR ELECTIONS ISSUER 460796.000000 0 FOR 460796.000000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/12/2025 Election of Directors: Sagar Lonial, MD DIRECTOR ELECTIONS ISSUER 460796.000000 0 FOR 460796.000000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/12/2025 Election of Directors: Michael S. Weiss DIRECTOR ELECTIONS ISSUER 460796.000000 0 FOR 460796.000000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/12/2025 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 460796.000000 0 FOR 460796.000000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/12/2025 An advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 460796.000000 0 FOR 460796.000000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/12/2025 To approve Amendment No. 2 to our 2022 Incentive Plan to increase the number of shares of common stock authorized for issuance under the 2022 Incentive Plan from 17,000,000 to 22,000,000 shares COMPENSATION ISSUER 460796.000000 0 FOR 460796.000000 FOR S000004450 Vaxcyte, Inc. 92243G108 US92243G1085 06/12/2025 Election of Class II Directors Nominees would serve until the 2028 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: John Furey DIRECTOR ELECTIONS ISSUER 349078.000000 0 FOR 349078.000000 FOR S000004450 Vaxcyte, Inc. 92243G108 US92243G1085 06/12/2025 Election of Class II Directors Nominees would serve until the 2028 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Jacks Lee DIRECTOR ELECTIONS ISSUER 349078.000000 0 FOR 349078.000000 FOR S000004450 Vaxcyte, Inc. 92243G108 US92243G1085 06/12/2025 Election of Class II Directors Nominees would serve until the 2028 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Heath Lukatch, Ph.D. DIRECTOR ELECTIONS ISSUER 349078.000000 0 FOR 349078.000000 FOR S000004450 Vaxcyte, Inc. 92243G108 US92243G1085 06/12/2025 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 349078.000000 0 FOR 349078.000000 FOR S000004450 Vaxcyte, Inc. 92243G108 US92243G1085 06/12/2025 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 349078.000000 0 FOR 349078.000000 FOR S000004450 Vaxcyte, Inc. 92243G108 US92243G1085 06/12/2025 Approval of the amendment and restatement of the Company's Amended and Restated Certificate of Incorporation to provide for officer exculpation as permitted by recent amendments to the Delaware General Corporation Law. CORPORATE GOVERNANCE ISSUER 349078.000000 0 FOR 349078.000000 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/12/2025 To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Bassil I. Dahiyat DIRECTOR ELECTIONS ISSUER 185939.000000 0 FOR 185939.000000 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/12/2025 To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Ellen G. Feigal DIRECTOR ELECTIONS ISSUER 185939.000000 0 FOR 185939.000000 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/12/2025 To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Kevin C. Gorman DIRECTOR ELECTIONS ISSUER 185939.000000 0 FOR 185939.000000 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/12/2025 To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Mr. Kurt A. Gustafson DIRECTOR ELECTIONS ISSUER 185939.000000 0 FOR 185939.000000 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/12/2025 To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Barbara Klencke DIRECTOR ELECTIONS ISSUER 185939.000000 0 FOR 185939.000000 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/12/2025 To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. A. Bruce Montgomery DIRECTOR ELECTIONS ISSUER 185939.000000 0 FOR 185939.000000 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/12/2025 To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Mr. Richard J. Ranieri DIRECTOR ELECTIONS ISSUER 185939.000000 0 FOR 185939.000000 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/12/2025 To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Mr. Todd E. Simpson DIRECTOR ELECTIONS ISSUER 185939.000000 0 FOR 185939.000000 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/12/2025 To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025; AUDIT-RELATED ISSUER 185939.000000 0 FOR 185939.000000 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/12/2025 To approve the proposed amendment and restatement of the Company's 2023 Equity Incentive Plan to increase the number of authorized shares reserved for issuance thereunder by 3,000,000 shares; COMPENSATION ISSUER 185939.000000 0 FOR 185939.000000 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/12/2025 To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers, as disclosed in the accompanying Proxy Statement; SECTION 14A SAY-ON-PAY VOTES ISSUER 185939.000000 0 FOR 185939.000000 FOR S000004450 Edgewise Therapeutics, Inc. 28036F105 US28036F1057 06/13/2025 Elect the directors named in the attached Proxy Statement to serve until the 2028 Annual Meeting of Stockholders: Alan Russell, Ph.D. DIRECTOR ELECTIONS ISSUER 146705.000000 0 FOR 146705.000000 FOR S000004450 Edgewise Therapeutics, Inc. 28036F105 US28036F1057 06/13/2025 Elect the directors named in the attached Proxy Statement to serve until the 2028 Annual Meeting of Stockholders: Arlene Morris DIRECTOR ELECTIONS ISSUER 146705.000000 0 FOR 146705.000000 FOR S000004450 Edgewise Therapeutics, Inc. 28036F105 US28036F1057 06/13/2025 Ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 146705.000000 0 FOR 146705.000000 FOR S000004450 Edgewise Therapeutics, Inc. 28036F105 US28036F1057 06/13/2025 Conduct an advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 146705.000000 0 FOR 146705.000000 FOR S000004450 Edgewise Therapeutics, Inc. 28036F105 US28036F1057 06/13/2025 Conduct an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 146705.000000 0 ONE YEAR 146705.000000 FOR S000004450 Monte Rosa Therapeutics, Inc. 61225M102 US61225M1027 06/13/2025 To elect three Class I director nominees to our board of directors, to serve until the Company's 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Christine Siu, MBA DIRECTOR ELECTIONS ISSUER 124879.000000 0 FOR 124879.000000 FOR S000004450 Monte Rosa Therapeutics, Inc. 61225M102 US61225M1027 06/13/2025 To elect three Class I director nominees to our board of directors, to serve until the Company's 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Kimberly L. Blackwell, M.D. DIRECTOR ELECTIONS ISSUER 124879.000000 0 FOR 124879.000000 FOR S000004450 Monte Rosa Therapeutics, Inc. 61225M102 US61225M1027 06/13/2025 To elect three Class I director nominees to our board of directors, to serve until the Company's 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Jan Skvarka, Ph.D., MBA DIRECTOR ELECTIONS ISSUER 124879.000000 0 FOR 124879.000000 FOR S000004450 Monte Rosa Therapeutics, Inc. 61225M102 US61225M1027 06/13/2025 To ratify the appointment of Deloitte & Touche, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025; and AUDIT-RELATED ISSUER 124879.000000 0 FOR 124879.000000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Election of Directors: Bonnie L. Bassler, Ph.D. DIRECTOR ELECTIONS ISSUER 336735.000000 0 FOR 336735.000000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Election of Directors: Michael S. Brown, M.D. DIRECTOR ELECTIONS ISSUER 336735.000000 0 FOR 336735.000000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Election of Directors: Leonard S. Schleifer, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 336735.000000 0 FOR 336735.000000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Election of Directors: George D. Yancopoulos, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 336735.000000 0 FOR 336735.000000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 336735.000000 0 FOR 336735.000000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Proposal to approve, on an advisory basis, executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 336735.000000 0 FOR 336735.000000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Proposal to approve an amendment to the Company's Certificate of Incorporation to declassify the board of directors. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 336735.000000 0 FOR 336735.000000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Amendments to the Company's Certificate of Incorporation to Eliminate Supermajority Vote Requirements Proposal to approve an amendment to Article IV, Section 2(e)(8) of the Certificate of Incorporation CORPORATE GOVERNANCE ISSUER 336735.000000 0 FOR 336735.000000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Amendments to the Company's Certificate of Incorporation to Eliminate Supermajority Vote Requirements Proposal to approve an amendment to Article VI of the Certificate of Incorporation. CORPORATE GOVERNANCE ISSUER 336735.000000 0 FOR 336735.000000 FOR S000004450 Supernus Pharmaceuticals, Inc. 868459108 US8684591089 06/16/2025 to elect two (2) directors to hold office for the ensuing three years and until their successors have been duly elected and qualified: Carrolee Barlow, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 172430.000000 0 FOR 172430.000000 FOR S000004450 Supernus Pharmaceuticals, Inc. 868459108 US8684591089 06/16/2025 to elect two (2) directors to hold office for the ensuing three years and until their successors have been duly elected and qualified: Jack A. Khattar DIRECTOR ELECTIONS ISSUER 172430.000000 0 FOR 172430.000000 FOR S000004450 Supernus Pharmaceuticals, Inc. 868459108 US8684591089 06/16/2025 to approve, on a non-binding basis, the compensation paid to our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 172430.000000 0 FOR 172430.000000 FOR S000004450 Supernus Pharmaceuticals, Inc. 868459108 US8684591089 06/16/2025 to ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025; AUDIT-RELATED ISSUER 172430.000000 0 FOR 172430.000000 FOR S000004450 4D Molecular Therapeutics, Inc. 35104E100 US35104E1001 06/17/2025 Election of three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Jacob Chacko, M.D., MBA DIRECTOR ELECTIONS ISSUER 81457.000000 0 FOR 81457.000000 FOR S000004450 4D Molecular Therapeutics, Inc. 35104E100 US35104E1001 06/17/2025 Election of three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Susannah Gray, MBA DIRECTOR ELECTIONS ISSUER 81457.000000 0 FOR 81457.000000 FOR S000004450 4D Molecular Therapeutics, Inc. 35104E100 US35104E1001 06/17/2025 Election of three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Charles Theuer, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 81457.000000 0 FOR 81457.000000 FOR S000004450 4D Molecular Therapeutics, Inc. 35104E100 US35104E1001 06/17/2025 Ratification of the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 81457.000000 0 FOR 81457.000000 FOR S000004450 4D Molecular Therapeutics, Inc. 35104E100 US35104E1001 06/17/2025 Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers ("say-on-pay vote"). SECTION 14A SAY-ON-PAY VOTES ISSUER 81457.000000 0 FOR 81457.000000 FOR S000004450 4D Molecular Therapeutics, Inc. 35104E100 US35104E1001 06/17/2025 Approval, on an advisory, non-binding basis, of the frequency of future advisory say-on-pay votes. SECTION 14A SAY-ON-PAY VOTES ISSUER 81457.000000 0 ONE YEAR 81457.000000 FOR S000004450 Agenus Inc. 00847G804 US00847G8042 06/17/2025 To elect Brian Corvese and Timothy Wright as Class I directors, for a term of three years expiring at the 2028 Annual Meeting of Stockholders: Brian Corvese DIRECTOR ELECTIONS ISSUER 73775.000000 0 FOR 73775.000000 FOR S000004450 Agenus Inc. 00847G804 US00847G8042 06/17/2025 To elect Brian Corvese and Timothy Wright as Class I directors, for a term of three years expiring at the 2028 Annual Meeting of Stockholders: Timothy Wright DIRECTOR ELECTIONS ISSUER 73775.000000 0 FOR 73775.000000 FOR S000004450 Agenus Inc. 00847G804 US00847G8042 06/17/2025 To approve an amendment to our Amended and Restated 2019 Equity Incentive Plan ("2019 EIP") to increase the number of shares of common stock authorized for issuance thereunder from 5,050,000 shares to 12,050,000 shares. COMPENSATION ISSUER 73775.000000 0 FOR 73775.000000 FOR S000004450 Agenus Inc. 00847G804 US00847G8042 06/17/2025 To approve an amendment to our Amended and Restated Directors' Deferred Compensation Plan (as amended) to increase the number of shares of common stock authorized for issuance thereunder from 63,750 shares to 88,750 shares. COMPENSATION ISSUER 73775.000000 0 FOR 73775.000000 FOR S000004450 Agenus Inc. 00847G804 US00847G8042 06/17/2025 To approve an amendment to our 2019 Employee Stock Purchase Plan (as amended) to increase the number of shares of common stock authorized for issuance thereunder from 100,000 shares to 150,000 shares. COMPENSATION ISSUER 73775.000000 0 FOR 73775.000000 FOR S000004450 Agenus Inc. 00847G804 US00847G8042 06/17/2025 To approve a one-time exchange modification of options to purchase shares under our 2019 EIP, our Amended and Restated 2009 Equity Incentive Plan, and our 2015 Inducement Equity Plan. COMPENSATION ISSUER 73775.000000 0 AGAINST 73775.000000 AGAINST S000004450 Agenus Inc. 00847G804 US00847G8042 06/17/2025 To approve, in a non-binding advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 73775.000000 0 AGAINST 73775.000000 AGAINST S000004450 Agenus Inc. 00847G804 US00847G8042 06/17/2025 To ratify the appointment of KPMG LLP as our Independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 73775.000000 0 AGAINST 73775.000000 AGAINST S000004450 AnaptysBio, Inc. 032724106 US0327241065 06/17/2025 To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: Rita Jain, M.D. DIRECTOR ELECTIONS ISSUER 2337.000000 50000.000000 FOR 2337.000000 FOR S000004450 AnaptysBio, Inc. 032724106 US0327241065 06/17/2025 To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: John Orwin DIRECTOR ELECTIONS ISSUER 2337.000000 50000.000000 FOR 2337.000000 FOR S000004450 AnaptysBio, Inc. 032724106 US0327241065 06/17/2025 To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: J. Anthony Ware, M.D. DIRECTOR ELECTIONS ISSUER 2337.000000 50000.000000 FOR 2337.000000 FOR S000004450 AnaptysBio, Inc. 032724106 US0327241065 06/17/2025 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 2337.000000 50000.000000 FOR 2337.000000 FOR S000004450 AnaptysBio, Inc. 032724106 US0327241065 06/17/2025 To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials. SECTION 14A SAY-ON-PAY VOTES ISSUER 2337.000000 50000.000000 FOR 2337.000000 FOR S000004450 AnaptysBio, Inc. 032724106 US0327241065 06/17/2025 To approve an amendment to our 2017 Equity Incentive Plan. COMPENSATION ISSUER 2337.000000 50000.000000 AGAINST 2337.000000 AGAINST S000004450 AnaptysBio, Inc. 032724106 US0327241065 06/17/2025 Non-binding advisory vote on the frequency of holding future advisory votes regarding named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2337.000000 50000.000000 ONE YEAR 2337.000000 FOR S000004450 Apogee Therapeutics, Inc. 03770N101 US03770N1019 06/17/2025 Election of Class II Directors for terms expiring in 2028: Lisa Bollinger, M.D. DIRECTOR ELECTIONS ISSUER 70368.000000 0 FOR 70368.000000 FOR S000004450 Apogee Therapeutics, Inc. 03770N101 US03770N1019 06/17/2025 Election of Class II Directors for terms expiring in 2028: Tomas Kiselak DIRECTOR ELECTIONS ISSUER 70368.000000 0 FOR 70368.000000 FOR S000004450 Apogee Therapeutics, Inc. 03770N101 US03770N1019 06/17/2025 Election of Class II Directors for terms expiring in 2028: Nimish Shah DIRECTOR ELECTIONS ISSUER 70368.000000 0 FOR 70368.000000 FOR S000004450 Apogee Therapeutics, Inc. 03770N101 US03770N1019 06/17/2025 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 70368.000000 0 FOR 70368.000000 FOR S000004450 Apogee Therapeutics, Inc. 03770N101 US03770N1019 06/17/2025 Vote on the frequency of future advisory votes to approve our named executive officers compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 70368.000000 0 ONE YEAR 70368.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/17/2025 Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Caroline D. Dorsa DIRECTOR ELECTIONS ISSUER 454070.000000 0 FOR 454070.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/17/2025 Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. Freire DIRECTOR ELECTIONS ISSUER 454070.000000 0 FOR 454070.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/17/2025 Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: William A. Hawkins DIRECTOR ELECTIONS ISSUER 454070.000000 0 FOR 454070.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/17/2025 Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. Langer DIRECTOR ELECTIONS ISSUER 454070.000000 0 FOR 454070.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/17/2025 Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. Mantas DIRECTOR ELECTIONS ISSUER 454070.000000 0 FOR 454070.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/17/2025 Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Lloyd Minor DIRECTOR ELECTIONS ISSUER 454070.000000 0 FOR 454070.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/17/2025 Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Menelas Pangalos DIRECTOR ELECTIONS ISSUER 454070.000000 0 FOR 454070.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/17/2025 Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Monish Patolawala DIRECTOR ELECTIONS ISSUER 454070.000000 0 FOR 454070.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/17/2025 Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. Rowinsky DIRECTOR ELECTIONS ISSUER 454070.000000 0 FOR 454070.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/17/2025 Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. Sherwin DIRECTOR ELECTIONS ISSUER 454070.000000 0 FOR 454070.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/17/2025 Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. Viehbacher DIRECTOR ELECTIONS ISSUER 454070.000000 0 FOR 454070.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/17/2025 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2025 AUDIT-RELATED ISSUER 454070.000000 0 FOR 454070.000000 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/17/2025 Say on Pay - To hold an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 454070.000000 0 FOR 454070.000000 FOR S000004450 DocGo Inc. 256086109 US2560861096 06/17/2025 Election of Directors: Class I Nominees: Lee Bienstock DIRECTOR ELECTIONS ISSUER 268112.000000 0 FOR 268112.000000 FOR S000004450 DocGo Inc. 256086109 US2560861096 06/17/2025 Election of Directors: Class I Nominees: Ira Smedra DIRECTOR ELECTIONS ISSUER 268112.000000 0 FOR 268112.000000 FOR S000004450 DocGo Inc. 256086109 US2560861096 06/17/2025 Election of Directors: Class I Nominees: Ely D. Tendler DIRECTOR ELECTIONS ISSUER 268112.000000 0 FOR 268112.000000 FOR S000004450 DocGo Inc. 256086109 US2560861096 06/17/2025 To approve on a non-binding, advisory basis the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 268112.000000 0 FOR 268112.000000 FOR S000004450 DocGo Inc. 256086109 US2560861096 06/17/2025 To approve an amendment to the Company's Second Amended and Restated Certificate of Incorporation regarding the waiver of corporate opportunities. CORPORATE GOVERNANCE ISSUER 268112.000000 0 FOR 268112.000000 FOR S000004450 DocGo Inc. 256086109 US2560861096 06/17/2025 To approve an amendment to the Company's Second Amended and Restated Certificate of Incorporation to limit the liability of certain officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 268112.000000 0 FOR 268112.000000 FOR S000004450 DocGo Inc. 256086109 US2560861096 06/17/2025 Ratification of the appointment of Urish Popeck & Co., LLC as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 268112.000000 0 FOR 268112.000000 FOR S000004450 iTeos Therapeutics, Inc. 46565G104 US46565G1040 06/17/2025 Election of the Class II director nominees to serve until the 2028 Annual Meeting of Stockholders: Tony Ho DIRECTOR ELECTIONS ISSUER 76780.000000 0 FOR 76780.000000 FOR S000004450 iTeos Therapeutics, Inc. 46565G104 US46565G1040 06/17/2025 Election of the Class II director nominees to serve until the 2028 Annual Meeting of Stockholders: Robert Iannone DIRECTOR ELECTIONS ISSUER 76780.000000 0 FOR 76780.000000 FOR S000004450 iTeos Therapeutics, Inc. 46565G104 US46565G1040 06/17/2025 Election of the Class II director nominees to serve until the 2028 Annual Meeting of Stockholders: Ann D. Rhoads DIRECTOR ELECTIONS ISSUER 76780.000000 0 FOR 76780.000000 FOR S000004450 iTeos Therapeutics, Inc. 46565G104 US46565G1040 06/17/2025 To ratify the appointment of Deloitte Bedrijfsrevisoren / Reviseurs d'Entreprises BV/SRL as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 76780.000000 0 FOR 76780.000000 FOR S000004450 Liquidia Corporation 53635D202 US53635D2027 06/17/2025 Election of Directors: Stephen Bloch DIRECTOR ELECTIONS ISSUER 159012.000000 0 FOR 159012.000000 FOR S000004450 Liquidia Corporation 53635D202 US53635D2027 06/17/2025 Election of Directors: Joanna Horobin DIRECTOR ELECTIONS ISSUER 159012.000000 0 FOR 159012.000000 FOR S000004450 Liquidia Corporation 53635D202 US53635D2027 06/17/2025 Election of Directors: Roger A. Jeffs DIRECTOR ELECTIONS ISSUER 159012.000000 0 FOR 159012.000000 FOR S000004450 Liquidia Corporation 53635D202 US53635D2027 06/17/2025 To ratify the Appointment of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the Year Ending December 31, 2025. AUDIT-RELATED ISSUER 159012.000000 0 FOR 159012.000000 FOR S000004450 Liquidia Corporation 53635D202 US53635D2027 06/17/2025 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 159012.000000 0 FOR 159012.000000 FOR S000004450 ModivCare Inc. 60783X104 US60783X1046 06/17/2025 Election of Directors: Todd J. Carter DIRECTOR ELECTIONS ISSUER 22541.000000 0 FOR 22541.000000 FOR S000004450 ModivCare Inc. 60783X104 US60783X1046 06/17/2025 Election of Directors: Alec Cunningham DIRECTOR ELECTIONS ISSUER 22541.000000 0 FOR 22541.000000 FOR S000004450 ModivCare Inc. 60783X104 US60783X1046 06/17/2025 Election of Directors: David Mounts Gonzales DIRECTOR ELECTIONS ISSUER 22541.000000 0 FOR 22541.000000 FOR S000004450 ModivCare Inc. 60783X104 US60783X1046 06/17/2025 Election of Directors: Leslie V. Norwalk DIRECTOR ELECTIONS ISSUER 22541.000000 0 FOR 22541.000000 FOR S000004450 ModivCare Inc. 60783X104 US60783X1046 06/17/2025 Election of Directors: Erin L. Russell DIRECTOR ELECTIONS ISSUER 22541.000000 0 FOR 22541.000000 FOR S000004450 ModivCare Inc. 60783X104 US60783X1046 06/17/2025 Election of Directors: L. Heath Sampson DIRECTOR ELECTIONS ISSUER 22541.000000 0 FOR 22541.000000 FOR S000004450 ModivCare Inc. 60783X104 US60783X1046 06/17/2025 Election of Directors: Daniel B. Silvers DIRECTOR ELECTIONS ISSUER 22541.000000 0 FOR 22541.000000 FOR S000004450 ModivCare Inc. 60783X104 US60783X1046 06/17/2025 A non-binding advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 22541.000000 0 FOR 22541.000000 FOR S000004450 ModivCare Inc. 60783X104 US60783X1046 06/17/2025 To ratify the appointment of KPMG LLP as the independent registered public accounting firm of the Company to serve for the 2025 fiscal year. AUDIT-RELATED ISSUER 22541.000000 0 FOR 22541.000000 FOR S000004450 OmniAb, Inc. 68218J103 US68218J1034 06/17/2025 Election of Directors: Carolyn R. Bertozzi, Ph.D. DIRECTOR ELECTIONS ISSUER 272088.000000 0 FOR 272088.000000 FOR S000004450 OmniAb, Inc. 68218J103 US68218J1034 06/17/2025 Election of Directors: John Higgins DIRECTOR ELECTIONS ISSUER 272088.000000 0 FOR 272088.000000 FOR S000004450 OmniAb, Inc. 68218J103 US68218J1034 06/17/2025 Ratification of Ernst & Young LLP as OmniAb, Inc.'s independent registered accounting firm. AUDIT-RELATED ISSUER 272088.000000 0 FOR 272088.000000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 US69366J2006 06/17/2025 Election of Three Class III Directors: Allan Jacobson, Ph.D. DIRECTOR ELECTIONS ISSUER 215909.000000 0 FOR 215909.000000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 US69366J2006 06/17/2025 Election of Three Class III Directors: David P. Southwell DIRECTOR ELECTIONS ISSUER 215909.000000 0 FOR 215909.000000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 US69366J2006 06/17/2025 Election of Three Class III Directors: Alethia Young DIRECTOR ELECTIONS ISSUER 215909.000000 0 FOR 215909.000000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 US69366J2006 06/17/2025 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 215909.000000 0 FOR 215909.000000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 US69366J2006 06/17/2025 Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 215909.000000 0 FOR 215909.000000 FOR S000004450 Rapport Therapeutics, Inc. 75383L102 US75383L1026 06/17/2025 To elect Reid Huber, Ph.D., John Maraganore, Ph.D.,and Wendy B. Young, Ph.D. as Class I Directors: Reid Huber, Ph.D. DIRECTOR ELECTIONS ISSUER 51474.000000 0 FOR 51474.000000 FOR S000004450 Rapport Therapeutics, Inc. 75383L102 US75383L1026 06/17/2025 To elect Reid Huber, Ph.D., John Maraganore, Ph.D.,and Wendy B. Young, Ph.D. as Class I Directors: John Maraganore, Ph.D. DIRECTOR ELECTIONS ISSUER 51474.000000 0 FOR 51474.000000 FOR S000004450 Rapport Therapeutics, Inc. 75383L102 US75383L1026 06/17/2025 To elect Reid Huber, Ph.D., John Maraganore, Ph.D.,and Wendy B. Young, Ph.D. as Class I Directors: Wendy B. Young, Ph.D. DIRECTOR ELECTIONS ISSUER 51474.000000 0 FOR 51474.000000 FOR S000004450 Rapport Therapeutics, Inc. 75383L102 US75383L1026 06/17/2025 To ratify the appointment of PricewaterhouseCoopers LLP as Rapport's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 51474.000000 0 FOR 51474.000000 FOR S000004450 Repare Therapeutics Inc. 760273102 US7602731025 06/17/2025 To elect the four nominees of our board of directors, to our board of directors as Class II directors, each to hold office until our Annual Meeting of Shareholders in 2028 and until such director's successor has been duly elected, or if sooner, until the director's death, resignation or removal: David Bonita, M.D. DIRECTOR ELECTIONS ISSUER 52143.000000 0 FOR 52143.000000 FOR S000004450 Repare Therapeutics Inc. 760273102 US7602731025 06/17/2025 To elect the four nominees of our board of directors, to our board of directors as Class II directors, each to hold office until our Annual Meeting of Shareholders in 2028 and until such director's successor has been duly elected, or if sooner, until the director's death, resignation or removal: Thomas Civik DIRECTOR ELECTIONS ISSUER 52143.000000 0 FOR 52143.000000 FOR S000004450 Repare Therapeutics Inc. 760273102 US7602731025 06/17/2025 To elect the four nominees of our board of directors, to our board of directors as Class II directors, each to hold office until our Annual Meeting of Shareholders in 2028 and until such director's successor has been duly elected, or if sooner, until the director's death, resignation or removal: Carol A. Schafer DIRECTOR ELECTIONS ISSUER 52143.000000 0 FOR 52143.000000 FOR S000004450 Repare Therapeutics Inc. 760273102 US7602731025 06/17/2025 To elect the four nominees of our board of directors, to our board of directors as Class II directors, each to hold office until our Annual Meeting of Shareholders in 2028 and until such director's successor has been duly elected, or if sooner, until the director's death, resignation or removal: Steven Stein, M.D. DIRECTOR ELECTIONS ISSUER 52143.000000 0 FOR 52143.000000 FOR S000004450 Repare Therapeutics Inc. 760273102 US7602731025 06/17/2025 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 52143.000000 0 FOR 52143.000000 FOR S000004450 Repare Therapeutics Inc. 760273102 US7602731025 06/17/2025 To appoint Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025, and to authorize our board of directors to fix Ernst & Young LLP's remuneration AUDIT-RELATED ISSUER 52143.000000 0 FOR 52143.000000 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/17/2025 The election of seven directors to serve until the 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Eliav Barr DIRECTOR ELECTIONS ISSUER 241727.000000 0 FOR 241727.000000 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/17/2025 The election of seven directors to serve until the 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Muna Bhanji DIRECTOR ELECTIONS ISSUER 241727.000000 0 FOR 241727.000000 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/17/2025 The election of seven directors to serve until the 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Karin Eastham DIRECTOR ELECTIONS ISSUER 241727.000000 0 FOR 241727.000000 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/17/2025 The election of seven directors to serve until the 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Jens Holstein DIRECTOR ELECTIONS ISSUER 241727.000000 0 FOR 241727.000000 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/17/2025 The election of seven directors to serve until the 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Tom Miller DIRECTOR ELECTIONS ISSUER 241727.000000 0 FOR 241727.000000 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/17/2025 The election of seven directors to serve until the 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Brent Shafer DIRECTOR ELECTIONS ISSUER 241727.000000 0 FOR 241727.000000 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/17/2025 The election of seven directors to serve until the 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Marc Stapley DIRECTOR ELECTIONS ISSUER 241727.000000 0 FOR 241727.000000 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/17/2025 The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 241727.000000 0 FOR 241727.000000 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/17/2025 The approval, on a non-binding advisory basis, of the compensation of our named executive officers, as disclosed in our proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 241727.000000 0 FOR 241727.000000 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/17/2025 The selection, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named executive officers should be held every one, two or three years. SECTION 14A SAY-ON-PAY VOTES ISSUER 241727.000000 0 ONE YEAR 241727.000000 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/17/2025 The approval of an amendment to our Veracyte, Inc. 2023 Equity Incentive Plan. COMPENSATION ISSUER 241727.000000 0 FOR 241727.000000 FOR S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 US98943L1070 06/17/2025 Election of Class II Directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified, subject to their earlier death, resignation or removal: Scott Myers DIRECTOR ELECTIONS ISSUER 154083.000000 0 FOR 154083.000000 FOR S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 US98943L1070 06/17/2025 Election of Class II Directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified, subject to their earlier death, resignation or removal: Karan Takhar DIRECTOR ELECTIONS ISSUER 154083.000000 0 FOR 154083.000000 FOR S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 US98943L1070 06/17/2025 Election of Class II Directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified, subject to their earlier death, resignation or removal: Luke Walker, M.D. DIRECTOR ELECTIONS ISSUER 154083.000000 0 FOR 154083.000000 FOR S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 US98943L1070 06/17/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 154083.000000 0 FOR 154083.000000 FOR S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 US98943L1070 06/17/2025 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 154083.000000 0 FOR 154083.000000 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/18/2025 Election of Directors - To elect the six director nominees to our board of directors, each to serve as a director for a term of one year expiring at the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified. The following persons have been nominated as directors: Terence Connors DIRECTOR ELECTIONS ISSUER 272974.000000 0 FOR 272974.000000 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/18/2025 Election of Directors - To elect the six director nominees to our board of directors, each to serve as a director for a term of one year expiring at the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified. The following persons have been nominated as directors: Brad Coppens DIRECTOR ELECTIONS ISSUER 272974.000000 0 FOR 272974.000000 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/18/2025 Election of Directors - To elect the six director nominees to our board of directors, each to serve as a director for a term of one year expiring at the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified. The following persons have been nominated as directors: Ted Lundberg DIRECTOR ELECTIONS ISSUER 272974.000000 0 FOR 272974.000000 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/18/2025 Election of Directors - To elect the six director nominees to our board of directors, each to serve as a director for a term of one year expiring at the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified. The following persons have been nominated as directors: Dr. Susan Weaver DIRECTOR ELECTIONS ISSUER 272974.000000 0 FOR 272974.000000 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/18/2025 Election of Directors - To elect the six director nominees to our board of directors, each to serve as a director for a term of one year expiring at the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified. The following persons have been nominated as directors: David Williams III DIRECTOR ELECTIONS ISSUER 272974.000000 0 FOR 272974.000000 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/18/2025 Election of Directors - To elect the six director nominees to our board of directors, each to serve as a director for a term of one year expiring at the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified. The following persons have been nominated as directors: Dale Wolf DIRECTOR ELECTIONS ISSUER 272974.000000 0 FOR 272974.000000 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/18/2025 Ratification of Appointment of KPMG LLP - To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 272974.000000 0 FOR 272974.000000 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/18/2025 Say-on-Pay - Non-binding advisory vote to approve the compensation paid to AdaptHealth's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 272974.000000 0 FOR 272974.000000 FOR S000004450 Addus HomeCare Corporation 006739106 US0067391062 06/18/2025 Election of Directors: Esteban Lopez, M.D. DIRECTOR ELECTIONS ISSUER 56652.000000 0 FOR 56652.000000 FOR S000004450 Addus HomeCare Corporation 006739106 US0067391062 06/18/2025 Election of Directors: Jean Rush DIRECTOR ELECTIONS ISSUER 56652.000000 0 FOR 56652.000000 FOR S000004450 Addus HomeCare Corporation 006739106 US0067391062 06/18/2025 Election of Directors: Susan T. Weaver, M.D., FACP DIRECTOR ELECTIONS ISSUER 56652.000000 0 FOR 56652.000000 FOR S000004450 Addus HomeCare Corporation 006739106 US0067391062 06/18/2025 To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditor for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 56652.000000 0 FOR 56652.000000 FOR S000004450 Addus HomeCare Corporation 006739106 US0067391062 06/18/2025 To approve, on an advisory, non-binding basis, the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 56652.000000 0 FOR 56652.000000 FOR S000004450 Addus HomeCare Corporation 006739106 US0067391062 06/18/2025 To approve, on an advisory, non-binding basis, the frequency of holding an advisory, non-binding vote on the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 56652.000000 0 ONE YEAR 56652.000000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 US00847X1046 06/18/2025 To elect each of the two Class III director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Jacqualyn A. Fouse, Ph.D. DIRECTOR ELECTIONS ISSUER 160134.000000 0 FOR 160134.000000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 US00847X1046 06/18/2025 To elect each of the two Class III director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: David Scadden, M.D. DIRECTOR ELECTIONS ISSUER 160134.000000 0 FOR 160134.000000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 US00847X1046 06/18/2025 To vote, on an advisory basis, to approve the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 160134.000000 0 FOR 160134.000000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 US00847X1046 06/18/2025 To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, to increase the number of shares of common stock available thereunder by 2,500,000 shares. COMPENSATION ISSUER 160134.000000 0 FOR 160134.000000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 US00847X1046 06/18/2025 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 160134.000000 0 FOR 160134.000000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 US0197701065 06/18/2025 Election of Directors: Elizabeth Barrett DIRECTOR ELECTIONS ISSUER 456771.000000 0 WITHHOLD 456771.000000 AGAINST S000004450 Allogene Therapeutics, Inc. 019770106 US0197701065 06/18/2025 Election of Directors: Arie Belldegrun, M.D. DIRECTOR ELECTIONS ISSUER 456771.000000 0 FOR 456771.000000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 US0197701065 06/18/2025 Election of Directors: David Chang, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 456771.000000 0 FOR 456771.000000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 US0197701065 06/18/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 456771.000000 0 FOR 456771.000000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 US0197701065 06/18/2025 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 456771.000000 0 FOR 456771.000000 FOR S000004450 Ardelyx, Inc. 039697107 US0396971071 06/18/2025 To elect two Class II directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified: David Mott DIRECTOR ELECTIONS ISSUER 735767.000000 0 FOR 735767.000000 FOR S000004450 Ardelyx, Inc. 039697107 US0396971071 06/18/2025 To elect two Class II directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified: Michael Raab DIRECTOR ELECTIONS ISSUER 735767.000000 0 FOR 735767.000000 FOR S000004450 Ardelyx, Inc. 039697107 US0396971071 06/18/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"); SECTION 14A SAY-ON-PAY VOTES ISSUER 735767.000000 0 FOR 735767.000000 FOR S000004450 Ardelyx, Inc. 039697107 US0396971071 06/18/2025 To ratify the selection, by the Audit and Compliance Committee of our Board of Directors, of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025; AUDIT-RELATED ISSUER 735767.000000 0 FOR 735767.000000 FOR S000004450 Ardelyx, Inc. 039697107 US0396971071 06/18/2025 To approve the Amendment to the Amended and Restated 2014 Equity Incentive Award Plan; and COMPENSATION ISSUER 735767.000000 0 FOR 735767.000000 FOR S000004450 ArriVent BioPharma, Inc. 04272N102 US04272N1028 06/18/2025 Election of Directors: Zhengbin (Bing) Yao, Ph.D. DIRECTOR ELECTIONS ISSUER 41944.000000 0 FOR 41944.000000 FOR S000004450 ArriVent BioPharma, Inc. 04272N102 US04272N1028 06/18/2025 Election of Directors: Kristine Peterson DIRECTOR ELECTIONS ISSUER 41944.000000 0 FOR 41944.000000 FOR S000004450 ArriVent BioPharma, Inc. 04272N102 US04272N1028 06/18/2025 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 41944.000000 0 FOR 41944.000000 FOR S000004450 Blueprint Medicines Corporation 09627Y109 US09627Y1091 06/18/2025 Election of class I directors each to serve for a three-year term, or until their successor has been duly elected and qualified: Jeffrey Albers DIRECTOR ELECTIONS ISSUER 198054.000000 0 FOR 198054.000000 FOR S000004450 Blueprint Medicines Corporation 09627Y109 US09627Y1091 06/18/2025 Election of class I directors each to serve for a three-year term, or until their successor has been duly elected and qualified: Mark Goldberg, M.D. DIRECTOR ELECTIONS ISSUER 198054.000000 0 FOR 198054.000000 FOR S000004450 Blueprint Medicines Corporation 09627Y109 US09627Y1091 06/18/2025 Election of class I directors each to serve for a three-year term, or until their successor has been duly elected and qualified: John Tsai, M.D. DIRECTOR ELECTIONS ISSUER 198054.000000 0 FOR 198054.000000 FOR S000004450 Blueprint Medicines Corporation 09627Y109 US09627Y1091 06/18/2025 Approval of a non-binding advisory vote on the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 198054.000000 0 FOR 198054.000000 FOR S000004450 Blueprint Medicines Corporation 09627Y109 US09627Y1091 06/18/2025 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 198054.000000 0 FOR 198054.000000 FOR S000004450 CARGO Therapeutics, Inc. 14179K101 US14179K1016 06/18/2025 To elect three Class II directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Abraham Bassan DIRECTOR ELECTIONS ISSUER 57317.000000 0 FOR 57317.000000 FOR S000004450 CARGO Therapeutics, Inc. 14179K101 US14179K1016 06/18/2025 To elect three Class II directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Kapil Dhingra DIRECTOR ELECTIONS ISSUER 57317.000000 0 FOR 57317.000000 FOR S000004450 CARGO Therapeutics, Inc. 14179K101 US14179K1016 06/18/2025 To elect three Class II directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: David Lubner DIRECTOR ELECTIONS ISSUER 57317.000000 0 FOR 57317.000000 FOR S000004450 CARGO Therapeutics, Inc. 14179K101 US14179K1016 06/18/2025 To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of Deloitte & Touche LLP as the independent registered public accounting firm and independent auditor of the Company for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 57317.000000 0 FOR 57317.000000 FOR S000004450 Cytek Biosciences, Inc. 23285D109 US23285D1090 06/18/2025 To elect our two Class I director nominees, each to serve a three-year term, expiring at our 2028 annual meeting of stockholders and until his or her successor is duly elected and qualified, or until his or her earlier death, resignation or removal: Richard Chin, M.D. DIRECTOR ELECTIONS ISSUER 341789.000000 0 FOR 341789.000000 FOR S000004450 Cytek Biosciences, Inc. 23285D109 US23285D1090 06/18/2025 To elect our two Class I director nominees, each to serve a three-year term, expiring at our 2028 annual meeting of stockholders and until his or her successor is duly elected and qualified, or until his or her earlier death, resignation or removal: Deborah Neff DIRECTOR ELECTIONS ISSUER 341789.000000 0 WITHHOLD 341789.000000 AGAINST S000004450 Cytek Biosciences, Inc. 23285D109 US23285D1090 06/18/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers for the year ended December 31, 2024, as set forth in our proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 341789.000000 0 FOR 341789.000000 FOR S000004450 Cytek Biosciences, Inc. 23285D109 US23285D1090 06/18/2025 To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 341789.000000 0 FOR 341789.000000 FOR S000004450 EyePoint Pharmaceuticals, Inc. 30233G209 US30233G2093 06/18/2025 Election of Directors: Goran Ando, M.D. DIRECTOR ELECTIONS ISSUER 182175.000000 0 FOR 182175.000000 FOR S000004450 EyePoint Pharmaceuticals, Inc. 30233G209 US30233G2093 06/18/2025 Election of Directors: Jay S. Duker, M.D. DIRECTOR ELECTIONS ISSUER 182175.000000 0 FOR 182175.000000 FOR S000004450 EyePoint Pharmaceuticals, Inc. 30233G209 US30233G2093 06/18/2025 Election of Directors: Nancy Lurker DIRECTOR ELECTIONS ISSUER 182175.000000 0 FOR 182175.000000 FOR S000004450 EyePoint Pharmaceuticals, Inc. 30233G209 US30233G2093 06/18/2025 Election of Directors: John B. Landis, Ph.D. DIRECTOR ELECTIONS ISSUER 182175.000000 0 FOR 182175.000000 FOR S000004450 EyePoint Pharmaceuticals, Inc. 30233G209 US30233G2093 06/18/2025 Election of Directors: Wendy DiCicco DIRECTOR ELECTIONS ISSUER 182175.000000 0 FOR 182175.000000 FOR S000004450 EyePoint Pharmaceuticals, Inc. 30233G209 US30233G2093 06/18/2025 Election of Directors: Karen Zaderej DIRECTOR ELECTIONS ISSUER 182175.000000 0 FOR 182175.000000 FOR S000004450 EyePoint Pharmaceuticals, Inc. 30233G209 US30233G2093 06/18/2025 Election of Directors: Stuart Duty DIRECTOR ELECTIONS ISSUER 182175.000000 0 FOR 182175.000000 FOR S000004450 EyePoint Pharmaceuticals, Inc. 30233G209 US30233G2093 06/18/2025 Election of Directors: Fred Hassan DIRECTOR ELECTIONS ISSUER 182175.000000 0 FOR 182175.000000 FOR S000004450 EyePoint Pharmaceuticals, Inc. 30233G209 US30233G2093 06/18/2025 Election of Directors: Reginald Sanders, M.D. DIRECTOR ELECTIONS ISSUER 182175.000000 0 FOR 182175.000000 FOR S000004450 EyePoint Pharmaceuticals, Inc. 30233G209 US30233G2093 06/18/2025 To approve Amendment No. 2 to the EyePoint Pharmaceuticals, Inc. 2023 Long-Term Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 2,900,000 shares. COMPENSATION ISSUER 182175.000000 0 FOR 182175.000000 FOR S000004450 EyePoint Pharmaceuticals, Inc. 30233G209 US30233G2093 06/18/2025 To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 182175.000000 0 FOR 182175.000000 FOR S000004450 EyePoint Pharmaceuticals, Inc. 30233G209 US30233G2093 06/18/2025 To vote, on an advisory basis, on the frequency of advisory stockholder votes on the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 182175.000000 0 ONE YEAR 182175.000000 FOR S000004450 EyePoint Pharmaceuticals, Inc. 30233G209 US30233G2093 06/18/2025 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 182175.000000 0 FOR 182175.000000 FOR S000004450 GeneDx Holdings Corp. 81663L200 US81663L2007 06/18/2025 Election of Directors: Eli D. Casdin DIRECTOR ELECTIONS ISSUER 51477.000000 0 FOR 51477.000000 FOR S000004450 GeneDx Holdings Corp. 81663L200 US81663L2007 06/18/2025 Election of Directors: Joshua Ruch DIRECTOR ELECTIONS ISSUER 51477.000000 0 FOR 51477.000000 FOR S000004450 GeneDx Holdings Corp. 81663L200 US81663L2007 06/18/2025 Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025 AUDIT-RELATED ISSUER 51477.000000 0 FOR 51477.000000 FOR S000004450 Guardant Health, Inc. 40131M109 US40131M1099 06/18/2025 Election of Class I Directors: Vijaya Gadde DIRECTOR ELECTIONS ISSUER 384600.000000 0 FOR 384600.000000 FOR S000004450 Guardant Health, Inc. 40131M109 US40131M1099 06/18/2025 Election of Class I Directors: Roberto Mignone DIRECTOR ELECTIONS ISSUER 384600.000000 0 FOR 384600.000000 FOR S000004450 Guardant Health, Inc. 40131M109 US40131M1099 06/18/2025 Election of Class I Directors: Myrtle Potter DIRECTOR ELECTIONS ISSUER 384600.000000 0 FOR 384600.000000 FOR S000004450 Guardant Health, Inc. 40131M109 US40131M1099 06/18/2025 Election of Class I Directors: Musa Tariq DIRECTOR ELECTIONS ISSUER 384600.000000 0 FOR 384600.000000 FOR S000004450 Guardant Health, Inc. 40131M109 US40131M1099 06/18/2025 Ratification of the appointment of Deloitte & Touche LLP as Guardant Health, Inc.'s independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 384600.000000 0 FOR 384600.000000 FOR S000004450 Guardant Health, Inc. 40131M109 US40131M1099 06/18/2025 Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 384600.000000 0 FOR 384600.000000 FOR S000004450 Harrow, Inc. 415858109 US4158581094 06/18/2025 Election of Directors: Mark L. Baum DIRECTOR ELECTIONS ISSUER 94372.000000 0 FOR 94372.000000 FOR S000004450 Harrow, Inc. 415858109 US4158581094 06/18/2025 Election of Directors: Adrienne L. Graves DIRECTOR ELECTIONS ISSUER 94372.000000 0 FOR 94372.000000 FOR S000004450 Harrow, Inc. 415858109 US4158581094 06/18/2025 Election of Directors: Lauren P. Silvernail DIRECTOR ELECTIONS ISSUER 94372.000000 0 FOR 94372.000000 FOR S000004450 Harrow, Inc. 415858109 US4158581094 06/18/2025 Election of Directors: Perry J. Sternberg DIRECTOR ELECTIONS ISSUER 94372.000000 0 FOR 94372.000000 FOR S000004450 Harrow, Inc. 415858109 US4158581094 06/18/2025 To approve the Harrow, Inc. 2025 Incentive Stock and Awards Plan COMPENSATION ISSUER 94372.000000 0 FOR 94372.000000 FOR S000004450 Harrow, Inc. 415858109 US4158581094 06/18/2025 Ratification of the selection of Crowe LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 94372.000000 0 FOR 94372.000000 FOR S000004450 Harrow, Inc. 415858109 US4158581094 06/18/2025 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as presented in the proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 94372.000000 0 FOR 94372.000000 FOR S000004450 Harrow, Inc. 415858109 US4158581094 06/18/2025 To approve, on a non-binding advisory basis, the frequency of a stockholder advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 94372.000000 0 ONE YEAR 94372.000000 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/18/2025 Election of Directors: Patrick Soon-Shiong, M.D. DIRECTOR ELECTIONS ISSUER 258747.000000 403100.000000 FOR 258747.000000 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/18/2025 Election of Directors: Cheryl L. Cohen DIRECTOR ELECTIONS ISSUER 258747.000000 403100.000000 FOR 258747.000000 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/18/2025 Election of Directors: Richard Adcock DIRECTOR ELECTIONS ISSUER 258747.000000 403100.000000 FOR 258747.000000 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/18/2025 Election of Directors: Michael D. Blaszyk DIRECTOR ELECTIONS ISSUER 258747.000000 403100.000000 FOR 258747.000000 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/18/2025 Election of Directors: Wesley Clark DIRECTOR ELECTIONS ISSUER 258747.000000 403100.000000 FOR 258747.000000 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/18/2025 Election of Directors: Linda Maxwell, M.D. DIRECTOR ELECTIONS ISSUER 258747.000000 403100.000000 FOR 258747.000000 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/18/2025 Election of Directors: Christobel Selecky DIRECTOR ELECTIONS ISSUER 258747.000000 403100.000000 FOR 258747.000000 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/18/2025 Election of Directors: Barry J. Simon, M.D. DIRECTOR ELECTIONS ISSUER 258747.000000 403100.000000 FOR 258747.000000 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/18/2025 To approve the ImmunityBio, Inc. 2025 Equity Incentive Plan. COMPENSATION ISSUER 258747.000000 403100.000000 AGAINST 258747.000000 AGAINST S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/18/2025 To ratify the selection of Deloitte & Touche LLP as ImmunityBio's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 258747.000000 403100.000000 FOR 258747.000000 FOR S000004450 MaxCyte, Inc. 57777K106 US57777K1060 06/18/2025 To elect the Board's three nominees as identified in the accompanying Proxy Statement as Class I directors: Maher Masoud DIRECTOR ELECTIONS ISSUER 311704.000000 0 FOR 311704.000000 FOR S000004450 MaxCyte, Inc. 57777K106 US57777K1060 06/18/2025 To elect the Board's three nominees as identified in the accompanying Proxy Statement as Class I directors: Yasir Al-Wakeel DIRECTOR ELECTIONS ISSUER 311704.000000 0 FOR 311704.000000 FOR S000004450 MaxCyte, Inc. 57777K106 US57777K1060 06/18/2025 To elect the Board's three nominees as identified in the accompanying Proxy Statement as Class I directors: Rekha Hemrajani DIRECTOR ELECTIONS ISSUER 311704.000000 0 FOR 311704.000000 FOR S000004450 MaxCyte, Inc. 57777K106 US57777K1060 06/18/2025 To approve an amendment to the MaxCyte, Inc. 2022 Equity Incentive Plan to increase the number of shares of the Company's common stock issuable thereunder by 2,950,000 shares. COMPENSATION ISSUER 311704.000000 0 FOR 311704.000000 FOR S000004450 MaxCyte, Inc. 57777K106 US57777K1060 06/18/2025 To approve the cancellation of admission of the Company's common stock to trading on the AIM market of the London Stock Exchange. CAPITAL STRUCTURE ISSUER 311704.000000 0 FOR 311704.000000 FOR S000004450 MaxCyte, Inc. 57777K106 US57777K1060 06/18/2025 To ratify the Audit Committee's selection of CohnReznick LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 311704.000000 0 FOR 311704.000000 FOR S000004450 MaxCyte, Inc. 57777K106 US57777K1060 06/18/2025 To approve the adjournment of the Annual Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies. CORPORATE GOVERNANCE ISSUER 311704.000000 0 FOR 311704.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/18/2025 Election of Directors: M. Kathleen Behrens, Ph.D. DIRECTOR ELECTIONS ISSUER 367117.000000 0 FOR 367117.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/18/2025 Election of Directors: Joseph H. Capper DIRECTOR ELECTIONS ISSUER 367117.000000 0 FOR 367117.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/18/2025 Election of Directors: James L. Bierman DIRECTOR ELECTIONS ISSUER 367117.000000 0 FOR 367117.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/18/2025 Election of Directors: William A. Hawkins, III DIRECTOR ELECTIONS ISSUER 367117.000000 0 FOR 367117.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/18/2025 Election of Directors: Cato T. Laurencin, M.D. DIRECTOR ELECTIONS ISSUER 367117.000000 0 FOR 367117.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/18/2025 Election of Directors: K. Todd Newton DIRECTOR ELECTIONS ISSUER 367117.000000 0 FOR 367117.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/18/2025 Election of Directors: Tiffany Olson DIRECTOR ELECTIONS ISSUER 367117.000000 0 FOR 367117.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/18/2025 Election of Directors: Dorothy Puhy DIRECTOR ELECTIONS ISSUER 367117.000000 0 FOR 367117.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/18/2025 Election of Directors: Martin P. Sutter DIRECTOR ELECTIONS ISSUER 367117.000000 0 FOR 367117.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/18/2025 Advisory approval of executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 367117.000000 0 FOR 367117.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/18/2025 Ratification of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 367117.000000 0 FOR 367117.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/18/2025 Amendment of 2016 Equity and Cash Incentive Plan. COMPENSATION ISSUER 367117.000000 0 FOR 367117.000000 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/18/2025 Advisory vote on frequency of advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 367117.000000 0 ONE YEAR 367117.000000 FOR S000004450 Nuvalent, Inc. 670703107 US6707031075 06/18/2025 Election of the following nominees as Class I directors: Grant Bogle DIRECTOR ELECTIONS ISSUER 112092.000000 0 FOR 112092.000000 FOR S000004450 Nuvalent, Inc. 670703107 US6707031075 06/18/2025 Election of the following nominees as Class I directors: James R. Porter, Ph.D. DIRECTOR ELECTIONS ISSUER 112092.000000 0 FOR 112092.000000 FOR S000004450 Nuvalent, Inc. 670703107 US6707031075 06/18/2025 Election of the following nominees as Class I directors: Anna Protopapas DIRECTOR ELECTIONS ISSUER 112092.000000 0 FOR 112092.000000 FOR S000004450 Nuvalent, Inc. 670703107 US6707031075 06/18/2025 To approve, on an advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 112092.000000 0 FOR 112092.000000 FOR S000004450 Nuvalent, Inc. 670703107 US6707031075 06/18/2025 To ratify the appointment of KPMG LLP as Nuvalent, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 112092.000000 0 FOR 112092.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2025 Election of Directors: Alan L. Bazaar DIRECTOR ELECTIONS ISSUER 101423.000000 0 FOR 101423.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2025 Election of Directors: Wayne Burris DIRECTOR ELECTIONS ISSUER 101423.000000 0 FOR 101423.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2025 Election of Directors: Massimo Calafiore DIRECTOR ELECTIONS ISSUER 101423.000000 0 FOR 101423.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2025 Election of Directors: Vickie L. Capps DIRECTOR ELECTIONS ISSUER 101423.000000 0 FOR 101423.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2025 Election of Directors: Michael M. Finegan DIRECTOR ELECTIONS ISSUER 101423.000000 0 FOR 101423.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2025 Election of Directors: Jason M. Hannon DIRECTOR ELECTIONS ISSUER 101423.000000 0 FOR 101423.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2025 Election of Directors: John B. Henneman, III DIRECTOR ELECTIONS ISSUER 101423.000000 0 FOR 101423.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2025 Election of Directors: Charles R. Kummeth DIRECTOR ELECTIONS ISSUER 101423.000000 0 FOR 101423.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2025 Election of Directors: Shweta Singh Maniar DIRECTOR ELECTIONS ISSUER 101423.000000 0 FOR 101423.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2025 Election of Directors: Michael E. Paolucci DIRECTOR ELECTIONS ISSUER 101423.000000 0 FOR 101423.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2025 Advisory and Non-Binding Vote to Approve Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 101423.000000 0 FOR 101423.000000 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/18/2025 Ratification of the Appointment of Ernst & Young LLP as Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025. AUDIT-RELATED ISSUER 101423.000000 0 FOR 101423.000000 FOR S000004450 Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 06/18/2025 Election of Directors: Zachary Bogue, J.D. DIRECTOR ELECTIONS ISSUER 82066.000000 698100.000000 FOR 82066.000000 FOR S000004450 Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 06/18/2025 Election of Directors: Zavain Dar DIRECTOR ELECTIONS ISSUER 82066.000000 698100.000000 FOR 82066.000000 FOR S000004450 Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 06/18/2025 Election of Directors: Robert Hershberg, M.D. Ph.D. DIRECTOR ELECTIONS ISSUER 82066.000000 698100.000000 WITHHOLD 82066.000000 AGAINST S000004450 Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 06/18/2025 Advisory vote to approve executive compensation as disclosed in the 2025 Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 82066.000000 698100.000000 FOR 82066.000000 FOR S000004450 Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 06/18/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 82066.000000 698100.000000 FOR 82066.000000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Roderick Wong, M.D. DIRECTOR ELECTIONS ISSUER 250125.000000 0 FOR 250125.000000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Elisabeth Bjork, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 250125.000000 0 FOR 250125.000000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Carsten Boess DIRECTOR ELECTIONS ISSUER 250125.000000 0 FOR 250125.000000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Mikael Dolsten, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 250125.000000 0 FOR 250125.000000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Pedro Granadillo DIRECTOR ELECTIONS ISSUER 250125.000000 0 FOR 250125.000000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Gotham Makker, M.D. DIRECTOR ELECTIONS ISSUER 250125.000000 0 FOR 250125.000000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Fady Malik, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 250125.000000 0 FOR 250125.000000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Piratip Pratumsuwan DIRECTOR ELECTIONS ISSUER 250125.000000 0 FOR 250125.000000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Gaurav Shah, M.D. DIRECTOR ELECTIONS ISSUER 250125.000000 0 FOR 250125.000000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: David P. Southwell DIRECTOR ELECTIONS ISSUER 250125.000000 0 FOR 250125.000000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Ratification of the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025; AUDIT-RELATED ISSUER 250125.000000 0 FOR 250125.000000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Consider and act upon a non-binding, advisory vote on the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 250125.000000 0 FOR 250125.000000 FOR S000004450 Schrodinger, Inc. 80810D103 US80810D1037 06/18/2025 Election of Class II Directors to serve until the 2028 Annual Meeting of Stockholders: Jeffrey Chodakewitz DIRECTOR ELECTIONS ISSUER 197158.000000 0 FOR 197158.000000 FOR S000004450 Schrodinger, Inc. 80810D103 US80810D1037 06/18/2025 Election of Class II Directors to serve until the 2028 Annual Meeting of Stockholders: Michael Lynton DIRECTOR ELECTIONS ISSUER 197158.000000 0 FOR 197158.000000 FOR S000004450 Schrodinger, Inc. 80810D103 US80810D1037 06/18/2025 Election of Class II Directors to serve until the 2028 Annual Meeting of Stockholders: Nancy A. Thornberry DIRECTOR ELECTIONS ISSUER 197158.000000 0 FOR 197158.000000 FOR S000004450 Schrodinger, Inc. 80810D103 US80810D1037 06/18/2025 Election of Class II Directors to serve until the 2028 Annual Meeting of Stockholders: Bridget van Kralingen DIRECTOR ELECTIONS ISSUER 197158.000000 0 FOR 197158.000000 FOR S000004450 Schrodinger, Inc. 80810D103 US80810D1037 06/18/2025 Approval of an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 197158.000000 0 FOR 197158.000000 FOR S000004450 Schrodinger, Inc. 80810D103 US80810D1037 06/18/2025 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 197158.000000 0 FOR 197158.000000 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/18/2025 Election of Directors: Arthur C. Butcher DIRECTOR ELECTIONS ISSUER 123134.000000 0 FOR 123134.000000 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/18/2025 Election of Directors: Stephen C. Farrell DIRECTOR ELECTIONS ISSUER 123134.000000 0 FOR 123134.000000 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/18/2025 Election of Directors: Wei Jiang DIRECTOR ELECTIONS ISSUER 123134.000000 0 FOR 123134.000000 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/18/2025 Election of Directors: Louis E. Silverman DIRECTOR ELECTIONS ISSUER 123134.000000 0 FOR 123134.000000 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/18/2025 Election of Directors: Elizabeth Yeu, M.D. DIRECTOR ELECTIONS ISSUER 123134.000000 0 FOR 123134.000000 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/18/2025 Election of Directors: Lilian Y. Zhou DIRECTOR ELECTIONS ISSUER 123134.000000 0 FOR 123134.000000 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/18/2025 Ratification of the appointment of BDO USA, P.C. as our independent registered public accounting firm for the year ending January 2, 2026. AUDIT-RELATED ISSUER 123134.000000 0 FOR 123134.000000 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/18/2025 Non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 123134.000000 0 FOR 123134.000000 FOR S000004450 Standard BioTools Inc. 34385P108 US34385P1084 06/18/2025 Election of Directors: Kathy Hibbs DIRECTOR ELECTIONS ISSUER 696192.000000 0 FOR 696192.000000 FOR S000004450 Standard BioTools Inc. 34385P108 US34385P1084 06/18/2025 Election of Directors: Frank Witney, Ph.D. DIRECTOR ELECTIONS ISSUER 696192.000000 0 FOR 696192.000000 FOR S000004450 Standard BioTools Inc. 34385P108 US34385P1084 06/18/2025 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 696192.000000 0 FOR 696192.000000 FOR S000004450 Standard BioTools Inc. 34385P108 US34385P1084 06/18/2025 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 696192.000000 0 FOR 696192.000000 FOR S000004450 Standard BioTools Inc. 34385P108 US34385P1084 06/18/2025 To approve an amendment to our Amended and Restated 2011 Equity Incentive Plan, as amended, to increase the number of shares of common stock available for issuance thereunder by 17,400,000 shares. COMPENSATION ISSUER 696192.000000 0 FOR 696192.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/18/2025 To elect the following to serve as directors until the annual meeting to be held in 2026 or until their successors are duly elected and qualified: Tim Cabral DIRECTOR ELECTIONS ISSUER 480588.000000 0 FOR 480588.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/18/2025 To elect the following to serve as directors until the annual meeting to be held in 2026 or until their successors are duly elected and qualified: Mark Carges DIRECTOR ELECTIONS ISSUER 480588.000000 0 FOR 480588.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/18/2025 To elect the following to serve as directors until the annual meeting to be held in 2026 or until their successors are duly elected and qualified: Peter P. Gassner DIRECTOR ELECTIONS ISSUER 480588.000000 0 FOR 480588.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/18/2025 To elect the following to serve as directors until the annual meeting to be held in 2026 or until their successors are duly elected and qualified: Mary Lynne Hedley DIRECTOR ELECTIONS ISSUER 480588.000000 0 FOR 480588.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/18/2025 To elect the following to serve as directors until the annual meeting to be held in 2026 or until their successors are duly elected and qualified: Priscilla Hung DIRECTOR ELECTIONS ISSUER 480588.000000 0 FOR 480588.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/18/2025 To elect the following to serve as directors until the annual meeting to be held in 2026 or until their successors are duly elected and qualified: Marshall Mohr DIRECTOR ELECTIONS ISSUER 480588.000000 0 FOR 480588.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/18/2025 To elect the following to serve as directors until the annual meeting to be held in 2026 or until their successors are duly elected and qualified: Gordon Ritter DIRECTOR ELECTIONS ISSUER 480588.000000 0 FOR 480588.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/18/2025 To elect the following to serve as directors until the annual meeting to be held in 2026 or until their successors are duly elected and qualified: Paul Sekhri DIRECTOR ELECTIONS ISSUER 480588.000000 0 FOR 480588.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/18/2025 To elect the following to serve as directors until the annual meeting to be held in 2026 or until their successors are duly elected and qualified: Matthew J. Wallach DIRECTOR ELECTIONS ISSUER 480588.000000 0 FOR 480588.000000 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/18/2025 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2026. AUDIT-RELATED ISSUER 480588.000000 0 FOR 480588.000000 FOR S000004450 IRADIMED CORPORATION 46266A109 US46266A1097 06/19/2025 Election of Directors: Roger Susi DIRECTOR ELECTIONS ISSUER 23787.000000 0 FOR 23787.000000 FOR S000004450 IRADIMED CORPORATION 46266A109 US46266A1097 06/19/2025 Election of Directors: Monty Allen DIRECTOR ELECTIONS ISSUER 23787.000000 0 FOR 23787.000000 FOR S000004450 IRADIMED CORPORATION 46266A109 US46266A1097 06/19/2025 Election of Directors: Anthony Vuoto DIRECTOR ELECTIONS ISSUER 23787.000000 0 FOR 23787.000000 FOR S000004450 IRADIMED CORPORATION 46266A109 US46266A1097 06/19/2025 Election of Directors: Hilda Scharen-Guivel DIRECTOR ELECTIONS ISSUER 23787.000000 0 FOR 23787.000000 FOR S000004450 IRADIMED CORPORATION 46266A109 US46266A1097 06/19/2025 Election of Directors: James Hawkins DIRECTOR ELECTIONS ISSUER 23787.000000 0 FOR 23787.000000 FOR S000004450 IRADIMED CORPORATION 46266A109 US46266A1097 06/19/2025 To ratify the appointment of RSM US LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2025; and AUDIT-RELATED ISSUER 23787.000000 0 FOR 23787.000000 FOR S000004450 IRADIMED CORPORATION 46266A109 US46266A1097 06/19/2025 To approve, on a non-binding advisory basis, the 2024 compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 23787.000000 0 FOR 23787.000000 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 US04683R1068 06/20/2025 Election of Class II Directors: Bruno Lucidi DIRECTOR ELECTIONS ISSUER 183687.000000 0 FOR 183687.000000 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 US04683R1068 06/20/2025 Election of Class II Directors: Polly Murphy, DVM, PhD DIRECTOR ELECTIONS ISSUER 183687.000000 0 FOR 183687.000000 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 US04683R1068 06/20/2025 Election of Class II Directors: Bruce Polsky, MD, MACP, FIDSA DIRECTOR ELECTIONS ISSUER 183687.000000 0 FOR 183687.000000 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 US04683R1068 06/20/2025 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 183687.000000 0 FOR 183687.000000 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 US04683R1068 06/20/2025 Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 183687.000000 0 FOR 183687.000000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/20/2025 To elect five (5) nominees for director, Neil Kumar, Ph.D., Charles Homcy, M.D., Douglas A. Dachille, Ronald J. Daniels and Andrew W. Lo, Ph.D., to serve as Class III directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2027 and until their successors are duly elected and qualified: Neil Kumar, Ph.D. DIRECTOR ELECTIONS ISSUER 382326.000000 0 FOR 382326.000000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/20/2025 To elect five (5) nominees for director, Neil Kumar, Ph.D., Charles Homcy, M.D., Douglas A. Dachille, Ronald J. Daniels and Andrew W. Lo, Ph.D., to serve as Class III directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2027 and until their successors are duly elected and qualified: Charles Homcy, M.D. DIRECTOR ELECTIONS ISSUER 382326.000000 0 FOR 382326.000000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/20/2025 To elect five (5) nominees for director, Neil Kumar, Ph.D., Charles Homcy, M.D., Douglas A. Dachille, Ronald J. Daniels and Andrew W. Lo, Ph.D., to serve as Class III directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2027 and until their successors are duly elected and qualified: Douglas A. Dachille DIRECTOR ELECTIONS ISSUER 382326.000000 0 FOR 382326.000000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/20/2025 To elect five (5) nominees for director, Neil Kumar, Ph.D., Charles Homcy, M.D., Douglas A. Dachille, Ronald J. Daniels and Andrew W. Lo, Ph.D., to serve as Class III directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2027 and until their successors are duly elected and qualified: Ronald J. Daniels DIRECTOR ELECTIONS ISSUER 382326.000000 0 FOR 382326.000000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/20/2025 To elect five (5) nominees for director, Neil Kumar, Ph.D., Charles Homcy, M.D., Douglas A. Dachille, Ronald J. Daniels and Andrew W. Lo, Ph.D., to serve as Class III directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2027 and until their successors are duly elected and qualified: Andrew W. Lo, Ph.D. DIRECTOR ELECTIONS ISSUER 382326.000000 0 FOR 382326.000000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/20/2025 To cast a non-binding, advisory vote to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 382326.000000 0 FOR 382326.000000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/20/2025 To ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 382326.000000 0 FOR 382326.000000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/20/2025 To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 5,000,000 shares. COMPENSATION ISSUER 382326.000000 0 FOR 382326.000000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/20/2025 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to include an officer exculpation provision that limits the liability of certain of our officers as permitted under current Delaware law. CORPORATE GOVERNANCE ISSUER 382326.000000 0 FOR 382326.000000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/20/2025 To approve the adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve any of the above proposals. CORPORATE GOVERNANCE ISSUER 382326.000000 0 FOR 382326.000000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/20/2025 Re-election of Class III directors: Julian Baker DIRECTOR ELECTIONS ISSUER 40782.000000 0 FOR 40782.000000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/20/2025 Re-election of Class III directors: Raymond Cheong, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 40782.000000 0 FOR 40782.000000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/20/2025 Re-election of Class III directors: Jacqualyn Fouse, Ph.D. DIRECTOR ELECTIONS ISSUER 40782.000000 0 FOR 40782.000000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/20/2025 Re-election of Class III directors: Richard Levy, M.D. DIRECTOR ELECTIONS ISSUER 40782.000000 0 FOR 40782.000000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/20/2025 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 AUDIT-RELATED ISSUER 40782.000000 0 FOR 40782.000000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/20/2025 Advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 40782.000000 0 FOR 40782.000000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/20/2025 Advisory vote to approve the frequency of future advisory votes to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 40782.000000 0 ONE YEAR 40782.000000 FOR S000004450 Novavax, Inc. 670002401 US6700024010 06/20/2025 Election of three Class III directors to serve on the board of directors, each for a three-year term expiring at the 2028 Annual Meeting of Stockholders: Rachel K. King DIRECTOR ELECTIONS ISSUER 450151.000000 0 FOR 450151.000000 FOR S000004450 Novavax, Inc. 670002401 US6700024010 06/20/2025 Election of three Class III directors to serve on the board of directors, each for a three-year term expiring at the 2028 Annual Meeting of Stockholders: John W. Shiver, Ph.D. DIRECTOR ELECTIONS ISSUER 450151.000000 0 FOR 450151.000000 FOR S000004450 Novavax, Inc. 670002401 US6700024010 06/20/2025 Election of three Class III directors to serve on the board of directors, each for a three-year term expiring at the 2028 Annual Meeting of Stockholders: Charles W. Newton DIRECTOR ELECTIONS ISSUER 450151.000000 0 FOR 450151.000000 FOR S000004450 Novavax, Inc. 670002401 US6700024010 06/20/2025 The approval, on an advisory basis, of the compensation paid of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 450151.000000 0 FOR 450151.000000 FOR S000004450 Novavax, Inc. 670002401 US6700024010 06/20/2025 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 450151.000000 0 FOR 450151.000000 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/20/2025 To elect the Class III director nominees named below to hold office until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Harold E. Selick, Ph.D. DIRECTOR ELECTIONS ISSUER 139789.000000 0 FOR 139789.000000 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/20/2025 To elect the Class III director nominees named below to hold office until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Bryan Giraudo DIRECTOR ELECTIONS ISSUER 139789.000000 0 FOR 139789.000000 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/20/2025 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 139789.000000 0 FOR 139789.000000 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/20/2025 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 139789.000000 0 FOR 139789.000000 FOR S000004450 Scilex Holding Company 80880W205 US80880W2052 06/20/2025 Election of Directors: Henry Ji, Ph.D. DIRECTOR ELECTIONS ISSUER 6281.000000 0 FOR 6281.000000 FOR S000004450 Scilex Holding Company 80880W205 US80880W2052 06/20/2025 Election of Directors: Jaisim Shah DIRECTOR ELECTIONS ISSUER 6281.000000 0 FOR 6281.000000 FOR S000004450 Scilex Holding Company 80880W205 US80880W2052 06/20/2025 Proposal to ratify the appointment of BPM LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 6281.000000 0 FOR 6281.000000 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/20/2025 To elect the three Class I director nominees to serve until the 2028 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Jeff Ajer DIRECTOR ELECTIONS ISSUER 173234.000000 0 FOR 173234.000000 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/20/2025 To elect the three Class I director nominees to serve until the 2028 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Chris Cain, Ph.D. DIRECTOR ELECTIONS ISSUER 173234.000000 0 FOR 173234.000000 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/20/2025 To elect the three Class I director nominees to serve until the 2028 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Sarah Gheuens, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 173234.000000 0 FOR 173234.000000 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/20/2025 To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 173234.000000 0 FOR 173234.000000 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/20/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 173234.000000 0 FOR 173234.000000 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/20/2025 To approve a further amendment and restatement of the Company's Amended and Restated 2016 Equity Incentive Plan, including increasing the number of shares available for issuance thereunder by 8,000,000 shares. COMPENSATION ISSUER 173234.000000 0 FOR 173234.000000 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/20/2025 To approve the Viridian Therapeutics, Inc. 2025 Employee Stock Purchase Plan. COMPENSATION ISSUER 173234.000000 0 FOR 173234.000000 FOR S000004450 HilleVax, Inc. 43157M102 US43157M1027 06/23/2025 To elect three directors to serve as Class III directors for a three-year term to expire at the 2028 annual meeting of stockholders: Robert Hershberg, M.D., Ph. D. DIRECTOR ELECTIONS ISSUER 57986.000000 0 FOR 57986.000000 FOR S000004450 HilleVax, Inc. 43157M102 US43157M1027 06/23/2025 To elect three directors to serve as Class III directors for a three-year term to expire at the 2028 annual meeting of stockholders: Jeryl Hilleman DIRECTOR ELECTIONS ISSUER 57986.000000 0 FOR 57986.000000 FOR S000004450 HilleVax, Inc. 43157M102 US43157M1027 06/23/2025 To elect three directors to serve as Class III directors for a three-year term to expire at the 2028 annual meeting of stockholders: Aditya Kohli, Ph.D. DIRECTOR ELECTIONS ISSUER 57986.000000 0 FOR 57986.000000 FOR S000004450 HilleVax, Inc. 43157M102 US43157M1027 06/23/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 57986.000000 0 FOR 57986.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/23/2025 Election of Directors: Robert Ades DIRECTOR ELECTIONS ISSUER 172175.000000 0 FOR 172175.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/23/2025 Election of Directors: Michael J. Driscoll DIRECTOR ELECTIONS ISSUER 172175.000000 0 FOR 172175.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/23/2025 Election of Directors: Prathyusha Duraibabu DIRECTOR ELECTIONS ISSUER 172175.000000 0 FOR 172175.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/23/2025 Election of Directors: Jon Giacomin DIRECTOR ELECTIONS ISSUER 172175.000000 0 FOR 172175.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/23/2025 Election of Directors: Gary S. Gillheeney, Sr. DIRECTOR ELECTIONS ISSUER 172175.000000 0 FOR 172175.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/23/2025 Election of Directors: Michele Korfin DIRECTOR ELECTIONS ISSUER 172175.000000 0 FOR 172175.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/23/2025 Election of Directors: Arthur S. Leibowitz DIRECTOR ELECTIONS ISSUER 172175.000000 0 FOR 172175.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/23/2025 Election of Directors: Glenn H. Nussdorf DIRECTOR ELECTIONS ISSUER 172175.000000 0 FOR 172175.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/23/2025 Election of Directors: Gilberto Quintero DIRECTOR ELECTIONS ISSUER 172175.000000 0 FOR 172175.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/23/2025 Approval, on an advisory basis, of the compensation paid to our named executive officers, as disclosed in the Company's proxy statement for its 2025 annual meeting of shareholders. SECTION 14A SAY-ON-PAY VOTES ISSUER 172175.000000 0 FOR 172175.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/23/2025 Approval of the issuance of, or in excess of, 20% of the Company's outstanding Class A common stock upon the conversion of the Company's Series A Convertible Preferred Stock at less than the "minimum price under Nasdaq Listing Rule 5635(d), and which may be deemed a "change of control" under Nasdaq Listing Rule 5635(b) or any successor rule, pursuant to the terms of the Certificate of Designations of Series A Convertible Preferred Stock governing the Series A Convertible Preferred Stock. CAPITAL STRUCTURE ISSUER 172175.000000 0 FOR 172175.000000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/23/2025 Appointment of RSM US LLP as independent registered public accounting firm for fiscal year 2025. AUDIT-RELATED ISSUER 172175.000000 0 FOR 172175.000000 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 US29337E1029 06/24/2025 To elect the three Class II directors named in the accompanying proxy statement to serve until the 2028 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Rahul D. Ballal, Ph.D. DIRECTOR ELECTIONS ISSUER 68949.000000 0 FOR 68949.000000 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 US29337E1029 06/24/2025 To elect the three Class II directors named in the accompanying proxy statement to serve until the 2028 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Jake Bauer, M.B.A. DIRECTOR ELECTIONS ISSUER 68949.000000 0 FOR 68949.000000 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 US29337E1029 06/24/2025 To elect the three Class II directors named in the accompanying proxy statement to serve until the 2028 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Andrew Phillips, Ph.D. DIRECTOR ELECTIONS ISSUER 68949.000000 0 FOR 68949.000000 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 US29337E1029 06/24/2025 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 68949.000000 0 FOR 68949.000000 FOR S000004450 Erasca, Inc. 29479A108 US29479A1088 06/24/2025 To elect three directors to serve as Class I directors for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Jonathan E. Lim, M.D. DIRECTOR ELECTIONS ISSUER 531494.000000 0 FOR 531494.000000 FOR S000004450 Erasca, Inc. 29479A108 US29479A1088 06/24/2025 To elect three directors to serve as Class I directors for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: James A. Bristol, Ph.D. DIRECTOR ELECTIONS ISSUER 531494.000000 0 FOR 531494.000000 FOR S000004450 Erasca, Inc. 29479A108 US29479A1088 06/24/2025 To elect three directors to serve as Class I directors for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Valerie Harding - Start, Ph.D. DIRECTOR ELECTIONS ISSUER 531494.000000 0 FOR 531494.000000 FOR S000004450 Erasca, Inc. 29479A108 US29479A1088 06/24/2025 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025 AUDIT-RELATED ISSUER 531494.000000 0 FOR 531494.000000 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 US45166A1025 06/24/2025 To elect two Class III directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Jeffery L. Stein. Ph.D. DIRECTOR ELECTIONS ISSUER 243539.000000 0 FOR 243539.000000 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 US45166A1025 06/24/2025 To elect two Class III directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Scott W. Morrison DIRECTOR ELECTIONS ISSUER 243539.000000 0 FOR 243539.000000 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 US45166A1025 06/24/2025 To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025; AUDIT-RELATED ISSUER 243539.000000 0 FOR 243539.000000 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 US45166A1025 06/24/2025 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders. SECTION 14A SAY-ON-PAY VOTES ISSUER 243539.000000 0 FOR 243539.000000 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2025 Election of the Class II directors, each to serve for a three year term until the 2028 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Jennifer Good DIRECTOR ELECTIONS ISSUER 143331.000000 0 FOR 143331.000000 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2025 Election of the Class II directors, each to serve for a three year term until the 2028 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Edward T. Mathers DIRECTOR ELECTIONS ISSUER 143331.000000 0 FOR 143331.000000 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2025 Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 143331.000000 0 FOR 143331.000000 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2025 Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 143331.000000 0 FOR 143331.000000 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2025 Approval of an amendment to our Amended and Restated Certificate of Incorporation to provide for exculpation of officers from breaches of fiduciary duty to the fullest extent permitted by the General Corporation Law of the State of Delaware (the "Officer Exculpation Proposal"). CORPORATE GOVERNANCE ISSUER 143331.000000 0 FOR 143331.000000 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2025 Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve the Officer Exculpation Amendment. CORPORATE GOVERNANCE ISSUER 143331.000000 0 FOR 143331.000000 FOR S000004450 ARS Pharmaceuticals, Inc. 82835W108 US82835W1080 06/25/2025 To elect the four nominees for Class II director named in the proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Richard Lowenthal DIRECTOR ELECTIONS ISSUER 122272.000000 0 FOR 122272.000000 FOR S000004450 ARS Pharmaceuticals, Inc. 82835W108 US82835W1080 06/25/2025 To elect the four nominees for Class II director named in the proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Peter Kolchinsky DIRECTOR ELECTIONS ISSUER 122272.000000 0 FOR 122272.000000 FOR S000004450 ARS Pharmaceuticals, Inc. 82835W108 US82835W1080 06/25/2025 To elect the four nominees for Class II director named in the proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Brenton L. Saunders DIRECTOR ELECTIONS ISSUER 122272.000000 0 WITHHOLD 122272.000000 AGAINST S000004450 ARS Pharmaceuticals, Inc. 82835W108 US82835W1080 06/25/2025 To elect the four nominees for Class II director named in the proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Peter A. Thompson DIRECTOR ELECTIONS ISSUER 122272.000000 0 FOR 122272.000000 FOR S000004450 ARS Pharmaceuticals, Inc. 82835W108 US82835W1080 06/25/2025 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 122272.000000 0 FOR 122272.000000 FOR S000004450 Arvinas, Inc. 04335A105 US04335A1051 06/25/2025 Election of three Class I directors: Linda Bain DIRECTOR ELECTIONS ISSUER 150723.000000 0 FOR 150723.000000 FOR S000004450 Arvinas, Inc. 04335A105 US04335A1051 06/25/2025 Election of three Class I directors: John Houston, Ph.D. DIRECTOR ELECTIONS ISSUER 150723.000000 0 FOR 150723.000000 FOR S000004450 Arvinas, Inc. 04335A105 US04335A1051 06/25/2025 Election of three Class I directors: Laurie Smaldone Alsup, M.D. DIRECTOR ELECTIONS ISSUER 150723.000000 0 FOR 150723.000000 FOR S000004450 Arvinas, Inc. 04335A105 US04335A1051 06/25/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 150723.000000 0 FOR 150723.000000 FOR S000004450 Arvinas, Inc. 04335A105 US04335A1051 06/25/2025 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 150723.000000 0 FOR 150723.000000 FOR S000004450 Kymera Therapeutics, Inc. 501575104 US5015751044 06/25/2025 To elect two class II directors to our Board of Directors, each to serve until the 2028 Annual Meeting of Shareholders and until his successor has been duly elected and qualified, or until his earlier death, resignation or removal: Jeffrey Albers, J.D., MBA DIRECTOR ELECTIONS ISSUER 121324.000000 0 FOR 121324.000000 FOR S000004450 Kymera Therapeutics, Inc. 501575104 US5015751044 06/25/2025 To elect two class II directors to our Board of Directors, each to serve until the 2028 Annual Meeting of Shareholders and until his successor has been duly elected and qualified, or until his earlier death, resignation or removal: Felix J. Baker, Ph.D. DIRECTOR ELECTIONS ISSUER 121324.000000 0 FOR 121324.000000 FOR S000004450 Kymera Therapeutics, Inc. 501575104 US5015751044 06/25/2025 To approve, on a non-binding advisory basis, the compensation of our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 121324.000000 0 FOR 121324.000000 FOR S000004450 Kymera Therapeutics, Inc. 501575104 US5015751044 06/25/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 121324.000000 0 FOR 121324.000000 FOR S000004450 Phreesia, Inc. 71944F106 US71944F1066 06/25/2025 To elect two Class III directors to serve until our 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Gillian Munson DIRECTOR ELECTIONS ISSUER 172273.000000 0 FOR 172273.000000 FOR S000004450 Phreesia, Inc. 71944F106 US71944F1066 06/25/2025 To elect two Class III directors to serve until our 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Mark Smith, M.D. DIRECTOR ELECTIONS ISSUER 172273.000000 0 FOR 172273.000000 FOR S000004450 Phreesia, Inc. 71944F106 US71944F1066 06/25/2025 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2026. AUDIT-RELATED ISSUER 172273.000000 0 FOR 172273.000000 FOR S000004450 Phreesia, Inc. 71944F106 US71944F1066 06/25/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 172273.000000 0 FOR 172273.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 06/26/2025 Election of 10 directors to serve until our 2026 annual meeting of stockholders: Jeffrey W. Bolton DIRECTOR ELECTIONS ISSUER 134542.000000 0 FOR 134542.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 06/26/2025 Election of 10 directors to serve until our 2026 annual meeting of stockholders: Tina L. Brown-Stevenson DIRECTOR ELECTIONS ISSUER 134542.000000 0 FOR 134542.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 06/26/2025 Election of 10 directors to serve until our 2026 annual meeting of stockholders: Charles M. Elson DIRECTOR ELECTIONS ISSUER 134542.000000 0 FOR 134542.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 06/26/2025 Election of 10 directors to serve until our 2026 annual meeting of stockholders: Erin P. Hoeflinger DIRECTOR ELECTIONS ISSUER 134542.000000 0 FOR 134542.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 06/26/2025 Election of 10 directors to serve until our 2026 annual meeting of stockholders: Barbara A. Jacobsmeyer DIRECTOR ELECTIONS ISSUER 134542.000000 0 FOR 134542.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 06/26/2025 Election of 10 directors to serve until our 2026 annual meeting of stockholders: Stuart M. McGuigan DIRECTOR ELECTIONS ISSUER 134542.000000 0 FOR 134542.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 06/26/2025 Election of 10 directors to serve until our 2026 annual meeting of stockholders: Mark W. Ohlendorf DIRECTOR ELECTIONS ISSUER 134542.000000 0 FOR 134542.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 06/26/2025 Election of 10 directors to serve until our 2026 annual meeting of stockholders: Stephan S. Rodgers DIRECTOR ELECTIONS ISSUER 134542.000000 0 FOR 134542.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 06/26/2025 Election of 10 directors to serve until our 2026 annual meeting of stockholders: Gregory S. Rush DIRECTOR ELECTIONS ISSUER 134542.000000 0 FOR 134542.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 06/26/2025 Election of 10 directors to serve until our 2026 annual meeting of stockholders: Barry P. Schochet DIRECTOR ELECTIONS ISSUER 134542.000000 0 FOR 134542.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 06/26/2025 Ratification of the appointment of our independent registered public accounting firm (PwC) AUDIT-RELATED ISSUER 134542.000000 0 FOR 134542.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 06/26/2025 Approval, on an advisory basis, of our named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 134542.000000 0 FOR 134542.000000 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 06/26/2025 Approval of the Enhabit, Inc. 2025 Equity and Incentive Compensation Plan COMPENSATION ISSUER 134542.000000 0 FOR 134542.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/26/2025 Election of nine directors to hold office until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Robert Selander DIRECTOR ELECTIONS ISSUER 270523.000000 0 FOR 270523.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/26/2025 Election of nine directors to hold office until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Scott Cutler DIRECTOR ELECTIONS ISSUER 270523.000000 0 FOR 270523.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/26/2025 Election of nine directors to hold office until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Stephen Neeleman, M.D. DIRECTOR ELECTIONS ISSUER 270523.000000 0 FOR 270523.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/26/2025 Election of nine directors to hold office until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Adrian Dillon DIRECTOR ELECTIONS ISSUER 270523.000000 0 FOR 270523.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/26/2025 Election of nine directors to hold office until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Evelyn Dilsaver DIRECTOR ELECTIONS ISSUER 270523.000000 0 FOR 270523.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/26/2025 Election of nine directors to hold office until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Debra McCowan DIRECTOR ELECTIONS ISSUER 270523.000000 0 FOR 270523.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/26/2025 Election of nine directors to hold office until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Rajesh Natarajan DIRECTOR ELECTIONS ISSUER 270523.000000 0 FOR 270523.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/26/2025 Election of nine directors to hold office until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Stuart Parker DIRECTOR ELECTIONS ISSUER 270523.000000 0 FOR 270523.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/26/2025 Election of nine directors to hold office until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Gayle Wellborn DIRECTOR ELECTIONS ISSUER 270523.000000 0 FOR 270523.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/26/2025 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending January 31, 2026. AUDIT-RELATED ISSUER 270523.000000 0 FOR 270523.000000 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/26/2025 To approve, on a non-binding, advisory basis, the fiscal 2025 compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 270523.000000 0 FOR 270523.000000 FOR S000004450 Praxis Precision Medicines, Inc. 74006W207 US74006W2070 06/26/2025 To elect the Class II Directors to serve until the 2028 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Jeffrey Chodakewitz, M.D. DIRECTOR ELECTIONS ISSUER 43729.000000 0 FOR 43729.000000 FOR S000004450 Praxis Precision Medicines, Inc. 74006W207 US74006W2070 06/26/2025 To elect the Class II Directors to serve until the 2028 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Merit Cudkowicz, M.D. DIRECTOR ELECTIONS ISSUER 43729.000000 0 FOR 43729.000000 FOR S000004450 Praxis Precision Medicines, Inc. 74006W207 US74006W2070 06/26/2025 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 43729.000000 0 FOR 43729.000000 FOR S000004450 Praxis Precision Medicines, Inc. 74006W207 US74006W2070 06/26/2025 To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2025 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrative discussion. SECTION 14A SAY-ON-PAY VOTES ISSUER 43729.000000 0 AGAINST 43729.000000 AGAINST S000004450 Revolution Medicines, Inc. 76155X100 US76155X1000 06/26/2025 To elect four Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until his or her successor is elected: Frank K. Clyburn, Jr. DIRECTOR ELECTIONS ISSUER 444647.000000 0 FOR 444647.000000 FOR S000004450 Revolution Medicines, Inc. 76155X100 US76155X1000 06/26/2025 To elect four Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until his or her successor is elected: Sandra J. Horning, M.D. DIRECTOR ELECTIONS ISSUER 444647.000000 0 FOR 444647.000000 FOR S000004450 Revolution Medicines, Inc. 76155X100 US76155X1000 06/26/2025 To elect four Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until his or her successor is elected: Sushil Patel, Ph.D. DIRECTOR ELECTIONS ISSUER 444647.000000 0 FOR 444647.000000 FOR S000004450 Revolution Medicines, Inc. 76155X100 US76155X1000 06/26/2025 To elect four Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until his or her successor is elected: Thilo Schroeder, Ph.D. DIRECTOR ELECTIONS ISSUER 444647.000000 0 FOR 444647.000000 FOR S000004450 Revolution Medicines, Inc. 76155X100 US76155X1000 06/26/2025 To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025; and AUDIT-RELATED ISSUER 444647.000000 0 FOR 444647.000000 FOR S000004450 Revolution Medicines, Inc. 76155X100 US76155X1000 06/26/2025 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 444647.000000 0 FOR 444647.000000 FOR S000004450 Springworks Therapeutics, Inc. 85205L107 US85205L1070 06/26/2025 A proposal to adopt the Agreement and Plan of Merger, dated as of April 27, 2025 (the "Merger Agreement"), by and among Merck KGaA, Darmstadt, Germany, a German corporation with general partners ("Parent"), EMD Holdings Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), and SpringWorks Therapeutics, Inc. (the "Company"), pursuant to which Merger Sub will be merged with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent (the "Merger"). EXTRAORDINARY TRANSACTIONS ISSUER 185763.000000 0 FOR 185763.000000 FOR S000004450 Springworks Therapeutics, Inc. 85205L107 US85205L1070 06/26/2025 A proposal to approve the adjournment of the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes in person or by proxy to approve the proposal to adopt the Merger Agreement at the time of the Special Meeting. CORPORATE GOVERNANCE ISSUER 185763.000000 0 FOR 185763.000000 FOR S000004450 Springworks Therapeutics, Inc. 85205L107 US85205L1070 06/26/2025 A proposal to approve, on a non-binding, advisory basis, certain compensation that may be paid or become payable to the Company's named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 185763.000000 0 FOR 185763.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2025 Election of Directors: Christopher Causey DIRECTOR ELECTIONS ISSUER 132311.000000 0 FOR 132311.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2025 Election of Directors: Raymond Dwek DIRECTOR ELECTIONS ISSUER 132311.000000 0 FOR 132311.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2025 Election of Directors: Richard Giltner DIRECTOR ELECTIONS ISSUER 132311.000000 0 FOR 132311.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2025 Election of Directors: Ray Kurzweil DIRECTOR ELECTIONS ISSUER 132311.000000 0 FOR 132311.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2025 Election of Directors: Jan Malcolm DIRECTOR ELECTIONS ISSUER 132311.000000 0 FOR 132311.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2025 Election of Directors: Linda Maxwell DIRECTOR ELECTIONS ISSUER 132311.000000 0 FOR 132311.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2025 Election of Directors: Nilda Mesa DIRECTOR ELECTIONS ISSUER 132311.000000 0 FOR 132311.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2025 Election of Directors: Judy Olian DIRECTOR ELECTIONS ISSUER 132311.000000 0 FOR 132311.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2025 Election of Directors: Christopher Patusky DIRECTOR ELECTIONS ISSUER 132311.000000 0 FOR 132311.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2025 Election of Directors: Martine Rothblatt DIRECTOR ELECTIONS ISSUER 132311.000000 0 FOR 132311.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2025 Election of Directors: Louis Sullivan DIRECTOR ELECTIONS ISSUER 132311.000000 0 FOR 132311.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2025 Election of Directors: Tommy Thompson DIRECTOR ELECTIONS ISSUER 132311.000000 0 FOR 132311.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2025 Advisory resolution to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 132311.000000 0 FOR 132311.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2025 Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan. COMPENSATION ISSUER 132311.000000 0 FOR 132311.000000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2025 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 132311.000000 0 FOR 132311.000000 FOR S000004450